TW464649B - Oxazolone derivatives and their use - Google Patents
Oxazolone derivatives and their use Download PDFInfo
- Publication number
- TW464649B TW464649B TW86114531A TW86114531A TW464649B TW 464649 B TW464649 B TW 464649B TW 86114531 A TW86114531 A TW 86114531A TW 86114531 A TW86114531 A TW 86114531A TW 464649 B TW464649 B TW 464649B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- compound
- methyl
- ethyl
- cns
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
464649 A7 B7 五、發明説明(1 ) 坊擗頜城 (請先閲讀背面之注意事項再填寫本頁) 本發明為有闞一種抗幽門螺桿菌劑,包括:|^唑啉-4-嗣衍生物,乃用作爾及十二指腸潰癍等之治療劑。 昔暑持菘 瞄於潰瘍之治療劑,已開發制酸劑、抗膽鹸能劑、 抗Μ泌素劑、胃腸激素劑、抗胃蛋白酶劑、組撖胺Η 2受體 拮抗劑、組織修復劑、黏膜防護劑、微循環改菩劑、質子 唧筒抑制劑等。組織胺Η 2受髖拮抗劑及質子唧筒抑制劑, 均具有強效制約酸分泌之活性,其開發尤其能促進潰瘍治 療。 然而,此等漬瘍治療劑,就對復發性潰瘍之制約效果 而言,未能令人滿意。另一方面,幽門螺桿菌 (Helicobacter pylori),乃一種螺桿菌屬(Helicolacter )之格蘭氏陰性微量需氧性细菌,已被視為胃炎、十二指 腸潰瘍、胃潰瘍等復發之可能主因。雖然,許多抗细菌劑 在體外對螺桿菌属各別微生物之增殖容易地抑制,但是若 單獨體内投予,則於人及動物測驗之效果非常低。 經濟部中'央標準局員工消費合作社印製 各種由幽門螺桿菌弓I起之疾病,均K化療劑治療,例 如,用鉍製劑及抗生素之雙重化療,及用鉍製劑、滅滴靈 (m e t r ο n i d a ζ ο 1 e ,美國専利2 , 9 4 4 , 0 6 1鲅)、及四環徽素 (tetracycline,如美國専利2,712,51?號)或羥氨苄青嫌 素(amoxicillin,美國專利3,19 2 ,198號)之參重化療。滅 滴靈(metronidazole),乃具有抗幽門螺桿菌活性之眯唑 衍生物t與抗生素合併使用。此等鉍製画、抗生素、滅滴 本紙張尺度適用中國國家標準(CMS )A4規格(210X297公釐> 1 39 221 464649 A7 ______^_B7_ 五、發明説明(2 ) 番等均經口投予。而且t由臨床研究顯示此微生物之根除 會導致痊癒且降低潰瘍之復發率。 然而,此等鉍製劑、抗生素、滅滴番等必須Μ高日劑 量投予,使之維持足夠濃度而於幽門螺桿菌增殖之部位抑 制幽門螺桿菌增殖,结果產生許多間題,包含不良作用如 嘔吐及下痢。 已開發許多具抗幽門螺桿菌活性之化合物。例如,日 本專利公開公報1 1 726 8/1 993號掲示具抗幽門螺桿菌活性 之吡啶衍生物,及歐洲專利ΕΡ0535528Α1號揭示具抗幽門 螺桿菌活性之脒唑衍生物。 链明犋呆 就上述問題經廣泛研究後,本發明人發現一霉特別锷 唑啉-4-酮衍生物,對Κ幽門螺桿菌代表之螺桿菌屬细菌, 展示極特別優異之抗细菌活性。基於此發現,本發明人進 行又進一步研究,乃開發出本發明。 於是,本發明為有翮: 經濟部中央標準局員工消費合作社印製 ^ϋ- .^1^1 ml I nn i nn (. 1^1 - i 二· I : - - —^n 一BJ (請先聞讀背面之注意事項再填寫本頁) (1) 一種抗幽門螺桿菌組成物,包括:下式化合物或其 鹽,及藥理學上可接受之稀釋劑、賦形劑或載劑, R1 R2 0464649 A7 B7 V. Description of the invention (1) Fang Yicheng (please read the precautions on the back before filling this page) The present invention is an anti-Helicobacter pylori agent, including: The substance is used as a therapeutic agent for ulcer and duodenal ulcer. Xishu holds a therapeutic agent for ulcers, has developed antacids, anticholinergics, anti-M secretin agents, gastrointestinal hormones, anti-pepsin agents, histamine 2 receptor antagonists, tissue repair Agents, mucosal protective agents, microcirculation agents, proton capsule inhibitors, etc. Histamine 2 is affected by hip antagonists and proton capsule inhibitors, both of which have a strong ability to restrict acid secretion, and its development can especially promote the treatment of ulcers. However, these agents for treating ulcers are unsatisfactory in terms of the curative effect on recurrent ulcers. On the other hand, Helicobacter pylori, a Gram-negative trace aerobic bacterium of the genus Helicolacter, has been regarded as a possible main cause of recurrence of gastritis, duodenal ulcers, and gastric ulcers. Although many antibacterial agents can easily inhibit the proliferation of individual microorganisms of the genus Helicobacter in vitro, the effects in human and animal tests are very low if they are administered alone in vivo. The Consumer Cooperative of the Central Bureau of Standards in the Ministry of Economic Affairs prints a variety of diseases caused by Helicobacter pylori bow I, all of which are treated with chemotherapeutics, for example, double chemotherapy with bismuth preparations and antibiotics, and bismuth preparations, metronidazole (metr ο nida ζ ο 1 e, U.S. Patrin 2, 9 4 4, 0 6 1 鲅), and tetracycline (such as U.S. Pat No. 2,712,51?) or amoxicillin (amoxicillin, U.S. Patent 3) , 19 2, 198)). Metronidazole, an oxazole derivative t with anti-Helicobacter pylori activity, is used in combination with antibiotics. These bismuth paintings, antibiotics, and antipyretic paper sizes are applicable to the Chinese National Standard (CMS) A4 specifications (210X297 mm > 1 39 221 464649 A7 ______ ^ _ B7_ V. Description of the invention (2) Fan etc. are orally administered And clinical studies have shown that the eradication of this microorganism will lead to healing and reduce the recurrence rate of ulcers. However, these bismuth preparations, antibiotics, metronidazole, etc. must be administered in high daily doses to maintain sufficient concentrations in the pylorus The site where H. pylori multiplies inhibits H. pylori proliferation, resulting in many problems, including adverse effects such as vomiting and chancre. Many compounds with anti-H. Pylori activity have been developed. For example, Japanese Patent Laid-Open Publication No. 1 1 726 8/1 993 No. 掲 shows pyridine derivatives having anti-Helicobacter pylori activity, and European Patent No. EP0535528A1 discloses oxazole derivatives having anti-Helicobacter pylori activity. After extensive research on the above problems, the inventors discovered that a mold is particularly The oxazoline-4-one derivative exhibits extremely excellent antibacterial activity against Helicobacter bacteria represented by Helicobacter pylori. Based on this finding, The inventor carried out further research and developed the present invention. Therefore, the present invention has the following features: Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs ^ ϋ-. ^ 1 ^ 1 ml I nn i nn (. 1 ^ 1- i II · I:--— ^ n BJ (Please read the precautions on the reverse side before filling out this page) (1) An anti-Helicobacter pylori composition, including: a compound of the following formula or its salt, and pharmacological Acceptable diluents, excipients or carriers, R1 R2 0
式中,Α示可經取代之芳族基,R1及R2各別示氫原子或可 本紙張尺度適用中国國家標準(CNS )A4規格(210X297公釐) 2 3 9 22 1 4 6 4649In the formula, A represents an aromatic group which may be substituted, and R1 and R2 each represent a hydrogen atom or may be used. The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 2 3 9 22 1 4 6 4649
A7 B7 五、發明説明(3 ) 經取代之烴基,R3及R4各別示氫原子、可經取代之烴基、 醯基、可經取代之胺甲藤基、或可經酷化之羧基, (2) 根據上述(1)之抗幽門螺稈菌組成物,其中A為可經 取代之芳族雜環基, (3) 根據上述(1)之抗幽門螺桿菌組成物,其中A為下式 之基, | 少 ,' (II) 式中,B環為可經取代之6員芳族環,X示CH或N, Y示0 、3或-»(-1{5(!?5示氫原子或可經取代之烴基), (4) 根據上述U)之抗幽門螺桿菌組成物,其中A為下式 之基, (請先閲讀背面之注意事項再填寫本頁)A7 B7 V. Description of the invention (3) Substituted hydrocarbyl groups, R3 and R4 each show a hydrogen atom, a substituted hydrocarbyl group, a fluorenyl group, a substituted carbatenyl group, or a carboxyl group that can be modified, (2 ) The Helicobacter pylori composition according to (1) above, wherein A is an aromatic heterocyclic group which may be substituted, (3) The Helicobacter pylori composition according to (1) above, wherein A is of the formula Group, | less, '(II) where ring B is a 6-membered aromatic ring that can be substituted, X is CH or N, Y is 0, 3, or-»(-1 {5 (!? 5 shows hydrogen Atomic or substituted hydrocarbon group), (4) anti-Helicobacter pylori composition according to U) above, where A is the following formula, (please read the precautions on the back before filling this page)
經濟部中央標準局員工消費合作社印聚 式中,Β瑁為可經取代之6員芳族環,R 5示氫原子或可經 取代之烴基, (5) 根據上述(1)之抗幽門螺桿菌組成(物,其中Α示吲味 基而可經1至3個選自羥基、鹵基、硝基、氰基、可經1 至5涸鹵素取代之低級烷基、及可經1至5個鹵素取代之 低级烷氧基之群中之取代基所取代,R1及R2各別示氫或可 經1至5個鹵素取代之低级烷基,R3及R4各別示氫或低级 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 3 3922 1 A7 4 6 4 6 4 9 __B7_ 五、發明説明(4 ) 烷基, (請先閱讀背面之注意事項再填寫本頁) (6) 根據上述(5 )之抗幽門螺桿菌組成物,其中A為吲睬 基,R1及R3為氫,及R2和”為“-·?烷基, (7) 根據上述(6)之抗幽門螺稈菌組成物,其中A為3-吲 睬基,R2及R4為甲基, (8) 根據上述(1)之抗幽門螺桿菌組成物,其中化合物為 吲昧徽素Undolmycin), (9) 根據上述(1)之抗幽門螺桿菌組成物,係由幽門螺桿 菌感染相關之疾病之預防或治療劑, (10) 根據上述(9)之抗幽門螺桿菌姐成物,其中幽門螺 桿菌感染之相關疾病為胃或十二指腸潰瘍、冑炎或胃癌, (id 根據上述α)之抗幽門螺稈菌組成物,係與抗细菌 劑合併使用, (12) 根據上述(1)之抗幽門螺桿菌組成物,係與抗潰瘍 劑合併使用, (13) 根據上述(1)之抗幽門螺桿菌組成物,係與抗细菌 劑及抗潰瘍劑合併使用, 經濟部中央標準局員工消費合作社印製 (14) 下式化合物或其鹽之用途係用於製備抗幽門螺桿菌 劑者,In the Indo-Public Cooperative of the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, B 瑁 is a 6-membered aromatic ring which can be substituted, R 5 represents a hydrogen atom or a substituted hydrocarbon group, (5) The anti-pylorus screw according to (1) above Bacteria composition (wherein A represents indyl and may be substituted by 1 to 3 selected from hydroxyl, halo, nitro, cyano, lower alkyl substituted by 1 to 5 halogen, and may be substituted by 1 to 5 A halogen-substituted lower alkoxy group is substituted by a substituent, R1 and R2 each represent hydrogen or a lower alkyl group which may be substituted by 1 to 5 halogens, and R3 and R4 each represent hydrogen or a lower paper size Applicable to China National Standard (CNS) A4 specification (210X297 mm) 3 3922 1 A7 4 6 4 6 4 9 __B7_ V. Description of the invention (4) Alkyl, (Please read the precautions on the back before filling this page) (6 ) The anti-Helicobacter pylori composition according to the above (5), wherein A is an indyl group, R1 and R3 are hydrogen, and R2 and "are"-·? Alkyl groups, (7) the anti-pylorus according to (6) above Spirulina composition, wherein A is 3-indino, R2 and R4 are methyl, (8) The anti-Helicobacter pylori composition according to (1) above, wherein the compound is indigo Undolmycin), (9) The anti-Helicobacter pylori composition according to (1) above, which is a preventive or therapeutic agent for diseases related to Helicobacter pylori infection, (10) the anti-Helicobacter pylori adult product according to (9) above In which, the disease related to Helicobacter pylori infection is gastric or duodenal ulcer, rickets or gastric cancer, (id according to the above α) anti-spirospira composition, used in combination with antibacterial agents, (12) According to the above (1 The anti-Helicobacter pylori composition is used in combination with an anti-ulcer agent. (13) The anti-Helicobacter pylori composition according to (1) above is used in combination with an anti-bacterial agent and an anti-ulcer agent. Central Standards Bureau, Ministry of Economic Affairs The use of the compound (14) of the following formula or its salt printed by employee consumer cooperatives is for the preparation of anti-Helicobacter pylori agents,
39221 本紙張尺度適用中國國家標準(CNS > Α4規格(210X297公釐) 464649 A7 B7 五、發明説明(5 ) 式中,A示可經取代之芳族基,R1及R2各別示氫原子或可 經取代之烴基,R3及R4各別示氫原子、可經取代之烴基、 醢基、可經取代之胺甲豳基、或可經酯化之羧基, (15) 一種哺乳類之幽門螺桿菌感染相關疾病之預防或治 療方法,包括:投予具有效量之下式(I)化合物或其鹽, 至有此需要的個體, R1 R2 039221 This paper size applies to Chinese national standards (CNS > A4 size (210X297 mm) 464649 A7 B7 V. Description of the invention (5) In the formula, A represents a substituted aromatic group, and R1 and R2 each show a hydrogen atom Or a substituted hydrocarbon group, R3 and R4 each show a hydrogen atom, a substituted hydrocarbon group, a fluorenyl group, a substituted carbamoyl group, or an esterified carboxyl group, (15) a mammalian pylorus A method for preventing or treating a bacillus infection-related disease, comprising: administering a compound of formula (I) or a salt thereof in an effective amount to an individual in need thereof, R1 R2 0
R3 R4 (請先閱讀背面之注意事項再填寫本頁) (I) 式中,A示可經取代之芳族基,R1及R2各別示氫原子或可 經取代之羥基,R3及R4各別示氫原子、可經取代之烴基、 醢基、可經取代之胺甲醢基、或可經醮化之羧基, (16) 一種抗幽門螺桿菌組成物之製法,包括:使下式化 合物或其鹽與藥理學上可接受之稀釋劑、賦形劑或/及載 劑混合, 經濟部中央標準局員工消費合作社印製R3 R4 (Please read the notes on the back before filling this page) (I) In the formula, A represents a substituted aromatic group, R1 and R2 each represent a hydrogen atom or a substituted hydroxyl group, and R3 and R4 each Do not show a hydrogen atom, a hydrocarbyl group which may be substituted, a fluorenyl group, a carbamoyl group which may be substituted, or a carboxyl group which may be tritiated, (16) A method for preparing an anti-Helicobacter pylori composition, comprising: using a compound of the formula Or its salt mixed with a pharmacologically acceptable diluent, excipient or / and carrier, printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
(I) R3 R4 式中,A示可經取代之芳族基,R1及R2各別示氫原子或可 經取代之烴基,R3及R4各別示氫原子、可經取代之烴基、 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 5 3 922 1 46 4649 A7 B7 五、發明説明(6 ) 醢基、可經取代之胺甲醸基、或可經醮化之羧基, (17) —種下式化合物或其鹽, R1 R2 〇(I) R3 R4 In the formula, A represents an aromatic group which may be substituted, R1 and R2 each represents a hydrogen atom or a substituted hydrocarbon group, and R3 and R4 each represents a hydrogen atom, a substituted hydrocarbon group, and the paper. The scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 5 3 922 1 46 4649 A7 B7 V. Description of the invention (6) fluorenyl group, carbamoyl group which can be substituted, or carboxyl group which can be converted, (17) A compound of the formula or a salt thereof, R1 R2.
V I,) R3· R4' 式中,A示可經取代之芳族基,R1及R2各別示氫原子或可 經取代之烴基,R3'及Ri各別示氫原子或經取代之烴基, 但是,(1)若A為3-吲睬基,R1及R3’為氫,及R2為甲基, 則U4’既不為C3-6環烷基,亦不為經選自鹵素、羥基、低 级烷氧基、低趿硫烷基、芳基、或不飽和之2〜4個碳原子 側鏈之取代基單取代之Ci-4烷基,及(2)若A為3 -P?丨睬基, R1及R3’為氫,及R2為Ci-3烷基,則R4'不選自氫、苯基、 甲氧苯基、甲苯胺基、及d-4烷基中, (18) 一種下式化合物或其鹽, -----------/^/-- (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 R1 R2VI,) R3 · R4 'wherein A represents a substituted aromatic group, R1 and R2 each represent a hydrogen atom or a substituted hydrocarbon group, and R3' and Ri each represent a hydrogen atom or a substituted hydrocarbon group, However, (1) if A is a 3-indino group, R1 and R3 'are hydrogen, and R2 is a methyl group, then U4' is neither a C3-6 cycloalkyl group nor a group selected from halogen, hydroxyl, Lower alkoxy, lower sulfanyl, aryl, or unsaturated mono-substituted Ci-4 alkyl with 2 to 4 carbon atoms in the side chain, and (2) if A is 3 -P? 丨Fluorenyl, R1 and R3 'are hydrogen, and R2 is Ci-3 alkyl, then R4' is not selected from hydrogen, phenyl, methoxyphenyl, tolylamino, and d-4 alkyl, (18) A compound of the following formula or its salt, ----------- / ^ /-(Please read the notes on the back before filling out this page) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economy
(ΐ'Ί RJ R4, 式中,A示可經取代之芳族基,R1及R2各別示氫原子或可 經取代之烴基,R3’為氫原子或可經取代之烴基,R4"為釀 基或可經取代之胺甲醢基,但是,若A為3-吲睜基,R1為 本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X297公釐) 6 39 2 21 464649 經濟部中央標隼局員工消費合作社印製 A7 B7 五、發明説明(7 ) 氫,及R2和f為甲基,則R4”既不為C2-5烷醢基或單取代 之C2-5烷醢基(其中該取代基乃選自胺基、鹵素、苯基、 對-羥苯基、或低級烷氧基),亦不為經(^-4烷基、C3-6環 烷基或苯基取代之胺甲酺基, (19) 一種下式化合物或其鹽, R1 R2 0(ΐ'Ί RJ R4, where A represents a substituted aromatic group, R1 and R2 each represent a hydrogen atom or a substituted hydrocarbon group, R3 'is a hydrogen atom or a substituted hydrocarbon group, R4 " is Alkyl or substituted aminocarbamyl, however, if A is 3-indyl, R1 is the paper standard and applies Chinese National Standard (CNS) A4 (2I0X297 mm) 6 39 2 21 464649 Central Ministry of Economic Affairs A7 B7 printed by the Consumers' Cooperative of the Bureau of Standards and Administration V. Description of the invention (7) Hydrogen, and R2 and f are methyl, then R4 "is neither a C2-5 alkyl group or a mono-substituted C2-5 alkyl group ( The substituent is selected from amine, halogen, phenyl, p-hydroxyphenyl, or lower alkoxy), and is not substituted by (^ -4 alkyl, C3-6 cycloalkyl, or phenyl Carbamate, (19) A compound of the formula or its salt, R1 R2 0
式中,A示可經取代之芳族基,Ri及R2各別示氬原子或可 經取代之烴基,R3’為氫原子或可經取代之烴基,R4’’’為 可經酯化之羧基, (20) 根據上逑(19)之化合物,其中A為硕睬基,Ri及R2 各別示氫原子或甲基,R3’為甲基及R4’’’為經酯化之羧基 9 (21) 一種吲睐徽素之製法,係於培養基中培育鏈嫌菌臑 HC,21 菌株(Streptoroyces sp. HC-21 strain), Μ 於培養 液中製造及蓄積吲睬徽素,及收成該吲睬徽素,及 (22) 一種鏈黴菌羼HC-21菌株,係消作L-鼠李糖(L-rhaanose)且其抱子具剌狀表面者。 於化學式(I)中,A所示之"可經取代之芳族基”,In the formula, A represents a substituted aromatic group, Ri and R2 each represent an argon atom or a substituted hydrocarbon group, R3 'is a hydrogen atom or a substituted hydrocarbon group, and R4' '' is an ester group Carboxyl, (20) The compound according to (19) above, where A is a sulfonyl group, Ri and R2 each represent a hydrogen atom or a methyl group, R3 'is a methyl group and R4' '' is an esterified carboxyl group 9 (21) A method for preparing indigoxin, which is cultivating Streptoroyces sp. HC-21 strain in culture medium, and manufacturing and accumulating indigoxin in culture medium, and harvesting the indigoxin Indrugin, and (22) a Streptomyces saccharum HC-21 strain, which is used as L-rhaanose and has a tadpole-shaped surface. In the chemical formula (I), " an aromatic group which may be substituted ",
例如單環或稠合多環芳族烴基或芳族雜環基。此等芳族烴 基包含:例如,笨基、萘基、憩基、菲基及苊烯萘基,K 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 3922 1 (請先閲讀背面之注意事項再填寫本頁) --0Examples are monocyclic or fused polycyclic aromatic hydrocarbon groups or aromatic heterocyclic groups. These aromatic hydrocarbon groups include: for example, benzyl, naphthyl, aryl, phenanthrene, and pinene naphthyl, K This paper size applies to China National Standard (CNS) A4 (210X297 mm) 3922 1 (Please read (Notes on the back then fill out this page) --0
464649 A7 B7 附件五 經濟部智慧財產局員工消費合作社印製 五、發明說明(3 ) 苯基、1-察基、2 -萘基等較佳。 芳族雜環基包含:例如,芳族單環雜環基,如呋喃基 、噬吩基、吡咯基、嗅唑基、異啤唑基、®唑基、異噬唯 基、眯唑基、H比唑基、1,2,3 -噚二唑基、1,2,4 -垮二唑基 、1,3,4 -吗二唑基、呋咕基、1,2,3 -噬二唑基、1,2,4-® 二唑基、1,3,4-噬二唑基、1,2,3-三唑基、1,2,4 -三唑基 、四唑基、吡啶基、嗒畊基、嘧啶基、吡畊基及三畊基; 及芳族稠合雜環基,如苯并呋喃基、異苯并呋喃基'、苯并 [6 ]睡盼基、睬基、異吲睐基、1 Η - 丨唑基、苯并咪唑基 、苯并噚唑基、1,2 -苯并異噚唑基、苯并噬唑基、1,2 -苯 并異噬唑基、1Η -笨并三唑基、〇f啉基、異哼咐基、哮琳 基、HI唑啉基、Bf喏啉基、呔畊基、味啶基、嘌呤基、喋 啶基、咔唑基、α-咔啉基、/3-咔啉基、7 -咔啉基、吖 啶基、啡D|哄基、啡噬畊基、啡畊基、啡鸣噬基、噬憩基 、啡啶基、啡啉基、吲皞阱基、吡咯并[1,2-a]嗒畊基、 吡咯并[1,5-a]吡啶基、脒唑并[1,2-b]吡啶基、咪唑并[ l,5-a]吡啶基、蹄唑并[1,2-b]嗒畊基、晞唑并[1,2-a]嘧 啶基、1,2,4-三哩并[4,3-a]吡啶基及lf2,4 -三哇并[4, 3-b]嗒畊基。於芳族稠合雑環基中,K吲睬基較佳,又Μ 3 -吲睬基更佳。 於化學式(I)中,Α所示之"可經取代之芳族環基或 芳族雜環基”中之取代基包含:例如,羥基、鹵素(如, 氣、氛、溴、碘)、硝基、氰基、可經1至5個鹵素(如, 氟、氯、溴、碘)取代之低級烷基、可經1至5個鹵素(如 本紙張反度適用中囷國家標準(CNS>A4規格(210 X 297公釐> 8 (修正頁) 3 9 2 2 1 -------------一 u 裝 i - ---訂·--------Rj (請先閱讀背面之注意事項再填寫本頁)464649 A7 B7 Annex 5 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 5. Description of the Invention (3) Phenyl, 1-tapyl, 2-naphthyl, etc. are preferred. Aromatic heterocyclyls include, for example, aromatic monocyclic heterocyclyls such as furyl, phenophyl, pyrrolyl, oxazolyl, isoxazolyl, oxazolyl, isophasyl, oxazolyl, H pyrazolyl, 1,2,3-oxadiazolyl, 1,2,4-diadiazolyl, 1,3,4-morphadiazolyl, furyl, 1,2,3-pyridine Oxazolyl, 1,2,4-®diazolyl, 1,3,4-diaphlyl, 1,2,3-triazolyl, 1,2,4-triazolyl, tetrazolyl, pyridine Base, daphthyl, pyrimidinyl, pyridyl, and trigyl; and aromatic fused heterocyclic groups, such as benzofuranyl, isobenzofuranyl ', benzo [6] sulfanyl, fluorenyl , Isoindiolyl, 1 Η-oxazolyl, benzimidazolyl, benzoxazolyl, 1,2-benzoisoxazolyl, benzopyrazolyl, 1,2-benzoisopyrazole Base, 1Η-benztriazolyl, oxolinyl, isohumidyl, carbolinyl, HIoxazolyl, Bfpyridinyl, amidinyl, amidinyl, purinyl, pyridinyl, Oxazolyl, α-carbolinyl, / 3-carbolinyl, 7-carolinyl, acridine, phlefinyl Pyrimidinyl, morpholinyl, indolyl, pyridine Acyl [1,2-a] dalophenyl, pyrrolo [1,5-a] pyridyl, oxazo [1,2-b] pyridyl, imidazo [l, 5-a] pyridyl, hoof Zolo [1,2-b] dalophenyl, oxazo [1,2-a] pyrimidinyl, 1,2,4-trimile [4,3-a] pyridyl, and lf2,4-tris Wow [4, 3-b] Da Gengji. Among the aromatic condensed fluorenyl ring groups, the K indyl group is preferred, and the M 3 -indyl group is more preferred. In the chemical formula (I), the substituent in the "optionally substituted aromatic ring group or aromatic heterocyclic group" shown by A includes: for example, a hydroxyl group, a halogen (eg, gas, atmosphere, bromine, iodine) , Nitro, cyano, lower alkyl which can be substituted with 1 to 5 halogens (eg, fluorine, chlorine, bromine, iodine), and 1 to 5 halogens (if this paper's inversion applies the China National Standard ( CNS > A4 specification (210 X 297 mm) 8 (correction page) 3 9 2 2 1 --- Rj (Please read the notes on the back before filling this page)
烷氧羰基(如,甲氧羰基、乙氧羰基、丙氧羰基、丁氧羰 基)。此等低级烷基包含:例如,具1至4假碳原子之烷 基,如甲基、乙基、正丙基、異丙基、正丁基、異丁基、 第二丁基及第三丁基,Μ甲基及乙基較佳。此等低级烷氧 基包含:具1至4個碳原子之烷氧基,如甲氧基、乙氧基 、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧 基及第三丁氧基,Κ甲氧基及乙氧基較佳。較佳乃存有相 同或不同之1至3個此等取代基(宜1至2個)。Α所示之 ”可經取代之芳族環基或芳族雜環基”中,取代基亦包含 伸烷二氧代基,如亞甲二氧基及伸乙二氧基。 於化學式(I)中,R1及R2所示之”可經取代之烴基” 包含:脂族鏈烴基、脂環族烴基及芳基,Μ脂族鐽烴基較 佳。 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 基等丙正、 基基、 基 烷基正、基、烷乙基 如炔、基乙基-3及丙⑽ , 级基 丁異丁C1基 烯 r 基 低乙三 、基 為甲、-1 烴、 、第 基甲佳 如基基 族基基、己 二較 ,烯甲 脂烯 甲基正3-。 基乙2-鐽級如 丁、3,基烷如 、 支低 ,二基、庚-2,基 或、基第 丙基正C1基烯 鍵基烷、基 丁及為烯丙 直烷~7基 甲基基佳-61-:級 C 丁 1 甲丁更 C 、 含低 ,異、 二基 , ,基 包為如、基2-乙基如丙 基佳例基戊2,2-丙例烯 烴特:丁新、 、及:基 鐽。含正、基基 基含甲 族基包、基丁 丙乙包2-脂 炔基基 戊基基、基 、 等 及烷丙 異甲甲 基烯基 此 基級異、 二 二 甲級烯 烯低、基1-3-如低丙 、 。基戊 13 ,。異 本紙張尺度適用中國國家標準<CNS>A4規格(210 X 297公釐) 9 (修正頁) 3 9 22 1 6 4649 ' A7 __B7_ 五、發明説明(10 ) 、2-甲基-2-丙烯基、i—丁烯基、2_丁烯基、3-甲基_2_丁 烯基、1-戊烯基、2-戊烯基、3-戊烯基、4-戊烯基、4-甲 基-3-戊烯基、1-己烯基、2 -己烯基、3 -己烯基、4 -己烯 基及5-己烯基,較佳為C2-s烯基,如乙烯基、烯丙基、異 丙烯基、2-甲基烯丙基、2-甲基-卜丙烯基、2-甲基-2-丙 燔基及3-甲基-2-丁烯基。低级炔基包含:例如,C2-6炔 基,如乙炔基、1-丙玦基。2-丙炔基、1-丁炔基、2-丁炔 基、3-丁炔基、1-戊炔基、2-戊玦基、3-戊炔基、4-戊炔 基、1-己炔基、2-己炔基、3-己炔基、4-己炔基及5-己炔 基,較佳為C2-4炔基,如乙炔基、1-丙炔基及2-丙炔基。 脂環族烴基包含:飽和或不飽和脂環族烴基,如環烷 子基 原 庚 碳環 個 、 9 基 至己 3 環 具、 為基 隹戊 較環 基 、 烷基 環丁 。 環 基、 烯基 二 丙 環環 及如 基 -烯基 環烷 、 環 基之 ^ϋ· ί^ί. nn 1«l I ami ^ ^ (請先閱讀背面之注意事項再填寫本頁) 基 壬 環 及 基 辛 環 基 己 環 及7 基烯 戊戊 環環 I 、 2 基如 基 經濟部中央標準局員工消費合作社印製 烯含 己包 環基 及 基 環 環Alkoxycarbonyl (eg, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl). These lower alkyl groups include, for example, alkyl groups having 1 to 4 pseudo carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl, and third Butyl, M methyl and ethyl are preferred. These lower alkoxy groups include: alkoxy groups having 1 to 4 carbon atoms, such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, Dibutoxy and tertiary butoxy, Kmethoxy and ethoxy are preferred. Preferably, there are 1 to 3 of these substituents (preferably 1 to 2) which are the same or different. In the "optionally substituted aromatic ring group or aromatic heterocyclic group" shown by A, the substituents also include butanedioxo, such as methylenedioxy and ethylenedioxy. In the formula (I), the "optionally substituted hydrocarbon group" represented by R1 and R2 includes an aliphatic chain hydrocarbon group, an alicyclic hydrocarbon group and an aryl group, and an M aliphatic fluorene hydrocarbon group is preferred. (Please read the precautions on the back before filling out this page.) Employees of the Intellectual Property Bureau of the Ministry of Economic Affairs, Consumer Cooperatives, etc. Printed bases such as propyl, phenyl, phenyl, phenyl, alkoxy, e.g., acetyl, ethyl-3, and Propane, butyl, isobutyl, C1, alkenyl, triethylene, trimethyl, trimethyl, -1 hydrocarbon, trimethyl, such as methyl group, hexamethylene group, melene methyl n-3- . Ethyl ethyl 2-fluorene grades such as butane, 3, alkane such as, branched, diyl, hept-2, alkynyl, or propyl n-C1 alkenyl alkenyl, butyl and allyl straight alkane ~ 7 Methyl methyl group Jia-61-: Grade C but 1 methyl butan C, containing low, iso, and di groups, the base package is, for example, 2-ethyl, such as propyl, pentyl 2,2-propion Olefin special: Dingxin,, and: based on fluorene. Contains n- and alkynyl groups, including methyl group groups, butyl butadiene groups, 2-alithynylpentyl groups, groups, etc., and alkylpropylisomethylalkenyl groups. Base 1-3- such as low propionate. Pentyl 13. Different paper sizes apply the Chinese national standard < CNS > A4 specification (210 X 297 mm) 9 (correction page) 3 9 22 1 6 4649 'A7 __B7_ V. Description of the invention (10), 2-methyl-2-propene Base, i-butenyl, 2-butenyl, 3-methyl-2-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 4 -Methyl-3-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl, preferably C2-salkenyl, such as Vinyl, allyl, isopropenyl, 2-methylallyl, 2-methyl-propenyl, 2-methyl-2-propenyl, and 3-methyl-2-butenyl. Lower alkynyl includes, for example, C2-6 alkynyl, such as ethynyl, 1-propenyl. 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 2-pentamyl, 3-pentynyl, 4-pentynyl, 1- Hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl and 5-hexynyl, preferably C2-4 alkynyl, such as ethynyl, 1-propynyl and 2-propynyl Alkynyl. The alicyclic hydrocarbon group includes: a saturated or unsaturated alicyclic hydrocarbon group, such as a cycloalkyl group, an original heptane carbocyclic group, a 9 group to a hexyl ring group, a base group, a cyclopentyl group, an alkylcyclobutane group. Ring group, alkenyl dipropane ring and ring-based alkenyl naphthenes, ^ ϋ · ί ^ ί. Nn 1 «l I ami ^ ^ (Please read the precautions on the back before filling this page) Nonane, Kissinyl, Hexyl, and 7-Based Pentapentyl Rings I, 2 Jiruki, Central Bureau of Standards, Ministry of Economic Affairs, Consumer Cooperatives, Printed Alkenyl, Hexahedral and Base Rings
烯 戊 7 佳環 環稀 較。T 環基 、 烯 基環 E-6 環C3 如 . -如 基例 烷 : 環含 -6包 C3基 為烯 基- - 烯 己 環 t 2 ' 基 及 2 基如 1-基 -烯 -1烯 烯二 戊戊 環環 烯二 環 ο 基 基 如 丨 , 基 基笨 烴為 族佳 芳較 環 · 多基 。 合察 基稠烯 1-或及 .環基 單苊 ί 及 含基 包菲 基 、 芳基 , 憩 中 、 -1基基 烯烴萘 二 於 、 己_ 基 環 苯 基 萘 等 基 萘 中 \/ I /m\ 式 學 化 於 烯二 己 環 基 烴 之 代 取 經 可 之 示 所 2 R 或 或 基 烷 環 之 代 取 經 可 基 芳 之 代 取 經 可 含 包 基 代 取 中 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 10 3922 1 4 ο 4 6 4 9 Α7 __^_Β7_ 五、發明説明(11 ) 經濟部中央標準局員工消費合作社印製 (請先閎讀背面之注意事項再填寫本頁) 環烯基、可經取代之雜環基、可經取代之胺基、可經取代 之羥基、可經取代之戆基、及鹵素(如,氟、氯、溴、碘) 。此等任意選擇之取代基可存在1至5個(較佳1至3個) 。可經取代之芳基,包含:苯基、察基、憩基、菲基及苊 烯蔡基,較佳為苯基、1-萘基及2-萘基。可經取代之芳基 中,取代基包含:具1至3個碳原子之烷氧基(如,甲氧 基、乙氧基、丙氧基)、鹵原子(如,氟、氯、溴、碘)及 具1至3個碳原子之烷基(如,甲基、乙基、丙基);此等 任意選擇之取代基可存在1至2個。可經取代之環烷基, 包含:C3-7環烷基,如環丙基、環丁基、環戊基、環己基 及環庚基。可經取代之環烷基所用取代基之種類和數目, 與上述可經取代之芳基所用取代基之種類和數目相同。可 經取代之環烯基包含:C 3-6環烯基,如環丙烯基、環丁烯 基、環戊烯基及環己烯基。可經取代之環烯基所用取代基 之種類和數目,與上述可經取代之芳基所用取代基之種類 和數目相同。可經取代之雜環基包含;具至少一個選自氧 、硫或氮中之雜原子作為環組成原子(環原子)之芳族雑環 基,及飽和或不飽和非芳族雜環基(脂族雜環基),較佳為 芳族雜環基。芳族雜環基包含:芳族單環雜環基(如,呋 喃基、睡盼基、吡咯基、唑基、異基、i®唑基、異 噬唑基、咪唑基、吡唑基、1,2,3 -吗二唑基、1,2,4 -B咢二 唑基、1,3,4 -噚二唑基、呋咕基、1,2,3-睡二唑基、1,2, 4-¾二唑基、1,3,4-睡二唑基1,2,3-三唑基、1,2,4-三唑 基、四唑基、吡啶基、嗒阱基、嘧啶基、吡肼基、三阱基 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1 1 3 922 1 ο 4 6 49 Α7 Β7 本沾年$月 £1 五、發明說明(l2) )及芳族稠合雜擐基(如,苯并呋喃基、異苯并呋喃基、苯 并[b ]趑吩基、吲睬基、異吲睬基、1 Η -吲睬基、笨并蹄唑 基 唑 Bnf 并 苯 \ 基 基 唑 噬 并 苯 ' 基 唑 ¥ nu 異 并 苯 基 唑 0 異 并 苯 基 啉 BI 異 基 啉 tit、 基 唑 三 并 苯 基 呤 嘌、 基 啶 晾 ' 基 畊 呔 ' 基 啉 喏 of ' 基 咐 唑 Df、 基 啉 、 啡 ί 基、并 啉基喀 咔畊吡 - il 电 、 、 基 基畊 畊睬 啡 、 α 、 基 、 基啉 基讲啡 哩Β1、 咔啡基 ' 、 啶 基基啡 啶啶 、 喋吖基 0P 、 基 咐 咔 基 啉 咔 - 7 憩 趑、 基m 基 畊 嗒 .A1 一 //9 鸣 I 基 吡,5啶 、Γ1嘧 并 基并并 啶唑唑 吡咪三 -a.]、4-5 基 2 1’ 啶 1, rL 吡 、 并 唑 眯 基 啶 吡 aj 并 唑 眯 (請先閲讀背面之注意事項再填寫本頁) r*并 2’唾 Π 三 并 4 唑2, 蹄1’ 、 、 基基 肼啶 D D bld 基 讲 嗒 3 基 畊 Dtt N 基 睬 B3I 異含 、 包 基基 睬環 吲雜 、 族 基芳 吩非 噬 。 、 等 基基 喃啶 呋 嘧 為 、 佳基 較啶 , 吡 、 氣 基四 丁、 環基 雑啶 硫吡 ' 氫 基六 丁 、 環基 雜吩 氧 噬 、 氫 基四 啶 、 丁基 吖喃 、 呋 基氫 乙四 氧 、 環基 , 啶 如咯 例吡 取 經基 可烷 〇 之 基子 畊原 吡碳 氫個 六 3 及 至 、 1 基具 咐 : 福含 嗎包 硫基 、 代 基取 啉 , 福中 嗎基 、 環 基雜 喃之 吡代 經濟部智慧財產局員工消費合作社印製 如 基 甲Dipentyl 7 is better. T ring group, alkenyl ring E-6 ring C3 such as-such as alkane: the ring contains -6 packets C3 group is alkenyl--alkenyl ring t 2 'group and 2 groups such as 1-yl-ene-1 Alkenyl dipentacyclocycloene bicyclic ο radicals such as 丨, the radicals of the alkyl radicals are better aromatic and polycyclic. Hechatyl fused alkenes 1- or and. Cyclomonophenyl and fluorenyl-containing phenanthryl, aryl, yinzhong, -1-based olefin naphthalene, hexylcyclophenylnaphthalene, etc. \ / I / m \ formula learned in the substitution of alkenyl hexyl hydrocarbons can be replaced by 2 R or alkane ring can be replaced by can be aromatic and can be included in the paper. Chinese paper standards are applicable to Chinese standards (CNS) A4 specification (2 丨 0X297 mm) 10 3922 1 4 ο 4 6 4 9 Α7 __ ^ _ Β7_ V. Description of invention (11) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back first) Please fill in this page for more details) Cycloalkenyl, heterocyclic group which can be substituted, amine group which can be substituted, hydroxyl group which can be substituted, fluorenyl group which can be substituted, and halogen (such as fluorine, chlorine, bromine, iodine ). These optional substituents may exist in 1 to 5 (preferably 1 to 3). The aryl group which may be substituted includes: phenyl group, pyridyl group, alkyl group, phenanthryl group, and pinencainyl group, preferably phenyl group, 1-naphthyl group, and 2-naphthyl group. In the aryl group which may be substituted, the substituent includes: an alkoxy group (e.g., methoxy, ethoxy, propoxy), a halogen atom (e.g., fluorine, chlorine, bromine, Iodine) and alkyl groups (eg, methyl, ethyl, propyl) having 1 to 3 carbon atoms; these optionally selected substituents may exist in 1 to 2 groups. Cycloalkyl which may be substituted includes: C3-7 cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl. The kind and number of the substituents used in the optionally substituted cycloalkyl group are the same as those in the aforementioned substituted aryl group. Cycloalkenyl which may be substituted includes: C 3-6 cycloalkenyl, such as cyclopropenyl, cyclobutenyl, cyclopentenyl, and cyclohexenyl. The kind and number of the substituents used in the cycloalkenyl group which may be substituted are the same as those in the above-mentioned substituted aryl group. An optionally substituted heterocyclic group includes: an aromatic fluorene ring group having at least one heteroatom selected from oxygen, sulfur, or nitrogen as a ring constituent atom (ring atom), and a saturated or unsaturated non-aromatic heterocyclic group ( Aliphatic heterocyclic group), preferably an aromatic heterocyclic group. Aromatic heterocyclyls include: aromatic monocyclic heterocyclyls (e.g., furyl, pyranyl, pyrrolyl, azolyl, isoyl, i? Azolyl, isoxazolyl, imidazolyl, pyrazolyl, 1,2,3 -morphazolyl, 1,2,4-B-oxadiazolyl, 1,3,4-oxadiazolyl, furyl, 1,2,3-oxadiazolyl, 1 , 2,4-¾diazolyl, 1,3,4-diadiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, tetrazolyl, pyridyl, datrayl The basic paper sizes of pyrimidyl, pyrazinyl, and triple wells are applicable to the Chinese National Standard (CNS) A4 (210X297 mm) 1 1 3 922 1 ο 4 6 49 Α7 Β7 This year $ 1 £ 1 5. Description of the invention ( l2)) and aromatic fused heterofluorenyl groups (eg, benzofuranyl, isobenzofuranyl, benzo [b] fluorenyl, indino, isoinfluorenyl, 1 fluoren-influorenyl, Benzozozozolium Bnf Acetyl \ Acylazolyl benzophenazine ¥ nu Isophenylazole 0 Isophenylphenoline BI Isomorpholine tit, Triazole benzopyridine purine, Pyridoxine 'Ji Geng 呔' 基 喏 喏 喏 of '咐 咐 f Df, 啉 啉, ί ί, 基 并 啉 啉 耕 耕 耕, 耕, 电, 、, 、 Glycogen, α, phenyl, phenyl, phenyl, phenyl, phenyl, phenyl, phenyl, phenyl, phenyl, phenyl, pyridyl, pyridyl, pyridyl, pyridyl, pyridyl, pyridyl, pyridyl G.A. 1 // 9, I, pyridyl, 5pyridine, Γ1 pyridopyridinopyrimidazolium pyrimidine tri-a.], 4-5 base 2 1 'pyridyl 1, rL pyridyl, oxazolyl Pyridazine apyrazolidine (please read the precautions on the back before filling out this page) r * and 2'sal hydrazine 4 azole 2, hoof 1 ', hydrazine DD bld base 3 Deng Dtt N-based fluorene B3I heterocyclic, cladyl fluorinated ring heterocyclic, non-phasic aryl phenone, etc., and the like aminopyrimidine furimidine, carbidine pyridine, pyridine, tetramethylpyridine, cyclopropylpyridine thiopyridine '' Hydroxyhexabutane, cycloheterophenoxine, hydrogen tetrapyridine, butyl acryl, furylhydroethylenetetroxy, cyclic group, pyrimidine, such as the example of pyridyl hydrocarbon Each of the six 3 and 1 bases is instructed to include: thiosulfan, phenyl, phenyl, and chloro. Benzyl, cyclic, and cyclic heteropyranyl. Printed by the Bureau's Consumer Cooperatives
可基 及烷 、 3 基1- 羥(C 之 代 取 經 可 ' 基 :R 胺含若 之包。 代基丨 取代 經取 可 ,Ο 中 } 基 基i 、 ^ ^ S 丙 _ 基 之、代甲 二, 二 5 基 丙 % 基 乙 級之 低示 , 所 如R2 例或 基 烴 族 環基 脂烷 為之 ” 子 基原 烴碳 之個 代 3 取 至 經 1 可具 為 可 亦 基 代 取 貝 基 芳 或 基 丙 、 基 乙 % 基 甲 及Coryl and alkane, 3-yl 1-hydroxyl (substituting C 'for alkoxy group: R amine containing the package. Substituting group 丨 Substituting for acetyl group, 0 in} group i, ^ ^ S propyl group, substitution The lower grades of two, two, five, five, and three percent of propyl and acetyl are shown below. For example, R2 is an example of a basic hydrocarbon cycloaliphatic alkane. The subgeneration of the original hydrocarbon carbon 3 is taken to 1 and can be substituted by 1 Take Beijifang or Jipropyl, Jiyi% Jiyi and
之 代 取 R 素 ),鹵 T- ( 個 式 5 學至 化 1 於經 關 可 為 2 R 乃 式 方 合 組 之 , 佳 如較 及 氩 為 基 烷 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 12 (修正頁) 3 92 2 1 4646^9 經濟部中央標準局負工消費合作社印製 A7 B7 五、發明説明(13 ) 於化學式(I)中之R3或R4,及於化學式(II中之R3’或 R4\所示"可經取代之烴基”中,所用之烴基及取代基分 別例如上述R1及R2處所用相同烴基及取代基。 關於化學式(I), 及R4較佳之組合方式乃R3為氫及 R4為C i -3烷基。 於化學式(I)中,R3或R4所示之醢基之實例為脂族醸 基,如燒醱基、烯醸基、環烷羰基及烷磺醯基;芳族豳基 ,如芳豳基、芳烷豳碁、芳烯醢基及芳烴磺醢基;雑環芳 族釀基,如芳族雜環羰基及芳族雜環垸醢基;及非芳族雜 環羰基(脂族雜環羰基)。 "烷酿基”指烷羰基,較佳之實例包含:具1至8個 碳原子之低級焼醢基,如甲醢基、乙醯基、丙醢基、丁醏 基、異丁醢基、戊酶基、異戊醯基、三甲基乙醢基及己醢 基。 "烯醢基”指烯羰基,較佳之實例包含:C3-6烯醢基 ,如丙烯豳基、甲基丙烯醸基、巴豆豳基及異巴豆醢基。 ”環烷羰基"指環烷基羰基,較佳之實例包含:具4 至7個碳原子者,如環丙烷羰基、環丁烷羰基、環戊烷羰 基及環己烷羰基。 ”烷磺豳基”指烷基磺醮基,其較p之實例包含:具 1至4個碳原子者,如甲磺醢基、乙磺醢基及丙磺醸基。 "芳醸基"指芳羰基,其較佳之實例包含:具7至11 個碳原子者,如苯甲醢基、對-甲苯甲醢基、1-萘甲醒基 及2-萘甲酿基。 --------------1T (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 13 392 2 1 A7 464649 B7 五、發明説明(14 ) (請先聞讀背面之注意事項再填寫本頁) ”芳烷醢基”指經芳基取代之烷羰基,其較佳之實例 包含:C6-8芳基-C2-5烷醢基,如苯乙醢基、苯丙醢基、 氫阿托醢基及苯丁醢基。、 ”芳烯醯基”指經芳基取代之烯羰基,較佳之實例包 含:C6-8芳基-C3-5烯醢基,如桂皮豳基及阿托醢基。 ”芳烴磺酿基”指芳磺醢基,其較佳之實例包含:具 6至8個碳原子者,如苯磺醸基及對-甲苯磺醢基。 ”芳族雜環羰基"較隹之實例,包含:呋喃甲醢基、 I*吩甲醯基、菸醮醢基、異菸鹼醢基、吡咯羰基、Bf唑羰 基、1«唑羰基、眯唑羰基及吡唑羰基。 "芳族雑環烷醸基"指經芳族雜環基取代之烷羰基, 其較佳之實例包含:芳族雑環-C2-5烷醱基,如1«吩乙醯 基、1«吩丙醢基、呋喃乙醢基、睡唑乙醢基、1,2,4-理二 唑乙醻碁及吡啶乙醢基。 "非芳族雜環羰基"較佳之實例,包含:脂族雜環羰 基,如吖丁啶羰基、吡咯啶羰基及六氫吡啶羰基。 經濟、邱中央標率局員工消費合作社印製 於化學式(I)中之R3及R4,及於化學式(I”)中之R4’所 示可經取代之胺甲醯基,例如"N -單取代之胺甲醢基”及 ” N,N -二取代之胺甲醢基"Μ及未取代之胺甲醸基。” Η -單 取代之胺甲醮基”指於氮上具1個取代華之胺甲釀基。該 ' / 取代棊之實例,包含:Cl-6烷基(如,甲基、乙基、丙棊 、異丙基、丁基、第三丁基、戊基、己基)、C3-6環烷基( 如,環丙基、環丁基、環戊基、環己基)、芳基(如,苯基 、:I-萘基、2-萘基)、芳烷基(如,苯甲基、苯乙基)及雜 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1 4 39 221 A6 A649 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(15) 環基(如,上述R1及R2所示"可經取代之烴殘基”中,”取 代基"所例舉之”雑環基")。此等芳基、芳烷基及雜環 基均可經取代。該取代基例如羥基可經1或2個低级烷基 (例如,具1至4個碳原子者,如甲基、乙基、丙基、異 丙基、及丁基)或藤基(如,甲醢基、乙醢基、丙醢基、笨 甲醢基)取代之胺基、鹵素(如,氟、氯、溴、碘)、硝基 、氛基、可經1至5個鹵素(如,氟、氯、溴、碘)取代之 低级烷基及可經1至5個鹵素(如,氟、氯、溴、碘)取代 之低级烷氧基。此等低级燒基包含:例如,具1至4個碳 原子之垸基,如甲基、乙基、正丙基、異丙基、正丁基、 異丁基、第二丁基及第三丁基,較佳為甲基及乙基。低級 烷氧基包含·•具1至4個碳原子之烷氧基,如甲氧基、乙 氧基、正丙氧基、異丙氧基、正.丁氧基、異丁氧基、第二 丁氧基及第三丁氧基,較佳為甲氧基及乙氧基。較佳乃存 在1至3個(宜1至2涸)相同或不同之此等取代基。 ”H,N -二取代之胺甲醯基”指於氮原子上具2個取代 基之胺甲醯基。該取代基之一實例包含上述"N -單取代之 胺甲醢基”所用之相同取代基;其他取代基之實例,包含 : Cl-6烷基(如,甲基、乙基、丙基、異丙基、丁基、第 三丁基、戊基、己基)、C3 -6環烷基(如(,環丙基、環丁基 、環戊基、環己基)及C6-l0芳烷基(如,苯甲基、苯乙基) 。二個取代基可與氮原子連合形成環狀胺基。於此例,環 狀胺基胺甲醢基之實例,包含:1-吖丁啶羰基、1-吡咯啶 羰基、六氫吡啶羰基、嗎福啉羰基、1-六氫吡畊羰基、及 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 15 3^22 1 1訂 (請先閱讀背面之注意事項再填寫本頁) 464649 Α7 Β7 五、發明説明(16) 卜六氫吡畊羰基,而於第4位上具低級烷基,例如Ci-6烷 基(如,甲基、乙基、丙基、異丙基、丁基、第三丁基、 戊基、己基)、芳垸基如苯甲基及笨乙基,芳基如苯基、 1-萘基及2-萘基,等者。 於化學式(I)中之R3及R4,及於化學式(I'’1)中之 R 4 ’’’,所示之”可經酷化之羧基”,例如,”低級垸氧羰 基"、”芳氧羰基”及"芳烷氧羰基”,以及自由羧基。 ”低級烷氧羰基"較佳之實例,包含:具2至δ個碳 原子者,例如,甲氧羰基、乙氧羰基、丙氧羰基、異丙氧 羰基、丁氧羰基、異丁氧羰基、第二丁氧羰基、第三丁氧 羰基、戊氧羰基、異戊氧羰基、新戊氧羰基及第三戊氧羰 基,較佳為具2至4個碳原子者,例如,甲氧羰基、乙氧 羰基、及丙氧羰基。 "芳氧羰基”較佳之實例,包含:具7至12個碳原子 (請先聞讀背面之注意事項再填寫本頁) ,ιτ 基0 : 氧含 察包 - 1Α 9 、 例 基實 貌之 氧佳 苯較 * U 如基 例羰 , 氧 者烷 基 截 氧 萘 I 2 及 芳 至 8 具 例 者 子 原 碳 個 經濟部中央標率局員工消費合作社印製 羰芳 氧處 烷基 芳醢 及甲 基胺 羰之 氧代 芳取 等軍 此Η-。 與 。 基基同 羰代相 氧取基 乙之代 笨用取 及可之 基;用 羰代所 氧取基 甲經烷 笨可芳 , 均及 如基基 式 學 化 於 族 芳 員 6 之 代 取 β 可 之 示 所 環 Β 中 環 苯 之 代 取 經 可 如 例 之 代 取 經 可 示 環 Β 若 ο 環 , 曝 蓑 3 赛Μ 雑 族 芳 員 6 之 代 取 經 可 及 式 β, 化 基 之 式 下 示 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 16 3922 1 46 4649 A7 B7 五、發明説明(17 ) φζΓ · (叫 (式中,C環可經取代;X及Y之定義悉如上述 >。若B環 示可經取代之6員芳族雜環,化學式(II)所示之基包含: 例如,下式之基, (請先聞讀背面之注意事項再填寫本頁)Substitute R element), halogen T- (each formula 5 learns to chemical 1 in Jingguan can be 2 R is a combination of formulas, better as compared to argon as the basis of the alkane paper standard applicable Chinese National Standards (CNS) A4 specification (210 X 297 mm) 12 (revised page) 3 92 2 1 4646 ^ 9 Printed by A7, B7, Consumer Work Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (13) R3 in chemical formula (I) or R4, and in the chemical formula (indicated by R3 'or R4 \ in "II" may be substituted hydrocarbon group ", the hydrocarbon groups and substituents used are, for example, the same hydrocarbon groups and substituents used in the above R1 and R2. About the chemical formula (I ), And R4 is a preferred combination in which R3 is hydrogen and R4 is C i -3 alkyl. In the chemical formula (I), examples of the fluorenyl group represented by R3 or R4 are aliphatic fluorenyl groups, such as fluorenyl, Alkenyl, cycloalkylcarbonyl, and alkylsulfonyl groups; aromatic fluorenyl groups, such as arylfluorenyl, aralkylfluorene, arenefluorenyl, and aromatic sulfonyl groups; fluorene aromatic aromatic groups, such as aromatic heterocyclic rings Carbonyl and aromatic heterocyclic fluorenyl groups; and non-aromatic heterocyclic carbonyl groups (aliphatic heterocyclic carbonyl groups). &Quot; Alkyl group " means an alkylcarbonyl group. Preferred examples include: Lower fluorenyl groups of 1 to 8 carbon atoms, such as formamyl, acetamyl, propionyl, butylamyl, isobutylamyl, pentylase, isopentamyl, trimethylacetamyl and hexamethylene. "Alkenyl" refers to alkenylcarbonyl, and preferred examples include: C3-6 alkenyl, such as propenyl, methacryl, crotonyl, and isocrotonyl. "Cycloalkoxy" refers to cycloalkane Preferable examples include: those having 4 to 7 carbon atoms, such as cyclopropanecarbonyl, cyclobutanecarbonyl, cyclopentanecarbonyl and cyclohexanecarbonyl. "Alkylsulfonyl" refers to alkylsulfonyl, Examples of p include: those having 1 to 4 carbon atoms, such as methylsulfonyl, ethylsulfonyl, and sulfonylsulfonyl. &Quot; Arylfluorenyl " refers to arylcarbonyl, and preferred examples include: Those with 7 to 11 carbon atoms, such as benzamyl, p-toluenyl, 1-naphthyl and 2-naphthyl. -------------- 1T (Please read the notes on the back before filling out this page) This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 13 392 2 1 A7 464649 B7 V. Description of the invention (14) (Please read first Note on the back, please fill in this page again) "Aralkyl" refers to alkoxy substituted by aryl, and its preferred examples include: C6-8aryl-C2-5 alkyl, such as phenethylfluorenyl, benzene Propionyl, hydrogen atomyl and phenbutylfluorenyl. "" Arylene "refers to an alkenyl group substituted with an aryl group. Preferred examples include: C6-8aryl-C3-5 alkenyl, such as cinnamon "Aromatic sulfonyl" refers to arylsulfonyl, and preferred examples thereof include those having 6 to 8 carbon atoms, such as benzenesulfonyl and p-toluenesulfonyl. "Aromatic heterocyclic carbonyl" More examples of fluorene, including: furanomethane, I * phenformamyl, nicotinyl, isonicotinylfluorenyl, pyrrolylcarbonyl, Bfazolecarbonyl, 1 «azolecarbonyl, An oxazole carbonyl and a pyrazole carbonyl. "Aromatic sulfonylcycloalkyl" refers to an alkylcarbonyl group substituted with an aromatic heterocyclic group, and preferred examples thereof include: aromatic sulfonyl-C2-5 alkylsulfonyl, such as 1 «phenethylfluorenyl, 1« phenpropylfluorenyl, furan ethylfluorenyl, dozosylethyl, 1,2,4-ridiazolidine, and pyridylacetinyl. &Quot; Non-aromatic heterocycles Preferred examples of carbonyls include: aliphatic heterocyclic carbonyls such as azetidinyl carbonyl, pyrrolidine carbonyl, and hexahydropyridine carbonyl. Economy, Qiu Central Standard Bureau Staff Consumer Cooperative R3 printed in Chemical Formula (I) And R4, and a substituted carbamoyl group represented by R4 'in Chemical Formula (I), such as " N-monosubstituted carbamoyl "and" N, N-disubstituted carbamoyl " &Quot; M and unsubstituted carbamoyl. "" -Mono-substituted carbamoyl "refers to a carbamoyl group having 1 substituted Hua on the nitrogen. Examples of the '/ substituted fluorene' include: Cl-6 alkyl (eg, methyl, ethyl, propane, isopropyl, butyl, tertiary butyl, pentyl, hexyl), C3-6 naphthene (Eg, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl), aryl (eg, phenyl, I-naphthyl, 2-naphthyl), aralkyl (eg, benzyl, Phenyl) and miscellaneous paper sizes are applicable to Chinese National Standard (CNS) A4 (210X297 mm) 1 4 39 221 A6 A649 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (15) Ring base (For example, in the "optionally substituted hydrocarbon residues" shown by R1 and R2 above, the "substituent" is exemplified by the "ring ring group"). These aryl groups, aralkyl groups, and heterocyclic groups May be substituted. The substituent such as hydroxy may be substituted by 1 or 2 lower alkyl (for example, those having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, and butyl) or Amines (such as formamyl, ethyl, propyl, propyl, and benzyl) substituted amines, halogens (eg, fluorine, chlorine, bromine, iodine), nitro, and aryl, which can pass through 1 to 5 halogens (eg, , Chlorine, bromine, iodine) substituted lower alkyl groups and lower alkoxy groups that may be substituted with 1 to 5 halogens (eg, fluorine, chlorine, bromine, iodine). These lower alkyl groups include, for example, 1 to The fluorenyl group of 4 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl and third butyl, is preferably methyl and ethyl. Lower alkoxy contains alkoxy groups with 1 to 4 carbon atoms, such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, Dibutoxy and tertiary butoxy, preferably methoxy and ethoxy. Preferably there are 1 to 3 (preferably 1 to 2) of these substituents which are the same or different. "H, N- "Disubstituted carbamoyl" refers to carbamoyl having 2 substituents on the nitrogen atom. An example of such a substituent includes the same substituents as used in the above-mentioned "N-monosubstituted carbamoyl"; Examples of other substituents include Cl-6 alkyl (eg, methyl, ethyl, propyl, isopropyl, butyl, third butyl, pentyl, hexyl), C3-6 cycloalkyl ( Such as (, cyclopropyl, cyclobutyl Cyclopentyl, cyclohexyl) and C6-l0 aralkyl (eg, benzyl, phenethyl). Two substituents can be bonded to the nitrogen atom to form a cyclic amine group. In this example, a cyclic amine group Examples of formazanyl include: 1-azetidine carbonyl, 1-pyrrolidinyl carbonyl, hexahydropyridine carbonyl, morpholine carbonyl, 1-hexahydropyridine carbonyl, and the Chinese standard (CNS) applicable to this paper standard A4 specifications (210X297 mm) 15 3 ^ 22 1 1 order (please read the precautions on the back before filling out this page) 464649 Α7 Β7 V. Description of the invention (16) Hexahydrophenyl carbonyl, and in the fourth position Has a lower alkyl group, such as Ci-6 alkyl (eg, methyl, ethyl, propyl, isopropyl, butyl, third butyl, pentyl, hexyl), arylfluorenyl such as benzyl and benzyl Ethyl, aryl such as phenyl, 1-naphthyl and 2-naphthyl, and the like. R3 and R4 in the chemical formula (I) and R 4 '' 'in the chemical formula (I''1), shown as "the carboxyl group which can be quenched", for example, "lower oxocarbonyl" ", "Aryloxycarbonyl" and "aralkoxycarbonyl", as well as free carboxyl groups. "Lower alkoxycarbonyl" preferred examples include those having 2 to δ carbon atoms, such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, The second butoxycarbonyl group, the third butoxycarbonyl group, the pentyloxycarbonyl group, the isopentyloxycarbonyl group, the neopentyloxycarbonyl group and the third pentyloxycarbonyl group are preferably those having 2 to 4 carbon atoms, for example, a methoxycarbonyl group, Ethoxycarbonyl and propoxycarbonyl. &Quot; Aryloxycarbonyl " Preferred examples include: 7 to 12 carbon atoms (please read the notes on the back before filling this page), ιτ group 0: oxygen content check Bao-1Α 9, the best examples of oxygen based benzene are better than U such as base carbonyl, oxyalkylnaphthyl naphthalene I 2 and aryl to 8 exemplified by the original carbon of the Ministry of Economic Affairs Central Standards Bureau Staff Consumer Cooperatives The alkyl aryl sulfonium and methylamine carbonyl oxon aryl are printed at the carbonyl aromatic oxygen department. versus . The basic group and the carbonyl phase oxygen are taken as the radical of the radical B and the radical is taken; the radical obtained by the carbonyl radical is replaced by the alkyl radical, which can be replaced by the alkyl radical as the radical 6 β can be represented by the substitution of the ring benzene in the ring B. As an example, the script can be replaced by the ring B. If the ring is exposed, 3 is replaced by the substitution of the family member 6 and the formula β is shown below. This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 16 3922 1 46 4649 A7 B7 V. Description of the invention (17) φζΓ (called (where C ring can be replaced; X and Y definitions It is as above. If the B ring represents a 6-membered aromatic heterocyclic ring which can be substituted, the base represented by the chemical formula (II) includes: For example, the base of the formula, (Please read the precautions on the back before filling in this page)
經濟部中央樣準局員工消費合作社印製 於此等化學式中,D環可經取代;X及Υ之定義悉 如上述。 關於上述化學式,C及D環之取代基與Α所示"可經 取代之芳族環基"中例舉之取代基相同。此等取代基可與 C及D環之任何碳原子鍵接。 於化學式(II-1)中,R5所示”可經取代之烴基”之實 例為可經取代之由R1或R2所示烴棊處所例舉之相同烴基。 闞於化學式(I), A、反1、!^、R3及R4較佳之組合方式 ,乃A為吲睬基、1^及1{3為氫、及R2和R4為Ci-3烷基。上 述鸣唑啉-4-醑衍生物之特別贄例,h含吲睐徽素。 本紙張尺度適用中國國家標準(CNS )A4規格(210X297公釐) 1 7 39 221 A7 __B7 . 五、發明説明(18 ) 化學式(I)、( I ’)、( I ’ ’)或(Γ u )所示化合物之鹽, 包含藥理學上可接受之酸加成鹽;彤成酸加成鹽所用之酸 ,包含:乙酸、乳酸、丁二酸、順丁烯二酸、酒石酸、捧 樺酸、葡萄糖酸、抗壞血酸、笨甲酸、甲磺酸、對-甲笨 碥酸、桂皮酸、反丁烯二酸、膦酸、鹽酸、氫溴酸、氫碘 酸、胺磺酸及磺酸。 化學式(I)所示之化合物,實例如下述。 —^ϋ tLtr nn 1 I 1^1 ml 1^1^1 \OJ (請先H讀背面之注意事項再填寫本頁) 經濟部中央標準局負工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 18 39 2 2 1 464649 A7 B7 五、發明説明(19 ) R1 R2 〇Printed by the Consumer Cooperatives of the Central Sample Bureau of the Ministry of Economic Affairs In these chemical formulas, the D ring can be replaced; the definitions of X and Υ are as described above. Regarding the above chemical formula, the substituents of the C and D rings are the same as those exemplified in the "Aromatic cyclic group which may be substituted" shown in A. These substituents may be bonded to any carbon atom of the C and D rings. In the chemical formula (II-1), an example of the "substitutable hydrocarbyl group" represented by R5 is the same hydrocarbyl group exemplified as the hydrocarbyl group represented by R1 or R2 which may be substituted.阚 于 Chemical formula (I), A, reverse 1 ,! ^, R3 and R4 are a preferred combination, in which A is indyl, 1 ^ and 1 {3 are hydrogen, and R2 and R4 are Ci-3 alkyl groups. The special examples of the above-mentioned oxazoline-4-fluorene derivatives, where h contains indene and flavin. This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 1 7 39 221 A7 __B7. V. Description of the invention (18) Chemical formula (I), (I '), (I' ') or (Γ u ) The salt of the compound shown includes pharmacologically acceptable acid addition salts; the acids used for the acid addition salts include: acetic acid, lactic acid, succinic acid, maleic acid, tartaric acid, and betulinic acid , Gluconic acid, ascorbic acid, stearic acid, methanesulfonic acid, p-formamic acid, cinnamic acid, fumaric acid, phosphonic acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, aminesulfonic acid and sulfonic acid. Examples of the compound represented by the chemical formula (I) are as follows. — ^ Ϋ tLtr nn 1 I 1 ^ 1 ml 1 ^ 1 ^ 1 \ OJ (Please read the precautions on the back before filling this page) Printed by the Central Standards Bureau of the Ministry of Economic Affairs, Consumer Cooperatives This paper is sized to Chinese national standards (CNS) A4 specification (2 丨 0X297 mm) 18 39 2 2 1 464649 A7 B7 V. Description of the invention (19) R1 R2 〇
經濟部中央標準局β貝工消費合作社印製 R4 化合物 編號 A R1 R2 R3 R4 1) Η Η Η H H 2) Η Η Η H ch3 3) Η Η Η H CH2CH3 4) Η Η Η H (ch2)2ch3 5) Η Η Η H CH(CH3)2 6) Η Η Η H ~<j 7) Η Η Η H (CH2)3CH3 8) Η Η ch3 H H 9) 〇/ Η Η ch3 H ch3 1〇) 〇/ Η Η ch3 H CH2CH3 11) Η Η ch3 . ΐ- H (ch2)2ch3 12) Η Η ch3 H CH{CH3)2 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) 19 39 2 2 1 464649 A7 B7 五、發明説明(2〇 ) R1 R2 〇Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, β Shelley Consumer Cooperative, R4 Compound No. A R1 R2 R3 R4 1) Η Η Η HH 2) Η Η Η H ch3 3) Η Η Η H CH2CH3 4) Η Η Η H (ch2) 2ch3 5) Η Η CH H CH (CH3) 2 6) Η Η Η H ~ < j 7) Η Η Η H (CH2) 3CH3 8) Η ch3 HH 9) 〇 / Η ch3 H ch3 1〇) 〇 / Η ch3 H CH2CH3 11) Η ch3. Ϊ́- H (ch2) 2ch3 12) Η ch3 H CH (CH3) 2 (Please read the precautions on the back before filling out this page) This paper applies Chinese national standard Rate (CNS) A4 specification (210X297 mm) 19 39 2 2 1 464649 A7 B7 V. Description of the invention (2) R1 R2 〇
經濟部中央標準局員工消費合作社印裝 化合物 編號 A R1 R2 R3 R4 13) Η ch3 H 14) Η Η ch3 H {CH2)3CS3 15) 〇/ Η Η ch3 H CH2CH(CH3)2 16) Η Η ch3 H 17) Η. Η ch3 H ch2-^Q 18) w Η Η ch3 H (CH2)2^Q 19} Η Η ch3 ch3 ch3 20) Η Η ch3 CH2CH3 CH2CH3 21) Η Η ch3 H CH2CH2OH 22) 〇/ Η Η ch3 H CH2CH2OCH3 23} Η Η ch3 H ch2ch2cn 24) Ος/ Η ch3 ch3 H CH3 (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 20 39221 4646^9 A7 _B7 五、發明説明(2 1 ) R1 R2 〇Printed Compound No. A R1 R2 R3 R4 13) Η ch3 H 14) Η ch3 H (CH2) 3CS3 15) 〇 / Η ch3 H CH2CH (CH3) 2 16) Η ch ch3 H 17) Η. Η ch3 H ch2- ^ Q 18) w Η Η ch3 H (CH2) 2 ^ Q 19} Η Η ch3 ch3 ch3 20) Η ch3 CH2CH3 CH2CH3 21) Η ch3 H CH2CH2OH 22) 〇 / Η ch3 H CH2CH2OCH3 23} Η ch3 H ch2ch2cn 24) Ος / Η ch3 ch3 H CH3 (Please read the precautions on the back before filling out this page) The paper size applies to the Chinese National Standard (CNS) Α4 size (210 × 297) %) 20 39221 4646 ^ 9 A7 _B7 V. Description of the invention (2 1) R1 R2 〇
經濟部中央標準局員工消費合作社印製 R4 化合物 編號 A R1 R2 R3 R4 25) Η ch3 ch3 ch3 ch3 26) Η Η CH2CH3 H ch3 27) Η Η CH2CH3 H ch3 28) w Η Η (CH2)2CH3 H ch3 29) 〇/ Η Η (CH2)2CH3 ch3 ch3 30) Η Η CH(CH3)2 H ch3 31) Η Η CH(CH3)2 ch3 ch3 32) Η Η ch3 ch3 COCH3 33) Η Η ch3 ch3 COCH2CH3 34) Η Η CH3 CH3 < CO(CH2)2CH3 35) W Η Η ch3 ch3 COCH(CH3)2 36) 〇/ Η Η ch3 ch3 CO{CH2)3CH3 ----------^1'^-- (請先閣讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 21 39221Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economy R4 Compound No. A R1 R2 R3 R4 25) Η ch3 ch3 ch3 ch3 26) Η Η CH2CH3 H ch3 27) Η Η CH2CH3 H ch3 28) w Η Η (CH2) 2CH3 H ch3 29) 〇 / Η CH (CH2) 2CH3 ch3 ch3 30) Η Η CH (CH3) 2 H ch3 31) Η Η CH (CH3) 2 ch3 ch3 32) Η Η ch3 ch3 COCH3 33) Η ch3 ch3 COCH2CH3 34) Η Η CH3 CH3 < CO (CH2) 2CH3 35) W Η Η ch3 ch3 COCH (CH3) 2 36) 〇 / Η Η ch3 ch3 CO (CH2) 3CH3 ---------- ^ 1 '^ -(Please read the notes on the back before filling out this page) This paper size applies to China National Standard (CNS) A4 (210X297 mm) 21 39221
T 464649 A7 B7 五、發明説明(22 ) R1 R2 〇T 464649 A7 B7 V. Description of the invention (22) R1 R2 〇
經濟部中央標準局員工消費合作社印策 R4 化合物 編號 A R1 R2 R3 R4 37) Η Η CH3 ch3 CO{CH2)4CH3 38) 〇/ Η Η ch3 ch3 CO(CH2)5CH3 39) Η Η ch3 ch3 CO^) 40) 〇/ Η Η CH3 CH3 coch2 — 41) Η Η ch3 ch3 C〇(CH2)2^Q) 42) Η Η ch3 ch3 co~G^~ci 43) Η Η ch3 ch3 CO—^Br 44) 〇/ Η Η ch3 ch3 C〇—^^~F 45) ' Η Η CH3 ch3 C0 CF3 46) Η Η ch3 ch3 ΐ C0~h〇—CH3 47) Η Η ch3 ch3 co—och3 48) W Η Η H H coch3 ------------ (請先聞讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 22 3922 1 464649 A7R4 Compound Number A, R2, R2, R3, R4 37) Η Η CH3 ch3 CO (CH2) 4CH3 38) 〇 / Η ch3 CO (CH2) 5CH3 39) Η ch3 ch3 CO ^ ) 40) 〇 / Η Η CH3 CH3 coch2 — 41) Η ch3 ch3 C〇 (CH2) 2 ^ Q) 42) Η Η ch3 ch3 co ~ G ^ ~ ci 43) Η ch3 ch3 CO-^ Br 44) 〇 / Η ch ch3 ch3 C〇 — ^^ ~ F 45) 'Η Η CH3 ch3 C0 CF3 46) Η Η ch3 ch3 ΐ C0 ~ h〇-CH3 47) Η Η ch3 ch3 co—och3 48) W Η Η HH coch3 ------------ (Please read the notes on the back before filling in this page) The size of the paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) 22 3922 1 464649 A7
7 B 五、發明説明(23 ) R1 R2 〇7 B V. Description of the invention (23) R1 R2 〇
經濟部中央標隼局員工消費合作社印製 化合物 編號 A R1 R2 R3 μ 49) Η Η Η Η co-^) 50) w Η Η ^ Η Η CONHCH3 51) Η Η Η Η CONHCH2CH3 52) 〇/ Η Η Η Η CONH{CH2)2CH3 53) Η Η Η Η CONHCH(CH3)2 54) 〇/ Η Η Η Η C〇NH(CH2)3CH3 55) Η Η Η Η CONH(CH2)5〇H3 56) Η Η Η Η CONH— 57) Η Η Η Η c〇nhch2 —<(3 58) Η Η Η Η CONH— 59) Η Η Η Η CONH —F 60) Οςί Η Η ch3 Η CONHCH3 (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 23 39 22 1 4 6 4 6 4 9 a? B7 五Printed Compound No. A R1 R2 R3 μ 49) 中央 Η Η Η co- ^) 50) w Η Η ^ Η Η CONHCH3 51) Η Η Η Η CONHCH2CH3 52) 〇 / Η Η Η Η CONH (CH2) 2CH3 53) Η Η Η Η CONHCH (CH3) 2 54) 〇 / Η Η Η 〇 C〇NH (CH2) 3CH3 55) Η Η Η Η CONH (CH2) 5〇H3 56) Η Η Η Η CONH— 57) Η Η Η Η c〇nhch2 — < (3 58) Η Η Η Η CONH— 59) Η Η Η Η CONH —F 60) Ος Η Η ch3 Η CONHCH3 (Please read the first Please fill in this page for the matters needing attention) This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297mm) 23 39 22 1 4 6 4 6 4 9 a? B7 5
、發明説明(2 4) R1 VDescription of the invention (2 4) R1 V
經濟部中央標準局負工消費合作社印製 化合物 編號 A R1 R2 R3 R4 61) W Η Η ch3 H conhch2ch3 62) Η Η ch3 H CONH (CH2) 2CH3 63) Η Η ch3 H CONHCH(CH3)2 64) Η Η ch3 H conh(ch2)3ch3 65) Η Η ch3 H conh(ch2)5ch3 66) Η Η ch3 H CONH—(h) 67} W Η Η ch3 H c〇nhch2 —<^y 68) Η Η ch3 H CONH— 69) Η Η ch3 H CONH —F 70) Η Η ch3 ch3 CONHCH3 71) W Η Η ch3 \· ch3 CONHCH2CH3 72) Η Η CH3 ch3 CONHCH(CH3)2 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公釐) 2 4 3 9 22 1 ''46 4649 A7 B7Printed Compound No. A R1 R2 R3 R4 61) W Η Η ch3 H conhch2ch3 62) Η Η ch3 H CONH (CH2) 2CH3 63) Η ch3 H CONHCH (CH3) 2 64) Η ch3 H conh (ch2) 3ch3 65) Η ch3 H conh (ch2) 5ch3 66) Η ch3 H CONH— (h) 67} W Η ch3 H c〇nhch2 — < ^ y 68) Η Η ch3 H CONH— 69) Η Η ch3 H CONH —F 70) Η Η ch3 ch3 CONHCH3 71) W Η Η ch3 \ · ch3 CONHCH2CH3 72) Η Η CH3 ch3 CONHCH (CH3) 2 (Please read the precautions on the back first (Fill in this page) This paper size is in accordance with China National Standard (CNS) A4 (210X297 mm) 2 4 3 9 22 1 ''46 4649 A7 B7
五、發明説明(25 ) R1 R2 〇 AV. Description of the invention (25) R1 R2 〇 A
經濟部中史標準局員工消費合作社印製Printed by the Employees' Cooperatives of the China History Standards Bureau, Ministry of Economic Affairs
化合物 钃號 A R1 R2 R3 R4 73) Η Η ch3 ch3 CONH(CH2)2CH3 74) Η Η ch3 ch3 CONH(CH2)3CH3 75) Η Η ch3 ch3 CONH(CH2)4CH3 76) Η Η ch3 ch3 CONH(CH2)5CH3 77) Η Η ch3 ch3 CONH 乂 78} Οςί Η Η ch3 ch3 com^y 79) Η Η ch3 ch3 CONH-—(T) 80) W Η Η ch3 ch3 c〇nhch2 —{3 81) 〇/ Η Η ch3 ch3 CONH— .82) Η .Η ch3 ch3 i. CONH —C1 83) Η Η ch3 ch3 CONHBr 84) 〇/ Η Η ch3 ch3 CONH F (請先闆讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 25 39 2 2 1 94 6 4 ίΌ 4 經濟部中央標隼局員工消費合作社印製 五、發明説明(26 ) R1 R2 〇Compound No. A R1 R2 R3 R4 73) Η ch3 ch3 CONH (CH2) 2CH3 74) Η ch3 ch3 CONH (CH2) 3CH3 75) Η ch3 ch3 CONH (CH2) 4CH3 76) Η ch3 ch3 CONH (CH2 ) 5CH3 77) Η Η ch3 ch3 CONH 乂 78} Οςί Η ch3 ch3 com ^ y 79) Η Η ch3 ch3 CONH -— (T) 80) W Η Η ch3 ch3 c〇nhch2 — {3 81) 〇 / Η Ch ch3 ch3 CONH— .82) Η .Η ch3 ch3 i. CONH —C1 83) Η ch3 ch3 CONHBr 84) 〇 / Η ch3 ch3 CONH F (please read the precautions on the back before filling in this page) The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 25 39 2 2 1 94 6 4 Ό 4 Printed by the Consumer Cooperatives of the Central Standardization Bureau of the Ministry of Economic Affairs 5. Description of the invention (26) R1 R2 〇
%%
化合物 编號 A R1 R2 R3 R4 85) Ogr Η Η ch3 ch3 CONH —CH3 86) Η Η ch3 ch3 CONH—0CH3 87) 〇ςί Η Η ch3 ch3 CONH —CF3 88) W Η ch3 ch3 ch3 CONHCH3 89} W Η ch3 ch3 CH3 CONHCH2CH3 90) Η ch3 ch3 ch3 CONH — 91) 〇/ Η ch3 CH3 ch3 CONH Cl 92) Η Η H H 93) Η Η H H Λ co> 94) W Η Η H H .. ΐ 95) Η Η H H Λ ccy 96) Η Η H .H coO (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 26 3922 1 ,V 4 6 4- 6 4 9 A7 B7 五、發明説明(27 ) R1A:Compound number A R1 R2 R3 R4 85) Ogr Η Η ch3 ch3 CONH —CH3 86) Η Η ch3 ch3 CONH—0CH3 87) 〇 ί ch ch3 ch3 CONH —CF3 88) W Η ch3 ch3 ch3 CONHCH3 89} W Η Η ch3 ch3 CH3 CONHCH2CH3 90) Η ch3 ch3 ch3 CONH — 91) 〇 / Η ch3 CH3 ch3 CONH Cl 92) Η Η HH 93) Η Η HH Λ co > 94) W Η Η HH .. ΐ 95) Η Η HH Λ ccy 96) Η Η H .H coO (Please read the notes on the back before filling this page) This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 26 3922 1, V 4 6 4- 6 4 9 A7 B7 V. Description of the invention (27) R1A:
經濟部中央標準局—工消費合作社印製 化合物 編號 Ά R1 R2 R3 R4 97) Η Η Η H C〇J〇I 98) Η Η Η H coO 99) Η Η ch3 ch3 100) O? Η Η ch3 ch3 Λ co^ 101) Η Η ch3 ch3 co^ 102) Η Η ch3 ch3 Λ CO" 103) Η Η ch3 ch3 CO 104) Η Η ch3 ch3 C0O 105) Η Η ch3 ch3 co^ 106) Η Η ch3 ch3 jl JJ C0CH2 s’ 107) Η Η ch3 . ch3 A coch/ 108) Η Η ch3 ch3 C0JCH3 ! - - I - - --I- - n x^- n - (請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) 27 39 22 1 ^464649 A7 B7 五、發明説明(28 )Central Standards Bureau of the Ministry of Economic Affairs—Industrial and Consumer Cooperatives printed compound numbers Ά R1 R2 R3 R4 97) Η Η Η HC〇J〇I 98) Η Η Η H coO 99) Η ch ch3 ch3 100) O? Η Η ch3 ch3 Λ co ^ 101) Η Η ch3 ch3 co ^ 102) Η ch ch3 ch3 Λ CO " 103) Η ch ch3 ch3 CO 104) Η ch3 ch3 C0O 105) Η Η ch3 ch3 co ^ 106) Η Η ch3 ch3 jl JJ C0CH2 s' 107) Η Η ch3. ch3 A coch / 108) Η ch3 ch3 C0JCH3!--I----I--nx ^-n-(Please read the notes on the back before filling this page) Paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) 27 39 22 1 ^ 464649 A7 B7 V. Description of invention (28)
經濟部中央標隼局員工消費合作社印製 化合物 編號 A R1 R2 R3 R4 109) Η Η ch3 ch3 110). Η Η ch3 ch3 111) 〇/ Η Η ch3 ch3 CO」y 112) Η Η CH3 ch3 儿JJ CONH〜S’ 113} W Η Η ch3 ch3 A CONH, 1X4) Η Η ch3 ch3 X Jl CONH 115) Η Η ch3 ch3 Λ CONH^ 116) Η Η ch3 ch3 Jl J] conhch2 s 117) Η Η ch3 ch3 A conhch2〆 118) Οςί Η H H H 119) Η H H 120) 〇/ Η H H C0NH— (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 28 3 922 1 44 1 I si^ ^ nzw ^ >^sv? ^Printed Compound No. A R1 R2 R3 R4 109) by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs CONH ~ S '113} W Η Η ch3 ch3 A CONH, 1X4) Η Η ch3 ch3 X Jl CONH 115) Η Η ch3 ch3 Λ CONH ^ 116) Η Η ch3 ch3 Jl J] conhch2 s 117) Η ch3 ch3 A conhch2〆118) Ος Η HHH 119) Η HH 120) 〇 / Η HH C0NH— (Please read the precautions on the back before filling out this page) This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ) 28 3 922 1 44 1 I si ^ ^ nzw ^ > ^ sv? ^
WQ w(flw2 3 2WQ w (flw2 3 2
HuHu
Hu O H2" ;L we H W7 H2e to3 Η M wHu O H2 "; L we H W7 H2e to3 Η M w
MQ 'oMQ 'o
KC offlu nffiw ΠΟΖΚ oKC offlu nffiw ΠΟZZΚ o
H nwu nwu OOHy oH nwu nwu OOHy o
H nw3 nw3 oo oH nw3 nw3 oo o
KCKC
OHWWOHWW
OMWUOMWU
MH oMH o
WHWH
MH mwMH mw
OO^HW o wOO ^ HW o w
WHWH
MW oo oMW oo o
HwHw
MHMH
WHWH
HH
SS
ECEC
nwHW OK 3 wr w- no^Mrt^ /w\^ s ,w- ,wl ,w A. wwnwHW OK 3 wr w- no ^ Mrt ^ / w \ ^ s, w-, wl, w A. ww
HwHw
ECEC
ElEl
H oww OH 3H oww OH 3
002HH OK3 OH 3 owww R.002HH OK3 OH 3 owww R.
MM
.IR: IRl >rj B7.IR: IRl > rj B7
nHWW nww nwrtunHWW nww nwrtu
R 3 oohy no wR 3 oohy no w
iJ 4u4549 A7 B7 五、發明説明(30 ) R1 R2 〇iJ 4u4549 A7 B7 V. Description of the invention (30) R1 R2 〇
經濟部中央標準局員工消費合作社印製Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs
化合物 編號 A R1 R2 R3 R4 133) Orr Η ch3 ch3 ji ii CONH S 134) W Η Η Η H H 135) Ogii Η Η Η H CO— 136) Η Η Η H CONH— 137) Η Η ch3 ch3 H 138) Η Η ch3 ch3 co^D 139) Η Η ch3 ch3 c。卩 140) Η Η ch3 ch3 rsn CO" 141) W Η Η ch3 CH3 CONH— 142) Η Η ch3 ch3 1 J CONH S 143) Η Η ch3 ch3 CO JCH3 144) Η Η ch3 ch3 C0_^D {請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨0Χ_297公釐) 30 39 2 2 1 46 4649 A7 B7 五、發明説明(31 ) R1 R2 0Compound number A R1 R2 R3 R4 133) Orr Η ch3 ch3 ji ii CONH S 134) W Η Η Η HH 135) Ogii Η Η Η H CO— 136) Η Η Η H CONH- 137) Η ch3 ch3 H 138) Η Η ch3 ch3 co ^ D 139) Η Η ch3 ch3 c.卩 140) Η ch3 ch3 rsn CO " 141) W Η ch3 ch3 CH3 CONH— 142) Η ch3 ch3 ch3 1 J CONH S 143) Η ch3 ch3 CO JCH3 144) Η ch3 ch3 C0_ ^ D {Please read first Note on the back, please fill in this page again.) This paper size applies Chinese National Standard (CNS) A4 specification (2 丨 0 × _297 mm) 30 39 2 2 1 46 4649 A7 B7 V. Description of the invention (31) R1 R2 0
經濟部中央標準局員工消費合作社印製 化合物 編號 A R1 R2 R3 R4 145) Η Η ch3 ch3 C00CH3 146) w Η Η ch3 ch3 COOCH2CH3 147) Η Η ch3 ch3 COO(CH2)2CH3 148) Η Η ch3 ch3 COOCH(CH3)2 149) Η Η ch3 ch3 COO(CH3)3CH3 150) Η Η ch3 ch3 COOCH2CH(CH3)3 151) Η Η ch3 ch3 COOC(CH3)3 152) Η Η ch3 ch3 COO(CH2)4CH3 153) Η Η ch3 ch3 coo(ch2)5ch3 X54) Η Η ch3 ch3 COOCH2 155) Η Η ch3 .\ ch3 S02CH3 156) Η Η ch3 ch3 so2ch2ch3 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4规格(2l〇X:2i»7公釐) 3 922 1 4 6 4649 A7 B7 五、發明説明(32 ) R1 R2 0Printed compound number A R1 R2 R3 R4 145) Η Η ch3 ch3 C00CH3 146) w Η Η ch3 ch3 COOCH2CH3 147) Η Η ch3 ch3 COO (CH2) 2CH3 148) Η Η ch3 ch3 COO (CH3) 2 149) Η Η ch3 ch3 COO (CH3) 3CH3 150) Η ch3 ch3 COOCH2CH (CH3) 3 151) Η ch3 ch3 COOC (CH3) 3 152) Η ch3 ch3 COO (CH2) 4CH3 153) Η ch3 ch3 coo (ch2) 5ch3 X54) Η ch3 ch3 COOCH2 155) Η ch3. \ Ch3 S02CH3 156) Η ch3 ch3 so2ch2ch3 (Please read the notes on the back before filling out this page) This paper is for China National Standard (CNS) A4 specification (2l0X: 2i »7mm) 3 922 1 4 6 4649 A7 B7 V. Description of the invention (32) R1 R2 0
經濟部中央標準局買工消費合作社印— 化合物 編號 A R1 R2 R3 R4 157) Η Η ch3 ch3 S〇2(CH2)2CH3 158) w Η Η ch3 ch3 S〇2(CH2)3CH3 159) Η Η ch3 ch3 S〇2(CH2)4CH3 160) Η Η ch3 ch3 S〇2(CH2)5CH3 161) Η Η ch3 ch3 S〇2 乂 162) Η Η ch3 ch3 S〇2-{h) 163) Η Η ch3 ch3 S〇2-^ 164) Η Η ch3 ch3 S〇2—Cl 165) Η Η ch3 ch3 S〇2^G>—CH3 166) Η Η ch3 ch31 S02xo (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X 2S>7公釐) 32 3 92 2 1 6 46 49 A7 B7 五、發明説明(33). 上述化合物可為消旋物或光學異構物。 本發明所用之化合物(I)或其鹽,因具抗细菌活性, (請先閲讀背面之注意事項再填窝本頁) 特別是對K幽門螺桿菌為代表之螺桿菌屬细菌具強效抗细 菌活性,而有效用作抗细菌劑,K預防或治療上述由幽門 螺桿菌感染引起之"十二指腸潰瘍、胃潰瘍、胃炎(包含 慢性胃炎)、屬癌等”。 本發明之製劑含化學物(I)或其藥理學上可接受之鹽, 可如抗细菌或抗潰瘍劑般經口或非經口投予哺乳類(如, 人、狗、貓、猴、老鼠、小鼠、馬、牛),其中K經口投 予方式較佳。 經口投予之劑型,實例包含:錠劑(包含糖衣-疑劑及 膜衣錠劑)、丸劑、粒劑、粉劑、膠囊劑(包含軟膠囊劑) 、漿液劑、乳液及懸浮液劑。非經口投予之劑型,實例包 含:注射製劑、浸劑、滴注浸劑及栓劑。 於本發明之製劑中,化合物(I)或其鹽之含量,通常 為2至85重量%,較佳為5至70重量%。 經濟部中央標準局員工消費合作社印製 為使化合物(I)或其鹽製備成上述劑型•乃採用相關 領域常用之已知製法。製成上述劑型時,需要的詰,可添 加適量之製藥領域常用之賦形劑、黏合劑、崩解劑、潤滑 劑' 甜味劑、表面活性劑、懸浮劑、乳〆b劑等,可以合宜 量加入。 例如,若化合物(I)或其鹽製備成錠劑,可含賦形劑 、黏合劑、崩解劑、潤滑劑等;若化合物(I)或其鹽製備 成九劑或粒劑,可含賦形劑、黏合劑、崩解劑等。若化合 本k張尺度適用中國國家標準(CNS ) A4規格(2丨OX297公釐) 33 39 2 2 1 6 4649 A7 B7 五、發明説明(34 ) 物(I)或其鹽製備成粉劑或膠囊劑,可含賦彤劑等;若化 合物(I)或其鹽製備成漿液劑,可含甜味劑等;若化合物 (I)或其蘧製備成乳液或懋浮液劑,可含懋浮劑、表面活 性劑、乳劑等。賦形劑之實例,包含:乳糖、蔗糖、葡萄 糖、澱粉、蔗糖、微晶纖維素、甘草粉、甘露糖酵、碳酸 氫納、磷酸鈣及硫酸鈣。黏合劑之實例,包含:5〜10重 量%澱粉膠溶液、10〜20重量%阿位伯膠溶液或明膠溶液 、1〜5重量%西黃爹膠溶液、羧甲基纘維素溶液,藻酸納 溶液及甘油。崩解劑之實例,包含:澱粉及碳酸鈣。潤滑 劑之實例,包含:硬脂酸鎂、硬脂酸、硬脂酸鈣及純化滑 石。甜味劑之實例,包含:葡萄糖、果糖、轉化糖、山梨 糖酵、木糖醇、甘油及單純糖漿。表面活性劑之實例,包 .含:月桂基硫酸納、聚山梨醇酯80、山梨糖醇酐單脂肪酸 酿及聚氧基硬脂酸酷40。(stearic acid polyoxyl 40)懸 浮劑之實例,包含:阿拉伯膠、藻酸納、羧甲基纖維素納 、甲基纖維素及膨潤土。乳化劑之實例,包含:阿拉伯膠 、西黃著膠、明膠及聚山梨醇酯八十。 經濟部中央標準局員工消費合作社印製 {請先閲讀背面之注意事項再填寫本頁} 為使化合物(I)或其鹽製備成上述劑型,需要的話, 可添加適量的製藥領域常用之著色劑、保存劑、調味劑、 矯诛劑、安定劑、增稠劑等。本發明之弊備,含通式U) 之化合物或其S藥上可接受之鹽.及穩定且毒性低微,可 安全使用。依病患之病況及體重、化合物種類、投予途徑 等而不同,本發明製劑之每日劑量,對由幽門螺桿菌感染 引起之1潰瘍病患經口投予時,Μ活性成分含量(化合物 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇Χ:297公釐) 34 3 9 22 1 6 4649 A7 B7五、發明説明(35 ) (I)或其鹽)計之,每位成人(重約60公斤)通常為1至500 毫克,較佳約10至20 0奄克。 於上述劑虽範圍,未有毒性。 而且,於本發明之製劑中,化合物(I)或其鹽可與其 他抗细菌劑及抗潰瘍劑合併使用。 可與化合物(I)或其鹽合併使用之其他抗细菌劑包含: 例如,硝基眯唑抗生素類[如,他眯唑(tinidazole)及滅Printed by the Central Laboratories of the Ministry of Economic Affairs and Consumer Cooperatives — Compound No. A R1 R2 R3 R4 157) Η Η ch3 ch3 S〇2 (CH2) 2CH3 158) w Η Η ch3 ch3 S〇2 (CH2) 3CH3 159) Η ch ch3 ch3 S〇2 (CH2) 4CH3 160) Η Η ch3 ch3 S〇2 (CH2) 5CH3 161) S〇2- ^ 164) Η Η ch3 ch3 S〇2-Cl 165) Η ch3 ch3 S〇2 ^ G >-CH3 166) Η Η ch3 ch31 S02xo (Please read the notes on the back before filling this page) This paper size applies Chinese National Standard (CNS) A4 specification (2I0X 2S> 7 mm) 32 3 92 2 1 6 46 49 A7 B7 V. Description of the invention (33). The above compounds can be racemates or optical isomers . Because the compound (I) or its salt used in the present invention has antibacterial activity, (please read the precautions on the back before filling in this page). It is especially effective against Helicobacter bacteria such as K. pylori. Bacterial activity, and effectively used as an antibacterial agent, K to prevent or treat the above-mentioned "duodenal ulcer, gastric ulcer, gastritis (including chronic gastritis), cancer, etc." caused by Helicobacter pylori infection. I) or a pharmacologically acceptable salt thereof, which can be administered orally or parenterally to mammals as an antibacterial or antiulcer agent (eg, human, dog, cat, monkey, mouse, mouse, horse, cow) Among them, K is better for oral administration. Examples of dosage forms for oral administration include: lozenges (including sugar-coated tablets and film-coated lozenges), pills, granules, powders, capsules (including soft capsules) ), Slurry, emulsion and suspension. Examples of dosage forms for parenteral administration include injection preparations, infusions, drip infusions and suppositories. In the preparation of the present invention, compound (I) or a salt thereof Content, usually 2 to 85% by weight, preferably 5 to 70% by weight. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs to make compound (I) or its salts into the above-mentioned dosage forms. • The known manufacturing methods commonly used in the related fields are used. Appropriate amounts of excipients, binders, disintegrating agents, lubricants, sweeteners, surfactants, suspending agents, emulsions, etc. commonly used in the pharmaceutical field can be added, and can be added in appropriate amounts. For example, if the compound (I ) Or its salt is prepared into lozenges, which may contain excipients, binders, disintegrating agents, lubricants, etc .; if compound (I) or its salt is prepared into nine agents or granules, it may contain excipients and binders , Disintegrating agent, etc. If the k-scale of the compound is applicable to the Chinese National Standard (CNS) A4 specification (2 丨 OX297 mm) 33 39 2 2 1 6 4649 A7 B7 V. Description of the invention (34) Object (I) or its Salts are prepared into powders or capsules, which can contain excipients, etc .; if compound (I) or its salts are prepared into slurry, sweeteners, etc .; if compound (I) or its tincture is prepared into emulsion or tincture float The agent may contain a flocculant, a surfactant, an emulsion, etc. Examples of the excipient include Lactose, sucrose, glucose, starch, sucrose, microcrystalline cellulose, licorice powder, mannose, sodium bicarbonate, calcium phosphate and calcium sulfate. Examples of binders include: 5 to 10% by weight starch gum solution, 10 to 20% by weight Aberber gum solution or gelatin solution, 1 ~ 5% by weight Xanthan gum solution, Carboxymethyl pavidin solution, Sodium alginate solution and glycerin. Examples of disintegrants include: starch and calcium carbonate Examples of lubricants include magnesium stearate, stearic acid, calcium stearate, and purified talc. Examples of sweeteners include glucose, fructose, invert sugar, sorbase, xylitol, glycerin, and Simple syrup. Examples of surfactants include: Sodium lauryl sulfate, polysorbate 80, sorbitan monofatty acid and polyoxystearate 40. Examples of (stearic acid polyoxyl 40) suspending agents include acacia, sodium alginate, sodium carboxymethyl cellulose, methyl cellulose and bentonite. Examples of emulsifiers include: gum arabic, tragacanth, gelatin, and polysorbate 80. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs {Please read the precautions on the back before filling this page} In order to prepare the compound (I) or its salt into the above dosage form, you can add an appropriate amount of coloring agents commonly used in the pharmaceutical field , Preservatives, flavoring agents, tinctures, stabilizers, thickeners, etc. The disadvantages of the present invention are that it contains a compound of general formula U) or a pharmaceutically acceptable salt thereof, and is stable and has low toxicity, and can be used safely. Depending on the patient's condition and weight, the type of compound, the route of administration, etc., the daily dose of the preparation of the present invention, when administered orally to a patient with 1 ulcer caused by Helicobacter pylori infection, the content of M active ingredient (compound This paper size applies the Chinese National Standard (CNS) A4 specification (21〇 ×: 297 mm) 34 3 9 22 1 6 4649 A7 B7 V. Description of invention (35) (I) or its salt) In terms of each adult (Weighing about 60 kg) is usually 1 to 500 mg, preferably about 10 to 200 g. Although it is in the above range, it is not toxic. Moreover, in the preparation of the present invention, the compound (I) or a salt thereof can be used in combination with other antibacterial agents and antiulcer agents. Other antibacterial agents that can be used in combination with compound (I) or a salt thereof include, for example, nitropyrazole antibiotics [eg, tinidazole and methoxazole
ffl 8 ( Γ 蜜 e 滴U 類 素 徽 環 四 C y X ο d /TV 素 撤 力 強 環 四 素胺 嫌甲 環二 四及 ,e 如in (請先鬩讀背面之注意事項再填寫本頁) m /t\ 素 嫌 素 徽 青 苄 氨 羥 如 ___ 類 素 黴 青 *1 P 0 9 素 黴 青 苄 氨 素 黴 青 洛 梅 及 ο S ο 11 3 h P e c /fv 類 素 菌 孢 頭ffl 8 (Γ honey e drop U class prime ring four C y X ο d / TV Suspension strength strong cyclotetracycline amine too ring A and two, and e as in (Please read the precautions on the back before filling in this (Page) m / t \ Sui Susu Huiqing penicillin ammonia hydroxyl such as ___ class mycocyanin * 1 P 0 9 Spore head
如 rL 氯 C ί £, { Φ 泰 素(C司 菌咐愛 孢唑IB 頭孢呋 素 菌 孢 頭 苄 氨 羥 Γ 頭 a 肟 呋 氨 孢 頭 X a β ra •1 ο Γ U ΛΙ e 氨 孢 頭 V TX 素 菌 孢 頭 a h 辛 杜 帕 孢 頭 X ο e ο 頭 汀 利 他 孢 若 jl jxtn 特 孢 賣 0 及 \—/ Θ 1 經濟部中央榇準局—工消費合作社印製 C /1. 類 Λν7 寧 配 巴 卡 er素 Μ κ ¢1 寧龍 配巴 諾 , ο ο Γ a 素 嫌 紅 如 ft 類 素 邁Such as rL chloro C ί £, {Φ Taisu (C spores order Acetozole IB Cefuroxime cephalosporin benzylamine hydroxyl Γ head a oxime furosemide X a β ra • 1 ο Γ U ΛΙ e Cephalosporin V TX spore cephalosporin ah sindupa cephalosporin X ο e ο cephalin Ritaspora jl jxtn Special spores sold 0 and \ — / Θ 1 Printed by the Central Bureau of Standards of the Ministry of Economic Affairs and Industry and Consumer Cooperatives C / 1. Class Λν7 Ning with bakaersu M κ ¢ 1 Ninglong with bano, ο ο Γ a is too red as ft
C 素 徽 汎 立 ί o B 寧 C (\ 配 Β 醋 米 U 內 依類環 ,甘大 如糖、 rL P-1 > 基 > s η m 胺 i β c n ^ y Θ --Lffl p ) o 米 及 ο Γ 素 徽 索 利 及 a 素 級 索 拉 ο 素 菌 絲 林 氯 如 1__ 類 素 生 抗 平 福 利 如 本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐) 35C prime emblem 立 o B Ning C (\ with β vinegar rice U inner ring, Gan Daru sugar, rL P-1 > group > s η m amine i β cn ^ y Θ --Lffl p) o Rice and ο Γ prime emblem Soly and a prime grade sora ο Mycelium mycelium chloride such as 1__ phytosanitary anti-level welfare benefits such as the paper size applicable to Chinese national standards (CNS > A4 specifications (210X297 mm) 35
C Θ 如 生 抗 西 可 林 a 39 2 2 1 Η 6 4 6 49 Α7 Β7 經濟部中央標準局員工消費合作社印製C Θ Rusheng Anti-Xicolin a 39 2 2 1 Η 6 4 6 49 Α7 Β7
五、發明説明(36) 及啳諾鬭Uuinolone)抗生素類[如,塞普沙辛 (ciprofloxacin)、歐洛沙辛(ofloxacin)]硝基呋喃妥因 。可與化合物(I)或其鹽合併使用之抗潰瘍劑包含:例如, 質子唧筒抑制劑類[如,藍索皮唑(lansoprazole)、歐衆 皮吨(o.meprazole)、泛托皮哩(pantoprazole)、拉伯皮唑 (rabeprazole)、組織胺H2拮抗劑類[如,雷尼替定 (ranitidine)、希美替定(cimetidine)及啡莫替定 (famotidine)]及黏膜防護抗潰瘍劑[如,索法爾康 (sofaicone)、普勞諾托(plaunotol)、特普利諾 (teprenone)、絲克雷費(sucralfate)]。 上述其他抗细菌劑及抗潰瘍劑可二種Μ上混合使用。 依此例,抗细菌劑之劑量,經口投予時,通常為每位成人 每天1至50 0奄克,較佳5至200毫克;而抗潰瘍劑之劑量 ,經口投予時,通常為每位成人每天0.5至1,000毫克,較 佳1至5 00奄克。 化學式(I)之化合物或其鹽可例如由下述方法Α至Ε 製得之。 方.法A R1 R2 入 (III)5. Description of the invention (36) and Uuinolone) antibiotics [eg, ciprofloxacin, ofloxacin] nitrofurantoin. Anti-ulcer agents that can be used in combination with compound (I) or a salt thereof include, for example, proton capsule inhibitors [eg, lansoprazole, o.meprazole, pantopeline ( pantoprazole), rabeprazole, histamine H2 antagonists [eg, ranitidine, cimetidine, and famotidine] and mucosal anti-ulcer agents [ For example, sofaicone, plaunotol, teprenone, sucralfate]. The other antibacterial agents and antiulcer agents mentioned above can be used by mixing two kinds of M. According to this example, the dosage of an antibacterial agent is usually 1 to 500 g per adult per day, preferably 5 to 200 mg when administered orally; while the dosage of an antiulcer agent is usually administered orally It is 0.5 to 1,000 mg per adult per day, preferably 1 to 500 g. The compound of the formula (I) or a salt thereof can be produced, for example, by the following methods A to E. Method A R1 R2 into (III)
(IV) m (I) 於上述化學式中,乙示_原子或-0-S〇2R6(Rs示低级 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 36 3 92 2 1 (請先閲讀背面之注意事項再填寫本頁) 〇 4 6 4 9 A7 B7 五、發明説明(37 ) 烷基或經取代之苯基);其他符號之定義悉如上述。 於化學式(III)中,乙所示之鹵原子,例如,氣、氯 、溴及碘。R6所示之低級烷基,例如具1至6個碳原子之 烷基,如甲基、乙基、丙基、異丙基、丁基、異丁基、第 二丁基、第三丁基、戊基、異戊基、新戊基、第三戊基、 1-乙基丙基、己基、異己基、1,1-二甲基丁基、2, 2-二甲 基丁基、3,3-二甲基丁基及2-乙基丁基,較佳為具1至4 個碳原子之烷基,如甲基、乙基、丙基、異丙基、丁基及 異丁基。 R6所示經取代之苯基中有用之取代基包含:例如,低 級烷基(與上逑R6所示低級烷基處之例舉相同)、低级烷氧 基(例如,具1至4個碳原子之烷氧基,如甲氧基、乙氧 基、丙氧基、異丙氧基及丁氧基)、鹵原子(例如,氟、氯 、溴、碘)、硝基、氰基及羧基。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 此方法之進行乃使化合物(III)或其鹽與化合物(IV) 於鹼之存在下反應。化合物(III)之鹽例如各彼等和化合 物(I)形成酸加成鹽之酸實例中的酸所形成之酸加成鹽。 此反應通常於溶劑中進行;溶劑乃合宜選擇不干擾反應之 溶劑。此等溶劑包含:例如,酵類如甲醇、乙醇、丙酵、 異丙醇、丁醇及第三丁醇;醚類如二噚燁、四氫呋喃、乙 瞇、第三丁基甲醚、二異丙醚及乙二醇-二甲醚;酯類如 甲酸乙酯、乙酸乙醅及乙酸正丁酯;齒化烴類如二氯甲烷 、氯彷、四氯化碳、三氯乙烯及1,2 -二氯乙烷;烴類如正 己烷、笨及甲笨;醯胺類如甲醢胺、Ν,Ν-二甲基甲醯胺及 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 37 39 22 1 4 6 4 6 4 9 A7 B7 五、發明説明(38) Η,Ν -二甲基乙豳胺;醑類如丙_、甲基乙酮及甲基異丁酮 ;腈類如乙腈及丙腈;二甲亞碾、二氧四氫噬吩、六甲基 磷豳胺及水;此等溶劑可成單獨或混合溶劑使用。 經濟部中央標準局貝工消費合作社印製 (請先閲讀背面之注意事項再填窝本頁) 有用之鍮包含:例如,Ci-6烷基或芳基鋰類如甲基鍾 、乙基鋰、正丁基鋰、第二丁基鋰、第三丁基鋰及苯基鋰 ;具2至6個碳原子之烷基醯胺鋰類,如二甲基醯胺鋰、 二乙基豳胺鋰及二異丙基醢胺鋰,金屬氫化物類如氫化鋰 及氫化納;具1至6個碳原子之金屬烷氧化物類,如乙酵 鋰、第三丁醇鋰、甲酵鈉、乙醇納及第三丁醇鉀;酿胺類 如氨基化鋰、氨基化鉀及氨基化納;無櫬鹼類如氫氧化鋰 、氫氧化鉀、氫氧化納、碳酸鈉、碳酸鉀及碳酸氩鈉;及 三级胺類如三乙胺、三(正丙基)胺、三(正丁基)胺、二異 丙基乙胺、瓌己基二甲胺、吡啶、二甲基吡啶、7 i -可力 丁(7 ^collidine)、Ν,Ν -二甲基苯胺、N -甲基六氫吡啶 、Ν -甲基吡咯啶及Ν -甲基嗎福啉。此反應進行時,每莫耳 化合物(III)用化合物(IV)1至5莫耳,較佳1至3莫耳 。反應溫度通常約-80至100¾,較佳-50至60¾。反應時 間通常1分鐘至72小時,較佳15分鐘至24小時,依化合物 (III)及(IV)之種類、溶劑種類,反應溫度等而不同。 本紙張尺度適用中國國家標準(CNS > A4规格(2丨0 X :297公釐) 38 39 2 2 1(IV) m (I) In the above chemical formula, B atom is represented by _ atom or -0-S〇2R6 (Rs indicates low grade) This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) 36 3 92 2 1 (Please read the notes on the back before filling this page) 〇 4 6 4 9 A7 B7 V. Description of the invention (37) Alkyl or substituted phenyl); the definitions of other symbols are as above. In the chemical formula (III), a halogen atom represented by B, for example, gas, chlorine, bromine and iodine. Lower alkyl represented by R6, for example, alkyl having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, second butyl, third butyl , Pentyl, isopentyl, neopentyl, third pentyl, 1-ethylpropyl, hexyl, isohexyl, 1,1-dimethylbutyl, 2, 2-dimethylbutyl, 3 , 3-dimethylbutyl and 2-ethylbutyl, preferably alkyl groups having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl and isobutyl . Useful substituents in the substituted phenyl group represented by R6 include, for example, a lower alkyl group (the same as exemplified at the lower alkyl group shown by R6 above), a lower alkoxy group (for example, having 1 to 4 carbons) Atomic alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, and butoxy), halogen atoms (for example, fluorine, chlorine, bromine, iodine), nitro, cyano, and carboxyl . Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) This method is performed by reacting compound (III) or its salt with compound (IV) in the presence of a base. The salt of the compound (III) is, for example, an acid addition salt formed by the acid in the acid example of each of them and the compound (I). This reaction is usually performed in a solvent; a solvent is a solvent which is suitably selected so as not to interfere with the reaction. These solvents include, for example, enzymes such as methanol, ethanol, propionate, isopropanol, butanol, and tertiary butanol; ethers such as dioxin, tetrahydrofuran, acetamidine, tertiary butyl methyl ether, and diisopropyl ether. And ethylene glycol-dimethyl ether; esters such as ethyl formate, ethyl acetate and n-butyl acetate; toothed hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, trichloroethylene, and 1,2- Dichloroethane; hydrocarbons such as n-hexane, benzyl, and methylbenzyl; amines such as formamide, Ν, Ν-dimethylformamide, and this paper size are applicable to China National Standard (CNS) A4 specifications (210 × 297) (%) 37 39 22 1 4 6 4 6 4 9 A7 B7 V. Description of the invention (38) Η, N-dimethylacetamide; hydrazones such as propane, methyl ethyl ketone and methyl isobutyl ketone; nitrile Such as acetonitrile and propionitrile; dimethyl arylene, dioxetane, hexamethylphosphamide and water; these solvents can be used alone or as a mixed solvent. Printed by the Central Standards Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives (please read the notes on the back, and then fill in this page) Useful ones include: for example, Ci-6 alkyl or aryl lithium such as methyl bell, ethyl lithium , N-butyllithium, second butyllithium, third butyllithium and phenyllithium; lithium alkylammonium amines having 2 to 6 carbon atoms, such as lithium dimethylammonium amine, diethylammonium amine Lithium and lithium diisopropylammonium, metal hydrides such as lithium hydride and sodium hydride; metal alkoxides having 1 to 6 carbon atoms, such as lithium ethionate, lithium third butoxide, sodium formate, Sodium ethoxide and potassium tert-butoxide; fermented amines such as lithium amide, potassium amide, and sodium amide; phosphonium bases such as lithium hydroxide, potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, and argon carbonate Sodium; and tertiary amines such as triethylamine, tri (n-propyl) amine, tri (n-butyl) amine, diisopropylethylamine, hexamethylenedimethylamine, pyridine, dimethylpyridine, 7 i -Collidine, N, N-dimethylaniline, N-methylhexahydropyridine, N-methylpyridine and N-methylmorpholine. When this reaction proceeds, the compound (IV) is used in an amount of 1 to 5 moles, preferably 1 to 3 moles per mole. The reaction temperature is usually about -80 to 100 ¾, preferably -50 to 60 ¾. The reaction time is usually 1 minute to 72 hours, preferably 15 minutes to 24 hours, depending on the kinds of the compounds (III) and (IV), the kind of the solvent, the reaction temperature and the like. This paper size applies to Chinese national standards (CNS > A4 size (2 丨 0 X: 297 mm) 38 39 2 2 1
464649五、發明説明(39) 方法R A7 B7 R1 R2 ,Ν: HN=C. R3 Ή4464649 V. Description of the invention (39) Method R A7 B7 R1 R2, N: HN = C. R3 Ή4
(I) OR8 (VIII) (請先閲讀背面之注意事項再填寫本頁) 基 護 保(I) OR8 (VIII) (Please read the precautions on the back before filling out this page)
所 7 R 基 羥 或 氫 示. 8 R 基 烷 鈒。A 低述法 或上方 氫如如 示悉例 os 義 , , 定基 中之烷 式號级 學符低 化他之 述其示 上. 處 基 烷 级 低 示 所 6 R 中 經濟部中央標準局員工消費合作社印製 擾 干 不 要 只 基 護 保 何 任 為 可 基 。 護 基保 烷基 级羥 低之 同乐 rm CMM. 相 抒 - a 之 R 述 所' 基 甲 氧 醚丁 : 三 含第 包 、 ,基 例甲 實基 之氧基 佳甲烷 較笨矽 _’ 、 甲 可基三 即甲 I .應氧-2 反甲基 基 甲 氧 乙 基 氧 甲 基 甲 苯 氧 甲 、 基 基甲 喃笨 吡基 氬硝 3 --Eg對 如 基 喃 類s;ott S 氧 ί 基 氫 護 _ 四 保 22- 之、 成.*基 形 甲 硫 甲 甲 氧 乙 氧 甲 對 ' 基 甲 笨 、 基 喃 呋 氫 四 基 甲 苯 三 及 基 甲 笨 基 硝 I 鄰 本紙張尺度適用中國國家標準(CNS > ΑΊ規格(210X297公釐) 39 392 2 1 4 6 4 S 4 9 Δ7 Α7 Β7 五、發明説明(40) ;矽烷基醚-形成之保護基類,如三甲矽烷基、三乙矽烷 基、三異丙矽烷基、異丙基二甲矽烷基、二乙基異丙矽烷 基、第三丁基二甲矽烷基、第三丁基二苯矽烷基、三苯甲 基矽烷基、三笨矽烷基及甲基二苯矽烷基;及_-形成之 保護基類,如甲醢基、乙醯基、氯乙醢基、二氛乙醢基、 三氯乙醯基、三甲基乙醣基及苯甲醢基。 若化學式(V)中之Rs為氫,則化合物(V)或其鹽與化合 物(VI)反應。化合物(V)之鹽,例如與彼等在和化合物(I) 形成酸加成鹽處所述之酸形成之酸加成鹽》此反應通常於 溶劑中進行,需要的話,於艙之存在下進行。此等溶劑及 鹸,與上述方法A所述之溶劑及相同。此反應進行時, 每莫耳化合物(V)或其鹽,用化合物(V 1)1至10奠耳,較 佳1至5莫耳。反應溫度通常約-30至20010,較佳-10至 1501C。反應時聞通常1分鐘至120小時,較佳15分鐘至48 小時,依化合物(V)及(VI)之種類、溶劑及醮之種類、反 應溫度等而不同。 鯉濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 化合物(I)之製造,亦可自化合物(V)及(VII)製得化 合物(VIII),然後使化合物(VIII)進行環化而得之。此方 法涉及化合物(VII)或其鹽與化合物(V)、其鹽或其反應性 衍生物之醯化反應。 < 詳言之,乃使自由酸(V)、其鹽(無機鹽、有機鹽)或 •其反懕性衍生物(例如,醢基鹵、酶基疊氮化物、酸酐、 混合酸酐、活性醯胺、活性脂、活性硫_等)進行醯化反 應。無機鹽類包含:餓金靥鹽類(例如,納鹽、鉀鹽)及鹼 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 40 3 92 2 1 464649 A7 _ B7 五、發明説明(41 ) 土金羼鹽類(例如,鈣鹽)。有機鹽類包含:例如,三甲胺 鹽、三乙胺鹽、第三丁基二甲胺鹽、二苯甲基甲胺鹽、笨 甲基二甲胺鹽、N,H -二甲基苯胺鹽、吡啶鹽及曈啉鹽。醯 基鹵類包含:例如,醯基氯及醢基溴。混合酸酐類包含: 單-Ci-4烷基碳酸混合酸酐類(例如,自由酸(V)及單甲基 碳酸、單乙基碳酸、單異丙基碳酸、單異丁基碳酸、單第 三丁基碳酸、單笨甲基碳酸、單(對-硝基笨甲基)碳酸、 單烯丙基碳酸等之混合酸酐類)、Ci - 6脂族羧酸混合酸酐 類(例如,自由酸(V)與乙酸、氰乙酸、丙酸、丁酸、異丁 酸、戊酸、異戊酸、三甲基乙酸、三氟乙酸、三氯乙酸、 乙醢乙酸等之混合酸酐類)、C7-H芳族羧酸混合酸酐類 (例如,自由酸(V)與苯甲酸、對-甲苯酸、對-氯苯甲酸等 .之混合酸酐類)及有機磺酸混合酸酐類(例如,與甲磺酸、 乙磺酸、苯磺酸、對-甲苯磺酸等彤成之混合酸酐類)。活 C請先閲讀背面之注意事項再填寫本頁) 與 包}環 類(V雜 胺酸氮 醢由含 性自等 類 胺 醯 之 成 形 物 t 類 三 合 基 化Μ焼 環 雜 氮η經 财 含 可 與一物 合 含 Ρ 化 如 例 基 之甲 成 . 形如 等例 唑ί 三 并 苯、 唑 咪 唑 ¾ 胺、 醢基 類 此 基 乙 經濟部中央標準局員工消費合作社印製 基 丙 異 基 丙 三 第 類、 基基 氧氧 焼 丁 6 - 、 C1基 基 三 第、 基二 第 基 丁 異 \ 基 如 例 基 代 硫 Λ 基 化 氧 基 硫 丙 基 基 硫 氧 丙 異 基 氧 丙 ' 基 氧 乙 Λ 基 氧 甲 溴 r 氯 氟 如 例、 /«V· 類 子 原 鹵 基 氧 硫 乙 ' 基 硫 甲 如 例 /f\ 類 基 硫 烷 例 含 包 類 酯 性 活 等如 代 取 所 類 酯 酸 類 酯 酸 磷 氧 苯二 類 酯 酸 磷 機對 有、 酯 笨 基 硝 如 例 4 2 磷笨 氧基 乙硝二 二 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 4 1 392 2 1 4.6 4649 A7 B7五、發明説明(42 ) 酯、氰甲酯、五氯笨基酯、N -羥基丁二睡亞胺酯、N -羥基 酞醮亞胺脂、1-羥基苯并三唑酷、6 -氯基-1-羥基笨并三 經濟部中央標準局員工消費合作社印製 族 J 丁 ¾類二 與Η第 基 ·· _> 烷 含 4 基 包1-丁 =異 酿 、 硫;* 性Ξ 了 活㈣、 。$基 酷一丙 酮類異 ® 酯、 他之基 2 成两 Η-形、 -1物基 基合乙 羥化、 1 酵基 及硫甲 酯環 , 唑雜如 、 基 )-氧 基丙 丁異 三 、 第基 、 氧 基丙 > 基 溴硫 、丁 氯、 、 基 氟硫 , 丙 如 、 Ο Γ—1 物 酿合 疏化 唑 皤 鋰類物 類 鹽 之 成 形 成 加 酸 及 氧 烷 基 氧 基、 氧一 甲基 ,氧 如 丁 例三 1(第 類 基、 類如 基例 ft 代 取 --► 等 基 氧 乙 例 /t\ 類 子 原 鹵 硫 烷 基 硫 乙 基 硫 甲 如 例 酯 巯 啶 Dtt 并 S- 3 鈉 ' 鉀 如 例 /( 類 靥 金 鹼 與 舉 例 鹽 之 酸 類之 雇成 金形 土酸 鹼與0 ( 類 、鹽 鹽 之 成 形 鎂 鈣 如 例 合 化 與 乃 酸 而 鹽 成 加 類 酸 之 舉 例 所 處 鹽 成 加 酸 成 形 合 均 劑 溶 之 應 反 此 擾 干 不 而 行 進 中 劑 溶 於 常 通 應 反 如 例 二 含醚 包甲 劑基 溶丁 等 三 此第 ο.' 用醚 選乙 宜 、 乙乙 及氯 酯三 乙 、 酸碳 乙化 、 氯 酷四 乙 、 酸仿 甲氯 如'、 如如 類 類 胺酮 醯 ., ; 胺 苯醯 甲乙 及基 苯甲 、二 .烷Ν-己R, 丙丁 及醢酮 異酸烯甲丙 喃類 呋酯 氫 四醚 、 甲 烷二 n§ii 二 二 如乙 類及 醚醚 烷正 甲如 氯類 二 烴 如 ·’ 類烷 烴乙 化氯 鹵二 ί ,, 2 S > 酿 1 及酮 胺丁 醯異 甲基 基甲 甲及 二 0 HV .乙 Ν 基 、 甲 胺、 基 甲 六The 7 R-based hydroxyl or hydrogen is shown. 8 R-based alkane hydrazone. A The low-level method or the upper hydrogen is as shown in the example os, and the alkane-type academic symbol in the fixed base reduces his description. The alkane-level low-level indicator 6 R The employee of the Central Standards Bureau of the Ministry of Economic Affairs Consumption cooperatives do not just base their protection on what can be a base. Protective group, alkyl-protecting, low-grade, low-molecular-weight rm CMM. Phase-a-R as described in 'Methoxybutane: three containing the first, the basic example of methyl ethyl oxy good methane is relatively stupid _' , Methylcothyl three is methyl I. oxy-2 transmethylmethoxyethyloxymethyltoluenemethyl, methylmethyl benzopyridine argon nitrate 3 --Eg pairs such as thios s; ott S Oxygen Hydroxyl protection_ Sibao 22- of, Cheng. * Base form of methylthiomethoxymethoxyethoxy para- 'dimethylbenzyl, thiofurfuryl tetramethyltoluene three and dimethylbenzyl nitrate I adjacent to the paper size Applicable to Chinese National Standards (CNS > ΑΊ specifications (210X297 mm) 39 392 2 1 4 6 4 S 4 9 Δ7 Α7 B7 V. Description of the invention (40); Silyl ether-protective groups such as trimethylsilyl , Triethylsilyl, triisopropylsilyl, isopropyldimethylsilyl, diethylisosilyl, third butyldimethylsilyl, third butyldiphenylsilyl, trityl Silyl groups, tribenzyl silyl groups and methyl diphenyl silyl groups; and the protective groups formed by _-, such as methyl, ethyl, and ethyl ethyl groups Dioxoethenyl, trichloroethenyl, trimethylethylglycosyl, and benzamidine. If Rs in formula (V) is hydrogen, compound (V) or a salt thereof reacts with compound (VI). Salts of compounds (V), such as the acid addition salts described with the acids described in the section where they form acid addition salts with compound (I). The reaction is usually carried out in a solvent, if necessary, in the presence of a tank. These solvents and amidines are the same as those described in the above method A. When this reaction is carried out, the compound (V 1) is used in the range of 1 to 10 moles per mole, preferably 1 To 5 moles. The reaction temperature is usually about -30 to 20010, preferably -10 to 1501C. The reaction time is usually 1 minute to 120 hours, preferably 15 minutes to 48 hours, depending on the types of compounds (V) and (VI). , Solvent, and the type of osmium, reaction temperature, etc. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Carp (please read the precautions on the back before filling this page). Manufacture of compound (I), also from compound (V ) And (VII) to obtain compound (VIII), and then cyclizing compound (VIII) to obtain it. This method And compound (VII) or a salt thereof and a compound (V), a salt thereof or a reactive derivative thereof. ≪ Specifically, a free acid (V), a salt thereof (inorganic salt, organic salt) Or • Its anti-fluorinated derivatives (for example, fluorenyl halide, enzyme-based azide, acid anhydride, mixed acid anhydride, active ammonium amine, active fat, active sulfur, etc.) for the amidine reaction. Inorganic salts include: starved gold靥 Salts (for example, sodium salt, potassium salt) and basic paper size are applicable to Chinese National Standard (CNS) A4 (210 X 297 mm) 40 3 92 2 1 464649 A7 _ B7 V. Description of the invention (41) Gold tincture salts (for example, calcium salts). Organic salts include, for example, trimethylamine salt, triethylamine salt, third butyldimethylamine salt, benzylmethylamine salt, benzyldimethylamine salt, N, H-dimethylaniline salt , Pyridine salts and phosphonium salts. The fluorenyl halides include, for example, fluorenyl chloride and fluorenyl bromide. Mixed acid anhydrides include: Mono-Ci-4 alkyl carbonate mixed acid anhydrides (for example, free acid (V) and monomethyl carbonate, monoethyl carbonate, monoisopropyl carbonate, monoisobutyl carbonate, Mixed anhydrides of butyl carbonate, monobenzylmethyl carbonate, mono (p-nitrobenzylmethyl) carbonate, monoallyl carbonate, etc.), Ci-6 aliphatic carboxylic acid mixed anhydrides (for example, free acid ( V) Mixed anhydrides with acetic acid, cyanoacetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, trimethylacetic acid, trifluoroacetic acid, trichloroacetic acid, acetic acid, etc.), C7- H aromatic carboxylic acid mixed acid anhydrides (for example, mixed acid anhydrides of free acid (V) and benzoic acid, p-toluic acid, p-chlorobenzoic acid, etc.) and organic sulfonic acid mixed acid anhydrides (for example, with methanesulfonic acid Acid, ethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid and other mixed anhydrides). Please read the precautions on the back before filling this page) and packages} Rings (V-Amino acid nitrogen 醢 is a formed product containing self-identifying amines 三 t-trimethylated cyclic aza nitrogen η The content can be combined with a substance containing P, such as the base of the example. Forms such as azole, tris, benzo, imimidazole, amine, and hydrazone, etc. This base is printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. Isopropylglycidyl group, base oxobutane 6-, C1 based triglycyl group, base diglycyl isobutyl group Propionyloxyethyl Λ oxymethyl bromide r chlorofluoro, for example, / «V · type protohalooxythioethyl 'methyl thiomethyl example, / f \ type sulfane examples containing encapsulating esters, etc. Substitute all kinds of ester acids, esters, phosphorous oxybenzenes, diesters, phosphoric acid, etc. For example, esters, esters, etc. 4 2 Phosphonic acid, ethyl nitrate, dibenzyl paper This paper applies the Chinese National Standard (CNS) A4 specification (210X297) (Mm) 4 1 392 2 1 4.6 4649 A7 B7 V. Description of the invention ( 42) ester, cyanomethyl, pentachlorobenzyl ester, N-hydroxysuccinimide, N-hydroxyphthalimide, 1-hydroxybenzotriazole, 6-chloro-1-hydroxyl Ben Bingsan, Ministry of Economic Affairs, Central Standards Bureau, Consumer Cooperatives, Printed Family, J D ¾ Class 2 and 二 Η · _ > Alkane contains 4 bases including 1-D = iso-fermented, sulfur; * properties ㈣ live ㈣,. $ Isopropyl acetone iso® esters, other radicals in two bis-forms, -1 alkynyl ethoxylation, 1 zymo and thiomethyl ring, oxazolyl, isopropyl) -oxypropyl isotriazine Benzyl bromide, butyl chloride, butyl bromide, butyl chloride, propyl sulfide, propyl thiophene, 〇 Γ -1 compounds to form oxazolyl lithium salts to form acid and oxyalkyloxy Radical, oxygen monomethyl, oxygen such as butyl example 3 1 (class radical, radical such as radical ft instead of --► etc. radicals such as ethyl radical / t \ proton halogen sulfanylthioethylthiomethyl as example Esters Thiolidine Dtt and S-3 Sodium 'Potassium as examples Examples of compounding with acid and salting into acids are where salt forming and acid forming are mixed and the solution should be disturbed instead of traveling. Rong Ding et al. 选. Ethyl ether, ethyl ethyl and chloroester triethyl, acid carbon ethylation, chlorotetraethyl, acid methyl chloride such as', such as amine ketones, etc. ;; Aminobenzoic acid ethyl and benzoic acid, dioxane N-hexane R, propyl butane and fluorenone isopropenoic acid furfuryl hydrogen tetraether, methane di n§ii dioxane such as ethyl and ether ether alkyl n-methyl Such as chlorinated dihydrocarbons such as · '-type alkane ethyl chloride halides, 2 S > 1 and ketoamine butyl isopropyl methyl methyl and 20 HV. Ethyl nitro, methylamine, methyl hexa
物 合 、 化 吩。 睡用 氫使 四劑 氧溶 二 合 、 混 獵或 亞獨 甲單 二 Μ 化 ., 劑耳 腈溶莫 丙等每 及此乃 腈 ·’ , 乙水量 如及用 類胺之 腈醯I) •,碟 V 耳 莫 ο 1 至 用 常 通 V /IV 物 合 較 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 42 3 922 1 464649 A7 B7 五、發明説明(43) 佳1至5莫耳。反應通常於-80至20(^,較佳-40至150¾ ,最佳-30至100¾進行。反應時間通常1分鐘至7 2小時, 較佳15分鐘至24小時,依化合物(V)及(VII)之種類、溶劑 之種類(若為混合溶劑,亦含混合比)、反應溫度等而不同 。若化合物(V)M醯基鹵使用,反應於脫氧劑之存在下進 行,Μ自反應糸統中移除所釋出之鹵化氫。此等脫氧劑包 含:例如,無機赖類如碳酸鈉、碳酸鉀、碳酸眄及碳酸i: 鈉;三級胺類如三乙胺、三丙胺、三丁胺、環己基二甲胺 、吡啶、二甲基吡啶、7 ^可力丁、Ν,Ν -二甲基苯胺、H-甲基六氫吡啶、Ν-甲基吡咯啶及Ν -甲基嗎福咐;及環氧類 如環氧丙垸及表氯醇。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 羥基保護基R8需要的話予以移除,然後,化合物 (VIII)經環化得化合物(I)。依保護基種類之不同。此脫 保護反應可依合宜選用之已知方法進行。脫保護反應之達 成例如,若為醚-形成之保護基,用酸(例如,甲酸、乙酸 、丙酸、鹽酸、硫酸、氫溴酸、磷酸、甲磺酸、乙磺酸、 對-甲笨磺酸)或經催化遒原反應[例如,於常懕或高壓(2 至1 0 0大氣壓)使用阮尼鎳、鉑、鈀、铑、等),作為催化 劑];若為矽烷基醚-形成之保護基,用上述酸之一或路易 士酸(例如,氯化鋅、溴化鋅、氯化鋁 '氯化鈦)或氣化物 (例如,氟化鉀、氟化納、氟化四乙銨、氟化四正丁銨); 或若為酯-形成保護基,用鹼(例如,碳酸氫鉀、碳酸氫納 、碳酸鉀、碳酸納、氫氧化鋰、氫氧化鉀、氫氧化納)。 反應通常於溶劑中進行;此等溶劑例如方法Α所用之溶劑 本紙張尺度適用中國國家標準(CNS > A4規格(2I0X297公釐) 43 3 922 1 4 6 4649 A7 B7 五、發明説明(44) 0 若為醚-形成之保護基或矽烷基魅*形成之保護基,酸 或路易士酸之用量,乃每莫耳化合物(V)通常用0·001至 1〇〇萁耳,較佳0.01至50奠耳。反應溫度通常為-50至 150Ρ,較佳-20至lOOt: °反應時間通常為1分鐘至72小 時,較佳15分鐘至48小時。 若為酿-形成之保護基,鹼之用最,乃每奠耳化合物 (V)通常用0,01至50莫耳,較佳0.1至20莫耳。反應溫度為 通常-20至150Ό,較佳-10至。反應時間為通常1分 鐘至72小時,較佳15分鐘至48小時。 經濟部中央標準局員工消費合作社印裂 (請先聞讀背面之注ί項再填寫本頁} 經脫保護基之化合物(VIII),予Μ環化成化合物U)° 此反應通常於溶劑中進行。此等溶劑例舉如方法兵所用之 溶劑。反應溫度為通常-10至200C,較佳-5至150¾°於 此反應,鹼可用作催化劑;此等鹼例舉為方法A所用之齡 。為促進反應,可用例如,2 -氯基-3-甲基苯并啤啤錄四 氟砸酸鹽、2-氯基-3-乙基苯并咩唑鎗四氟硼酸鹽、2-氯-3-甲基苯并1«唑鎗四氟砸酸鹽、2-氯-3-乙基苯并睡唑鑰 氟硼酸鹽、2 -氯基-1-甲基吡啶鎗四氟硼酸鹽及2 -氯基-1-乙基吡啶綸四氟硼酸鹽。反應促進劑之用量,乃每奠耳化 合物(VIII)用通常1至10莫耳,較佳1萆3莫耳。若用反 應促進劑,亦可用醮。此等鹸例舉如方法A所用之醮°反 應溫度為通常-30至1501,較佳-20至100¾。反應時間通 常1分鐘至72小時,較佳15分鐘至48小時。 若R3及R4中之一為可具有取代基之醢基、經酯化之羧 本紙張尺度適用中國國家摞举(CNS ) A4規格(210X297公釐) 44 39 2 21 464649 A7 B7 五、發明説明(45) 基或胺甲醢基,化合物(I)可依下述方法C、D及E製得之 0 於化學式(I)化合物中之化合物(lb)(其中R3或R4具醸 基)可依方法C製得之。Compounding and phenochemistry. Sleep with hydrogen to make four doses of oxygen-soluble dioxin, mixed hunting, or methylene monodimerization., Acetonitrile, molybdenum, etc. are nitriles, and the amount of ethyl water is the same as that of amine-like nitriles (I). •, disc V ear Mo ο 1 to Changtong V / IV comparison (please read the precautions on the back before filling this page) This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 42 3 922 1 464649 A7 B7 V. Description of the invention (43) Preferably 1 to 5 moles. The reaction is usually performed at -80 to 20 °, preferably -40 to 150¾, and most preferably -30 to 100¾. The reaction time is usually 1 minute to 72 hours, preferably 15 minutes to 24 hours, depending on the compound (V) and ( The type of VII), the type of the solvent (if it is a mixed solvent, also the mixing ratio), the reaction temperature, etc. are different. If the compound (V) M is used, the reaction is carried out in the presence of a deoxidizing agent, and M is reacted automatically. The hydrogen halide released is removed from the system. These deoxidants include, for example, inorganic lysines such as sodium carbonate, potassium carbonate, osmium carbonate and sodium carbonate: tertiary amines such as triethylamine, tripropylamine, Butylamine, cyclohexyldimethylamine, pyridine, dimethylpyridine, 7-collidine, N, N-dimethylaniline, H-methylhexahydropyridine, N-methylpyrrolidine and N-methyl Modal orders; and epoxy such as propylene oxide and epichlorohydrin. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). The hydroxyl protecting group R8 should be removed if necessary. Then, compound (VIII) is cyclized to obtain compound (I). Depending on the type of protecting group, this deprotection reaction It is carried out according to a known method selected by Dee. The deprotection reaction is achieved, for example, if it is an ether-protecting group, using an acid (for example, formic acid, acetic acid, propionic acid, hydrochloric acid, sulfuric acid, hydrobromic acid, phosphoric acid, methanesulfonic acid). , Ethanesulfonic acid, p-toluenesulfonic acid) or catalyzed rhenium reactions [for example, using Raney nickel, platinum, palladium, rhodium, etc. at constant pressure or high pressure (2 to 100 atmospheres) as a catalyst ]; For a silyl ether-forming protective group, use one of the above acids or Lewis acid (eg, zinc chloride, zinc bromide, aluminum chloride 'titanium chloride) or a gaseous product (eg, potassium fluoride , Sodium fluoride, tetraethylammonium fluoride, tetra-n-butylammonium fluoride); or if it is an ester-forming protective group, use a base (for example, potassium bicarbonate, sodium bicarbonate, potassium carbonate, sodium carbonate, lithium hydroxide , Potassium hydroxide, sodium hydroxide). The reaction is usually carried out in a solvent; these solvents, such as those used in Method A, are applicable to Chinese national standards (CNS > A4 size (2I0X297 mm)) 43 3 922 1 4 6 4649 A7 B7 V. Description of the invention (44) 0 If it is an ether-forming protective group or a silane-based protective group, the amount of acid or Lewis acid is usually from 0.001 to 100 moles per mole of compound (V), preferably 0.01 To 50 mol. The reaction temperature is usually -50 to 150P, preferably -20 to 100t: ° The reaction time is usually 1 minute to 72 hours, preferably 15 minutes to 48 hours. If it is a protective group formed, the base The most commonly used is that 0,01 to 50 moles, preferably 0.1 to 20 moles per mole of compound (V). The reaction temperature is usually -20 to 150 ° F, preferably -10 to. The reaction time is usually 1 Minutes to 72 hours, preferably 15 minutes to 48 hours. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the note on the back before filling out this page) The deprotected compound (VIII) is given to Μ Cyclization to compound U) ° This reaction is usually carried out in a solvent. Such solvents are exemplified by methods Solvent. The reaction temperature is usually -10 to 200C, preferably -5 to 150 ¾. At this reaction, a base can be used as a catalyst; these bases are exemplified by the age of Method A. To promote the reaction, for example, 2-chloro Tetrafluoromethyl salt, 2-chloro-3-ethylbenzoxazole tetrafluoroborate, 2-chloro-3-methylbenzo1 Tetrafluoroammonium salt, 2-chloro-3-ethylbenzimidazole fluoroborate, 2-chloro-1-methylpyridine tetrafluoroborate, and 2-chloro-1-ethylpyridine Tetrafluoroborate. The amount of the reaction accelerator is usually 1 to 10 moles, preferably 1 to 3 moles per mole of the compound (VIII). If a reaction accelerator is used, osmium can also be used. Examples of these include The reaction temperature at 醮 ° as used in Method A is usually -30 to 1501, preferably -20 to 100¾. The reaction time is usually 1 minute to 72 hours, preferably 15 minutes to 48 hours. If one of R3 and R4 is available, Substituted fluorenyl groups and esterified carboxyl paper sizes are applicable to China National Examination (CNS) A4 specifications (210X297 mm) 44 39 2 21 464649 A7 B7 V. Description of the invention (45) or carbamoyl groups, Compound (I) Method C was prepared to follow the above methods C, D and E in the chemical 0 in formula (I) compounds of the compound (LB) (wherein R3 or R4 group having Niang) to give the.
R4bCOOH (IX)R4bCOOH (IX)
R4bS〇3H (X) 於此等化學式中,1?4&示醯基;R4b示自醢基中移除羰 基或磺醢基後之基;其他符號之定義悉如上述。 R4a所示之醯基指R4所示之醢基;R4bm示”自醢基中 移除猿基或磺醯基後之基"指R4所示之醯基。 經濟部中央標準局負工消費合作社印裝 (請先閱讀背面之注意事項再填寫本頁)R4bS03H (X) In these chemical formulas, 1-4 & shows a fluorenyl group; R4b shows a group after removing a carbonyl or sulfonyl group from a fluorenyl group; the definitions of other symbols are as described above. The base shown by R4a refers to the base shown by R4; R4bm shows "the base after removing the ape or sulfo base from the base" " refers to the base shown by R4. Offset consumption of the Central Standards Bureau of the Ministry of Economic Affairs Cooperative printed (please read the notes on the back before filling this page)
R3 R4a R1 R2 〇R3 R4a R1 R2 〇
依此反應,化合物(la)或其鹽可與化合物(IX)或(X) 或其反應性衍生物,經醢化得化合物Ub)。化合物(la)之 鹽例舉如化合物(I)之鹽處所述之相同酸加成鹽。化合物 (IX)之反應性衍生物例舉如方法B所述之反應性衍生物。 化合物(X)之反應性衍生物例舉如磺醯_類(例如,磺醢溴 、磺醯氯)及磺酸酐;此反應依方法B所述之方法或其改 良方法進行。 於化學式(I)之化合物中.化合物(Ic)(乃R4具酯化羧 基者)可依方法D製得之。 本紙張尺度適用中國國家標準(CNS ) A4规格(210X 297公釐) 45 3 9 22 1 464649五、發明説明(46) 方法1) A7 B7 (la) QR4c (Xi) R1 R2 ΟAccording to this reaction, compound (la) or a salt thereof can be compounded with compound (IX) or (X) or a reactive derivative thereof to obtain compound Ub). The salt of the compound (la) is exemplified by the same acid addition salt as described for the salt of the compound (I). The reactive derivative of the compound (IX) is exemplified by the reactive derivative described in Method B. Examples of the reactive derivative of the compound (X) include sulfonium (e.g., sulfonium bromide, sulfonium chloride) and sulfonic anhydride; this reaction is carried out according to the method described in Method B or a modified method thereof. Among the compounds of formula (I). Compound (Ic) (where R4 has an esterified carboxyl group) can be prepared according to method D. This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 45 3 9 22 1 464649 V. Description of invention (46) Method 1) A7 B7 (la) QR4c (Xi) R1 R2 Ο
R3 經濟部中央標準局員工消費合作社印製 於此等化學式中,R4e示酷化羧基;Q示齒原子;其 他符號..之定義悉如上述。 R4c及R4所示可經酯化之羧基中,除了自由羧基K外 之任一基。 Q所示之_素例舉如氟、氯、溴及碘。此反應乃使化 合物(la)或其鹽與化合物(XI)反應而進行。化合物(la)之 鹽例舉如上述反應D之化合物(la)之酸加成鹽處所述之酸 加成鹽。此反應通常於溶劑中進行;溶劑例舉如方法B所 用之溶劑。於此反應,釋出鹵化氫。為移除鹵化氫,反應 可於酸清除劑之存在下進行。酸清除劑包含,例如,無機 鹼類如碳酸鈉、碳酸鉀、碳酸鈣及碳酸氫納;三級胺類如 三乙胺、三丙胺、三丁胺、環己基二甲胺、吡啶、二甲基 吡啶、7 h可力丁、d,N -二甲基苯胺、N -甲基六氫吡啶、 K-甲基吡咯啶及N -甲基嗎襌啉;及環氧丙烷及表氯酵。 化合物(XI)之用量,乃每莫耳化合物Ua)通常1至20 萁耳,較佳1至10莫耳。反應溫度通常為-30至120t:,較 佳-20至80¾。反應時間通常1分鐘至72小時,較佳15分 鐘至4 8小時。 (請先閲讀背面之注意事項再填寫本頁) 本紙浪尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 46 3 922 1 46 4649 A7 B7 經濟部中央標準局負工消費合作社印製 五、發明説明(47) 於化學式(I)之化合物中,化合物(Ic|)(乃具可經取代 之胺甲醯基者 可依方法E製得之。R3 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. In these chemical formulas, R4e indicates a carboxyl carboxyl group; Q indicates a tooth atom; other symbols .. Among the carboxyl groups which R4c and R4 can be esterified, any group other than the free carboxyl group K is used. Examples of _ elements shown by Q include fluorine, chlorine, bromine and iodine. This reaction is carried out by reacting the compound (la) or a salt thereof with the compound (XI). The salt of the compound (la) is exemplified by the acid addition salt of the compound (la) of the reaction D described above. This reaction is usually performed in a solvent; the solvent is exemplified as the solvent used in the method B. At this reaction, hydrogen halide is released. To remove the hydrogen halide, the reaction may be performed in the presence of an acid scavenger. Acid scavengers include, for example, inorganic bases such as sodium carbonate, potassium carbonate, calcium carbonate and sodium bicarbonate; tertiary amines such as triethylamine, tripropylamine, tributylamine, cyclohexyldimethylamine, pyridine, dimethyl Pyridine, 7-hour collidine, d, N-dimethylaniline, N-methylhexahydropyridine, K-methylpyrrolidine and N-methylmorpholine; and propylene oxide and epichloromethane. The compound (XI) is used in an amount of usually 1 to 20 moles, preferably 1 to 10 moles per mole of the compound Ua). The reaction temperature is usually -30 to 120 t :, preferably -20 to 80¾. The reaction time is usually 1 minute to 72 hours, preferably 15 minutes to 48 hours. (Please read the precautions on the back before filling this page) The paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 46 3 922 1 46 4649 A7 B7 2. Description of the invention (47) Among the compounds of the formula (I), the compound (Ic |) (which may have a substituted carbamoyl group may be prepared according to method E).
方法EMethod E
於此等化學式中,R4d示可經取代之胺甲醢基;R3、 R10及R11,乃相同或不同,示氫或R4所示可經取代之胺甲 醯基中取代基處所述之相同取代基;其他符號之定義悉如 上述。 . 依此方法,化合物(Ic)或其鹽可與化合物(XII)反應, 獲得化合物(Id)。化合物(Ic)之鹽例舉如化合物(I)之鹽 處所述之相同酸加成鹽。此反應通常於溶劑中進行;溶劑 例舉如方法A所用之溶劑。化合物(XII)之用量,乃每莫 耳化合物(Ic)通常用1至100莫耳,較佳1至30莫耳。反 應溫度通常-30至200Ό,較佳-10至10 0$。反應時間通常 1分鐘至72小時,較佳15分鐘至48小時。 化合物(Id)亦可藉使化合物(la)與異氤酸鹽衍生物 (XIII)反應而製得◊此反應通常於溶劑中進行。該溶劑可 為任一溶劑,只要不干擾反應即可。例如,醚類如二啤烷 --------Ί)^-- C- (請先鬩讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨ΟΧ297公釐) 47 3 9 22 1 .4b4b4^ 4 6 46 49 a? B7 五、發明説明(48) 、四氫呋喃、乙醸、第三丁基醚、二異丙醚及乙二醇-二 甲醚;酯類如甲酸乙酯、乙酸乙酯及乙酸正丁酷;鹵化烴 類如二氯甲烷、氯仿、四氯化碳、三氯乙烯及1,2 -二氯乙 烷;烴類如正己烷、苯及甲苯;藤胺類如甲醯胺、Ν,Ν-二 甲基甲醢胺及Ν,Η-二甲基乙醸胺;酮類如丙酮、甲基乙酮 及甲基異丁鬭;腈類如乙腈及丙腈;二甲亞通、二氧四氫 18吩、六甲基磷酿胺;此等溶劑乃軍獨或成混合溶劑使用 化合物(XIII)之用量,乃每莫耳化合物(la)用通常1 至30莫耳,較佳1至15莫耳。反應溫度通常為-20至150t ,較佳為-10至100 υ。反應時間通常1分鐘至72小時,較 佳1 5分鐘至4 8小時。In these chemical formulae, R4d represents a carbamoyl group which may be substituted; R3, R10 and R11 are the same or different, showing hydrogen or the same as described in the substituent in the carbamoyl group which may be substituted. Substituents; other symbols are as defined above. According to this method, the compound (Ic) or a salt thereof can be reacted with the compound (XII) to obtain the compound (Id). The salt of the compound (Ic) is exemplified by the same acid addition salt as described for the salt of the compound (I). This reaction is usually performed in a solvent; the solvent is exemplified as the solvent used in the method A. The compound (XII) is used in an amount of usually 1 to 100 moles, preferably 1 to 30 moles per mole of the compound (Ic). The reaction temperature is usually -30 to 200 ° C, preferably -10 to 100 $. The reaction time is usually 1 minute to 72 hours, preferably 15 minutes to 48 hours. The compound (Id) can also be prepared by reacting the compound (la) with an isocyanate derivative (XIII). This reaction is usually carried out in a solvent. The solvent may be any solvent as long as it does not interfere with the reaction. For example, ethers such as dimer -------- Ί) ^-C- (Please read the precautions on the back before filling out this page) The size of the paper is applicable to China National Standard (CNS) Α4 specifications (2 丨 〇 × 297mm) 47 3 9 22 1. 4b4b4 ^ 4 6 46 49 a? B7 V. Description of the invention (48), tetrahydrofuran, acetamidine, tertiary butyl ether, diisopropyl ether and ethylene glycol- Dimethyl ether; esters such as ethyl formate, ethyl acetate and n-butyl acetate; halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, trichloroethylene and 1,2-dichloroethane; hydrocarbons Such as n-hexane, benzene, and toluene; amines such as formamide, Ν, Ν-dimethylformamide, and Ν, 二 -dimethylacetamide; ketones such as acetone, methyl ethyl ketone, and methyl Isobutyrium; nitriles such as acetonitrile and propionitrile; dimethylarylene, dioxolane 18 phen, hexamethylphosphonium amine; these solvents are used alone or as a mixed solvent in the amount of compound (XIII), 1 to 30 moles, preferably 1 to 15 moles per mole of compound (la) is used. The reaction temperature is usually -20 to 150 t, preferably -10 to 100 υ. The reaction time is usually 1 minute to 72 hours, more preferably 15 minutes to 48 hours.
方法F {請先閱讀背面之注意事項再填寫本頁) ηMethod F (Please read the notes on the back before filling this page) η
(XVI) 鯉濟部中央標準局員工消費合作社印製 水解 或氫解 R 12(XVI) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Carpling Hydrolysis or Hydrolysis R 12
R3 R4 加熱 (I) 於此等化學式中,R12示氫、低级烷基、環焼基、芳 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 48 39 2 2 1 經濟部中央標準局舅工消費合作社印製 4 6 4 6 49 Α7 Β7 五、發明説明(49) \ 烷基或醯基;R 13及R14,乃相同或不同,示氫或低級烷基 ;R15示氩、低级烷基或芳烷基ί R16示低级烷基或芳基; 其他符號之定義悉如上述。 於化學式(XIV)中,R12所示之低級烷基例舉具1至6 個碳原子之烷基,如甲基、乙基、丙基、異丙基、丁基、 異丁基、第二丁基、第三丁基、戊基、異戊基、新戊基、 第三戊基、1-乙基丙基、己基、異己基、1,1-二甲基丁基 、2,2-二甲基丁基、3,3-二甲基丁基及2-乙基丁基,較佳 為具1至4個碳原子之烷基,如甲基、乙基、丙基、異丙 基、丁基及異丁基。R12所示之環烷基,例舉環丙基、環 丁基、環戊基、環己基、環庚基、環辛基及環壬基,較佳 為環丙基、環丁基、環戊基及環己基。R12所示之芳烷基, 例舉苯甲基、笨乙基及苯丙基。 R12所示之醯基,例舉脂族_基如烷醯基、烯醸基、 / 環烷羰基及及烷磺醗基;芳族醢基如芳醢基、芳烷醸基、 芳烯醢基及芳烴磺醯基;雜環芳族醢基如芳族雜環羰基及 芳族雜環烷醢基;及非芳族雜環羰基(脂族雜環羰基)。 "烷醯基"指垸羰基,其較佳之實例包含:具1至8 個碳原子之低級烷醯基,如甲醯基、乙醢基、丙醢基、丁 醢基、異丁醯基、戊醸基、異戊酿基、3甲基乙醯基及己 釀基。 "烯醢基"指烯羰基,其較佳之實例包含:C3-6烯醯 基,如丙烯釀基、甲基丙烯醯基、Β豆醢基及異巴豆醯基 0 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 4 9 3 92 2 1 (請先聞讀背面之注意事項再填寫本頁)R3 R4 Heating (I) In these chemical formulas, R12 shows hydrogen, lower alkyl, cyclofluorenyl, and aromatic paper. The paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 48 39 2 2 1 Central Standard of the Ministry of Economic Affairs Printed by the Bureau ’s Consumer Cooperatives 4 6 4 6 49 Α7 Β7 V. Description of the Invention (49) \ Alkyl or fluorenyl; R 13 and R14 are the same or different and show hydrogen or lower alkyl; R15 shows argon and lower Alkyl or aralkyl R16 represents a lower alkyl or aryl group; the definitions of other symbols are as described above. In the chemical formula (XIV), examples of the lower alkyl group represented by R12 include alkyl groups having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, and second Butyl, third butyl, pentyl, isopentyl, neopentyl, third pentyl, 1-ethylpropyl, hexyl, isohexyl, 1,1-dimethylbutyl, 2,2- Dimethylbutyl, 3,3-dimethylbutyl and 2-ethylbutyl, preferably alkyl groups having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl , Butyl and isobutyl. The cycloalkyl group represented by R12 is exemplified by cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and cyclononyl, preferably cyclopropyl, cyclobutyl, cyclopentyl And cyclohexyl. Examples of the aralkyl group represented by R12 include benzyl, benzyl, and phenylpropyl. The fluorenyl group represented by R12 is exemplified by aliphatic radicals such as alkylfluorenyl, alkenyl, / cycloalkylcarbonyl, and alkylsulfonyl; aromatic fluorenyl such as arylfluorenyl, aralkylfluorenyl, and arenefluorenyl And aromatic hydrocarbon sulfonyl groups; heterocyclic aromatic fluorenyl groups such as aromatic heterocyclic carbonyl groups and aromatic heterocycloalkanoyl groups; and non-aromatic heterocyclic carbonyl groups (aliphatic heterocyclic carbonyl groups). " Alkino " refers to fluorenyl carbonyl. Preferred examples include: lower alkyl fluorenyl having 1 to 8 carbon atoms, such as methyl, ethyl, propyl, propyl, butyl, isobutyl, and pentyl. Base, isoamyl, 3methylacetamyl and hexamethylene. " Alkenyl " refers to alkenyl carbonyl, and its preferred examples include: C3-6 alkenyl, such as acryl, methacryl, methacryl and isocrotonyl. 0 This paper is applicable to China National Standard (CNS) Α4 Specification (210X297 mm) 4 9 3 92 2 1 (Please read the precautions on the back before filling this page)
A7 B7 164649 五、發明説明(50) (請先閲讀背面之注意事項再填寫本頁) ”環烷羰基”指環烷基羰基,其較佳之實例包含:具 4至7個碳原子之環烷羰基,如環丙羰基、環丁羰基、環 戊羰基及環己羰基。 ”烷磺醸基"指烷基磺醢基,其較佳之實例包含:具 1至4個碳原子之烷基磺醢基,如甲磺醢基、乙磺酿基及 丙磺醸基。 , •’芳酿基”指芳羰基,其較佳之實例包含:具7至11 個碳原子之芳羰基,如苯甲醢基、對-甲笨豳基、1-萘甲 醯基及2-禁甲醢基。 "芳烷醯基”指經芳基取代之垸羰基,較隹之實例包 含:C6-8芳基- C2-5烷酿基,如笨乙醢基、苯丙醸基、氫 阿托醢基及苯丁醢基。 ”芳烯醢基"指經芳基取代之烯羰基,其較佳之實例 包含:C6-8芳基C3-5烯酿基,如挂皮醸基及阿托釀基。 ”芳烴磺醢基"指芳基磺醢基,其較佳之實例包含: 具6至8個碳原子之芳磺豳基,如笨磺醢基及對-甲苯磺 醢基。 經濟部中央標準局負工消費合作社印製 ”芳族雜環羰基”較佳之實例包含:呋喃甲醯基、噬 吩甲醯基、菸鹼甲醢基、異菸鹼甲酿基、吡咯羰基、鸣唑 羰基、噬唑羰基、眯唑羰基及吡唑羰基。 ”芳族雜環烷酿基”指經芳族雜環基取代之烷羰基, 其較佳之實例包含:芳族雜環-C2-5烷酿基,如1¾吩乙豳 基、®吩丙醢基、呋喃乙醢基、噬唑乙豳基、1,2,4-«二 唑乙豳基及吡啶乙豳基。 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 5 0 3 922 1 46A649 A7 B7 五、發明説明(51) "非芳族雜環羰基”較佳之實例包含:脂族雜環羰基 ,如吖丁啶羰基、吡咯啶羰基及六氫吡啶羰基。 於他學式(XIV)、 (XV)及(XVI)中,R13、Ri4、R15或 R16所示之低级烷基,例舉如R12所示之低級烷基。1MS所 示之芳烷基例舉如R12所示之芳烷基。R16所示之芳基例舉 苯基、萘基、憩基、菲基及苊烯萘基,較隹為苯基及萘基 。此等芳基可具有1至5個取代基。此等取代基包含:具 „1至3個碳原子之烷基(如,甲基、乙基、丙基)、具1至 3個碳原子之烷氧基(如,甲氧基、乙氧基、丙氧基)及鹵 原子(如,氟、氟、溴、碘)。 依此方法,化合物UIV)及(XV)於化合物(XVI)之存在 下反應,獲得化合物(XVII)。 經濟部中央標準局員工消費合作社印製 (請先聞讀背面之注意事項再填寫本頁) 此反應通常於溶劑中進行;溶劑乃合宜選用不干擾反 應之溶劑。此等溶劑包含:例如,醇類如甲酵、乙酵、丙 醇、異丙醇、丁醇及第三丁醇;醚類如二鸣垸、四氫呋喃 、乙醚、第三丁基甲醚、二異丙醚及乙二醇-二甲醚;酯 類如甲酸乙酯、乙酸乙酯及乙酸正丁酯;鹵化烴類如二氯 甲烷、氯仿、四氯化碳、三氯乙烯及1,2 -二氛乙烷;烴類 如正己烷、苯及甲苯;醢胺類如甲醢胺、Η,Ν-二甲基甲醯 胺及Ν,Ν-二甲基乙醯胺;闞類如丙酮、甲基乙酮及甲基異 丁酮;睛類如乙睛及丙腈;二甲亞碾、二氧四氫!《吩、六 甲基瞵醯胺及水;此等溶劑从單獨或混合溶劑使用。 反應溫度通常為-80至1501C,較佳為-50至120¾。各 化合物(XV)及(XVI)之用董,乃每萁耳化合物(XIV)通常用 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X297公釐) 51 39 2 2 1 4. 6 4 6 4 9 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明( 52 ) 1 I 1 至 5 莫 耳 » 較 佳 1 至 3 Μ 耳 0 1 1 然 後 化 合 物 (XV I I)之酯進 行 水 解 > m 解 等 f 獲 得化 1 1 合 物 (XVIII) > 1 I 此 氫 解 反 應 通 常 於 溶 劑 中 進 行 ♦ , 溶 劑 乃 合 宜 選 用 不干 請 閱 1 1 I 擾 反 應 之 溶 劑 0 此 等 溶 劑 包 含 X 例 如 9 酵 類 如 甲 醇 % 乙醇 讀 背 面 1 ί 丙 醇 % 異 丙 醇 丁 醇 及 第 丁 醇 ; 醚 類 如 二 D咢 烷 四氫 之 注 意 事 項 再 1 1 呋 喃 乙 醚 > 第 三 丁 基 甲 醚 、 二 異 丙 醚 及 乙 二 酵 -二甲醚; 1 1 鹵 化 烴 類 如 二 氯 甲 烷 氯 仿 四 氯 化 碳 > 三 氯 乙 烯及1 ,2- 填 寫 本 ) 装 二 氮 乙 烷 9 烴 類 如 正 己 烷 笨 及 甲 苯 * 釅 胺 類 如 甲 豳 胺、 頁 1 1 H, N - 二 甲 基 甲 醢 胺 及 Η, Ν - 二 甲 基 乙 豳 胺 酮 類 如 丙 酮 、甲 1 1 基 乙 m 及 甲 基 田 異 丁 酮 * 腈 類 如 乙 腈 及 丙 腈 二 甲 亞 獵 、二 1 I 氧 四 氫 睡 吩 % 甲 基 磷 醢 胺 及 水 此 等 溶 劑 >λ 單 獨 或 混合 訂 I 溶 劑 使 用 〇 1 1 | 此 反 應 於 鹼 之 存 在 下 進 行 〇 所 用 之 鹼 較 佳 包 含 : 金屬 1 1 I 氫 氧 化 物 如 氫 氧 化 鋰 氫 氧 化 鉀 氫 氧 化 納 及 氫 氧 化 鋇; 1 " X 及 金 靥 碳 酸 鹽 類 如 碳 酸 鉀 Λ 碳 酸 鈉 及 碳 酸 鋇 〇 鹼 之 用 置》 3 1 乃 每 奠 耳 化 合 物 (XVII)通常用 1 至30莫耳 » 較 佳 1 至 10莫 1 1 耳 0 反 US' 腥 溫 度 通 常 為 -30 至 15〇υ f 較 佳 為 -10至 120υ 。反 1 I 應 時 間 通 常 為 15分 鐘 至4 8小 時 較佳為30分鐘至 2 4小 時。 1 I 若 化 合 物 (XVIII)M氫解反應製造, 此反應通常用催 1 1 I 化 劑 進 行 0 此 催 化 劑 乃 催 化 遢 原 反 應 所 用 較 佳 之 催 化 劑, 1 1 例 舉 鉑 催 化 劑 類 (如, 氧化鉑, '鉑黑 4納- 碳 ) 、鈀催化劑 1 1 類 (如, 氯化鈀· 、鈀- 碳 \ 鈀 -碳酸鈣 、鈀- 硫 酸 鋇 ) 、铑催 1 1 化 劑 類 (如, 铑- 碳 姥 -氧化鋁)及釕催化劑類 (如, 氧化 1 1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 5 2 3 9 2 2 1 A7 B7 4 6 46 49 五、發明説明(53) (請先聞讀背面之注意事項再填寫本頁) 釕、釕-碳),較佳為鈀催化劑類。此反應通常於溶劑中進 行;溶劑乃合宜選用不干擾反應之溶劑。此等溶劑包含: 例如,醇類如甲醇、乙醇、丙醇、異丙醇、丁醇及第三丁 酵;醚類如二鸣烷、四氫呋喃、乙醚、第三丁基甲醚、二 異丙醚及乙二酵-二甲醸;酯類如甲酸乙酯、乙酸乙酯及 乙酸正丁酯;烴類如正己烷、笨及甲苯;醢胺類如甲醯胺 、Κ,Ν -二甲基甲醢胺及Ν,Ν -二甲基乙醯胺ί及水;此等溶 劑Μ單獨或混合溶劑使用。 反應溫度通常為-10至120Ό,較佳為0至lOOt:。雖 然此反應通常於常壓進行,但有時應可於高壓下進行。壓 力較佳為1至200大氣壓。 經濟部中央標準局員工消費合作社印製 化合物(XV III)可經加熱脫碳,獲得化合物(I)。此反 應通常於溶劑中進行;溶劑乃合宜選用不干搛反應之溶劑 。此等溶劑包含:例如,醇類如甲酵、乙酵、丙酵、異丙 醇、丁醇及第三丁醇;醚類如二啤烷、四氫呋喃、乙醚、 第三丁基甲醚、二異丙醚及乙二醇-二甲醚;賄類如甲酸 乙酯、乙酸乙酯及乙酸正丁酯;鹵化烴類如二氯甲烷、氛 仿、四氯化碳、三氯乙烯及1,2 -二氯乙烷;烴類如己烷、 苯及甲苯;醢胺類如甲醢胺、Η,Ν-二甲基甲醸胺及Κ,Ν-二 甲基乙醢胺;酮類如丙酮、甲基乙圈及用基異丁酮;腈類 如乙腈及丙腈;二甲亞通、二氧四氫睡吩、六甲基磷醢胺 及水;此等溶劑Κ單獨或混合溶劑使用。 反應溫度通常為0至1801C,較佳為10至150¾。反應 時間通常為5分鐘至24小畤,較佳為10分鐘至12小時。 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 53 39 22 1 c /i 5 49 A7 ' ___ B7 五、發明説明(5 4) 若上述各反應所涉及之化合物具胺基、羧基或羥基作 經濟部中央標準局負工消費合作社印製 基物 護合 保化 之之 用要 常所 域得 領獲 他而 其基 及護 學保 化除 肽移 脞可 併 -合話 可的 基要 此需 基後 代應 取反 基 醯 甲 如 例 含 包 基 護 保 基 胺 之 用 有 基 羰 乙 、 基 豳 乙 如 /V 基 三 第 基 甲 笨 羰 烷 甲 笨 ' 基 羰 氧 基 羰 苯 > 基 羰 氧 丙 烯 基 羰 氧 甲 0 基 羰 氧 乙 ' 基 羰 氧 甲 9 ' 基S 羰基 氧羰 氧 烷 ) 經 基可 羰基 甲等 及 基 醯 酞、 基 甲 苯 三 氟 如 yi. 子 原 鹵 個 3 至 含 包 基 護 保 基 3 丁至 三 1 第經 、 可 基基 丁等 、 此 基基。 羧丙基 之異丙 用、烯 有基及 丙基 、 甲 溴 基 7 如 基 羰 烷 芳 基 甲 亞 、 基)> 胺溴 甲 、 二 氯 苯 此 代 取 等 基 硝 基 乙 ' 基 甲 如 /ί, 基 烷 基 苯 子 原 鹵 個 苯氯'、 基氟 烷 , 矽如 (請先閱讀背面之注意事項再填寫本頁) 代 取 等 基 硝 基 甲 氧 甲 含 包 基 護 保 - 基 羥 之 用 有 如 fv 基 烷 芳 基 甲 苯 基 酿 甲 三基 第羰 、 烷 基-6 西C1 烯、 如 基 羰 甲 苯 基 酺 @1 苯 如 可 基 基等 羰此 烷。 芳基 10烷 7-砂 C基 、烷 三 及 基 喃 广味 基 、 羰基 乙喃 基 、 ). 豳 乙 溴 ' 氯 7 ' 氣基 如丙 (itl異 子、 原基 鹵丙 個 、 3 基 至乙 1 、 經基 基 甲» 、 如基 8(¾ 基 -6基 C1Η 、 三 I第A7 B7 164649 V. Description of the invention (50) (Please read the notes on the back before filling out this page) "Cycloalkylcarbonyl" refers to cycloalkylcarbonyl, and its preferred examples include: cycloalkylcarbonyl with 4 to 7 carbon atoms , Such as cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl and cyclohexylcarbonyl. "Alkylsulfonyl" refers to alkylsulfonyl, and preferred examples thereof include alkylsulfonyl having 1 to 4 carbon atoms, such as methylsulfonyl, ethylsulfonyl, and sulfonylsulfonyl. "Aromatic" refers to an arylcarbonyl group, and preferred examples thereof include an arylcarbonyl group having 7 to 11 carbon atoms, such as benzamyl, p-methylbenzyl, 1-naphthylmethyl, and 2- Forbidden. " Aralkylfluorenyl "refers to fluorenyl carbonyl substituted with aryl. Examples include: C6-8aryl-C2-5 alkyl alcohol, such as benzyl, phenylpropanyl, and hydrogen atomol. "Phenyl" and "phenylalkenyl" refers to an alkenyl group substituted with an aryl group, and preferred examples thereof include: C6-8 aryl C3-5 alkenyl groups, such as epithelyl and atropyl. "Aromatic sulfonyl" refers to arylsulfonyl. Preferred examples include: arylsulfonyl having 6 to 8 carbon atoms, such as benzylsulfonyl and p-toluenesulfonyl. Central standard of the Ministry of Economic Affairs Preferable examples of "aromatic heterocyclic carbonyl" printed by local consumer cooperatives include: furanomethane, phenphenamidine, nicotinemethane, isonicotinylmethyl, pyrrolecarbonyl, oxazole carbonyl, Pyrazole carbonyl, oxazole carbonyl, and pyrazole carbonyl. "Aromatic heterocycloalkyl" refers to an alkylcarbonyl substituted with an aromatic heterocyclic group, and preferred examples include: aromatic heterocyclic-C2-5 alkyl , Such as 1¾ phenethylfluorenyl, phenpropylfluorenyl, furan acetylfluorenyl, oxazolidinyl, 1,2,4- «diazolethylfluorenyl, and pyridylacetinyl. This paper size applies to Chinese national standards (CNS) A4 specification (210X297 mm) 5 0 3 922 1 46A649 A7 B7 V. Description of the invention (51) " Non-aromatic heterocyclic carbonyl "Preferred examples include: aliphatic heterocyclic carbonyl, such as azetidine carbonyl , Pyrrolidine carbonyl and hexahydropyridine carbonyl. In other formulae (XIV), (XV) and (XVI), the lower alkyl group represented by R13, Ri4, R15 or R16 is exemplified by the lower alkyl group represented by R12. The aralkyl group shown in 1MS is exemplified as the aralkyl group shown in R12. Examples of the aryl group represented by R16 include phenyl, naphthyl, aryl, phenanthryl, and pinenaphalyl, and phenyl is more than phenyl and naphthyl. These aryl groups may have 1 to 5 substituents. These substituents include: alkyl groups with 1 to 3 carbon atoms (eg, methyl, ethyl, propyl), alkoxy groups with 1 to 3 carbon atoms (eg, methoxy, ethoxy Group, propoxy group) and halogen atoms (eg, fluorine, fluorine, bromine, iodine). According to this method, compounds UIV) and (XV) are reacted in the presence of compound (XVI) to obtain compound (XVII). Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards (please read the notes on the back before filling this page) This reaction is usually performed in a solvent; the solvent is a suitable solvent that does not interfere with the reaction. These solvents include: for example, alcohols such as Formic acid, acetic acid, propanol, isopropanol, butanol, and tertiary butanol; ethers such as diming tincture, tetrahydrofuran, ether, tertiary butyl methyl ether, diisopropyl ether, and ethylene glycol-dimethyl ether; Esters such as ethyl formate, ethyl acetate and n-butyl acetate; halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, trichloroethylene and 1,2-dioxane; hydrocarbons such as n-hexane, Benzene and toluene; amidines such as formamide, amidine, N-dimethylformamide and Ν, Ν-dimethylacetamide; amidines such as propyl Ketones, methyl ethyl ketones, and methyl isobutyl ketones; eyes such as acetonitrile and propionitrile; dimethyl arylene, dioxotetrahydro! Phen, hexamethylammonium, and water; these solvents can be used alone or Mixed solvents are used. The reaction temperature is usually -80 to 1501C, preferably -50 to 120¾. The use of each compound (XV) and (XVI) is usually per Xerium compound (XIV). This paper is applicable to China. Standard (CNS) A4 specification (2! 0X297 mm) 51 39 2 2 1 4. 6 4 6 4 9 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (52) 1 I 1 to 5 Mo Ear »Preferable 1 to 3 M Ear 0 1 1 Then the ester of compound (XV II) is hydrolyzed > m etc. f to obtain the compound 1 1 (XVIII) > 1 I This hydrogenolysis reaction is usually carried out in a solvent ♦ Solvents are suitable. Please read 1 1 I Solvents that interfere with the reaction 0 These solvents contain X For example 9 Ferments such as methanol% Ethanol Read back 1 ί Propanol% isopropanol butanol and dibutanol; Ethers Such as Precautions for di-doxane tetrahydro 1 1 Furan ether > Third butyl methyl ether, diisopropyl ether and oxalase-dimethyl ether; 1 1 Halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride > (Trichloroethylene and 1,2-fill in this)) Diazine 9 hydrocarbons such as n-hexane and toluene * amines such as formamide, page 1 1 H, N-dimethylformamide and hydrazone, Ν-dimethylacetamidone such as acetone, methyl 1 1 methyl ethyl and methyl isobutyl ketone * nitriles such as acetonitrile and propionitrile dimethyl sulfite, di 1 I oxytetrahydrophenone% methyl Solvents such as phosphatidylamine and water > λ Solvents used alone or in mixtures 〇1 1 | This reaction is performed in the presence of a base. The base used preferably contains: metal 1 1 I hydroxide such as lithium hydroxide hydrogen Potassium oxide sodium hydroxide and barium hydroxide; 1 " X and gold carbonates such as potassium carbonate Λ sodium carbonate and barium carbonate The use of alkali >> 3 1 is usually 1 to 30 moles per mole of compound (XVII) »preferably 1 to 10 moles 1 1 ear 0 Anti-US 'fishy temperature is usually -30 to 15〇υ f is more preferably -10 to 120υ. The inverse 1 I response time is usually 15 minutes to 48 hours, preferably 30 minutes to 24 hours. 1 I If the compound (XVIII) M is produced by a hydrogenolysis reaction, this reaction is usually carried out with a catalyst of 1 1 I. This catalyst is a better catalyst for catalyzing the prinogen reaction. 1 1 Platinum catalysts (for example, platinum oxide, 'Platinum Black 4 Na-Carbon), Palladium Catalyst 1 1 (eg, Palladium Chloride, Palladium-Carbon \ Palladium-Calcium Carbonate, Palladium-Barium Sulfate), Rhodium Catalyst 1 1 (eg, Rhodium-Carbon Samarium-alumina) and ruthenium catalysts (eg, oxidation 1 1) This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 5 2 3 9 2 2 1 A7 B7 4 6 46 49 5. Description of the invention ( 53) (Please read the notes on the back before filling out this page) Ruthenium, Ruthenium-Carbon), preferably palladium catalysts. This reaction is usually carried out in a solvent; a solvent is a solvent which is suitably selected so as not to interfere with the reaction. These solvents include, for example, alcohols such as methanol, ethanol, propanol, isopropanol, butanol, and tertiary butyrate; ethers such as dioxane, tetrahydrofuran, ether, third butyl methyl ether, diisopropyl ether, and Glyoxal-dimethylformamide; esters such as ethyl formate, ethyl acetate, and n-butyl acetate; hydrocarbons such as n-hexane, benzyl, and toluene; amidines such as formamidine, K, N-dimethylformamide Amidine and Ν, Ν-dimethylacetamide and water; these solvents M are used alone or in a mixed solvent. The reaction temperature is usually -10 to 120 ° F, preferably 0 to 100t :. Although this reaction is usually carried out under normal pressure, it should sometimes be carried out under high pressure. The pressure is preferably 1 to 200 atmospheres. The compound (XV III) printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs can be decarburized by heating to obtain compound (I). This reaction is usually carried out in a solvent; a solvent is a solvent which is suitable for a non-drying reaction. These solvents include, for example, alcohols such as formazan, ethylase, propionase, isopropanol, butanol, and tertiary butanol; ethers such as dimethyl, tetrahydrofuran, ether, tertiary butyl methyl ether, diisopropyl Ethers and ethylene glycol-dimethyl ether; bribes such as ethyl formate, ethyl acetate and n-butyl acetate; halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, trichloroethylene and 1,2- Dichloroethane; hydrocarbons such as hexane, benzene and toluene; ammoniums such as formamide, amidine, N-dimethylformamide and K, N-dimethylacetamide; ketones such as acetone, Methyl ethyl ring and isobutyl ketone; nitriles such as acetonitrile and propionitrile; dimethylarylene, dioxetane, hexamethylphosphamide and water; these solvents K are used alone or in a mixed solvent. The reaction temperature is usually 0 to 1801C, and preferably 10 to 150¾. The reaction time is usually 5 minutes to 24 hours, preferably 10 minutes to 12 hours. This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 53 39 22 1 c / i 5 49 A7 '___ B7 V. Description of the invention (5 4) If the compounds involved in the above reactions have amine groups, The carboxyl or hydroxyl group is used by the Central Standards Bureau of the Ministry of Economic Affairs to print the substrate protection and protection of the consumer cooperatives. It is often necessary to obtain him, and the bases and protections can be merged in addition to peptide transfer. The basic needs of the progeny should be taken from the trans-methyl fluorenyl for example, containing carbonyl amines for protecting the stilbylamine. Carbonylbenzene > carbonylcarbonylpropenylcarbonyloxymethyl 0 carbonylcarbonyloxyethyl 'carbonyloxymethyl 9'yl S carbonyloxycarbonyloxyalkane) carbonyl carbonyl such as methyl carbonyl phthalate, methyl phthalide, methyl toluene trifluoro such as yi. The original halogens 3 to 3 containing the protective base protecting the base 3 to 3, the first base, etc., this base. Carboxypropyl isopropyl, alkenyl and propyl, methyl bromide 7 (e.g. carbonylcarbonylarylarylmethylene, methyl) > Ammonium bromide, dichlorobenzene This is substituted for isopropylnitroethyl 'methyl a Such as / ί, alkyl alkyl benzene, halogen benzene, chloro, fluoroalkane, silicon (Please read the precautions on the back before filling out this page). Examples of hydroxy groups include carbonyl such as fv, aryl, aryl, tolyl, methyltriylcarbonyl, alkyl-6, C1, alkenyl, and carbonyl such as tolyl. Aryl 10 alkane 7-sand C-based, alkane tri- and sulfanyl, carbonyl ethanyl,). Ethyl bromide 'chloro 7 ′ gas groups such as propane (itl heterogen, primary halopropyl, 3 groups) To B1, via carbamoyl », such as base 8 (¾yl-6yl C1Η, three I
用 含 包 法 良 改 其 或 法 方 、 知 ^ B 基般 甲 一 苯依 , 可 如基 ί護 保 等 此 IX I 7 C 基 烷 芳 代 取 等 基 硝 鈉 酸 甲 胺 硫 二 基 。 甲之 Η-除 、 移 肼 * 苯法 、 方 肼之 、 等 線鈀 外酸 紫乙 、 \ 原銨 堪丁 、 四 鹼化 、 氟 酸、 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 54 39 22 1 A7 ____B7_ 五、發明説明(55 ) 依本發明上述各反應獲得圼自由型之化合物,可依習 知方法轉化成鹽;若是獲得鹽,可依習知方法轉化成自由 型或另一鹽。 所得之化合物(I),可自反應混合物,依一般已知方 式,如萃取、濃縮、中和、過Μ、再結晶、管柱層析及薄 層曆析,予以單離及純化。 化合物(I)之鹽可依一般已知方式,例如,加上述無 機酸或有機酸中之一種酸至化合物(I),而製得之。 於上述方法Α中用作起始化合物之化合物(III)及(IV) ,可依例如美國專利4,584,385號所述之方法,或其類Μ 方法,製得之。 於上述方法Β中用作起始化合物之化合物(V),可依 例如發藥化學雜誌(Journal of Medicinal Chemistry), 經濟部中央標準局舅工消費合作社印製 (請先聞讀背面之注意事項再填寫本頁) 2 1 期,82頁(1978年)或化學通訊(Chemistry Letters), 166期( 1 980年)所述之方法或其類似方法,製得之;化合 物(VI)可依例如有機化學雜誌(Journal of Organic Chem istry), 期,360 8頁( 1 97 7年)所述之方法或其類似方法 ,製得之;化合物(VII)可依化學會會誌(Journal of the Chemical Society),9 5 期,132 頁(1909年)所述之方法 或其類Μ方法,製得之。 ( 除了上述方法外,化合物(I)亦可依美國專利 4,584,385號所述之方法或其類似方法,製得之。 雖然化合物(I)可依上逑化學方法製得,其亦可用微 生物製得。於化學式(I)之化合物中,吲睬嫌素可依例如 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 5 5 3 9 2 2 1 4649 Α7 Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(56 ) 文獻[K.V.Rao著,抗生素及化學治療(Antibiotics and Cheaotherapy)(華盛頓),ULSS, 312 頁(1960 年);W.S. Marsh等著,同書,10 期.316頁(1960年);Schach von Wittenau, Μ.等著,美國化學會會誌(J, Am. Chem. Soc. )6_3JI , 467 8頁(1961年),同書,, 3 425 頁( 1 9 6 3 年)] 所述之方法,用生産者菌株灰色鍵徽菌灰色亞種 (Streptomyces grisftiis subsp. g r i s e u s ΐ A T C C 1 264 號 [美國品種培育庫細菌及噬菌體目錄(American Type Calture Collection Catalogue of Bacteria & Bacteriophages),第18販,1992年]等,製得之〇鏈撤菌 屬(S t r e p t 〇 m .v c e s s p . ) H C - 2 1 , 一種新菌株,亦可用作生 産者菌株。 本發明吲睐徽素之製造方法所用之撤生物,乃自曰本 北海道島旭川市Tenninfcyo之土壤樣品單離之鍵徽菌靥HC- * . · 21菌株(後文亦稱作"HC-21菌株” >。 根據國際分類細菌學雜誌(the InternationalUse the encapsulation method to improve the method or the method of the method, and know the ^ B group as a methyl-phenylene, such as hydration and protection, etc. This IX I 7 C-based alkane is aromatically substituted to obtain the methyl nitrite sodium methylamine thiodiyl group. Formazan-except, transfer hydrazine * benzene method, hydrazine, isoline palladium-exogen acid violet ethyl, \ ortho ammonium kantin, tetrabasic, fluoric acid, this paper size applies Chinese National Standard (CNS) A4 specifications ( 210X297 mm) 54 39 22 1 A7 ____B7_ V. Description of the invention (55) The compound obtained by the above reactions of the present invention can be converted into salt according to conventional methods; if salt is obtained, it can be converted into salt according to conventional methods Free form or another salt. The obtained compound (I) can be isolated and purified from the reaction mixture according to generally known methods, such as extraction, concentration, neutralization, purification, recrystallization, column chromatography and thin-layer chromatography. The salt of the compound (I) can be prepared in a generally known manner, for example, by adding one of the aforementioned inorganic acids or organic acids to the compound (I). The compounds (III) and (IV) used as the starting compounds in the above method A can be prepared according to, for example, the method described in U.S. Patent No. 4,584,385, or a method like M thereof. The compound (V) used as the starting compound in the above method B can be printed according to, for example, the Journal of Medicinal Chemistry, the Central Standards Bureau, Ministry of Economic Affairs, and the Consumers' Cooperatives (please read the precautions on the back first) (Fill in this page again) 21, 82 (1978) or Chemical Letters, 166 (1980) or a similar method, prepared; compound (VI) can be obtained according to, for example, Journal of Organic Chemistry (Issue), Issue 360, p. 8 (1979), or a method similar thereto; compound (VII) can be obtained according to the Journal of the Chemical Society), 9 5, 132 (1909), or a method similar to that of M, was prepared. (In addition to the above method, compound (I) can also be prepared according to the method described in US Patent No. 4,584,385 or a similar method. Although compound (I) can be prepared according to the above-mentioned chemical method, it can also be prepared using microorganisms In the compound of formula (I), indole may be applied in accordance with the Chinese paper standard (CNS) A4 specification (210X297 mm) according to this paper size. 5 5 3 9 2 2 1 4649 Α7 Β7 Employees of the Central Bureau of Standards, Ministry of Economic Affairs Printed by Consumer Cooperatives 5. Description of Invention (56) Literature [KVRao, Antibiotics and Cheaotherapy (Washington), ULSS, 312 pages (1960); WS Marsh et al., Id., No. 10, 316. (1960); Schach von Wittenau, M. et al., Journal of the American Chemical Society (J, Am. Chem. Soc.) 6_3JI, 467 8 pages (1961), same book, 3 425 pages (1 9 6 3 years)], using the producer strain Streptomyces grisftiis subsp. Griseus ΐ ATCC 1 264 [American Type Calture Collection Catalogue of Bacteria & Bacteriophages), No. 18, 1992], etc., prepared HC-21, a new strain, can also be used as a producer strain. The withdrawn organism used in the method for producing indocyanin of the present invention is a strain of HC- *. · 21 strain (hereinafter also referred to as "" HC-") isolated from soil samples of Tenninfcyo, Asahikawa, Hokkaido 21 strains ">. According to the International Journal of Bacteriology
Journal of SysteBatic Bacteriology), Lfi_( 3)期,313 〜3 40頁( 1 9 60年)所述之方法,HC-21菌株之特徽如下:除 非另有指明,否則培養基觀察均於14天培育期間及281下 進行。 (I)形態特徴 氣生菌絲體自已延長及分枝之基層菌絡’體延長成單純 分枝,於其頂尖具稍微波狀或鍮匙狀孢子鋪(通常10至50 個抱子以上)。未見輸狀物。孢子成囫柱狀(1·1至υχ (請先閲讀背面之注意事項再填寫本頁) > -訂. 本紙条尺度逋用中國國家標準(CNS)A4规格(210x297公釐) 5 6 3922 1 'Λ 6 46 49 Α7 Β7 五、發明説明(57 ) 1.4至1.5微米)且具棘狀表面。 (I I)培育性質 各培養基之生長程度(G)、氣生菌絲體(Am)之生長情 形及色調、底面色調(R)、可溶性色素(SP)之有或無及色 調等記述如下。記述顔色時,括弧内之標準色調符號及Μ 美國容器公司之顔色調和手冊(Color* Harmony Manual of Container Corporation of America),第4 版,1958年 為基準。 表1 U)蔗糖- G :劣、淡乳白色(2ca) 硝酸鹽- Am :無 瓊脂培養基 R:淡乳白色(2ca) SP :無 {請先閲讀背面之注意事項再填寫本I) - 胺 糖豳 萄冬 葡天 經濟部中央標準局員工消費合作社印製 基 養 培 旨 Bn 瓊 G :良、乳白色(2ea) Am :良、乳白色(2ea) R :淡黃掠色(2ia)至黃棕色(3na) SP :無 - 基 胺養 > 醢培 油冬脂 甘天瓊 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) G :良、黃棕色(3ic) Am :良、淡黃灰色(2sc) R :黃棕色(3 la)至棕色(41a) SP :無δΐ 39 22 1 46 4649 a? B7 五、發明説明(58 ) (d)澱粉- G :中等、乳白色(2ec) 無機鹽- Am :中等、淡綠灰色(2cb) 瓊脂培養基 R :淡黃棕色(2ga)至淡黃灰色(2gc) SP :無 (e)賂胺酸- G :良、淡黃棕色(2ga) 瓊脂培養基 Am :乳白色(2ea) R :淡黃棕色(21a)至黃棕色(31c) SP :無 (f)營養強化之瓊脂 G :中等、淡灰紅棕色(5ic) 培養基 Am :劣、白色 R :淡灰棕色(4s a)至紅棕色(6〗a) SP :無 (g)酵母抽取物 G :良、黃棕色(4ia) 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) ——麥芽抽取物 Am :中等、淡灰棕色(5ga)至灰 黃棕色(4ge) -瓊脂培養基 R :黃棕色(31a)至紅黃棕色(5pa) SP :無 (h)燕麥- G:良、淡灰棕色(4gc) 瓊脂培養基 Am :中等、淡紅白色(5ea)至灰 本紙張尺度適用中國國家標準(CNS ) A4規格(2i〇X297公釐) 58 3922 1 464649 A7 B7 五、發明説明(59 棕色(5 g c ) 亮紅様色(6ia)至灰掠色(5gc) SP :無 (i)蛋白陳-酵母抽取物 A*ti -鐵- 瓊脂培養基 (請先閱讀背面之注意事項再填寫本X ) G :中等、乳白色(2ea>、局部 Am :無 R :淡黃棟色(2ga)至黃灰棕色(3U SP :無 (11 I)生理性質 (a) 生長溫度範圍 :11至29¾ 最適生長溫度範圍 :18至24 (b) 硝酸還原反應 :弱正 (c )明膠液化 :負 (葡萄糖-蛋白陳-明膠培養基) (d) 澱粉水解作用 :負 (e) 脫脂乳凝固作用 :負 經濟部中央標準局員工消費合作社印製 脫脂乳腺化作用 :負 (f) 似黑色素之色素形成 酪胺酸-瓊脂培養基 :負 蛋白陳-酵母抽取物 鐵-瓊脂培養基 :負 U)碳源同化作用[含普利漢(pridham)及高特利 (sottlieb)之瓊脂培養基] 本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X297公釐) 59 39 22 1 )4649 A7 B7 五、發明説明(60 ) L -阿拉伯糖 D-木糖 D-葡萄糖 D-果糖 蔗糖 肌醇 L-鼠李糖 棉子糖 D-甘露耱醇 料照組 (註)+ + : (請先聞讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 生長極佳 生長顯着 +或一不能確定 -:未生長 I · (IV)細胞分析 根據Hasegawa等[通用撤生物學雜誌(Journal of General Applied Microbiology)29期,319〜322頁 (1983年)之方法分析,鑑定於細胞之鹽酸水解産物中之二 胺基庚二酸為LL-組態。 根據上述結果判斷,特別是根據淡黃棕色至灰棕色氣 生隱絲體、稍微波狀或輸狀孢子鏈、棘狀孢子表面、二胺 基庚二酸成LL -組態、及其他發現,證明此菌株靥於鏈徽 菌靥(Streptomyces);且此菌株命名為鏈徽菌屬HC-21菌 株(S t r e p t 〇 m y c e s s p . H C - 2 1) 〇 土 本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐) 60 39 22 1 d 6 4 6 4 9 A7 B7 五、發明説明(ei ) 此鏈徽菌靥HC-21菌株t特徽在具L-竄李糖同化作用 之能力及棘狀孢子表面。 此鏈徽豳羼H C-21菌株已於1996年6月12日以寄存编號 IF0-15984號寄存於大阪醱酵研究所基金會[the Institute for Fermentation, Osaka(foundation)]卜及 於1996年6月25日以寄存编號FERM BP-5571寄存於日本國 際貿易盛工業部工業科技局國立生物科學及人類技術研究 所(the National Institute of Bioscience and Human Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry of the Japan)[茨城縣筑波市谷田部郡東-1 丁 目 1-3號(1-3, Higashi-l-chome, yatabe, Tsukuba City (請先閲讀背面之注意事項再填寫本頁) ,•11 經濟部中央標準局負工消費合作社印製 式 ag 産, 要大之 棚 方、ia然素 只適化 、 然線ii天徽 體較消 糖 自射 或睬 固基可 芽 以 x^g·吲 或養、 麥 能如 h 法生 體培源 、 S3 -線自方産 液體養 糖 質射 他能 為液營 0 性放 其要 可以之 、 般以 δ 及只 基但化 糖 一如 、 , 養 ,同。乳 之例 法株 培可可素 、 物由 β 育異 ,卽充養糖 。生至 h 培變 法源補營萄 > 微甚^; 基種 方養宜量葡 re同 。1^養各。之營合微 , tu如異 、培之法明之可及如 ec菌變 之得方發用基 、例 ef細行卜物獲之本利養質 ΡΓ靥進 Μ 藥,明依可培物含 .1菌劑 含物發 ,株 。機包 ak徽變 、變本然菌理無源 ar鏈突 Μ 法突用雖用處、碳 lb用 f 理之/可- 所模源 > . 或 γ 處生 均 含規氮 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 6 1 392 2 1 464649 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(62 ) 1 I 精 澱 粉 甘 油 甘 露 糖 酵 山 梨 糖 酵 油 脂 類 (如, 1 1 大 豆 油 橄 檷 油 .、 米 糠 油 芝 麻 油 精 製 豬 油 雞 油 ); 1 1 氮 源 包 含 : 例 如 1 肉 抽 取 物 酵 母 抽 取 物 乾 酵 母 、 大豆 1 I 請 1 1 粉 \ 玉 米 漿 a» 蛋 白 陳 棉 仔 粉 赤 糖 蜜 尿 素 銨 幽 ΈΆ (如, 龙 閱 1 | 讀 I 硫 酸 銨 氛 化 銨 % m 酸 銨 、 乙 酸 銨 )及其他= 亦合宜使用 背 面 [ 1 之 1 含 納 > 鉀 、 鈣 鎂 等 之 鹽 Ϊ 金 屬 鹽 如 含 鐵 錳 、 鋅 \ 鈷、 注 素 1 事 鎳 等 之 鹽 磷 酸 砸 酸 等 之 鹽 * 及 有 機 酸 如 乙 酸 及 丙 酸之 項 再 1 1 鹽 0 此 外 亦 可 含 胺 基 酸 類 (如, 麩胺酸、 >天冬胺酸、 丙 眚 太 木 頁 1 胺 酸 % 離 胺 酸 纈 胺 酸 甲 硫 胺 酸 脯 胺 酸 )、 維生素類 1 (如, Β 1, B 2 ' >菸鹼酸' B 12 C) 核 酸 類 (如, 嘌呤、 喳 1 1 啶 及 其 衍 生 物 )等 ,當然- -般實施時, 會加無機或有機酸 1 1 输 媛 衝 液 等 K 調 節 培 養 基 之 pH值 » 及 合 宜 量 之 油 脂、 訂 | 表 面 活 性 劑 等 >λ 消 泡 0 1 I 培 商 方 式 可 由 靜 置 培 養 搖 盪 培 養 、 旋 鐘 培 養 等達 1 1 成 0 大 規 模 處 理 時 9 當 然 Μ 深 浸 旋 轉 培 養 (S u b m e r g e d 1 i SP i η n e r salt u r e) 為 理 想 0 〇 雖 然 1 培 養 條 件 依 培 養 基 之 條 件 及 組 成 菌 株 種 類、 1 1 及 培 養 方 式 而 不 同 但 通 常 推 Μ 溫 度 及 初 始 pH分 別 為 15至 1 1 26 及 約 5 至 9 〇 較 佳 乃 培 育 中 間 階 段 之 溫 度 及 初 始 pH分 1 I 別 為 20 至 25 及 約 6 至 8 〇 培 育 期 限 亦 i: 述 條 件 而 不 同, 1 1 I 推 m 持 續 培 育 直 至 所 要 生 物 活 性 物 質 之 濃 度 達 最 高 止0 1 1 1 若 用 液 體 培 養 基 進 行 搖 盪 培 養 或 旋 轉 培 養 時 t 通 常 約 1至 1 1 10天 0 1 1 所 得 之 生 物 活 性 物 質 Κ引 睬 徽 素 9 可 基 於 其 化 學 性 質, 1 1 β 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 62 69 2 2 1 4 4649 A7 B7 五、發明説明(63 ) 自培秦物中萃取及純化。 由於吲曄徽素產生於培養液及细胞中,此吲睬嫌素之 純化可自培養物K過滹或離心分離培養液及细胞,用有機 溶劑自所得之漶液或離心上層液中萃取,或用有機溶劑自 细胞中萃取,及自各萃取物或混合之萃取物中單離而成。 為達產業製造目的,較佳乃直接加有機溶劑如甲酵、 丙酮、丁醇或乙酸乙酯至培養物自所得之萃取物中純化吲 睬徽素,而省略细胞分離操作。 由於吲睬徽素為弱鹼性及油溶性物質,自培養液收集 時,可用收集相闞微生物代謝物時常用之分雛及純化方式 。例如,基於不純物質溶解度差異之方法,及用各種載劑 如活性碳非離子性多孔樹脂、矽膠、氧化鋁及葡聚醣凝膠 進行之層析,可單獨或混合使用。 經濟部中央標準局J工消費合作社印製 (請先聞讀背面之.注意事項再填寫本頁) 自培養液單離及收集吲睬徽素之方法,詳述如後文。 首先,细胞自培養液中過滤移除;所得上澄液調至合宜pH 值;加溶劑如乙酸乙酯,接著予以激烈搜拌,獲得乙酸乙 酯層。所得之有機層依序以鹼、酸及水洗滌,然後予以濃 縮;所得濃縮物進行矽膠管柱層析。有用之展開溶劑包含 :例如,氯仿-甲醇或己烷-丙酮混合溶劑◊有效區分經收 集及濃縮後,濃縮物進行Sephadex LH-20層析。有用之展 開溶劑為甲酵及混合溶劑如己烷-甲苯-甲醇及己烷-二氯 甲垸-甲醇。經濃縮後,含有效區分之溶離物經製備性高 效液相層析予Μ純化。此處所用之裝填管柱為ODS-S Η 3 43 S-15(Yainamura Kagaku Kenkyujo製造);所用之溶劑糸統 本紙張尺度適用中國國家標準{ CNS ) A4規格(2!0X 297公釐) ft 3 3 9 2 2 1 4 b 46 4-9 A7 B7 五、發明説明(64 ) 為0.02M磷酸鹽緩衝液(pH6.3>及26%乙腈之混合。 官旆本發明^最住椹忒 (請先鬩讀背面之注意事項再填寫本頁) 玆由下述實施例、試驗例及製劑例詳述本發明,但絶 不由此限制本發明之範圍。於下文中,”室溫”指約15至 3 0t) 〇 [實施例] 謇掄例1 經濟部中央標準局員工消費合作杜印製 取-鉑環量之於由酵母抽取物-麥芽抽取物-瓊脂組成 之斜面培養基上預先充分生長之鏈徽菌屬HC-21菌株,接 種至含500毫升接種培養基(PH7.0)之無菌2升板口氏( Sakaguchi)燒瓶中(此接種培養基由2%葡萄糖、3%可溶 性澱粉、1%玉米漿、1%新鮮大豆粉、0.5%多蛋白陳、 0.3%氣化鈉及0.5%沈澱碩酸鈣組成),於24¾之往復搖 盪器上培育2天。於此500毫升培養液中,注入120升基本 培養基(P Η 7 . 0 ),此基本培養基由2 . 0 %葡萄糖、3 . 0 %可 溶性澱粉、1.0%脫脂大豆粉、0.3%玉米漿、0.1%酵母 抽取物、0.5%多蛋白陳、0.2%燕麥粉瓊脂、0.3%氯化 鈉、0.5%沈澱碩酸鈣、0.05%ACTC0L 31-56(日本武田藥 品工業株式會社製造)及0.05%聚烴矽氧組成,接著移植 入無菌200升醱酵缸中,於溫度、1.Ί公斤/厘米2内壓 、120升/分鐘通氣率及120「pm攙拌達率之條件下,予以培 育9 0小時。 所得之120升培養液用Hyflo Super Cel過濾,獲得 110升濾液。此濾液以稀硫酸調至PH3.0;加等量乙酸乙酯 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 64 39 2 2 1 石 4 6 4· 9 a7 B7 五、發明説明(65 ) (請先閱讀背面之注意事項再填寫本頁) ,接著激烈攪泮,獲得8 0升乙酸乙酿層。此乙酸乙酯層K 30升之2%碳酸氫鈉溶液洗滌,然後Μ30升之0.02H鹽酸溶 .液洗滌,Κ水洗滌完全後,經減壓湄縮,獲得約30克濃縮 物。此湄縮物通過矽膠管柱(0.8升)以吸附活性成分,接 著依序Κ4升己烷-丙酮(80: 20)、4升己烷-丙釅(50:50 )及4升己烷-丙酮(20: 80)溶雛。有效區分經混合後,予 以減壓灑縮,獲得1.53克濃縮物。此濃縮物溶於甲醇;所 得溶液通過Sephadex LH-20(瑞典Pharmacia公司製造)管 柱(2升),預先洗滁完全;自1.3升至1.7升之有效溶離區 分予K混合,經減壓濃縮,獲得49 0毫克粉末。此粉末K 0.02H瞵酸鹽緩衝液(PH6.3)及26%乙腈之溶劑糸統.用製 備性液體層析(日立型號L-6 2 5 0,偵測器1- 4000,¥»10 Pack, ODS SH343 S-15 120A, 214 毫微米)進一步展開(20 毫升/分鐘,20毫升之區分),獲得有效區分(區分30至39 號)。移除乙腈後,有效區分以水洗滌,又K乙酸乙酯萃 取;乙酸乙酯層經減壓濃縮,獲得315毫克结晶型吲睬徽 素。 經濟部中央標準局員工消費合作社印製 元素分析(C 14H 15N3〇2): 計算值:C,65.35; Η,5.δ8; H.16.33 實測值:C,65,14; H,5.87; N,16.p7 物理化學性質亦與吲睬徽素符合一致。 當施例2 (5S)-2-(N-苯甲氧羰基-N-甲基)胺基- 5[(1R)-1-(b3丨睬-3-基)乙基]-2 -_唑啉-4 -鬭 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 65 3 92 2 1 a 4 6 4 9 A7 B7 五、發明説明(66 ) (請先閎讀背面之注意事項再填寫本頁) 吲睐徽素ΠΟΟ毫克)於四氫呋喃(5毫升)之溶液,經 冷却至-30t:。於此冷却溶液中,於- 30¾隨後滴加三乙胺 (0.217毫升)及苯甲氧羰基氯(0.167毫升)。全部加溫至 0¾,予以攪拌80分鐘。加乙酸乙酯至反應混合物。此混 合物分別以水、飽和碳酸氫鈉水溶液及食鹽液洗滌,然後 乙酸乙酯溶液經硫酸鎂使之乾燥。移除有機溶劑,獲得之 殘物自異丙醚中再結晶,獲得標題化合物(115毫克, 75. 5% )熔點 136 〜138C。 IRtKBrJcm-1: 3299, 1748. 1 Η - N M R (C D C 1 3 ) δ : 1 . 3 9 (3 H , d , J = 7 . 2 Η z ), 3.34 (3Η,s) , 3.81-3.93 (1Η , m), 5.10 (1Η,d,J = 2 . 8Ηζ) , 5.31 (2H,s), 6.97-7.40(8H,m), 7.62(lH,d,J=7.4Hz), 7 ‘ 95 (1Η,bs) g淪例3 經濟部中央標準局員工消費合作社印製 依實施例2之相同程序,製備下述化合物。 (5S)-2-(H-乙氧羰基-K-甲基)胺基-5[ (1R)-1_(吲睬-3 -基)乙基]-2 - 唑咐-4 -嗣, IR (KBr ) ciB-1 : 329 3, 1 769, 1 7 38. 1 H-HHR (CDC Is) θ : 1 . 3 4 ( 3 Η , d , J = 7 0 Η ζ ), 1.41(3H,t,J = 7.2Hz), 3.32(3H,s), 3.88(1Η,ιπ), 4.35(2H,q,J=7.2Hz), 5.10(lH,d,J=2.6Hz), 7.07-7.26(3H,m), 7.36(lH,d,J=8.2Hz), 7.67 (1H,d,J = 8 . 2Hz) , 8.15(lH,bs). 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 66 39 22 1 4 υ 4 6 4 9 a? Β7 五、發明説明(67 ) (5S) - 5- [ (1R) -1-(吲睬-3-基)乙基]-2-(N-異丙氧羰 基-N-甲基)胺基-2-η等唑咐-4 -酮, IR (KBr)cnr 1 : 3 2 7 2 , 1 73 2. 1 H-HHR (CDC 1 3) 5 : 1 .36 (6H,d , J = 6.4Hz), 1.43 (3H , d,J = 7 . 4Hs) , 3.31(3H,s), 3.91 (1 H,m), 5.08(1H,ib), 5.12(lH,d,J=2.6Hz), 7.07-7.35(3H,i), 7.37(lH,d,J=8.0Hz), 7.67 (1H , d , J = 7 . 8Hz) , 8.17(lH,bs). (5S)-2-[it-(2-乙基己氧羰基)-H-甲基]胺基-5-[(lR) -1-( B3I睬-3-基)乙基]-2 -b署唑啉-4 -酹, IR (KBr) cm-1 : 32 9 8, 1 769, 1 742. iH-HMRCCDClajS : 0.90(6H,t,J=7.6Hz), 1.26-1.60(9H,m), 3.29(3H,s), 3.90(lH,m), 4.19(2H,d,J=5.8Hz), 5.12(lH,d,J=3.0Hz), 7.06-7.38(4H,m), 7.66(lH,d,J = 7.6H2), 8.14 (1H,bs). 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) (5S)-2-[N-(4-乙醯氧苯甲氧羰基)-N-甲基]胺基-5-[(IR) -1 -(吲睬-3-基)乙基]-2-唁唑啉-4-酮, IR (KBr)c®- 1 : 3 3 33 , 1 746. ^-NHRiCDCls)^ : 1.24(3H,d,J = 7,. 4Hz), 2.41(3H,s), 3.50(3H,s), 3.80(lH,m), 5.09(lH,d,J=2.8Hz), 5.30(2H,s), 6.52(lH,d,J=2.2Hz), 7.03-7.46(7H,m), 7.57 (1H , d , J = 7.6Hz) , 8.56(lH,bs). 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 67 39 22 1 經濟部中央標準局員工消費合作社印製 464649 五、發明説明(68) ' (5S)-5-[(1R)-1-(b引睐-3-基)乙基]-2-[N-(4-硝苯甲 氧羰基)-N -甲基]胺基-2-鸣哩啉-4-酮, IR (K B r ) c b - 1 : 3 2 9 9,1 7 7 3,1 7 4 6 · iH-HMR (CDC 1 3) 5 : 1.44(3H , d , J = 7 . 2 Ηζ ), 3.35(3H,s), 3.90(1Η,ιι), 5 . 1 5 (1 Η , d , J = 2 . 6 Η ζ ), 5 . 37 (2Η , s) , 7 . 0 3-7 . 2 4 (3 Η,m), 7.37(lH,d,J=8.2Hz), 7.47(2H,d,J=8.8Hz), 7 . 64 (1Η , d , J = 8 . 4Ηζ) , 8.10(lH,bs), 8.14(2H,d,J=6.8Hz). (5S)_5-[(lli)-l-(吲睬-3-基)乙基]-2-(Ν-甲基-Ν-笨 氧羰基)胺基-2 -噚唑咐-4 -豳, IR (RBr) car 1 : 328 1 , 1 77 9, 1 746 . iH-HHR (CDCla) δ : 1.45 (3Η,d,J = 7.2Ηε), 3.47(3H,s), 3.91(lH,m), 5.15(lH,d,J=3.0Hz), 7.03-7.49(9H,m) , 7.67(lH,d,J = 7.4Hz) , 8 · 05 (1H,bs). g淪例4 (5 S)-5-[(lR)-l-(B 引睬-3-基)乙基]-2-[N-(N-(4-甲氧笨 基)胺甲酿基)-N-甲基]胺基-2 -n号唑啉- 4- _ 吲睬徽素(150毫克)及二氛甲烷(3牽升)之混合物中, 於冰冷却下,加4 -甲氧苯基異氰酸醋(261毫克 >。混合物 於室溫攪拌2小時後,溶劑經蒸餾移除,獲得殘物。加異 丙醚至殘物後,獲得標題化合物,為結晶(213毫克, 89.9%)。 —^1- ^^1 «^^1 ^^1 ^^1 ^^^1 . - - n^i m In V 、言 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐〉 68 392 2 1 ''464649 A7 B7 經濟部中央標準局負工消費合作社印製 五、發明説明(69 ) IRaBrOcm-1: 3382,1717. 1H-NHR(CDCl3) δ :1.48(3H,d,J=7.0Hz), 3.34(3H,s), 3.78(3H,s), 3.95 (1 H , m), 5.08(lH,d,J=3.0Hz), 6.83(2H1d,J=9.2Hz), 7.11- 7.40(6H,m), 7,67(lH,d,J=8.4Hz), 8.21 (lH.bs) , 11.21 (lH,bs). 當撇例fi 依實施例4所述之相同程序,製備下述化合物。 (5S)-2-[N-(H-(4 -氯苯基)胺甲藤基)-N-甲基]胺基-5 -[(lR)-2-(吲睬-3-基)乙基]-2-噚唑啉-4-酮, IR (KBr) cm- 1 : 337 2 , 1 7 1 3. 1H-HMR (CDC 1 3) a : 1.49(3H,d,J = 7.4Hz), 3.34(3H,s), 3.97(lH,m), 5.09 (1H , d,J = 3.2Hz), 7.15-7.47(8H,m) t 7.67(lH,d,J=7.4Hz), 8. 17 (lH.bs) , 1 1 .48 (1H , bs). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-[N-U-(2-苯 乙基)胺甲醢基)-N-甲基]胺基-2 -B等唑啉-4-麵, IR (KBr)cm-1 : 3 243, 1 7 1 3 . ^-NHR (CDCls) 8 : 1 . 4 4 ( 3 Η , d , J = 7 . 4 Η z ), 2.82(2H,t,J = 8.0Hz), 3,28(311,3)(, 3.47(2H,ra), 3 . 91 (1H , id) , 5.02(lH,d,J = 3. 0Hz), 7.11- 7.40(9H,m), 7.65(lH,d,J=7.8Hz), 8.15 (1H , bs) , 9.33 (1H , bs). (5S)-2-[H-(N-(2,4-二甲氧苯基)胺甲醢基)-N-甲基] (請先聞讀背面之注意事項再填寫本頁)Journal of SysteBatic Bacteriology), Lfi_ (3), pages 313 ~ 3 40 (1960), the special emblem of the HC-21 strain is as follows: Unless otherwise specified, culture medium observations are cultivated on 14 days Period and under 281. (I) Morphology: The aerial mycelium has been extended and the branched basal fungi's body has been extended into simple branches, with a slightly wavy or spore-like spore spread at its apex (usually 10 to 50 brussels). . No infusion was seen. The spores are columnar (1 · 1 to υχ (please read the precautions on the back before filling out this page) > -Order. The size of this note is in accordance with Chinese National Standard (CNS) A4 (210x297 mm) 5 6 3922 1 'Λ 6 46 49 Α7 B7 V. Description of the invention (57) 1.4 to 1.5 microns) and a spiny surface. (I I) Cultivation properties The growth degree (G) of each medium, the growth condition and hue of aerial mycelium (Am), the presence or absence of soluble pigment (SP), and the hue are described below. When describing colors, the standard tone symbols in parentheses and the Color * Harmony Manual of Container Corporation of America, 4th edition, 1958 are used as the basis. Table 1 U) Sucrose-G: Inferior, milky white (2ca) Nitrate-Am: Agar-free medium R: Milky white (2ca) SP: None {Please read the precautions on the back before filling in this I)-Amine sugar Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China. Bn Jean G: Good, milky white (2ea) Am: Good, milky white (2ea) R: Light yellow (2ia) to yellow brown (3na ) SP: None-based amine cultivation > Anthracite oil winter fat Gan Tianqiong This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) G: Good, yellow-brown (3ic) Am: Good, yellowish-gray (2sc) R: yellow-brown (3 la) to brown (41a) SP: no δΐ 39 22 1 46 4649 a? B7 V. Description of the invention (58) (d) Starch-G: Medium, milky white (2ec) inorganic salt -Am: medium, light greenish gray (2cb) agar medium R: light yellowish brown (2ga) to light yellowish gray (2gc) SP: no (e) glycine-G: good, light yellowish brown (2ga) agar medium Am: milky white (2ea) R: light yellow brown (21a) to yellow brown (31c) SP: no (f) nutrient fortified agar G: medium, light gray red brown (5ic) medium Am: inferior White R: light gray-brown (4s a) to red-brown (6〗 a) SP: no (g) yeast extract G: good, yellow-brown (4ia) printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read first Note on the back, please fill out this page again) ——Malt extract Am: Medium, light gray brown (5ga) to gray yellow brown (4ge)-Agar medium R: yellow brown (31a) to red yellow brown (5pa) SP : No (h) oats-G: Good, light gray brown (4gc) Agar medium Am: Medium, light red white (5ea) to gray Paper size Applicable to Chinese National Standard (CNS) A4 specification (2i0 × 297 mm) 58 3922 1 464649 A7 B7 V. Description of the invention (59 brown (5 gc) bright red ochre (6ia) to gray grazing (5gc) SP: no (i) protein aging-yeast extract A * ti-iron-agar medium (Please read the notes on the back before filling in this X) G: Medium, Milky white (2ea >, Partial Am: No R: Light yellow building color (2ga) to yellow-gray brown (3U SP: None (11 I) Physiological properties (a) Growth temperature range: 11 to 29¾ Optimum growth temperature range: 18 to 24 (b) Nitric acid reduction reaction: weak positive (c) gelatin liquefaction: negative (glucose) Glucose-Protein-Gelatin Media) (d) Starch hydrolysis: negative (e) Skim milk coagulation: negative Skimmed milk glandification printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs: negative (f) melanin-like pigment formation Tyrosine-agar medium: negative protein Chen-yeast extract iron-agar medium: negative U) carbon source assimilation [agar medium containing pridham and sotlieb] This paper is applicable to China National Standard (CNS) A4 specification (2I0X297 mm) 59 39 22 1) 4649 A7 B7 V. Description of the invention (60) L-arabinose D-xylose D-glucose D-fructose sucrose inositol L-rhamnose cotton Seed sugar D-mannose alcohol photo group (Note) +: (Please read the precautions on the back before filling out this page) The central government bureau of the Ministry of Economic Affairs's consumer co-operative prints have excellent growth and significant growth + or one cannot Confirmation :: Immune (I) (IV) cell analysis According to the method of Hasegawa et al. [Journal of General Applied Microbiology 29th issue, pages 319 ~ 322 (1983), hydrochloride hydrolysate identified in the cells Diamine Pimelic acid as LL- configuration. Judging from the above results, especially based on light yellow-brown to gray-brown aerial cryptofilaments, slightly undulating or transmissive spore chains, surface of spinous spores, diaminopimelate into LL-configuration, and other findings, It was proved that this strain was streptomyces; and this strain was named Streptomyces HC-21 strain (Strept 〇mycessp. HC-2 1) 〇 The paper size of the paper is applicable to Chinese national standards (CNS > A4 specification (210X297 mm) 60 39 22 1 d 6 4 6 4 9 A7 B7 V. Description of the invention (ei) This streptococcus sp. HC-21 strain t special emblem has the ability to assimilate with L-channeling sugar and The surface of spinous spores. This chain emblem H C-21 strain was deposited at the Institute for Fermentation, Osaka (foundation) under the deposit number IF0-15984 on June 12, 1996. Biao deposited with the National Institute of Bioscience and Human Technology, Agency of Industrial under the registration number FERM BP-5571 on June 25, 1996 at the National Institute of Bioscience and Human Technology, Agency for Industrial Science and Technology, Ministry of International Trade and Industry, Japan. Science and Technology, Mini stry of International Trade and Industry of the Japan) [1-3, Higashi-l-chome, yatabe, Tsukuba City (1-3, Higashi-l-chome, yatabe, Tsukuba City, Tsukuba City, Ibaraki Prefecture (Please read the precautions on the back before filling out (This page), • 11 The Central Aggregate Bureau of the Ministry of Economic Affairs, the Consumers ’Cooperative Co., Ltd. prints ag products, and requires a large shed, ia ransu only to adapt, but the line emblem is better than sugar self-emission or solidification. Buds can be cultivated with x ^ g · ind, wheat can be cultivated by h method, S3-line produced liquid glucosides can be used for liquid camps, and can be used as δ and only base but The sugar is the same as that of the nutrient. It is cultivated by the same method. The milk is cultivated in the form of cocoa, and the material is cultivated by β. The sugar is supplemented by sugar. The amount of Portuguese re is the same. 1 ^ Each of each. The combination of micro, tu is different, the method of cultivation can be reached, such as the ec fungus, the hair base, such as ef, the fine nutrient properties obtained by the line ΓΓ 靥Into M medicine, Ming Yi Ke Pei Wu contains .1 bacteria agent containing hair, strain. Machine package ak emblem change, change the nature of mycological passive ar chain process M method, although the use of the use, carbon lb use f management / can-the model source >. Or γ all contain regular nitrogen This paper size applies China National Standard (CNS) A4 specification (210 X 297 mm) 6 1 392 2 1 464649 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (62) 1 I refined starch glycerol mannose fermented sorbose Fermented oils and fats (eg, 1 1 soybean oil, olive oil, rice bran oil, sesame oil, refined lard, chicken oil); 1 1 nitrogen sources include: for example, 1 meat extract, yeast extract, dry yeast, soybean 1 I please 1 1 powder \ Corn syrup a »Protein scented cotton seed powder red sugar molasses urea ammonium cyanide (eg, Longyue 1 | read I ammonium sulfate aerated ammonium% m ammonium acid, ammonium acetate) and others = also suitable for use on the back [1 of 1 inclusive > Salts of potassium, calcium, magnesium, etc. Ϊ Metal salts such as iron, manganese, zinc \ 1 、 Injector 1 matters such as nickel salts, phosphoric acid and other salts * and organic acids such as acetic acid and propionic acid. 1 1 Salt 0 In addition, it can also contain amino acids (such as glutamic acid, > asparagine) Acids, Propionate Page 1 Amino Acid% Leucine Valine Methyl Thiuran Proline), Vitamins 1 (eg, B 1, B 2 '> Nicotinic Acid' B 12 C) Nucleic Acids (For example, purine, pyridine and its derivatives), etc. Of course, in general implementation, it will add inorganic or organic acids, 1 1 Yuanyuan solution and other K to adjust the pH value of the culture medium »and a suitable amount of fat, order | Surfactants etc. lambda defoaming 0 1 I The culture method can be from 1 to 10 for stationary culture, shaking culture, bell culture, etc. For large-scale processing 9 Of course, immersed spin culture (S ubmerged 1 i SP i η ner salt ure) is ideal 0 〇 Although 1 culture conditions depend on the conditions of the medium And composition strain types, 1 1 and culture methods are different but usually the temperature and initial pH are 15 to 1 1 26 and about 5 to 9 respectively. It is preferred that the temperature and initial pH of the middle stage of incubation 1 I be 20 to 25 and about 6 to 8 〇 The incubation period is also different from the above conditions. 1 1 I push m to continue incubation until the concentration of the desired biologically active substance reaches a maximum of 0 1 1 1 When shaking culture or rotary culture is performed using liquid medium t Usually about 1 to 1 1 10 days 0 1 1 The biologically active substance ketinin 9 obtained can be based on its chemical properties, 1 1 β This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 62 69 2 2 1 4 4649 A7 B7 V. Description of the invention (63) Extraction and purification from the cultivating substance. Since indigoxin is produced in culture medium and cells, the purification of this indole hormone can be carried out from culture K or by centrifugation of the culture solution and cells, and the organic solvent is used to extract from the obtained solution or centrifuged supernatant. Or use organic solvents to extract from cells, and separate from each extract or mixed extracts. For industrial manufacturing purposes, it is preferred to directly add an organic solvent such as formazan, acetone, butanol, or ethyl acetate to the culture to purify the indrugin from the resulting extract, and omit the cell isolation operation. Because indigoxin is a weakly alkaline and oil-soluble substance, when collecting it from the culture medium, it is possible to use the separation and purification methods commonly used in collecting related metabolites of microorganisms. For example, a method based on the difference in the solubility of impurities and chromatography using various carriers such as activated carbon nonionic porous resin, silica gel, alumina, and dextran gel can be used alone or in combination. Printed by J Industry Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs (please read and read the notes on the reverse side, and then fill out this page). The method for the isolation and collection of indigo emblem from the culture medium is detailed below. First, the cells are removed by filtration from the culture solution; the resulting supernatant solution is adjusted to a suitable pH value; a solvent such as ethyl acetate is added, and then vigorously searched to obtain an ethyl acetate layer. The obtained organic layer was sequentially washed with alkali, acid, and water, and then concentrated; the obtained concentrate was subjected to silica gel column chromatography. Useful developing solvents include, for example, a chloroform-methanol or hexane-acetone mixed solvent, which effectively distinguishes the concentrate after collection and concentration, and performs Sephadex LH-20 chromatography. Useful development solvents are formic acid and mixed solvents such as hexane-toluene-methanol and hexane-dichloroformamidine-methanol. After concentration, the eluate containing effective differentiation was purified by preparative high performance liquid chromatography. The packing column used here is ODS-S Η 3 43 S-15 (manufactured by Yainamura Kagaku Kenkyujo); the solvent used is the paper standard applicable to the Chinese National Standard {CNS) A4 specification (2! 0X 297 mm) ft 3 3 9 2 2 1 4 b 46 4-9 A7 B7 V. Description of the invention (64) is a mixture of 0.02M phosphate buffer (pH6.3 >) and 26% acetonitrile. 官 旆 本 发明 ^ 最 住 椹 忒 ( Please read the precautions on the reverse side before filling out this page) The following examples, test examples, and formulation examples are used to describe the present invention in detail, but the scope of the present invention is not limited by this. In the following, "room temperature" refers to 15 to 3 0t) 〇 [Example] 謇 抡 Example 1 The consumption cooperation of employees of the Central Bureau of Standards of the Ministry of Economic Affairs, Du-printing-the amount of platinum ring is preliminarily sufficient on the slanted medium composed of yeast extract-malt extract-agar The growing Streptomyces HC-21 strain was inoculated into a sterile 2 liter Sakaguchi flask containing 500 ml of inoculation medium (PH7.0) (this inoculation medium consists of 2% glucose, 3% soluble starch, 1 Composition of% corn pulp, 1% fresh soybean flour, 0.5% polyprotein, 0.3% sodium gasification and 0.5% precipitated calcium sulphate) The reciprocal shaking at 24¾ the oscillator incubated for 2 days. In this 500 ml culture medium, 120 liters of basic medium (P Η 7.0) was injected, and the basic medium was composed of 2.0% glucose, 3.0% soluble starch, 1.0% defatted soybean flour, 0.3% corn pulp, 0.1 % Yeast Extract, 0.5% Polyprotein, 0.2% Oatmeal Agar, 0.3% Sodium Chloride, 0.5% Precipitated Calcium Phosphate, 0.05% ACTC0L 31-56 (manufactured by Takeda Pharmaceutical Industry Co., Ltd.) and 0.05% Polycarbonate The composition of silicon and oxygen was then transplanted into a sterile 200 liter fermentation tank, and cultivated under the conditions of temperature, 1. 厘米 kg / cm2 internal pressure, 120 liters / minute aeration rate, and 120 pm mixing rate. The obtained 120 liters of the culture solution was filtered with Hyflo Super Cel to obtain 110 liters of filtrate. This filtrate was adjusted to pH 3.0 with dilute sulfuric acid; an equivalent amount of ethyl acetate was added. The size of the paper was adapted to Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 64 39 2 2 1 Stone 4 6 4 · 9 a7 B7 V. Description of the invention (65) (Please read the precautions on the back before filling in this page), then stir vigorously to obtain 80 liters of ethyl acetate The ethyl acetate layer was washed with 30 liters of 2% sodium bicarbonate solution, and then 30 liters of 0.02H hydrochloric acid was dissolved. After washing, washing with K water was completed, and then reduced under reduced pressure to obtain about 30 g of concentrate. This Ma shrink was passed through a silica gel column (0.8 liter) to adsorb the active ingredient, followed by K 4 liters of hexane-acetone (80: 20), 4 liters of hexane-propanone (50:50) and 4 liters of hexane-acetone (20:80). Effectively distinguish after mixing, and reduce the pressure to obtain 1.53 g of concentrate. This concentration The product was dissolved in methanol; the resulting solution was passed through a Sephadex LH-20 (manufactured by Pharmacia, Sweden) column (2 liters), and washed in advance; the effective dissolution from 1.3 liters to 1.7 liters was mixed with K, and concentrated under reduced pressure to obtain 49 0 mg powder. This powder is K 0.02H osmate buffer solution (PH6.3) and a solvent system of 26% acetonitrile. Preparative liquid chromatography (Hitachi model L-6 2 50, Detector 1- 4000, ¥ »10 Pack, ODS SH343 S-15 120A, 214 nm) is further expanded (20 ml / min, 20 ml division) to obtain a valid distinction (differentiation between 30 and 39). After removing acetonitrile, effective discrimination It was washed with water and extracted with ethyl acetate; the ethyl acetate layer was concentrated under reduced pressure to obtain 315 mg of crystalline indigoxin. Analysis of Printed Elements of Employees' Cooperatives of the Central Bureau of Standards of the Ministry (C 14H 15N302): Calculated: C, 65.35; 35, 5.δ8; H.16.33 Measured: C, 65, 14; H, 5.87; N, 16.p7 The physicochemical properties are consistent with those of indigoxin. When Example 2 (5S) -2- (N-benzyloxycarbonyl-N-methyl) amino-5 [(1R) -1- (b3 丨 睬 -3-yl) ethyl] -2 -_ Oxazoline-4-鬭 This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) 65 3 92 2 1 a 4 6 4 9 A7 B7 V. Description of the invention (66) (Please read the note on the back first Please fill in this page again) Solution of Indigo Huixin Π 100 mg) in tetrahydrofuran (5 ml), cooled to -30t :. In this cooled solution, triethylamine (0.217 ml) and benzooxycarbonyl chloride (0.167 ml) were added dropwise at -30¾. Warm all to 0¾ and stir for 80 minutes. Ethyl acetate was added to the reaction mixture. The mixture was washed with water, a saturated aqueous sodium hydrogen carbonate solution and a common salt solution, respectively, and then the ethyl acetate solution was dried over magnesium sulfate. The organic solvent was removed, and the obtained residue was recrystallized from isopropyl ether to obtain the title compound (115 mg, 75.5%). The melting point was 136 to 138C. IRtKBrJcm-1: 3299, 1748. 1 Η-NMR (CDC 1 3) δ: 1.3 9 (3 H, d, J = 7. 2 Η z), 3.34 (3Η, s), 3.81-3.93 (1Η , m), 5.10 (1Η, d, J = 2. 8Ηζ), 5.31 (2H, s), 6.97-7.40 (8H, m), 7.62 (lH, d, J = 7.4Hz), 7 '95 (1Η , Bs) Example 3 The consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs printed the same procedure as in Example 2 to prepare the following compounds. (5S) -2- (H-ethoxycarbonyl-K-methyl) amino-5 [(1R) -1_ (indio-3-yl) ethyl] -2-oxazolam-4 -fluorene, IR (KBr) ciB-1: 329 3, 1 769, 1 7 38. 1 H-HHR (CDC Is) θ: 1. 3 4 (3 Η, d, J = 7 0 Η ζ), 1.41 (3H, t , J = 7.2Hz), 3.32 (3H, s), 3.88 (1Η, ιπ), 4.35 (2H, q, J = 7.2Hz), 5.10 (lH, d, J = 2.6Hz), 7.07-7.26 (3H , m), 7.36 (lH, d, J = 8.2Hz), 7.67 (1H, d, J = 8.2Hz), 8.15 (lH, bs). This paper size applies to China National Standard (CNS) A4 specification (210X297 Mm) 66 39 22 1 4 υ 4 6 4 9 a? B7 V. Description of the invention (67) (5S)-5- [(1R) -1- (indio-3-yl) ethyl] -2- (N-isopropoxycarbonyl-N-methyl) amino-2-η and other oxazol-4-ones, IR (KBr) cnr 1: 3 2 7 2, 1 73 2. 1 H-HHR (CDC 1 3) 5: 1.36 (6H, d, J = 6.4Hz), 1.43 (3H, d, J = 7.4Hs), 3.31 (3H, s), 3.91 (1 H, m), 5.08 (1H, ib), 5.12 (lH, d, J = 2.6Hz), 7.07-7.35 (3H, i), 7.37 (lH, d, J = 8.0Hz), 7.67 (1H, d, J = 7.8Hz), 8.17 (lH, bs). (5S) -2- [it- (2-ethylhexyloxycarbonyl) -H-methyl] amino-5-[(lR) -1- (B3Ifluoren-3-yl) Ethyl] -2 -b oxazoline-4 -fluorene, IR (KBr) cm-1: 32 9 8, 1 769, 1 742. iH-HMRCCDClajS: 0.90 (6H, t, J = 7.6Hz), 1.26-1.60 (9H, m), 3.29 (3H, s), 3.90 (lH, m), 4.19 (2H, d, J = 5.8Hz), 5.12 (lH, d, J = 3.0Hz), 7.06-7.38 (4H, m), 7.66 (lH, d, J = 7.6H2), 8.14 (1H, bs). Central standard of the Ministry of Economic Affairs Printed by the Bureau's Consumer Cooperative (please read the precautions on the back before filling out this page) (5S) -2- [N- (4-Ethyloxybenzyloxycarbonyl) -N-methyl] amino-5- [(IR) -1-(Indino-3-yl) ethyl] -2-oxazolin-4-one, IR (KBr) c®-1: 3 3 33, 1 746. ^ -NHRiCDCls) ^ : 1.24 (3H, d, J = 7, .4Hz), 2.41 (3H, s), 3.50 (3H, s), 3.80 (lH, m), 5.09 (lH, d, J = 2.8Hz), 5.30 ( 2H, s), 6.52 (lH, d, J = 2.2Hz), 7.03-7.46 (7H, m), 7.57 (1H, d, J = 7.6Hz), 8.56 (lH, bs). This paper is applicable to China National Standard (CNS) A4 Specification (210X297 mm) 67 39 22 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 464649 V. Description of Invention (68) '(5S) -5-[(1R) -1- (b Preferred 3-yl) ethyl] -2- [N- (4-nitrobenzyloxycarbonyl) -N-methyl] amino-2-umolinolin-4-one, IR (KB r) cb -1: 3 2 9 9, 1 7 7 3, 1 7 4 6 · iH-HMR (CDC 1 3) 5: 1.44 (3H, d, J = 7. 2 Ηζ), 3.35 (3H, s), 3.90 (1Η, ιι), 5. .1 5 (1 Η, d, J = 2. 6 Η ζ), 5. 37 (2Η, s), 7 . 0 3-7. 2 4 (3 Η, m), 7.37 (lH, d, J = 8.2Hz), 7.47 (2H, d, J = 8.8Hz), 7.64 (1Η, d, J = 8 4Ηζ), 8.10 (lH, bs), 8.14 (2H, d, J = 6.8Hz). (5S) _5-[(lli) -1- (indio-3-yl) ethyl] -2- ( N-methyl-N-benzyloxycarbonyl) amino-2 -oxazolyl-4 -fluorene, IR (RBr) car 1: 328 1, 1 77 9, 1 746. IH-HHR (CDCla) δ: 1.45 (3Η, d, J = 7.2Ηε), 3.47 (3H, s), 3.91 (lH, m), 5.15 (lH, d, J = 3.0Hz), 7.03-7.49 (9H, m), 7.67 (lH, (d, J = 7.4 Hz), 8 · 05 (1H, bs). Example 4 (5 S) -5-[(lR) -l- (B fluoren-3-yl) ethyl] -2- [N- (N- (4-methoxybenzyl) aminomethyl) -N-methyl] amino-2 -n-oxazoline-4-indigoxin (150 mg) and dichloromethane To the (3-stretched) mixture was added 4-methoxyphenyl isocyanate (261 mg >) under ice-cooling. After the mixture was stirred at room temperature for 2 hours, the solvent was removed by distillation to obtain a residue. After adding isopropyl ether to the residue, the title compound was obtained as a crystal (213 mg, 89.9%). — ^ 1- ^^ 1 «^^ 1 ^^ 1 ^^ 1 ^^^ 1.--N ^ im In V, (Please read the precautions on the back before filling this page) This paper size is applicable to China Standard (CNS) A4 size (210X 297 mm) 68 392 2 1 '' 464649 A7 B7 Printed by the Consumers ’Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of invention (69) (CDCl3) δ: 1.48 (3H, d, J = 7.0Hz), 3.34 (3H, s), 3.78 (3H, s), 3.95 (1 H, m), 5.08 (lH, d, J = 3.0Hz) , 6.83 (2H1d, J = 9.2Hz), 7.11- 7.40 (6H, m), 7,67 (lH, d, J = 8.4Hz), 8.21 (lH.bs), 11.21 (lH, bs). When skimming Example fi According to the same procedure as described in Example 4, the following compound was prepared. (5S) -2- [N- (H- (4-chlorophenyl) aminomethylmethyl) -N-methyl] amino-5 -[(lR) -2- (indio-3-yl) ethyl] -2-oxazolin-4-one, IR (KBr) cm-1: 337 2, 1 7 1 3. 1H-HMR ( CDC 1 3) a: 1.49 (3H, d, J = 7.4Hz), 3.34 (3H, s), 3.97 (lH, m), 5.09 (1H, d, J = 3.2Hz), 7.15-7.47 (8H, m) t 7.67 (lH, d, J = 7.4Hz), 8. 17 (lH.bs), 1 1 .48 (1H, bs). (5S) -5-[(lR) -l- (ind -3-yl) ethyl] -2- [NU- (2-phenethyl) aminomethyl) -N-methyl] amino-2 -B, etc. -4- plane, IR (KBr) cm-1: 3 243, 1 7 1 3. ^ -NHR (CDCls) 8: 1. 4 4 (3 Η, d, J = 7.4 Η z), 2.82 ( 2H, t, J = 8.0Hz), 3,28 (311,3) (, 3.47 (2H, ra), 3.91 (1H, id), 5.02 (lH, d, J = 3. 0Hz), 7.11 -7.40 (9H, m), 7.65 (lH, d, J = 7.8Hz), 8.15 (1H, bs), 9.33 (1H, bs). (5S) -2- [H- (N- (2,4 -Dimethoxyphenyl) aminoformyl) -N-methyl] (Please read the precautions on the back before filling this page)
本紙張尺度適用中國國家標準(CNS > A4規格(210Χ2ί»7公釐) 69 39 22 1 經濟部中央標準局員工消費合作社印製 4 6 4 6 4 9 Α7 Β7 五、發明説明(70) 胺基-5 - [ ('1 R)_-l-(i引畴-3-基)乙基.]-2-Df 睡啉-4- _ , I R ( K B r)c 1 - 1 : 3 3 9 7 , 1 7 1 1 . ^-NHRCCDCls)^ : l,45(3H,d,J = 7.2Hz), 3.37(3H,s), 3.79(3H,s), 3.89(3H,s), 3.92(lH,m) ,5.07(lH,d,J=2.8Hz), 6.42~6.47(2H,m), 7.14-7.26(3H,m), 7.39(lH#d,J=7.4Hz), 7.69(lH,d,J=6.8Hz), 7.90(lH,d,J=9.2Hz), 8.14(lH,bs), 11.45(lH,bs). (5S)-2-[N-(N-(7-乙氧羰庚基)胺甲醢基)-N-甲基]胺 基- 5- [(lR)-l-(吲睬-3-基)乙基]-2-吗唑啉-4 -酮, IR (KBr) cm" 1 : 3 235 , 1 7 1 6 . ^-NMRtCDCU) d : 1.17-1.32(9Htm), 1.45(3H,d,J=7.4Hz), 1.50-1.72(4H,m), 2.30(2H,t,J=7.4Hz), 3.20(2H,m), 3.28(3H,s), 4.13(2H,q,J = 7.0Hz), 5.02(lH,d,J = 3.0HE), 7.10-7,25(3H,m), 7*38(lH,d,J=7.6Hz), 7.65(lH,d,J=7.8Hz), 8.34(lH,bs), 9.18(lH,bs). 倫例β (5S)-5-[(lR)-l-(吲睐-3-基)乙基]-2-(H-(4-三氟甲基苯 甲酿基)-Η-甲基]胺基-2-Β等唑啉-4-_ < 吲睐黴素(150毫克)、三乙胺(325微升)、4 -二甲胺基 吡啶(39.8毫克)及四氫呋喃(10毫升)之攪拌完全混合物中 ,於冰冷却下,加4-三氟甲基苯甲醢氯(260微升)°混合 物於0¾攪拌30分鐘,加乙酸乙酯。全部分別Μ水、飽和 (請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) Α4規格U10X297公釐) 7 0 3922 1 A7 B7 五、發明説明(Ή ) (請先閲讀背面之注f項再填寫本頁} 碩酸氫鈉水溶液及食鹽液洗滌,然後乙酸乙酯溶液經硫酸 鎂使之乾堞。移除有機溶劑,獲得之殘物進行矽膠層析。 以己烷-丙_(4:1>進行溶離,獲得標題化合物(176毫克, 70.4%),溶點 146 〜148Ό。 IRiKBrJcm'1: 3390, 1749, 1714. ^-HMR (CDCla) δ : 1 . 42 (3Η , d , J = 7 . 2Hz), 3 . 41 (3Η,s) , 3.7 7 - 3.8 9 ( 1 Η,m), 4.92(lHfd,J=2.8Hz), 6.64(lH,d,J=2.0Hz), 7.13-7.56(8Η,m) , 8.03 (1Η , bs). 奮掄Μ 7 依實施例6所述之相同程序,製備下述化合物。 (5S>-5-[(lR)-l-(吲睬-3-基)乙基]-2-(Ν~(2-三氣甲 基苯甲酵基)-Κ -甲基]胺基-2 -鸣唑啉-4 -酮, IR (KBr)cm-1 : 3287, 1 7 48 , 1 7 1 7. ^-NMRiCDCls)^ ί 1.23(3H,d,J = 7.2Hz), 3.51(3H,s), 3.68(1H,b), 4.87 (1 Η ,d,J = 2.8Hz), 6.60(lh,d,J=1.8Hz), 7.08-7.26(3H,m), 經濟部中央標準局員工消費合作社印製 7 . 36-7.61 (5H,m) t 8 . 02 (1H,bs). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-[N-(3-三氟甲 基i甲醯基-甲基]胺基- 2-D琴唑咐-4 , IR (KBr)cm-1 : 3 33 5, 1 7 1 5. 1 Η - Η M R (C D C 1 3 ) S : 1 . 3 7 (3 Η , d,J = 7 . 2 Η z ) · 3.41(3H,s), 3.78(lH,ra), 4.91 (1 Η ,d.J = 3.4Hz), 6.62(lH,d,J=2.2Hz), 7.11-7.40(5H,m), 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 71 39 22 1 4 6 4 6 4 9 A7 B7 五、發明説明(72 ) 7.51(lH,d,J=8.0Hz), 7.73(lH,d,J=7.4Hz), 7 . 78(1H,s)v 8.00 (1H,bs). (請先閱讀背面之注意事項再填寫本頁) (5S)-2-[N-(4-氟苯甲醯基)-U-甲基]胺基- 5-[(lR)-l -(项睐-3 -基)乙基]-2-Bf唑咐-4-_ , IR(KBr)cm~1 : 3300, 17 4 1, 1 707 . 1H-NHR(CDCla) δ : 1.44(3H,d,J = 7.4Hz), 3.38(3H,s) , 3.76-3.90(1H,m), 4.93(lH,d,J=3.0Hz), 6.76(lH,d,J=2.4Hz), 6.92-7.00(2H,m), 7.09-7.27(4H,m), 7.40(lH,d,J=8.0Hz), 7.56(lH,dtJ=7.2Hz), 8 . 13(1H , bs). (5S)-2-[N-(4-氣苯甲醯基)-N-甲基]胺基- 5-[(lR)-l -(»51睐-3-基)乙基]-2 -增唑啉-4-酮, IRUBrOc®- 1: 3296,1746, 1705. . 1 H-HMR (CDC Is) δ : 1 . 42 (3Η(d , J = 7.4Hz), 3.38(3H,s), 3.75-3.86(lH,m), 4.93(lH,d,J=3.0Hz), 6.70(lH,d,J=2.6Hz), 經濟部中央標準局員工消費合作社印製 7.09-7.28(6H,a), 7.40(lH,d,J=7.8Hz), 7 . 55 (1H,d,J = 8.OHe) , 8.09(lH,bs). (5S)-5-〔(1R)-1-(b3丨睬-3-基)乙基]'-2-[N-(4-甲基苯 甲醛基)-N -甲基]胺基-2-D等唑啉-4-酮, IR (KBr) cm-1 ^ 3 300, 17 44, 1 703. 1 H-HMR (CDC Is) δ : 1 .36 (3H , d , J = 7.4Hz), 2.39(3H,s), 3.38(3H,s), 3 . 7 1 - 3 . 83 (1 H,m), 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 72 3 922 1 A7 B7 4 6 4 6 4 Φ 五、發明説明(73 ) 4.89(lH,d,J=3.0Hz), 6.59(lH,d,J=2.2Hz), 7.06- 7.38(7 H,id), 7.50(lH,d,J = 8.4Hz), (請先鬩讀背面之注意事項再填寫本頁) 8.00(1 Η ,bs). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-[N-(4-甲氧苯 甲藤基)-N_甲基]胺基_2-D等唑咐_4__ , IR (KBr) cm-1 : 329 9 , 1 744, 1 7 01. ^-NHR (CDCla) δ : 1 . 39 (3Η , d , J = 7 . 4Hz), 3.38(3Hts), 3.82(3H,s), 4.91 (1 Η,d,J = 2.8 Ηζ), 6.67(lH,d,J=2.2Hz), 6.81(2H,d,J=8.8Hz), 7.06- 7.26(3H,m), 7.36(2H,d,J=8.8Hz), 7 . 52 (1Η , d , J = 7.4Ηζ) , 8.01(lH,bs). (5S)-2-(N-桂皮醯基-Ν-甲基)胺基-5-[(1R)-1-(b3丨味 -3 -基)乙基]-2 -唑咐-4-酮, IR (KBr)cm*1 : 339 5 , 1 753, 1 6 8 2 , 1 6 1 5 . (CDC 1 s) δ : 1 . 46 (3Η , d , J = 7 . 2Ηζ), 3 . 38 (3Η , s),3 . 88-3 · 99 (1Η,m), 5 · 1 4 (1 Η , d , J = 3 . 0 Η ζ ) , 7 . 0 6 - 7 . 8 2 ( 1 2 Η , ιη), 經濟部中央標準局員工消費合作社印製 7.96(1Η,bs). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-(Ν -甲基-Ν -菸 鹼醯基)胺基-2-鸣唑啉-4-酮, 、 1 IR (KBr) cm-1 : 3277, 1 748, 1 703. ^-NHRfCDCls)^ : 1.48(3H,d,J = 7.4Hz), 3.37(3H,s), 3.79-3.92(lH(m), 4.95(lH,d,J=3.4Hz), 6.80(lH,d,J=2.2Hz), 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 73 3 922 1 Λ7 B7 464649 五、發明説明(74 ) ?.09-7.58(6H,nt), 8.12(lH,d,J = 2.2Hz), , (請先閱讀背面之注意事項再填寫本頁) 8.40(lH,bs), 8.63(lH,dd,J=1.8&4.8Hz). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-甲基-N -苯 乙醯基)胺基-2-鸣唑啉-4-酮, IRUBrOcm· 1: 3 300, 1 724. 1 H-NMR (CDC U) δ : 1 . 45 (3Η , d , J = 7 . 0Hz), 3.25 (3Η,s) , 3.8 5 -3.99 ( 1 Η,a), 4.10(lH,d,J=16.6Hz), 4.25(lH,d,J=16.6Hz), 5.05(lH,d,J=2.8Hz), 6.98-7.39(9H,m), 7.63(lH,d,J=8.6Hz), 8.18(lH,bs). (5S)-5-[(lR>-l-(吲睬-3-基)乙基]-2-(K-甲基- H- (2 -«盼)羰基]胺基-2 -鸣唑啉-4-酮, IR (KBr) cm- 1 : 329 8, 1 739 , 1 672. 1H-NHR(CDC13) δ : 1.48(3H,d,J=7.4Hz), 3.37(3H , s) , 3 . 81 -3 . 90(1 Η , m), 4.99(lH,d,J=3.0Hz), 6.87-7.66(8H,m), 8.08(1 Η,bs). 經濟部中央標準局員工消費合作社印掣 (5S)-5-[(lR)-l-(吲味-3-基)乙基]-2-(Η -甲基- Η- (2 -1*吩基)乙醯基]胺基-2-鸣唑啉- 4- _ , IR (KBr)cm- 1 : 3 289 , 1 726 . < ^-NHRCCDCUJS : 1.49(3H,d,J = 7.2Hz), 3.26(3H,s), 3.88-3.99(lH,m), 4.34(lH,d,J=17.6Hz), 4.51(lH,d,J=17.6Hz), 5.09(lH,d,J=3.2Hz), 6.8〇-7.22(6H,m), 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 3922 1 74 4 6 4649 at B7 五、發明説明(75 ) 7.38aH,<j,J = 7.4Hz), 7.64(lH,d,J = 7.6Hz), 8.17(1H,bs). (5S)-2-(N-庚醯基-K-甲基)胺基- 5-[(lR)-l-(吲睐-3 -基)乙基]-2-BM唑啉-4-酮, IRCKBricm-1: 3275, 1732. ^-NMRiCDClsJS : 0.88(3H,t,J = 6.2Hz), 1.18-1.33(6H,m), 1.47(3H,d,J=7.2Hz), 1.55-1.63(2H,m), 2.84(2H,q,J=5.4Hz), 3.26(3H,s), 3.87-3.99(lH,m), 5.07(lH,d,J=3.0Hz), 7.09-7.25(3H,i), 7.38(lH,d,J=7.4Hz), 7,65(lH,d,J=7.4Hz), 8.14(lh,bs). (5S)-2-(N -璟己羰基-N-甲基)胺基-5-[(lR)-l-(吲睬 -3-基)乙基]-2-鸣唑啉-4-酮, IRtKBrici-1: 3320, 1717. 1 Η - _ (C D C 1 3 ) δ : 1 . U - 1 , 3 9 (6 Η,m ), 1.50(3H,dtJ=7.2Hz), 1.53-1.83(4H,m), 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 3.23(3H,s), 3.46 -3 . 60 ( 1 H,m) , 3.8 5 - 3.99 ( 1 H,m), 5.06(lH,d,J=3.0Hz), 7.09-7.24(3Htm), 7.37(lH,d,J = 7.0Hz), 7 . 6 5 (1 H , d , J(= 7 . 6 H z ), 8.11 (lH,bs). (5S)-5~[(1R)_1-(b 引探-3-基)乙基]_2_(N_ 甲基-N_ 二 甲基乙醯基)胺基-2-11馨脞啉-4-·, IR (KBr ) cm" 1 : 3 287 , 1 7 3 6, 1 6 24. 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 75 39 22 1 經濟部中央標準局員工消費合作社印製 6 4649 A7 B7 五、發明説明(76 ) 1H-NMR (CDC 1 3) δ : 1.12 (9Η , s), 1.47(3H,d,J=7.4Hz), 3.16(3H,s), 3.90(lH,m), 5.02(lH,d,J=3.0Hz), 7.08-7.26(3H,m), 7.36(lH,d,J=7.2Hz), 7.64(lH,d,J=7.2Hz), 8 . 2 7 (1H , b s ). (5S)-2-(N-乙醛基-H-甲基)胺基-5-[(lR)-l-(n3丨睬-3 -基)乙基]-2-11署唑咐-4 -酮, IRtKBrJcm-1: 3378, 1750, 1722. ^-NMR (CDCU) δ : 1 . 47 (3Η , d , J = 7 . 0Hz), 2.48(3Hts), 3.25(3H,s), 3.94(lH,m), 5.08(lH,d,J=3.4Hz), 7.09-7.22(3H,ia)t 7.38(lK,d,J=7.4Hz)f 7.65(lH,d,J=8.0Hz), 8.15(1H,bs). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-(N-異丁基-N-甲基)胺基-2 -鸣唑啉-4-酮, IR (KBr) cm-1 : 3 300, 1 736, 1 7 25. 1 H-NMR (CDC 1 3) 5 ί 0 . 86 (3Η , d , J = 7.ΟΗζ), 1.07(3H,d,J=6.8Hz), 1.50(3H,d,J=7.4Hz), 3 . 2 4 ( 3 Η , s ) , 3 . 8 6 (1 Η , m ) , 3 . 9 4 (1 Η , m ), 5.05(lH,d,J = 3.0Hz), 7.09-7.23(3^,11), 7.36(lH,d,J=7.4Hz), 7.64(lH,d,J=7.4Hz), 8 . 13 (1H , bs). (5S)-5-[(1R)-1-(b引睬-3-基)乙基]-2MN -甲基-N-丙 醛基)胺基-2-鸣唑啉-4-酮, 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X297公釐) 76 39221 (請先閲讀背面之注意事頃再填寫本頁) 訂 • \Ly— A7 464649 B7 五、發明説明(77 ) IR (KBr) cia-1 : 33 8 1 , 1736, 1 7 2 3 . ^-NMRiCDCls) δ : 1.05(3H,t,J = 7.2Hz), (請先閲讀背面之注意事項再填寫本頁) 1 . 47 (3Η , dtJ = 7.2Hz) , 2.87(2H,m), 3.26(3H,s), .3.88-4.00(lH,m),5.06(lH,d,J=3.0Hz), 7.09-7.25(3H,m), 7.38(lH,d,J=7.4Hz), 7.64 (1 H,d,J = 7.4Hz) , 8.13(lH,bs). (5S)-5-[(1R)-1-(b3 丨味-3-基)乙基]_2-(N -甲基-N-掠 榈醯基)胺基-2 -噚唑咐-4 -酮, IRiKBricf1: 3370, 1726. 1 H-NHR (CDC 1 a) 5 : 0 . 88 (3Η , t , J = 6.6Hz), 1.16-1.19(26H,m) , 1.46(3H,d,J = 7.2Hz), 2.82(2H,m), 3.25(3H,s), 3 . 9 1 (1 Η ,m), 5 · 06 (1Η,d , J = 3_2Hz),7.09-7 . 21 (3Η,m), 7.37(lH,d,J=7.4Hz), 7.64(lH,d,J=7,8Hz), 8. 12 (1H , bs). 實掄例《 經濟部中央標準局貝工消費合作.社印製 (5S)-2-[N-(2-苯甲氣苯甲醯基)-H-甲基]胺基-5-[(lR)-l _(b3丨睬-3-基)乙基]-2-B§唑咐-4-_ 吲睬徽素( 400毫克)、三乙胺(8 6 8微升)及4-二甲胺基 吡啶(106毫克)於四氫呋喃(20毫升)之攪、泮完全混合物, 於冰冷却下,加2-苯甲氧苯甲醯氛(1 . 15克)。混合物於 Ot;攪拌40分鐘,加乙酸乙酯。全部分別以水、飽和碳酸 氬鈉水溶液及食鹽液洗滌,然後,乙酸乙酯溶液經硫酸鎂 使之乾燥。移除有機溶劑,獲得之殘物進行矽膠層析。以 本紙張尺度適用中國國家操準(CMS ) A4規格(210X297公釐) 77 39 22 1 4 6 4 6 4 9 A7 ' B7 五、發明説明(78 ) 己烷-丙顧I (5: 1)溶離,獲得標題化合物(5 34毫克,73.3% )〇 IR(KBr)cm- 1 : 3 3 0 3 , 1 744 t 1701 . 1H-NMR(CDC13) δ : 1.15(3H,d,J=7.OHz), 3 . 4 0 (3 H , s ),3 · 6 5 (1 H,m ),4.6 8 (1 H,d , J = 2 . 6 H z ), 4.97(2H,s), 6.28 (1H,d,J = 2 . 6Hz), 6.89(lH,dtJ = 8.4Hz) , 7.04-7.50(12H,m), 7 . 85 C1H , bs). 奮施例9 (5S)-2-[N-(2-羥苯甲酵基)-N -甲基]胺基- 5- [(1R)-1-(b3【 睬-3-基)乙基]-2 -nf唑咐-4-酮 (5S)-2-[N-(2-苯甲氣苯甲醱基)甲基]胺基-5-_ [(11{)-1-(时丨睬-3-基)乙基]-2-Di唑晰-4-酮(420毫兗)於 四氫呋喃(10毫升)之溶液中,加10%耙-磺( 300毫克)。金 部進行氫化反應,然後過濾移除催化劑。此濾液經蒸餾移 除,獲得殘物,以乙醚處理,獲得標題化合物(104毫克, 30.7%),為結晶〇 經濟部中央標準局貝工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) IRUBrOcm-1: 3430, 3250, 1752,1649. 1 H-HHR (DMSO-de) δ : 1 . 38 (3 Η ,d,J = 7.4 Ηζ), 2.59(3H,s), 3.56(lH,m), 4.77(lff,d,J=3.0Hz), 6 . 89 -7 . 8 4 ( 9 Η , πι) , 10.62(lH,bs), 1 0 . 8 7 (1 Η , b s ). 奮施例1 0 (5S)-5-[(1I〇-1-(b3丨睬-3-基)乙基]-2-[Ν-(1-六氩吡啶羰 基)-Η-甲基]胺基- 2-Bi唑啉-4-酮 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 78 3 922 1 4 6 4649 A7 B7 五、發明説明(79 ) (請先閱讀背面之注意事項再填寫本頁) 吲睬徽素(150毫克)及三乙胺(3 24徹升)於四氫呋喃 (7.0毫升)之混合物中,於Ot:加氣甲酸4-硝基苯酯(353毫 克)。混合物於0¾樓拌15分鐘,然後加六氫吡啶(17 3徹升 )。金部於〇°C又攪拌8分鐘後,加乙酸乙酯。全部分別以 水、飽和磺酸氫鈉水溶液及食鹽液洗滌,然後,乙酸乙酯 溶液經硫酸鎂使之乾燥。移除有機溶劑,獲得之殘物進行 矽膠層析。以己烷-丙酿I (3: 1)溶離,獲得標題化合物( 154 毫克,71.6%)。 IR (KBr) cm"1 : 327 9, 1 6 98. 1 H-HMR (CDC 1 3) δ : 1 . 20 - 1 . 75 ( 9 Η , m ), 3 . 09 -3 . 3 5 (5 Η,m) , 3.40 - 3 . 7 0 ( 2 Η , ra) , 3.88(1Η,ι), 4.99(lH,d,J=2.6Hz), 7.10-7.19(3H,m), 7 . 34 (1 Η , dtJ = 7.4Ηζ) , 7 . 67 (1 Η , d , J = 8 · 4Hz ), 8 . 17 (1Η,bs). 啻掄彻Μ 1 (5 3)-2-[1(-(11-苯甲氣羰基-[-丙胺醛基卜卜甲基]胺基-5-[(1{〇-1-(吲睬-3-基)乙基]-2-唁唑啉-4-_ 經濟部中央標準局貝工消費合作社印製 Ν-苯甲氣羰基-L-丙胺酸(893毫克)及三乙胺(1.11毫 升)於四氫呋喃(10毫升)之混合物中,於-15¾加氣甲酸乙 酯(381徹升)。比混合物於-15C攢拌5分鐘,然後加吲睬 徽素(257毫克)。全部於0¾又攪拌8分鐘後,加乙酸乙酯 。全部加溫至室溫,攪拌40分鐘。加乙酸乙酯至混合物。 此混合物分別以水、飽和磺酸氩鈉水溶液及食鹽液洗滌, 然後,乙酸乙酯溶液經硫酸鎂使之乾燥。移除有機溶劑, 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 79 3 9 22 1 4 6 46 49 A1 B7 五、發明説明(SO ) 獲得之殘物進行矽膠層析。以己烷-丙酮(4:1)溶離,獲得 標題化合物( 387毫克,83. 3% )。 (請先聞讀背面之注意事項再填寫本頁) IR(KBr) cm- 1 ί 3233 , 1 7 1 5 . XH-NMR(CDC13) δ : 1.26 - 1.6 0 (6Η,m) , 2.20(3H,s), 4.14(lH,m), 5 . 0 5 -5 , 2 4 (4Η , in) , 6.69(lH,s), 7.U-7.36(9H,m), 7.64(lH,bs), 8.11(lH,s). 富旆剜1 2 依實施例11所述之相同程序,製備下述化合物。 (5S)-2-[N-(H-苯甲氧羰甘胺醯基)-K -甲基]胺基-5-[(lR)-l-(吲睬-3-基)乙基]-2-嘻唑啉-4-酮, IR (KBr) cm'1 : 3 277, 1 7 1 7. iH-NMR (CDC la) δ : 1 . 55 (3H , d,J = 7 . 8Hz) , _ 2 . 44 (3H , s) , 3.9niH,d,J = 15.8Hz), 4 . 01 (1H,d,J = 15.8Hz) , 4.53(lH,m), 5.11(2H,s), 5 . 2 0 (1 H,m ) , 6 . 6 1 (1 H , s ) , 7 . 1 5 - 7 , 3 4 ( 9 H,m ), 7.62(1H,m) , 8.13 (1H,bs). 經濟部中央標準局員工消費合作社印製 (5S)-2-[N-(H-苯甲氣羰基-L-亮胺醯基)-N-甲基]胺 基- 5- [(lR)-l-(吲睬-3-基)乙基]-2-Di 唑咐-4-_ , IR (KBr)cm- 1 : 3 300 , 1 7 1 7. ^-NMRfCDClsiS : 0.75(6H,m), 1 .4 4 - 1 . 8 1 ( 6 Η , m ), 2.19(3H,s), 4.14(lH,m), 5.0 1 - 5 . 27 ( 4 Η , m), 6.67(lH,s), 7 . 07 -7.22 (4H,m) , 7.33(5H,m), 7.60 (1H,m) , 8.11 (lH.bs).This paper size applies Chinese national standards (CNS > A4 size (210 × 2ί »7mm) 69 39 22 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 4 6 4 6 4 9 Α7 Β7 V. Description of the invention (70) Amine -5-[('1 R) _- l- (i) -3-yl) ethyl.]-2-Df Porphyrin-4- _, IR (KB r) c 1-1: 3 3 9 7, 1 7 1 1. ^ -NHRCCDCls) ^: l, 45 (3H, d, J = 7.2Hz), 3.37 (3H, s), 3.79 (3H, s), 3.89 (3H, s), 3.92 (lH, m), 5.07 (lH, d, J = 2.8Hz), 6.42 ~ 6.47 (2H, m), 7.14-7.26 (3H, m), 7.39 (lH # d, J = 7.4Hz), 7.69 ( lH, d, J = 6.8Hz), 7.90 (lH, d, J = 9.2Hz), 8.14 (lH, bs), 11.45 (lH, bs). (5S) -2- [N- (N- (7 -Ethoxycarbonylheptyl) carbamoyl) -N-methyl] amino-5-[(lR) -1- (indio-3-yl) ethyl] -2-morphazoline-4- Ketone, IR (KBr) cm " 1: 3 235, 1 7 1 6. ^ -NMRtCDCU) d: 1.17-1.32 (9Htm), 1.45 (3H, d, J = 7.4Hz), 1.50-1.72 (4H, m ), 2.30 (2H, t, J = 7.4Hz), 3.20 (2H, m), 3.28 (3H, s), 4.13 (2H, q, J = 7.0Hz), 5.02 (lH, d, J = 3.0HE ), 7.10-7,25 (3H, m), 7 * 38 (lH, d, J = 7.6Hz), 7.65 (lH, d, J = 7.8Hz), 8.34 (lH, bs), 9.18 (lH, bs). Examples of β (5S) -5-[(lR) -l- (indio-3-yl) ethyl] -2- (H- ( 4-trifluoromethylbenzyl) -fluorene-methyl] amino-2-B and other oxazoline-4-_ < indoxacin (150 mg), triethylamine (325 μl), To a fully stirred mixture of 4-dimethylaminopyridine (39.8 mg) and tetrahydrofuran (10 ml), add 4-trifluoromethylbenzidine chloride (260 µl) under ice cooling and stir the mixture at 0¾ for 30 minutes Add ethyl acetate. All are water and saturated respectively (please read the notes on the back before filling this page) The size of the paper is applicable to the Chinese National Standard (CNS) A4 specification U10X297 mm) 7 0 3922 1 A7 B7 V. Description of the Invention (Ή) (Please read note f on the back before filling out this page} Wash with sodium bisulfate aqueous solution and common salt solution, then dry the ethyl acetate solution with magnesium sulfate. The organic solvent was removed, and the obtained residue was subjected to silica gel chromatography. Isolation with hexane-propane (4: 1>) to obtain the title compound (176 mg, 70.4%), melting point 146 to 148 ° C. IRiKBrJcm'1: 3390, 1749, 1714. ^ -HMR (CDCla) δ: 1 42 (3Η, d, J = 7.2Hz), 3. 41 (3Η, s), 3.7 7-3.8 9 (1 Η, m), 4.92 (lHfd, J = 2.8Hz), 6.64 (lH, d , J = 2.0Hz), 7.13-7.56 (8Η, m), 8.03 (1Η, bs). Fendam 7 According to the same procedure as described in Example 6, the following compounds were prepared. (5S > -5-[( lR) -l- (indio-3-yl) ethyl] -2- (N ~ (2-trifluoromethylbenzyl) -K-methyl] amino-2 -oxazoline-4 -Ketone, IR (KBr) cm-1: 3287, 1 7 48, 1 7 1 7. ^ -NMRiCDCls) ^ 1.23 (3H, d, J = 7.2Hz), 3.51 (3H, s), 3.68 (1H , b), 4.87 (1 Η, d, J = 2.8Hz), 6.60 (lh, d, J = 1.8Hz), 7.08-7.26 (3H, m), printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs7. 36-7.61 (5H, m) t 8. 02 (1H, bs). (5S) -5-[(lR) -1- (indio-3-yl) ethyl] -2- [N- (3 -Trifluoromethyl i-methylfluorenyl-methyl] amino- 2-D oxazolidine-4, IR (KBr) cm-1: 3 33 5, 1 7 1 5. 1 Η-Η MR (CDC 1 3) S: 1. 3 7 (3 Η, d, J = 7. 2 Η z) · 3.41 (3H, s), 3.78 (lH, ra), 4.91 (1 , dJ = 3.4Hz), 6.62 (lH, d, J = 2.2Hz), 7.11-7.40 (5H, m), this paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 71 39 22 1 4 6 4 6 4 9 A7 B7 V. Description of the invention (72) 7.51 (lH, d, J = 8.0Hz), 7.73 (lH, d, J = 7.4Hz), 7.78 (1H, s) v 8.00 (1H , bs). (Please read the precautions on the back before filling this page) (5S) -2- [N- (4-fluorobenzyl) -U-methyl] amino- 5-[(lR) -l-(Xiayi-3 -yl) ethyl] -2-Bfazole command-4-_, IR (KBr) cm ~ 1: 3300, 17 4 1, 1 707.1 1H-NHR (CDCla) δ: 1.44 (3H, d, J = 7.4Hz), 3.38 (3H, s), 3.76-3.90 (1H, m), 4.93 (lH, d, J = 3.0Hz), 6.76 (lH, d, J = 2.4Hz ), 6.92-7.00 (2H, m), 7.09-7.27 (4H, m), 7.40 (lH, d, J = 8.0Hz), 7.56 (lH, dtJ = 7.2Hz), 8.13 (1H, bs) (5S) -2- [N- (4-Azobenzyl) -N-methyl] amino- 5-[(lR) -l-(»51 Preferred-3-yl) ethyl]- 2-Zoxazolin-4-one, IRUBrOc®- 1: 3296, 1746, 1705.. 1 H-HMR (CDC Is) δ: 1.42 (3Η (d, J = 7.4Hz), 3.38 (3H, s), 3.75-3.86 (lH, m), 4.93 (lH, d, J = 3.0Hz), 6.70 (lH, d, J = 2.6Hz), printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 7.09-7.28 ( 6H, a), 7.40 (lH, d, J = 7.8Hz), 7.55 (1H, d, J = 8.OHe), 8.09 (lH, bs). (5S) -5-[(1R) -1- (b3 丨 睬 -3-yl) ethyl] '-2 -[N- (4-methylbenzaldehyde) -N-methyl] amino-2-D and other oxazolin-4-ones, IR (KBr) cm-1 ^ 3 300, 17 44, 1 703. 1 H-HMR (CDC Is) δ: 1.36 (3H, d, J = 7.4Hz), 2.39 (3H, s), 3.38 (3H, s), 3. 7 1-3.83 (1 H, m), this paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 72 3 922 1 A7 B7 4 6 4 6 4 Φ 5. Description of the invention (73) 4.89 (lH, d, J = 3.0Hz) , 6.59 (lH, d, J = 2.2Hz), 7.06- 7.38 (7 H, id), 7.50 (lH, d, J = 8.4Hz), (Please read the precautions on the back before filling this page) 8.00 (1 Η, bs). (5S) -5-[(lR) -1- (indio-3-yl) ethyl] -2- [N- (4-methoxybenzyl) -N-form Amine] amino_2-D, etc., _4__, IR (KBr) cm-1: 329 9, 1 744, 1 7 01. ^ -NHR (CDCla) δ: 1. 39 (3Η, d, J = 7.4Hz), 3.38 (3Hts), 3.82 (3H, s), 4.91 (1 Η, d, J = 2.8 Ηζ), 6.67 (lH, d, J = 2.2Hz), 6.81 (2H, d, J = 8.8Hz), 7.06- 7.26 (3H, m), 7.36 (2H, d, J = 8.8Hz), 7.52 (1Η, d, J = 7.4Ηζ), 8.01 (lH, bs). (5S)- 2- (N-Cinnamonyl-N-methyl) amino-5-[(1R)- 1- (b3 丨 taste-3 -yl) ethyl] -2-oxazol-4-one, IR (KBr) cm * 1: 339 5, 1 753, 1 6 8 2, 1 6 1 5. (CDC 1 s) δ: 1.46 (3Η, d, J = 7.2Ηζ), 3.38 (3Η, s), 3.88-3 · 99 (1Η, m), 5 · 1 4 (1 Η, d, J = 3. 0 Η ζ), 7.0 6-7. 8 2 (1 2 Η, ιη), printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 7.96 (1Η, bs). (5S) -5 -[(lR) -l- (indio-3-yl) ethyl] -2- (N-methyl-N-nicotinylfluorenyl) amino-2-oxazoline-4-one,, 1 IR (KBr) cm-1: 3277, 1 748, 1 703. ^ -NHRfCDCls) ^: 1.48 (3H, d, J = 7.4Hz), 3.37 (3H, s), 3.79-3.92 (lH (m), 4.95 (lH, d, J = 3.4Hz), 6.80 (lH, d, J = 2.2Hz), this paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 73 3 922 1 Λ7 B7 464649 V. Description of the invention (74)? .09-7.58 (6H, nt), 8.12 (lH, d, J = 2.2Hz), (Please read the precautions on the back before filling this page) 8.40 (lH, bs), 8.63 (lH, dd, J = 1.8 & 4.8Hz). (5S) -5-[(lR) -l- (indio-3-yl) ethyl] -methyl-N-phenethylfluorenyl) amine 1-2-oxazoline-4-one, IRUBrOcm · 1: 3 300, 1 724.1 1 H-NMR (CDC U) δ 1.45 (3Η, d, J = 7.0 Hz), 3.25 (3Η, s), 3.8 5 -3.99 (1 Η, a), 4.10 (lH, d, J = 16.6Hz), 4.25 (lH, d , J = 16.6Hz), 5.05 (lH, d, J = 2.8Hz), 6.98-7.39 (9H, m), 7.63 (lH, d, J = 8.6Hz), 8.18 (lH, bs). (5S) -5-[(lR > -l- (indio-3-yl) ethyl] -2- (K-methyl-H- (2-«pan) carbonyl] amino-2 -oxazoline-4 -Ketone, IR (KBr) cm- 1: 329 8, 1 739, 1 672.1 1H-NHR (CDC13) δ: 1.48 (3H, d, J = 7.4Hz), 3.37 (3H, s), 3. 81 -3. 90 (1 Η, m), 4.99 (lH, d, J = 3.0Hz), 6.87-7.66 (8H, m), 8.08 (1 Η, bs). Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (5S) -5-[(lR) -l- (indyl-3-yl) ethyl] -2- (fluorene-methyl-fluorene- (2 -1 * phenyl) ethylfluorenyl] amino- 2-oxazoline- 4- _, IR (KBr) cm- 1: 3 289, 1 726. ≪ ^ -NHRCCDCUJS: 1.49 (3H, d, J = 7.2Hz), 3.26 (3H, s), 3.88 -3.99 (lH, m), 4.34 (lH, d, J = 17.6Hz), 4.51 (lH, d, J = 17.6Hz), 5.09 (lH, d, J = 3.2Hz), 6.80-7.22 (6H , m), this paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 3922 1 74 4 6 4649 at B7 V. Description of the invention (75) 7.38aH, < j, J = 7.4Hz), 7.64 (lH, d, J = 7.6Hz), 8.17 (1H, bs) (5S) -2- (N-heptyl-K-methyl) amino- 5-[(lR) -l- (indyl-3 -yl) ethyl] -2-BMoxazoline-4 -Ketone, IRCKBricm-1: 3275, 1732. ^ -NMRiCDClsJS: 0.88 (3H, t, J = 6.2Hz), 1.18-1.33 (6H, m), 1.47 (3H, d, J = 7.2Hz), 1.55- 1.63 (2H, m), 2.84 (2H, q, J = 5.4Hz), 3.26 (3H, s), 3.87-3.99 (lH, m), 5.07 (lH, d, J = 3.0Hz), 7.09-7.25 (3H, i), 7.38 (lH, d, J = 7.4Hz), 7,65 (lH, d, J = 7.4Hz), 8.14 (lh, bs). (5S) -2- (N -Hex Carbonyl-N-methyl) amino-5-[(lR) -l- (indio-3-yl) ethyl] -2-oxazolin-4-one, IRtKBrici-1: 3320, 1717. 1 Η-_ (CDC 1 3) δ: 1. U-1, 3 9 (6 Η, m), 1.50 (3H, dtJ = 7.2Hz), 1.53-1.83 (4H, m), employees of the Central Standards Bureau of the Ministry of Economic Affairs Printed by a consumer cooperative (please read the precautions on the back before filling out this page) 3.23 (3H, s), 3.46 -3. 60 (1 H, m), 3.8 5-3.99 (1 H, m), 5.06 (lH , d, J = 3.0Hz), 7.09-7.24 (3Htm), 7.37 (lH, d, J = 7.0Hz), 7. 6 5 (1 H, d, J (= 7.6 Hz), 8.11 ( lH, bs). (5S) -5 ~ [(1R) _1- (b Induction-3-yl) ethyl] _2_ (N_methyl-N_dimethylacetamido) amino-2-11 Perylene-4- ·, IR (KBr) cm " 1: 3 287, 1 7 3 6, 1 6 24. This paper size applies to China National Standard (CNS) A4 (210X297 mm) 75 39 22 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 6 4649 A7 B7 V. Description of the invention (76) 1H-NMR (CDC 1 3) δ: 1.12 (9Η, s), 1.47 (3H, d, J = 7.4Hz), 3.16 (3H, s), 3.90 (lH, m), 5.02 (lH, d, J = 3.0Hz), 7.08-7.26 (3H, m), 7.36 (lH, d, J = 7.2Hz), 7.64 (lH, d, J = 7.2Hz), 8. 2 7 (1H, bs). (5S) -2- (N-B Aldehyde-H-methyl) amino-5-[(lR) -l- (n3 丨 3-3 -yl) ethyl] -2-11sulfazol-4-one, IRtKBrJcm-1: 3378, 1750, 1722. ^ -NMR (CDCU) δ: 1.47 (3Η, d, J = 7.0 Hz), 2.48 (3Hts), 3.25 (3H, s), 3.94 (lH, m), 5.08 (lH, d, J = 3.4Hz), 7.09-7.22 (3H, ia) t 7.38 (lK, d, J = 7.4Hz) f 7.65 (lH, d, J = 8.0Hz), 8.15 (1H, bs). (5S ) -5-[(lR) -l- (indio-3-yl) ethyl] -2- (N-isobutyl-N-methyl) amino-2 -oxazolin-4-one, IR (KBr) cm-1: 3 300, 1 736, 1 7 25. 1 H-NMR (CDC 1 3) 5 ί 0. 86 (3Η, d, J = 7.〇Ηζ), 1.07 (3H, d, J = 6.8Hz), 1.50 (3H, d, J = 7.4Hz), 3. 2 4 (3 Η, s), 3. 8 6 (1 Η, m), 3. 9 4 (1 Η, m) , 5.05 (lH, d, J = 3.0Hz), 7.09-7.2 3 (3 ^, 11), 7.36 (lH, d, J = 7.4Hz), 7.64 (lH, d, J = 7.4Hz), 8.13 (1H, bs). (5S) -5-[(1R ) -1- (b-fluoren-3-yl) ethyl] -2MN-methyl-N-propionyl) amino-2-imidazolin-4-one, this paper size applies to Chinese National Standard (CNS ) A4 specification (2! 0X297 mm) 76 39221 (Please read the notes on the back before filling this page) Order • \ Ly— A7 464649 B7 V. Description of the invention (77) IR (KBr) cia-1: 33 8 1, 1736, 1 7 2 3. ^ -NMRiCDCls) δ: 1.05 (3H, t, J = 7.2Hz), (Please read the notes on the back before filling this page) 1. 47 (3Η, dtJ = 7.2 Hz), 2.87 (2H, m), 3.26 (3H, s), 3.88-4.00 (lH, m), 5.06 (lH, d, J = 3.0Hz), 7.09-7.25 (3H, m), 7.38 ( lH, d, J = 7.4Hz), 7.64 (1 H, d, J = 7.4Hz), 8.13 (lH, bs). (5S) -5-[(1R) -1- (b3 丨 味 -3- (Yl) ethyl] _2- (N-methyl-N-pyridyl) amino-2 -oxazolyl-4 -one, IRiKBricf1: 3370, 1726. 1 H-NHR (CDC 1 a) 5: 0. 88 (3Η, t, J = 6.6Hz), 1.16-1.19 (26H, m), 1.46 (3H, d, J = 7.2Hz), 2.82 (2H, m), 3.25 (3H, s), 3 9 1 (1 Η, m), 5.06 (1Η, d, J = 3_2Hz), 7.09-7. 21 (3Η, m), 7.37 (lH, d, J = 7.4Hz), 7 .64 (lH, d, J = 7,8Hz), 8. 12 (1H, bs). Examples: "Peace Consumer Consumption Cooperation of the Central Standards Bureau of the Ministry of Economic Affairs. Printed by the agency (5S) -2- [N- ( 2-benzyl benzamidine) -H-methyl] amino-5-[(lR) -1_ (b3 丨 3-3-yl) ethyl] -2-B _ The complete mixture of indigoxin (400 mg), triethylamine (888 microliters) and 4-dimethylaminopyridine (106 mg) in tetrahydrofuran (20 ml) was added. Under ice cooling, add 2-benzyloxybenzoate (1.15 g). The mixture was stirred at Ot; for 40 minutes, ethyl acetate was added. The whole was washed with water, a saturated sodium bicarbonate aqueous solution and a common salt solution, and then the ethyl acetate solution was dried over magnesium sulfate. The organic solvent was removed, and the obtained residue was subjected to silica gel chromatography. Applicable to China Papers (CMS) A4 specification (210X297 mm) on this paper scale 77 39 22 1 4 6 4 6 4 9 A7 'B7 V. Description of the invention (78) Hexane-Bing Gu I (5: 1) Dissolve to obtain the title compound (534 mg, 73.3%). IR (KBr) cm-1: 3 3 0 3, 1 744 t 1701. 1H-NMR (CDC13) δ: 1.15 (3H, d, J = 7. OHz), 3. 40 (3 H, s), 3.65 (1 H, m), 4.68 (1 H, d, J = 2. 6 Hz), 4.97 (2H, s), 6.28 (1H, d, J = 2.6Hz), 6.89 (lH, dtJ = 8.4Hz), 7.04-7.50 (12H, m), 7.85 C1H, bs). Example 9 (5S) -2- [ N- (2-hydroxybenzyl) -N-methyl] amino-5-[(1R) -1- (b3 [fluoren-3-yl) ethyl] -2 -nfazole-4- Keto (5S) -2- [N- (2-benzylbenzyl) methyl] amino-5-_ [(11 {)-1- (hr 丨 睬 -3-yl) ethyl] To a solution of -2-Dizoxan-4-one (420 mTorr) in tetrahydrofuran (10 ml) was added 10% rake-sulfur (300 mg). The gold portion undergoes a hydrogenation reaction, and then the catalyst is removed by filtration. This filtrate was removed by distillation to obtain a residue, which was treated with diethyl ether to obtain the title compound (104 mg, 30.7%), which was crystallized. Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling (This page) IRUBrOcm-1: 3430, 3250, 1752, 1649. 1 H-HHR (DMSO-de) δ: 1.38 (3 Η, d, J = 7.4 Ηζ), 2.59 (3H, s), 3.56 ( lH, m), 4.77 (lff, d, J = 3.0Hz), 6.89-7.8.4 (9 9, πm), 10.62 (lH, bs), 1 0. 8 7 (1 Η, bs) Example 1 10 (5S) -5-[(1I〇-1- (b3 丨 fluoren-3-yl) ethyl] -2- [N- (1-hexahydropyridylcarbonyl) -fluoren-methyl ] Amine-2-Biazolin-4-one This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 78 3 922 1 4 6 4649 A7 B7 V. Description of the invention (79) (Please read first Note on the back page, please fill in this page again) Indigoxin (150 mg) and triethylamine (324 liters) in a mixture of tetrahydrofuran (7.0 ml), in Ot: aerated 4-nitrophenyl formate ( 353 mg). The mixture was stirred at 0¾ floor for 15 minutes, then hexahydropyridine (173 liters) was added. The gold part was stirred at 0 ° C for another 8 After 20 minutes, ethyl acetate was added. All were washed with water, saturated aqueous sodium hydrogen sulfonate solution, and common salt solution, and then the ethyl acetate solution was dried over magnesium sulfate. The organic solvent was removed, and the obtained residue was subjected to silica gel chromatography. Dissolved in hexane-propanol I (3: 1) to obtain the title compound (154 mg, 71.6%). IR (KBr) cm " 1: 327 9, 1 6 98. 1 H-HMR (CDC 1 3) δ: 1.20-1.75 (9 Η, m), 3.09 -3.35 (5 Η, m), 3.40-3.70 (2 Η, ra), 3.88 (1Η, ι) , 4.99 (lH, d, J = 2.6Hz), 7.10-7.19 (3H, m), 7.34 (1 Η, dtJ = 7.4Ηζ), 7.67 (1 Η, d, J = 8 · 4Hz) , 8.17 (1Η, bs). 啻 抡 M 1 (5 3) -2- [1 (-(11-benzyl carbonyl-[-propylaminoaldehyde bumethyl] amino-5-[(1 {〇-1- (indio-3-yl) ethyl] -2-oxazoline-4-_ printed by N-benzylcarbonyl-L-alanine (893 Mg) and triethylamine (1.11 ml) in a mixture of tetrahydrofuran (10 ml), and ethyl formate (381 tL) was aerated at -15¾. Mix the mixture at -15C for 5 minutes, then add indoxin (257 mg). After all stirring at 0¾ for another 8 minutes, ethyl acetate was added. All were warmed to room temperature and stirred for 40 minutes. Ethyl acetate was added to the mixture. This mixture was washed with water, a saturated aqueous sodium sulfonate solution and a common salt solution, respectively, and then the ethyl acetate solution was dried over magnesium sulfate. The organic solvent is removed, and the paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) 79 3 9 22 1 4 6 46 49 A1 B7 5. The residue obtained by the invention (SO) is subjected to silica gel chromatography. Dissolve in hexane-acetone (4: 1) to obtain the title compound (387 mg, 83.3%). (Please read the notes on the back before filling in this page) IR (KBr) cm- 1 ί 3233, 1 7 1 5. XH-NMR (CDC13) δ: 1.26-1.6 0 (6Η, m), 2.20 (3H , s), 4.14 (lH, m), 5.05-5, 2 4 (4Η, in), 6.69 (lH, s), 7.U-7.36 (9H, m), 7.64 (lH, bs) , 8.11 (lH, s). Fluorene 1 2 According to the same procedure as described in Example 11, the following compounds were prepared. (5S) -2- [N- (H-Benzyloxycarbonylglycinyl) -K-methyl] amino-5-[(lR) -l- (indio-3-yl) ethyl] 2-Hipazolin-4-one, IR (KBr) cm'1: 3 277, 1 7 1 7. iH-NMR (CDC la) δ: 1. 55 (3H, d, J = 7.8 Hz) , _ 2. 44 (3H, s), 3.9niH, d, J = 15.8Hz), 4. 01 (1H, d, J = 15.8Hz), 4.53 (lH, m), 5.11 (2H, s), 5. 2 0 (1 H, m), 6. 6 1 (1 H, s), 7. 1 5-7, 3 4 (9 H, m), 7.62 (1H, m), 8.13 (1H, bs ). Printed by (5S) -2- [N- (H-Benzylcarbonyl-L-leucineamido) -N-methyl] amino- 5-[(lR ) -l- (indio-3-yl) ethyl] -2-Dizolamidine-4-_, IR (KBr) cm-1: 3 300, 1 7 1 7. ^ -NMRfCDClsiS: 0.75 (6H, m), 1.4 4-1.8 1 (6 Η, m), 2.19 (3H, s), 4.14 (lH, m), 5.0 1-5.27 (4 Η, m), 6.67 (lH, s), 7.07 -7.22 (4H, m), 7.33 (5H, m), 7.60 (1H, m), 8.11 (lH.bs).
(5S)-2-[N-(N-苯甲氣羰基-L-苯丙胺醯基)-N -甲基]I 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 80 39 2 2 1 經濟部中央標準局員工消費含作社印製 4 6 4 6 49 A.7 B7 五、發明説明(SI ) 胺基-5-[(lR)-l-(B引睬-3-基)乙基]-2-鸣唑啉- 4- _ , IRtKBricni-1: 337 5, 1719. 1H-HHR(CDC13) 5 : 1.31(1H,d,J^7.4Hz), 1.45(2H,d,J=7.2Hz), 3.13(3H,s), 3.50(2H,m), 4.42(lH,m), 4.52(lH,m), 5 . 0 8 - 5 . 44 ( 3H , m), 6.70-7.60(15H,m), 8.04(lH,s). (5S)-2-[N-(N-苯甲氧羰基-L-脯胺醯基)-N-甲基]胺 基- 5-[(lR)-l-(吲睬-3-基)乙基]-2-D|唑啉-4-酮, 332 4, 1 70 1. 1 H-NHR (CDC Is) δ : 1 . 28 (1 . 5Η , d,J = 7.2Hz), 1 . 42 (1 .5Η,d,J = 5.2Hz) , 1.90(3Htm), 2.39(lH,m), 3.11(1.5H,s), 3.30(1.5H,s), 3.51-3.66(2H,m), 3.89(lH,m), 4.89 - 5.21 ( 3 Η , m) , 5.40 - 5.52 ( 1 Η ,m), 7 . 01-7.36 (9H,m) , 8.01 ( 0 . 5 Η ,bs) , 8 , 1 9 ( 0 . 5 Η , bs). (5S)-2-[N-(N-苯甲氧羰基- L-7 苯甲基麩胺醯基)-11-甲基]胺基-5-[(11〇-1-(»引睬-3-基)乙基]-2-喝唑啉-4-酮, IR (KBr)cm~1 : 33 5 4 , 1 7 1 9. 1 H-NMR (CDC 13) δ : 1.56(3H,m), 1 . 75 ( 2 Η , m ), 2.17(3H,s), 2.40(2H,m), 3.73(1Ήμ〇), 4 . 25 (1 Η,m) ,5 . 00 -5 . 22 (5Η,m) , 7.11 -7.34(14Η,m), 7.64(lH,m), 8.10(lH,bs). 審掄例1 :¾ (5S)-2-[H-(N-(L-丙胺醯基)-Η-甲基]胺基- 5-[(lR)-l- (請先鬩讀背面之注意事項再填寫本頁) 4 ,ιτ 本紙張尺度適用中國國家樣準(CNS ) Α4規格(21ΟΧ297公釐) 81 3 9 22 1 464649 a? B7 五、發明説明(82 ) (吲睬-3 -基)乙基]-2 - Di唑咐-4 - _ (5S) - 2- [N- (N-苯甲氧羰基丙胺醯基)-H-甲基]胺 基- 5- [(lR)-l-(吲踩-3-基)乙基]-2-Bf 唑啉-4-_ (387毫 克)於四氫呋喃(4毫升)之溶液中,加10%鈀-磺(100毫克) 。全部進行氫化反應,然後過濾移除催化劑。濾液經蒸餾 移除t獲得之殘物以乙醚處理,獲得標題化合物(141毫克 ,51.6%),為結晶。 IRiKBrJcm-1: 3372, 3287, 1736, 1633. iH-NMRtCDCUJS : 1.26(3H,dtJ = 7.0Hz), 1 . 52 (3H,d,J = 7.0Hz) , 3.13(3H,s), 3.80(lH,m), 4.22(lH,q, J = 7.0Hz) , 4.53(lH,bs), 7.07-7.22 (2 H,m) , 7.36(lH,d,J = 7.2Hz), 7.72(lH,d,J=7.0Hz), 8.02(lH,bs), 9.09(lH,bs). 窨掄例1 4 依實施例13所述之相同程序,製備下述化合物。 (5S)-2-(N-甘胺醯基-N-甲基)胺基- 5- [(lR)-l-(吲睬 -3-基)乙基]-2 -鸣唑咐-4- _, 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) IR (KBr) cm-1 : 33 33, 1 7 48, 1 63 0. iH-NMR (CDC la) δ : 1 . 27 (3H , d , J = 7 . 2Hz), 3.14(3H,s), 3.80(lH,m), 4.15(2H<,s), 4.54(lH,dtJ=2.8Hz), 7.08-7.22(2H,m), 7 . 36 (1H , d , J = 7 . 2Hz) , 7.72(lH,d,J = 7.4Hz), 8.03 (1H , bs) , 9 .02 (1H, bs). (5S)-5-[(lR)-l-(«引睬-3-基)乙基]-2-(if-L-亮胺醯 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 82 3 92 2 1 4 6 4649 A7 ._B7_ 五、發明説明(83 ) 基-N-甲基)胺基- 2-B等唑啉-4-_ , IRtKBrJci-1: 3368, 1759, 1644. 1H-NM8 (CDC 1 3) 5 : 1.00(6Η,d,J = 4.8Hz), 1.27(3Η,d,J = 7.0Hz) , 1.63(lH,m), 1.77 ( 2 Η(m), 3.13 (3Η , s ) , 3.80(1 Η,m), 4.18(lH,dd, J=3.8&9.2Hz), 4.52(lH,d,J = 2.6Hz), 7.07-7.21(2H,m), 7.36(lH,d,J = 7.4Hz), 7.72(1Η,d,J=7.4Ηζ), 8.02(lH,bs), 9.18(lH,bs). (5S)-5-[(lfi)-卜(吲睬-3-基)乙基]- 2-U-L-苯丙胺 醯基-N-甲基)胺基-2-噚唑啉-4-酮, IRCKBricm-1: 3380, 1707, 1637. 1 H-NMR(CDC 1 3) δ : 1 . 22 (3Η,d,J = 7.ΟΗζ), 2 . 93 (1Η , dd,J = 14·0&8·4Ηζ),3 , 04 (3Η , s), 3.32(lH,d,J=14.0&4.0Hz), 3.95(lH,m), 4.37(lH,dd,J = 8.4&4.0Hz), 7.07-7.41 (9H,m), 7 . 70 (1H , d,J = 8.0Hz) , 8.01(lH,bs). (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-U-L-脯胺醯 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 基-N -甲基)胺基-2-噚唑咐-4-酮, IR (KBr) cm- 1 : 3 289, 1 707. 1 H-NHR (CDC 1 3) δ : 1 . 5 1 (3Η , d , J = 7 .(4Ηζ), 1.89(2Η,πι), 2.06(2H,m), 2.78(3H,s)( 3.00(lH,m) ,3.25(lH,m), 3.80(2Η,ι), 4 . 83 (1 Η , d,J = 3.2 Ηz), 6.59(lH,s), 7.09-7.21(3H,m), 7.38(lH,d,J=7.4Hz), 7.64(lH,d,J=7.8Hz), 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83 3 9 22 1 4 6 4649 A? B7 五、發明説明(84 ) 8.13 (1H,bs). (5S)-2-(N-L-麩胺醯基-N-甲基)胺基- 5-[(lR)-l-(吲 睬-3-基)乙基]-2 -鸣唑啉-4 -酮, IRtKBrJcm-1: 3299, 1724, 1623. 1 H-NMR(DMSO-de) δ : 1 . 18 (3Η , d,J = 6 . 8Hz), 2.03(2H,a), 2.22(2H,m), 2.99(3H,s), 3 . 66 (1 Η ,m) ,4.27 (2H,m) , 6.91 -7.12(3H,m), 7.32(lH,d,J=7.4Hz), 7.58(lH,d,J=6.6Hz), 9 . 57 (lli,bs). 窗掄例1 5 (5S)-5-[(1R)-1-(ii 引睬-3-基)乙基- 2- (N -甲磺醯基-N-甲 基)胺基-2-鸣唑琳-4-酮 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 吲味徽素(100毫克)及三乙胺(217徹升)於四氫呋喃 (5毫升)之混合物中,於-30亡加甲磺醯氯(90. 3徹升)。 全部於-30¾攪拌5分鐘,然後於0它又攪拌1小時。加乙 酸乙酯至混合物。此混合物分別以水、飽和碩酸氫鈉水溶 液及食鹽液洗滌,然後,乙酸乙酯溶液經硫酸鎂使之乾燥 。移除有機溶劑,獲得殘物,加異丙醚,則獲得標題化合 物(74毫克,57 . 0% )。 IR (KBr)cm~ 1 : 330 3, 1 7 48. ' . 1 Η - Η M R (C D C 1 3 ) δ : 1 . 5 3 (3 H , d , J = 7.4 Η z ), 2.88(3H,s), 3.33(3H,s), 3.88-3.97(lH,m), 5.06(lH,d,J=3.4Hz)t 7.10-7.25(3H,m), 7,37(lH,d,J=7.0Hz), 7.67(lH,d,J=7.8Hz), 本紙張尺度適用中國國家標準(CNS > A4规格(210X 297公釐) 84 3 9 2 2 1 4 6 4649 A7 B7 五、發明説明(85 ) 8.28 (1 Η,bs). 营旃例1 β (請先閱讀背面之注意事項再填寫本頁) 依實施例15所述之相同程序,製備下述化合物。 (5S)-2-(N-苯磺醯基-Ν-甲基)胺基-5-[(lR)-l-(a3l 味 -3-基)乙基]-2 -唁唑咐-4-酮 IR (KBr)cm-1 : 3 300, 1 7 48. VH-NMRCCDClsiS : 1.23(3H,<i,J = 7.2H?.), 3 . 5 4 ( 3 Η , s ) , 3 · 7 6 - 3 . 8 9 ( 1 Η,m), 4.99(lH,d,J=2.6Hz), 7.15-7.78(10H,i)f 8.12(1H,bs). 窗旆例1 7 / 經濟部中央標準局員工消費合作社印製(5S) -2- [N- (N-benzyl carbonyl-L-amphetamine fluorenyl) -N-methyl] I This paper size applies to China National Standard (CNS) A4 specification (2 丨 0X297 mm) 80 39 2 2 1 Consumption printed by the Central Bureau of Standards of the Ministry of Economic Affairs, including printed by the company 4 6 4 6 49 A.7 B7 V. Description of the invention (SI) Amino-5-[(lR) -l- (B 引 睬 -3 -Yl) ethyl] -2-oxazoline- 4- _, IRtKBricni-1: 337 5, 1719. 1H-HHR (CDC13) 5: 1.31 (1H, d, J ^ 7.4Hz), 1.45 (2H, d, J = 7.2Hz), 3.13 (3H, s), 3.50 (2H, m), 4.42 (lH, m), 4.52 (lH, m), 5.08-5.44 (3H, m), 6.70-7.60 (15H, m), 8.04 (lH, s). (5S) -2- [N- (N-benzyloxycarbonyl-L-proline) -N-methyl] amino-5 -[(lR) -l- (indio-3-yl) ethyl] -2-D | oxazolin-4-one, 332 4, 1 70 1. 1 H-NHR (CDC Is) δ: 1. 28 (1.5., D, J = 7.2Hz), 1.42 (1.5Η, d, J = 5.2Hz), 1.90 (3Htm), 2.39 (lH, m), 3.11 (1.5H, s), 3.30 (1.5H, s), 3.51-3.66 (2H, m), 3.89 (lH, m), 4.89-5.21 (3 Η, m), 5.40-5.52 (1 Η, m), 7. 01-7.36 ( 9H, m), 8.01 (0.5 Η, bs), 8, 1 9 (0.5 Η, bs). (5S) -2- [N- (N-benzyloxycarbonyl-L-7 benzyl Glutaminyl) -11-methyl] amine 5--5-[(11〇-1-(»induction-3-yl) ethyl] -2-oxazolin-4-one, IR (KBr) cm ~ 1: 33 5 4, 1 7 1 9 1 H-NMR (CDC 13) δ: 1.56 (3H, m), 1.75 (2Η, m), 2.17 (3H, s), 2.40 (2H, m), 3.73 (1Ήμ〇), 4. 25 (1 Η, m), 5.00-5.22 (5Η, m), 7.11 -7.34 (14Η, m), 7.64 (lH, m), 8.10 (lH, bs). Examination example 1: ¾ (5S) -2- [H- (N- (L-propylaminofluorenyl) -fluorenyl-methyl] amino- 5-[(lR) -l- (Please read the precautions on the back before filling this page ) 4, ιτ This paper size is applicable to China National Standard (CNS) A4 specification (210 × 297 mm) 81 3 9 22 1 464649 a? B7 V. Description of the invention (82) (Indino-3 -yl) ethyl]- 2-Diazole command -4-_ (5S)-2- [N- (N-benzyloxycarbonylpropylaminoamidino) -H-methyl] amino-5-[(lR) -l- (ind -3-yl) ethyl] -2-Bf oxazoline-4- (387 mg) was added to a solution of tetrahydrofuran (4 ml), and 10% palladium-sulfonic acid (100 mg) was added. All were hydrogenated and then the catalyst was removed by filtration. The filtrate was distilled to remove the residue, and the residue was treated with diethyl ether to obtain the title compound (141 mg, 51.6%) as crystals. IRiKBrJcm-1: 3372, 3287, 1736, 1633.iH-NMRtCDCUJS: 1.26 (3H, dtJ = 7.0Hz), 1.52 (3H, d, J = 7.0Hz), 3.13 (3H, s), 3.80 (lH , m), 4.22 (lH, q, J = 7.0Hz), 4.53 (lH, bs), 7.07-7.22 (2 H, m), 7.36 (lH, d, J = 7.2Hz), 7.72 (lH, d , J = 7.0 Hz), 8.02 (lH, bs), 9.09 (lH, bs). Example 1 4 Following the same procedure as described in Example 13, the following compounds were prepared. (5S) -2- (N-Glycinyl-N-methyl) amino-5-[(lR) -1- (indio-3-yl) ethyl] -2 -_, Printed by the Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs (please read the precautions on the back before filling this page) IR (KBr) cm-1: 33 33, 1 7 48, 1 63 0. iH-NMR (CDC la) δ: 1.27 (3H, d, J = 7.2Hz), 3.14 (3H, s), 3.80 (lH, m), 4.15 (2H <, s), 4.54 (lH, dtJ = 2.8Hz) , 7.08-7.22 (2H, m), 7.36 (1H, d, J = 7.2Hz), 7.72 (lH, d, J = 7.4Hz), 8.03 (1H, bs), 9 .02 (1H, bs). (5S) -5-[(lR) -l-(«Indene-3-yl) ethyl] -2- (if-L-leucine) The paper size is applicable to Chinese National Standard (CNS) A4 Specifications (210 X 297 mm) 82 3 92 2 1 4 6 4649 A7 ._B7_ V. Description of the invention (83) -N-methyl) amino-2B and other oxazoline-4-_, IRtKBrJci-1 : 3368, 1759, 1644. 1H-NM8 (CDC 1 3) 5: 1.00 (6Η, d, J = 4.8Hz), 1.27 (3Η, d, J = 7.0Hz), 1.63 (lH, m), 1.77 ( 2 Η (m), 3.13 (3Η, s), 3.80 (1 Η, m), 4.18 (lH, dd, J = 3.8 & 9.2Hz), 4.52 (lH, d, J = 2.6Hz), 7.07- 7.21 (2H, m), 7.36 (lH, d, J = 7.4Hz), 7.72 (1Η, d, J = 7.4Ηζ), 8.02 (lH, bs), 9.18 (lH, bs). (5S ) -5-[(lfi) -Bu (indio-3-yl) ethyl]-2-UL-amphetamine-N-methyl) amino-2-oxazoline-4-one, IRCKBricm- 1: 3380, 1707, 1637. 1 H-NMR (CDC 1 3) δ: 1.22 (3Η, d, J = 7.〇Ηζ), 2.93 (1Η, dd, J = 14 · 0 & 8 · 4Ηζ), 3, 04 (3Η, s), 3.32 (lH, d, J = 14.0 & 4.0Hz), 3.95 (lH, m), 4.37 (lH, dd, J = 8.4 & 4.0Hz), 7.07 -7.41 (9H, m), 7.70 (1H, d, J = 8.0Hz), 8.01 (lH, bs). (5S) -5-[(lR) -l- (indio-3-yl) Ethyl] -2-UL-proline 醯 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 4-ketone, IR (KBr) cm- 1: 3 289, 1 707.1 H-NHR (CDC 1 3) δ: 1.5 1 (3Η, d, J = 7. (4Ηζ), 1.89 (2Η, π), 2.06 (2H, m), 2.78 (3H, s) (3.00 (lH, m), 3.25 (lH, m), 3.80 (2Η, ι), 4. 83 (1 Η, d, J = 3.2 Ηz), 6.59 (lH, s), 7.09-7.21 (3H, m), 7.38 (lH, d, J = 7.4Hz), 7.64 (lH, d, J = 7.8Hz), this paper size applies to Chinese national standards (CNS) A4 specifications (210X297 mm) 83 3 9 22 1 4 6 4649 A? B7 V. Description of the invention (84) 8.13 (1H, bs). 5S) -2- (NL-glutamine-N-methyl) amino-5-((lR) -1- (indio-3-yl) ethyl] -2 -oxazoline-4- Ketone, IRtKBrJcm-1: 3299, 1724, 1623. 1 H-NMR (DMSO-de) δ: 1. 18 (3Η, d, J = 6.8Hz), 2.03 (2H, a), 2.22 (2H, m ), 2.99 (3H, s), 3.66 (1 Η, m), 4.27 (2H, m), 6.91 -7.12 (3H, m), 7.32 (lH, d, J = 7.4Hz), 7.58 (lH , d, J = 6.6Hz), 9.57 (lli, bs). Example of window 1 5 (5S) -5-[(1R) -1- (ii) -3-methyl) ethyl-2- (N-Methanesulfonyl-N-methyl) amino-2-imidazolin-4-one printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) Huixin (100 mg) and triethylamine (217 liters) in a mixture of tetrahydrofuran (5 ml), and methanesulfonyl chloride (90. 3 liters) were added at -30 ° C. The whole was stirred at -30¾ for 5 minutes and then at 0 for another hour. Add ethyl acetate to the mixture. The mixture was washed with water, a saturated aqueous solution of sodium bisulfate, and a common salt solution, and then the ethyl acetate solution was dried over magnesium sulfate. The organic solvent was removed to obtain a residue, and isopropyl ether was added to obtain the title compound (74 mg, 57.0%). IR (KBr) cm ~ 1: 330 3, 1 7 48. '. 1 Η-Η MR (CDC 1 3) δ: 1.5 3 (3 H, d, J = 7.4 Η z), 2.88 (3H, s), 3.33 (3H, s), 3.88-3.97 (lH, m), 5.06 (lH, d, J = 3.4Hz) t 7.10-7.25 (3H, m), 7,37 (lH, d, J = 7.0Hz), 7.67 (lH, d, J = 7.8Hz), this paper size applies to Chinese national standards (CNS > A4 size (210X 297 mm) 84 3 9 2 2 1 4 6 4649 A7 B7 V. Description of the invention (85) 8.28 (1 Η, bs). Example 1 β (Please read the precautions on the back before filling this page) According to the same procedure as described in Example 15, the following compounds were prepared. (5S) -2- (N-benzenesulfonyl-N-methyl) amino-5-[(lR) -l- (a3l odor-3-yl) ethyl] -2 -oxazol-4-one IR (KBr) cm-1: 3 300, 1 7 48. VH-NMRCCDClsiS: 1.23 (3H, < i, J = 7.2H ?.), 3. 5 4 (3 Η, s), 3 · 7 6-3. 8 9 (1 Η, m), 4.99 (lH, d, J = 2.6Hz), 7.15-7.78 (10H, i) f 8.12 (1H, bs). Example of window 17 / Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs Print
5-[l-(6 -氟B3丨睬-3-基)乙基]-2 -甲胺基-2-嗒唑咐-4-酮 乙醛(1.0克)於甲苯(7毫升)之溶液中,加異丙胺 (1.3克)。混合物經硫酸鎂使之乾燥,予以過濾。所得濾 液於冰冷却下加至6-氟吲睐(3.32克)於乙酸(20毫升)之溶 液。全部於冰箱中貯存3天,倒至冰水中。混合物以25% 氨水中和。全部以乙酸乙酯萃取。所得萃取物以食鹽液洗 滌,然後經硫酸鎂使之乾燥。移除溶劑,獲得殘物,加乙 酸乙酯及乙醚及混合物,則獲得6-氟基-3-(1-異丙胺基) 乙基吲睬(1 . 3 1克),為結晶。 V 1 H-HHR (CDC Is) S : 1 . 07 (6H,m), 1 . 4 9 (3 Η,d,J = 6 . 6 Η z ),2 . 8 5 (1 Η,in >, 4.23(lH,q,6.6Hz), 6.80-7.10(3H,m), 7.62(lH,dd,J = 5.4&8.4Hz) , 8.12(lH,bs). 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 85 3 9 2 2 1 A7 B7 464649 五、發明説明(86 ) (請先閱讀背面之注意事項再填寫本頁) 6 -氟基- 3- (1-異丙胺基)乙基吲睬(435毫克)、2 -二甲 胺基-4 -氣代基-2 -枵唑啉-5 -羧酸苯甲酯(ΰ 1 8毫克)於乙腈 (15毫升)之混合物中,加三正丁基勝(492徹升)。混合物 經回流2.5小時。移除溶劑,獲得殘物,加乙酸乙酯及乙 醚(10:1)之混合液,則獲得2-二甲胺基-5-[1-(6-氟11?丨睬-3 -基)乙基]-4-氧代基-2-噚唑咐-5-羧酸苯甲酯(509毫克) ,為結晶。 ^-NMR (CDC U) 5 : 1 . 28 (2Η , d , J = 7 . 2Hz), 1.51(lH,d,J = 7.2Hz), 2.84-3.26(6H,ra), 4.24(1H,ra), 4.99(1.4H,ABq,J=4.8Hz), 5.32(0.7H,ABq,J=4.8Hz), 6.70-7.70(9H,m), 8. 14 (0.7H , bs) , 8.45 (0.35 H,bs). 經濟部中央—準局員工消費合作社印製 2-二甲胺基-5-[1-(6-氟时丨除-3-基)乙基]-4-氣代基-2 -啤唑啉-5-羧酸苯甲酯(500毫克)溶於乙醇及四氫呋喃 (5:1)之15毫升溶液。加10%钯-硪(170毫克)。全部於常 溫及常壓下進行氫化反應1.5小時。全部於80勺氮大氣下 攪拌1小時,然後過濾移除催化劑。濾液予以濃縮,獲得 2-二甲胺基-5-[1-(6-氟吲睬-3-基)乙基]-2-D咢唑啉-4-酮 (340毫克)。 ^-NMRiCDCla)^ : 1 . 4 3 (1 , 2 Η , d , J =<7 . 2 Η z ), 1.62(1.8H,d,J=7.2Hz) , 2.97-3.06(6H,m),A solution of 5- [l- (6-fluoroB3 丨) -3-yl) ethyl] -2-methylamino-2-tazolyl-4-ketonealdehyde (1.0 g) in toluene (7 ml) Add isopropylamine (1.3 g). The mixture was dried over magnesium sulfate and filtered. The resulting filtrate was added to a solution of 6-fluoroindole (3.32 g) in acetic acid (20 ml) under ice-cooling. All were stored in the refrigerator for 3 days and poured into ice water. The mixture was neutralized with 25% ammonia water. All were extracted with ethyl acetate. The obtained extract was washed with a common salt solution and then dried over magnesium sulfate. The solvent was removed to obtain a residue. Ethyl acetate and diethyl ether and the mixture were added to obtain 6-fluoro-3- (1-isopropylamino) ethylindole (1.31 g) as crystals. V 1 H-HHR (CDC Is) S: 1.07 (6H, m), 1. 4 9 (3 Η, d, J = 6. 6 Η z), 2. 8 5 (1 Η, in > , 4.23 (lH, q, 6.6Hz), 6.80-7.10 (3H, m), 7.62 (lH, dd, J = 5.4 & 8.4Hz), 8.12 (lH, bs). The paper size applies to Chinese national standards ( CNS) A4 specification (210X297 mm) 85 3 9 2 2 1 A7 B7 464649 V. Description of invention (86) (Please read the precautions on the back before filling this page) 6 -Fluoro- 3- (1-isopropylamine Methyl) ethyl indene (435 mg), 2-dimethylamino-4-oxo-2-oxazoline-5-carboxylic acid benzyl ester (ΰ 18 mg) in acetonitrile (15 ml) To the mixture was added tri-n-butyl acetone (492 liters). The mixture was refluxed for 2.5 hours. The solvent was removed to obtain a residue, and a mixture of ethyl acetate and ether (10: 1) was added to obtain 2-dimethylformate. Amino-5- [1- (6-fluoro11? 丨 睬 -3 -yl) ethyl] -4-oxo-2-oxazolyl-5-carboxylic acid benzyl ester (509 mg) is Crystallization. ^ -NMR (CDC U) 5: 1.28 (2Η, d, J = 7.2Hz), 1.51 (lH, d, J = 7.2Hz), 2.84-3.26 (6H, ra), 4.24 (1H , ra), 4.99 (1.4H, ABq, J = 4.8Hz), 5.32 (0.7H, ABq, J = 4.8Hz), 6.70-7.70 (9H, m), 8. 14 (0.7H, bs), 8.45 (0.35 H, bs). 2-dimethylamino-5- [1- (6-fluoro hours 丨 except-3-yl) printed by the Central-Quasi Bureau Employee Consumer Cooperative of the Ministry of Economic Affairs ) Ethyl] -4-oxo-2-benzazoline-5-carboxylic acid benzyl ester (500 mg) was dissolved in 15 ml of ethanol and tetrahydrofuran (5: 1). Add 10% palladium-rhenium ( 170 mg). All were subjected to a hydrogenation reaction at normal temperature and pressure for 1.5 hours. All were stirred under 80 scoops of nitrogen for 1 hour, and then the catalyst was removed by filtration. The filtrate was concentrated to obtain 2-dimethylamino-5- [1 -(6-fluoroindio-3-yl) ethyl] -2-Doxazolin-4-one (340 mg). ^ -NMRiCDCla) ^: 1.4 3 (1, 2 Η, d, J = &7; 2 Η z), 1.62 (1.8H, d, J = 7.2Hz), 2.97-3.06 (6H, m),
I 3.60-3.80(lH,n), 4.90(0.6H,d,J=1.5Hz), 4.97(0.4H,d,J=1.5Hz), 6.85(lH,m), 6.90 -7.30 ( 2H , m) , 7.58(lH,m), 8.66 ( 0.4 Η , bs ), 本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X297公釐) 86 3 922 1 A7 B7 4 6 4649 五、發明説明(87 ) 8.67(0.6H,bs). (請先閲讀背面之注意事項再填寫本頁) 2-二甲胺基- 5- C1-C6-氟吲睬-3-基)乙基]-2-π等唑啉-4-酮(340毫克)於-10¾溶於甲胺(5毫升)中。混合物於同 溫攙拌3小時。混合物予以濃縮,獲得之殘物進行管柱層 析·以己烷-丙酮(1:1)溶離,獲得標題化合物(254毫克)。 IR(KBr)cm_1: 3195, 1733, 1644, 1627. 1 H-HHR (DHSO-de) δ ; 1 . 1 8 ( 0 . 9 Η ,d,J = 7.2 Ηζ), 1.27(0.4H,d,J=7.4Hz), 1.43(l.lH,d,J=7.2Hz), 1.49(0.6H,d,J=7.2Hz), 2.60-2.80(3Η,·)· 3.40-3 . 60 (lH,m) , 4 . 80 - 5 . 00 (1 Η,t) , 6.81(1Η,«), 7 . 00 - 7.2 0 (2Η,m) , 7 . 55 (1 Η , m) , 8.50 - 8 . 70 ( 1 Η , bs), 10.9-11.0(1Η,ι). 管倫俐1 8 依實施例11所述之相同程序,製備下述化合物。 (5S)-2-[N-(3-苯甲氧羰基睽丙醛基)-H-甲胺基]-5-[(lR)-l-(吲睬-3-基)乙基]-2 -唑啉-4-酮, IRUBrOcn-1: 3327,2 971,1715, 1557,1539, 經濟部中央標準局貞工消費合作社印製 1456 , 1397 , 1316 , 1246 , 1200 , 1 138 . ^-NHR (CDCI3) δ ί 1 . 48 (3Η , d , J = 7.4Ηζ), 2 . 76 - 3 . 07 (2Η , m) , 3.20(3H,s), 3 .^3 0 - 3 . 4 2 ( 2 Η , πι), 3.93(lH,m), 5.06(lH,d,J=3.2Hz), 5.11(2H,s), 7.07-7.22(3H,mJ, 7.30-7.40(6H,m), 7 . 62 (1H,d,J = 7.8Hz) , 8.24(lH,bs). (5S)-5-[(1I〇-1-(b3丨睬-3-基)乙基]-2-[N-[3-(N -苯 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 87 3922 1 4 6 4 6 49 A7 ' B7 五、發明説明(88 ) 甲氣羰基-N-甲基)胺基]丙醛基-卜甲胺基]-2-η等唑咐-4- m, IRUBHcb- 1: 3296 , 1 700-1 750,1 646. 1H-NHR (CDC la) 5 : 1 . 38 - 1.50 ( 3 Η , π), 2.86(1.2H,s) ,2.90(1.8H,s), 2.97-3.U(2H,m), 3.16(1.8H,s), 3.22 (1 . 2H , s) , 3.4-3.6 (2H , i) , 3.92(1H,b), 5.04(lH,d,J=2.8Hz), 5.13(2H,s), 6.9-7.4(9H,ra), 7.61(lH,d,J=7.4Hz), 8.1-8.3(lH,bs). (5S)-2-[N-(4-苯甲氣羰基胺丁醯基>-N-甲胺基]-5-[(lR)-l-(吲睬-3-基)乙基]-2-b署唑啉-4-酮, ' IR (KBr)cm" 1 : 3 3 37, 2969 , 2940 , 1 7 1 1 , 1 56 1 , 1 53 7, 1 45 4, 1 4 3 3, 1 3 97 , 1 3 1 4, 1 252, 1 1 92. 1H-NHR (CDC Is) δ : 1.48(3Η ,d,J = 7.4Ηz), 1.64(2H,m), 2.76(2H,b), 3.12(2H,n), 3.23(3H,s) ,3.93(1H,b), 4.82(lH,bs), 5.05(1H,d,J = 3.2Hz), 5.12(2H,s), 7.00-7.41(9H,m), 7.62(1H,d,J=6.8Hz), 8.35(lH,bs). 經濟部中央標準局貝工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) (5S)-2-[N-(4-苯甲基丁二醒基)-N -甲胺基]-5-[(lR) -1-( b3丨睬-3-基)乙基]-2 - Bf唑啉-4 -酮, IRtKBrJcm-1: 3400, 1733, 1558,<1538, 1456, 1432, 1394, 1209, 1166. ^-HMRtCDClsiS : 1.46(3H,d,J=7.3Hz), 2 . 52-2 . 66 (2H,m) , 2.99 - 3.34 (2H,m) , 3.24(3H,s), 3.93(lH,dq,J=7.3&3.0Hz), 5.06(lH,d,J=3.0Hz), 本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐) 88 3 9 2 2 1 A7 B7 464649 五、發明説明(89 ) 5.12(2H,s) , 7.0 7 -7.38 (9H,m), (請先聞讀背面之注意事項再填寫本頁) 7 . 6 3 (1 H , d , J = 7 . 2 H z ) , 8 . 1 0 (1 Η , b s ). (5S)-2-[N-[(2S)-2,5-雙(Ν-苯甲氣羰胺基)戊醯基]-卜甲胺基-5-[(11〇-1-(吲睬-3-基)乙基]-2-11§唑啉-4-酬, IR (KBr)cm-1 : 3327, 30 64, 303 3, 29 68, 29 39, 2877 , 1 7 1 8, 1 52 3 , 1 455, 1 388, 1 3 45, 1 26 3 , 1 2 2 0. iH-NMRiCDCla) δ : 1 . 25 - 1 . 55 (4 Η,ra), 1 . 57 (3Η,d,J = 6Hz) , 2.33(3H,s), 2.7 0 - 2.90 ( 2 Η,a), 4.15-4.30(2H,m) , 4.83-5.29(7Η,ιι), 7 . 0 7 -7 . 68 ( 1 5Η , m) , 8 . 12 (1Η , bs). (5S)-2-[N-[(S)-4-苯甲基(H-苯甲玻胺基)天冬胺醯 基]-N -甲胺基]-5 - [(1 R ) - 1 - (»3丨曄-3 -基)乙基]-2 -枵唑啉 '-4-酮, IRUBrOcn-1: 3396 , 3064 , 3035 , 2970 , 2937 , 1722, 1455, 1423, 1386, 1344, 1311. 1 Η - Η M R (C D C 1 3 ) S : 1 . 3 6,1 · 6 0 (全部 3 H,d , J = 7 . 8 Η z ), 2 . 1 9 (3 Η,s ) , 2.2 8 - 3 . 1 8 ( 2 Η,β > , 3 . 7 8 (1 Η,η ), 經濟部中央標準局負工消费合作社印製 4.21 (1Η,m) , 4.29 -4.47 (1 Η , η) , 4.99 - 5.32 ί5 Η , ο), 6.70-7.47(14H,m), 7.68(lH,d,J=8.2Hz), 8 . 10 (1Η , bs). 、 (5S)-5-[(1R)-1-(b3I 睐-3-基)乙基]-2-[N-[(S)-4 -甲 基[N-苯甲氣羰胺基)天冬胺醯基]-N-甲胺基]-2-11等唑啉 -4-酮, IR (KBr) cm-1 : 3402 , 3060, 3037 , 2954, 2937 , 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 89 3922 1 464649 A7 B7 五、發明説明(90 ) 1 7 2 2, 1 45 7, 1 436, 1 37 6 , 1 344 , 1 3 1 3 . UMlUCDCls)^: 1.36· 1.61(全部 3H,d,J = 7.6Hz), 2.20(3H,s), 2.82-3.82 (3H,m) , 3.57, 3.60(全部311,8>,4.18-4.50(211,《1), 5.02- 5.32(3H,b), 6.85-7.36(9H,m), 7-45, 7.68(金部 lH,d,J=7.2Hz), 8,14(lH,bs). (5S)-2-[N-(2 -第三丁基二甲矽烷氣辛醸基)-N -甲胺 基]-5-[(lR)-l-(吲睬-3-基)乙基]-2-鸣唑啉-4-酮, 1 H-NMR (CDCI3) δ : -0 . 1-0 . 1 (6Η , m) f 〇 . 85 (4.5 Η , s), 0 . 87 (4 . 5Η,s) , 1 . 0-1 .2 (10Η,m), 1.46(3H,t,J=7.0Hz), 3.25(1.5H,s), 3.26(1.5H,s) ,3 . 93 (1H , dq , J = 3.0&7.0Hz), 5.05(0.5H,d,J=3.0Hz), 5.07(0.5H,d,J=3.0Hz), 5.40-5.48(lH,m), 7.1-7.7(5H,n), 8.13(lH,bs). (5S)-2-[N-(2-苯甲氧辛醛基甲胺基]-5-[(lR)-l -(吲睬-3-基)乙基]-2-B|唑咐-4-酮 IRUBrOcm· 1 : 181 0 , 1 733,1704 , 1634 . 鋰濟部中央標準局貞工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) ^-NMR (CDCla) δ : 0 . 8 - 0.9 (3 Η , m ) , 1 . 1 - 1.4 (9 Η , η ), 1.45(3H,d,J=7.2Hz), 1.5-1.83(lH,m), 3.2- 3.3(3Η,β), 3.89(lH,dq,J = 3. 0<& 7 . 2 Η ζ ) t 3.97 -4.73 ( 3 Η,m) , 5 . 03 (0 . 5Η , m), 5.11-5.17(0.5Η,π), 6.9-7.7(10 Η ,ιπ), 8.11(0.5H,bs), 8.16(0.5H,bs). (5S)-2-(H-苯甲氧乙醛基)-Η-甲胺基)-5-[(lR)-l- 本紙張尺度適用中國國家標準(CNS > A4规格(210X297公釐) 90 39221 A7 B7 464649 五、發明説明(91 ) (吲睬-3 -基)乙基]-2 -噚唑啉-4 -酮, IR (KBr)cm-33 47, 1 7 3 3, 1 627, 1 55 7. (請先閱讀背面之注意事項再填寫本頁) 1 H-HMR (CDC 1 3) 5 J 1.46(3Η,d,J = 7.2Hz), 3.26(3H,s), 3,92 (1Η,dq,J = 3.4&7.2Hz) , 4.42, 4.66(2H,ABq,J=18.0Hz), 4.55(2H,s), 5.05(lH,d,J = 3.4Hz), 7.0-7.7(10H,iD), 8.09 (1H,bs). (5S)-2-[H-(2-苯甲氧基-4-甲基戊醯基)-N-甲胺基]-5-[(1R)-1-(b引味-3-基)乙基]-2-BM ® 咐-4-酮, IR(KBr) cm-1 : 1 742, 1 72 9, 1 5 57, 1 5 38. l-NMMCDClsJS: 0.66, 0.7 8 (各為 3H,d,J = 6,6Hz), 0.88, 0 . 9 3 (3 H , dtJ = 7.0Hz) , 1 . 3 - 1 . 6 ( 3H , m), 3 . 2-3 . 3 (3H,m) , 3.91 (1 H , m) , 3 . 8~4 . 6 ( 2 . 5H,m), 5.00-5.05(lH,m),5. 2 5(0.5H,m), 7.0-7.7(10H,m), 8.09-8.2(1H,m).I 3.60-3.80 (lH, n), 4.90 (0.6H, d, J = 1.5Hz), 4.97 (0.4H, d, J = 1.5Hz), 6.85 (lH, m), 6.90 -7.30 (2H, m ), 7.58 (lH, m), 8.66 (0.4 Η, bs), this paper size applies Chinese National Standard (CNS) A4 specification (2I0X297 mm) 86 3 922 1 A7 B7 4 6 4649 V. Description of the invention (87) 8.67 (0.6H, bs). (Please read the precautions on the back before filling this page) 2-Dimethylamino-5-C1-C6-fluoroindio-3-yl) ethyl] -2-π etc. Zazolin-4-one (340 mg) was dissolved in -10¾ in methylamine (5 ml). The mixture was stirred at the same temperature for 3 hours. The mixture was concentrated, and the obtained residue was subjected to column chromatography. The residue was dissolved in hexane-acetone (1: 1) to obtain the title compound (254 mg). IR (KBr) cm_1: 3195, 1733, 1644, 1627. 1 H-HHR (DHSO-de) δ; 1. 8 (0.9 Η, d, J = 7.2 Ηζ), 1.27 (0.4H, d, J = 7.4Hz), 1.43 (l.lH, d, J = 7.2Hz), 1.49 (0.6H, d, J = 7.2Hz), 2.60-2.80 (3Η, ·) · 3.40-3. 60 (lH, m), 4.80-5.00 (1 Η, t), 6.81 (1Η, «), 7.00-7.2 0 (2Η, m), 7.55 (1 Η, m), 8.50-8. 70 (1 Η, bs), 10.9-11.0 (1 Η, ι). Guan Lunli 1 8 According to the same procedure as described in Example 11, the following compounds were prepared. (5S) -2- [N- (3-Benzyloxycarbonylfluorenal) -H-methylamino] -5-[(lR) -1- (indio-3-yl) ethyl]- 2-oxazolin-4-one, IRUBrOcn-1: 3327, 2 971, 1715, 1557, 1539, printed by Zhengong Consumer Cooperative, Central Standards Bureau of the Ministry of Economic Affairs, printed 1456, 1397, 1316, 1246, 1200, 1 138. NHR (CDCI3) δ 1. 48 (3Η, d, J = 7.4Ηζ), 2. 76-3. 07 (2Η, m), 3.20 (3H, s), 3. ^ 3 0-3. 4 2 (2 Η, πι), 3.93 (lH, m), 5.06 (lH, d, J = 3.2Hz), 5.11 (2H, s), 7.07-7.22 (3H, mJ, 7.30-7.40 (6H, m), 7.62 (1H, d, J = 7.8Hz), 8.24 (lH, bs). (5S) -5-[(1I〇-1- (b3 丨 睬 -3-yl) ethyl] -2- [ N- [3- (N-Benzene paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 87 3922 1 4 6 4 6 49 A7 'B7 V. Description of the invention (88) Carbonyl-N- (Methyl) amino] propanal-methylamino] -2-η and other azoles-4-m, IRUBHcb-1: 3296, 1 700-1 750, 1 646.1 1H-NHR (CDC la) 5 : 1. 38-1.50 (3 Η, π), 2.86 (1.2H, s), 2.90 (1.8H, s), 2.97-3.U (2H, m), 3.16 (1.8H, s), 3.22 ( 1.2H, s), 3.4-3.6 (2H, i), 3.92 (1H, b), 5.04 (lH, d, J = 2.8Hz), 5.13 (2H, s), 6.9-7. 4 (9H, ra), 7.61 (lH, d, J = 7.4Hz), 8.1-8.3 (lH, bs). (5S) -2- [N- (4-Benzylcarbonylaminobutanyl)>-N -Methylamino] -5-[(lR) -l- (indio-3-yl) ethyl] -2-bsilazolin-4-one, 'IR (KBr) cm " 1: 3 3 37 , 2969, 2940, 1 7 1 1, 1 56 1, 1 53 7, 1 45 4, 1 4 3 3, 1 3 97, 1 3 1 4, 1 252, 1 1 92. 1H-NHR (CDC Is) δ: 1.48 (3Η, d, J = 7.4Ηz), 1.64 (2H, m), 2.76 (2H, b), 3.12 (2H, n), 3.23 (3H, s), 3.93 (1H, b), 4.82 (lH, bs), 5.05 (1H, d, J = 3.2Hz), 5.12 (2H, s), 7.00-7.41 (9H, m), 7.62 (1H, d, J = 6.8Hz), 8.35 (lH, bs). Printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) (5S) -2- [N- (4-Benzylbutyryl) -N- Methylamino] -5-[(lR) -1- (b3 丨 fluoren-3-yl) ethyl] -2-Bfoxazolin-4-one, IRtKBrJcm-1: 3400, 1733, 1558, < 1538 , 1456, 1432, 1394, 1209, 1166. ^ -HMRtCDClsiS: 1.46 (3H, d, J = 7.3Hz), 2.52-2.66 (2H, m), 2.99-3.34 (2H, m), 3.24 (3H, s), 3.93 (lH, dq, J = 7.3 & 3.0Hz), 5.06 (lH, d, J = 3.0Hz), this paper size applies Chinese national standard (CNS > A4 specification (210X297) ) 88 3 9 2 2 1 A7 B7 464649 V. Description of the invention (89) 5.12 (2H, s), 7.0 7 -7.38 (9H, m), (Please read the precautions on the back before filling this page) 7. 6 3 (1 H, d, J = 7.2 H z), 8. 1 0 (1 Η, bs). (5S) -2- [N-[(2S) -2,5-double (N- Benzylcarbamyl) pentamyl] -bromomethyl-5-[(11〇-1- (indio-3-yl) ethyl] -2-11 (KBr) cm-1: 3327, 30 64, 303 3, 29 68, 29 39, 2877, 1 7 1 8, 1 52 3, 1 455, 1 388, 1 3 45, 1 26 3, 1 2 2 0 iH-NMRiCDCla) δ: 1.25-1.55 (4 Η, ra), 1.57 (3Η, d, J = 6Hz), 2.33 (3H, s), 2.7 0-2.90 (2 Η, a ), 4.15-4.30 (2H, m), 4.83-5.29 (7Η, ιι), 7. 0 7 -7. 68 (1 5Η, m), 8.12 (1Η, bs). (5S) -2- [N-[(S) -4-benzyl (H-benzylamido) aspartyl] -N-methylamino] -5-[(1 R)-1-(»3 丨Fluoren-3 -yl) ethyl] -2-oxazoline'-4-one, IRUBrOcn-1: 3396, 3064, 3035, 2970, 2937, 1722, 1455, 1423, 1386, 1344, 1311. 1 Η- Η MR (CDC 1 3) S: 1. 3 6, 1 · 6 0 (all 3 H, d, J = 7.8 Η z), 2. 1 9 (3 Η, s), 2.2 8-3. 1 8 (2 Η, β >, 3. 7 8 (1 Η, η), 4.21 (1Η, m), 4.29 -4.47 (1 Η, η), 4.99 -5.32 ί5 Η, ο), 6.70-7.47 (14H, m), 7.68 (lH, d, J = 8.2Hz), 8.10 (1Η, bs)., (5S) -5-[(1R)- 1- (b3I favors 3-yl) ethyl] -2- [N-[(S) -4 -methyl [N-benzylcarbonylamino] aspartamido] -N-methylamino ] -2-11 Isoxazolin-4-one, IR (KBr) cm-1: 3402, 3060, 3037, 2954, 2937, This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 89 3922 1 464649 A7 B7 V. Description of the invention (90) 1 7 2 2, 1 45 7, 1 436, 1 37 6, 1 344, 1 3 1 3. UMlUCDCls) ^: 1.36 · 1.61 (all 3H, d, J = 7.6Hz), 2.20 (3H, s), 2.82-3.82 (3H, m), 3.57, 3.60 (all 311,8 >, 4.18-4.50 (211, 《1), 5.02- 5.32 (3H, b), 6.85 -7.36 (9H, m), 7-45, 7.68 (gold part lH, d, J = 7.2Hz), 8,14 (lH, bs). (5S) -2- [N- (2 -Third Ding Dimethylsilyl octyl) -N-methylamino] -5-[(lR) -1- (indio-3-yl) ethyl] -2-oxazoline-4-one, 1 H-NMR (CDCI3) δ: -0. 1-0. 1 (6Η, m) f 0.85 (4.5 Η, s) , 0. 87 (4.5 Η, s), 1. 0-1.2 (10 Η, m), 1.46 (3H, t, J = 7.0Hz), 3.25 (1.5H, s), 3.26 (1.5H, s), 3.93 (1H, dq, J = 3.0 & 7.0 Hz), 5.05 (0.5H, d, J = 3.0Hz), 5.07 (0.5H, d, J = 3.0Hz), 5.40-5.48 ( lH, m), 7.1-7.7 (5H, n), 8.13 (lH, bs). (5S) -2- [N- (2-benzyloxyoctanylmethylamino) -5-[(lR) -1 -(Indino-3-yl) ethyl] -2-B | oxazol-4-one IRUBrOcm · 1: 181 0, 1 733, 1704, 1634. Printed by Zhengong Consumer Cooperative, Central Standards Bureau, Ministry of Lithium Economy ( Please read the notes on the back before filling this page) ^ -NMR (CDCla) δ: 0.8-0.9 (3 Η, m), 1.1-1.4 (9 Η, η), 1.45 (3H, d, J = 7.2Hz), 1.5-1.83 (lH, m), 3.2- 3.3 (3Η, β), 3.89 (lH, dq, J = 3. 0 < & 7. 2 Η ζ) t 3.97 -4.73 (3 Η, m), 5.03 (0.5Η, m), 5.11-5.17 (0.5Η, π), 6.9-7.7 (10 Η, ιπ), 8.11 (0.5H, bs), 8.16 (0.5H, bs ). (5S) -2- (H-benzyloxyacetaldehyde group) -fluorene-methylamino group) -5-[(lR) -l- This paper size applies to Chinese national standards (CNS > A4 specifications (210X297 (Mm) 90 39221 A7 B7 464649 V. Description of the invention (91) (Indino-3 -yl) ethyl] -2 -oxazoline-4 -one, IR (KBr) c m-33 47, 1 7 3 3, 1 627, 1 55 7. (Please read the notes on the back before filling this page) 1 H-HMR (CDC 1 3) 5 J 1.46 (3Η, d, J = 7.2 Hz), 3.26 (3H, s), 3,92 (1Η, dq, J = 3.4 & 7.2Hz), 4.42, 4.66 (2H, ABq, J = 18.0Hz), 4.55 (2H, s), 5.05 ( lH, d, J = 3.4Hz), 7.0-7.7 (10H, iD), 8.09 (1H, bs). (5S) -2- [H- (2-benzyloxy-4-methylpentanyl) ) -N-methylamino] -5-[(1R) -1- (b-triol-3-yl) ethyl] -2-BM ® 4--4-one, IR (KBr) cm-1: 1 742, 1 72 9, 1 5 57, 1 5 38. l-NMMCDClsJS: 0.66, 0.7 8 (each 3H, d, J = 6, 6Hz), 0.88, 0.93 (3 H, dtJ = 7.0Hz ), 1.3-1.6 (3H, m), 3. 2-3. 3 (3H, m), 3.91 (1 H, m), 3.8 ~ 4.6 (2.5 H, m) , 5.00-5.05 (lH, m), 5. 2 5 (0.5H, m), 7.0-7.7 (10H, m), 8.09-8.2 (1H, m).
奮掄例1 Q 經濟部中央標準局員工消費合作社印製 依實施例6所述之相同程序,製備下述化合物。 (5S)-5-[(lR)-l-(n3 丨睬-3-基)乙基]-2-[K-月桂醯基-Ν -甲胺基]-2-ΒΜ唑啉-4- _, IR(KBr)cm-1 : 32 98, 2925, 2854,1 7 29, 1 558 , 1538, 1455, 1394, 1195. 1H-NMR(CDC13) δ : 0.83(3Η,t,J=6.6Ηζ), 1.23-1.35(16Η,ιη), 1.46(3Hfd,J = 7.2Hz), 1,51-1.64(2Η,ι), 2.85(2Η,π), 3.25(3H,s)f 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 91 3 92 21 464649 A7 __B7_ 五、發明説明(9 2 ) 3.93(1H,b), 5.06(lH,d,J=3.0Hz>, 7.09-7.25(3H.a), 7.37(lH,d,J = 7.8Hz), 7 . 64 (1Η,d,J:7.8Hz) , 8.14(1Η,bs). (5S)-2-[N-氯乙醯基-Ν-甲胺基]-5-[(lR)-:l-(吲睬-3 -基)乙基]-2 -鸣唑啉-4-酮, IR (RBr)cm-1: 338 3, 2972, 1 73 3, 1 5 58, 1 45 5, 1 436, 1 3 9 8 , 1 340 , 1 3 1 7 , 1 203. ^-NMR (CDCla) δ : 1 . 5 2 ( 3 Η , d , J = 7 . 3 Η ζ ), 3.28(3H,s), 3.95(lH,m), 4 . 48 (1 Η,dtJ = 1 6 . 5 Ηζ), 4.72(lH,d,J=16.5Hz), 5.08(lHfd,J=3.3Hz), 7.08-7.26(3H,a)f 7.38(lH,d,J=7.4Hz), 7 . 62 (1H,d,J = 7.6Hz) , 8.25(lH,bs). (5S)-2-[N-[2-(5-胺基- 二唑-3-基)-2(Z)- 乙氣亞胺乙醛基]-N-甲胺基]-5-(1R>-1-(b5丨陳-3-基)乙基 ]-2-鸣唑咐-4-酮, IRUBrOcm· 1: 3400,2 976, 17 47, 1 7 1 4, 1 6 1 6, 1538, 1455, 1403, 1245, 1224. 經濟部中央標準局員工消費合作社印策 (請先閱讀背面之注意事項再填寫本頁) 1 H-NMR (CDC 1 3) 5 : 1 . 14 (3Η , t , J = 7.1 Hz), 1 , 2 3 ( 3 Η,in) , 3 ‘ 5 6 (3 Η,s ) , 3 . 7 9 (1 Η m),5 . 0 8 (1 Η , m ) ,6.85-7.25(5Η,π), 7.33(lH,d,J=^.2Hz), 7.56 (lH,d, J = 7.0Hz) , 8.60(lH,bs). (5S)-2-(N-烯丙草醯基-Ν-甲胺基)-5-[(lR)-l-(吲味 -3 -基)乙基]-2 -噚唑啉-4 -酮, IR (KBr) cm'1 : 1746 , 1704 , 1634 , 1 6 1 5. 本紙張尺度適用中國國家標準(CMS ) A4規格(210X297公釐) 92 39 2 2 1 4 6 4649 A7 B7 五、發明説明(93 ) iH-HMMCDClaM : 1 . 2 5 - 1 . 4 5 ( 3 Η , η), 3.00- 3.U(3H,m), 3.76ilH,dq,J = 3.46.7.2Hz), 4.90-5.01(3H,b), 5.40(lH,d,J=11.2Hz), 5.5 1 (1 H , d d , J = 1 . 2 & 1 7.0 H z ) , 5.9 5 - 6 . 1 5 (1 H,m). 7.1- 7.7(5H.n) , 8.46(1H,bs). 管掄俐20 依實施例13所述之相同程序,製備下述化合物。 (5S)-2-[N-(3 -肢丙酵基)-N -甲胺基]-5-[(lR)-l-(吲 味-3-基)乙基]-2 -鸣唑咐-4-闕, IRUBrOcm·1: 3266, 2969, 2928,1705,1622, 1 584, 1 495, 1 456 t 1 399, 1 34 1 , 1 308 , 1236 . 1 H-NHR (CDC 1 3) 5 : 1 . 27 (3H , d , J = 7 . 0Hz), 2 . 78 (2H , t , J = 7 . 0Hz) , 3.30 (3H , s ), 3.56(2H,t,J=7.0Hz), 3.65(2H,bs), 3.77(lH,m), 4.48(1H,ra) , 7.06 - 7.21(3 Η ,m), 7.35(lH,d,J=7.6Hz), 7.71(lH,d,J=7.0Hz), 8 . 08(1H,bs). 經濟部中央標準局員工消費合作社印聚 (請先閱讀背面之注意事項再填寫本頁) (5S)-5-[(lR)-l-〇3 丨睬-3-基)乙基]-2-[N-[(S)-4 -甲 基天冬胺醯基]-N -甲肢基]-2 -B辱唑咐-4-酮, IRiKBrJcm-1: 3352, 2966, 1735,4643, 1577, 1488, 1 457 , 1 438, 1 40 3, 1 32 2, 1 25 5, 1 0 99. ^-HMRiCDCls)^ : 1.27(3H,d,J=7.1Hz), 2 . 73 (1H , dd , J = 17 . 6&9 . 0Hz), 3.07(lH,dd,J=17.6&3.4Hz), 3.15(3H,s), 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 93 392 2 1 4 64649 A7 B7 五、發明説明(9 4 ) 3 · 5 7 (1 H , b s ) , 3 · 7 6 ( 3 Η,s ) , 3 . 8 2 (1 Η,in), 4.46(lH,ddtJ=9.0&3.4Hz), 4.54(1Η,ι), (請先閲讀背面之注意事項再填窝本頁) 7.03-7.27(3 Η,m), 7.36(lH,d,J = 7.0Hz), 7 . 73 (1Η , d , J = 7 . 4Hz) , 8.07(lH,bs), 9.12(lH,bs). (5S)-2-[N-[(S)-天冬胺醯基]-Ν-甲胺基]-5-[(lR)-1-(吲除-3-基)乙基]-2-n咢唑咐-4-酮, IR(KBr)ci~1: 3400, 1720, 1629, 1560, 1425, 1 39 9 , 1 3 42. 1 H-NMR (DMSO-de) 5 : 1 . 1 7 (3 Η , d,J = 7 . 0 Ηζ ), 2 . 3 0-2.7 0 (2 Η,m) , 2.99(3H,s), 3.64 (1 Η,m), 4.24-4.38(2H,m), 6.93-7.36(4H,m), 7 . 60 (1Η,d,J = 8.ΟΗζ) , 10.78(lHfbs) (5S)-5-[(1R)-1-(b3 丨睬-3 -基)乙基]-2-[Η -甲基- Ν- (3 -甲胺丙醒基)胺基]唑咐-4-_, IRUBrOcm- 1: 3 244,1 73 3, 16 0 7 ‘ ^-NMR (CDCls) δ : 1 . 49 (2 . OH , d , J = 7 . 4Ηζ), 1.54(1.OH,d,J=7.4Hz), 1.9-2.5(2Η,ι), 經濟部中央標準局員工消費合作社印製 2.59(1.0H,d,J=2.4Hz), 2.71(2.0H,d,J=2.4Hz), 2.97(2.OH,s), 3.00(1.0Hts), 3.4~3.6(lH,a), 3 . 6-3 . 8 (1H , m) , 3.86(lH,dq,J = 3.0'&7.4Hz), 4.80(0.33H,bs) , 4.98(lH,d,J=3.0Hz), 6 . 08 ( 0 . 6 7 H , bs) , 7.0 - 7.7 ( 5 Η ,m) , 8.6 4 ( 0.67 Η ,bs), 8 . 7 0 (0.33 H , bs). w m m 2i 本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐) 94 3 922 1 4 6 4 6 49 a? B7 五、發明説明(95 ) (5S)-2-[N-(2-苯甲酞醯基)-}(-甲胺基]-5-[(lR)-l-(吲味 -3-基)乙基]-2-噚唑啉-4-酮 酞酸單苯甲酷(1.60克)於甲苯(20毫升)之溶液中,加 硫酸氣(1毫升 >。於80t:攪拌1小時後,混合物經減壓濃 縮,獲得殘物。加四氫呋喃(20毫升)至殘物,然後,於 -15¾加吲睬徽素(400毫克)。加三乙胺(1.74毫升)後,混 合物於室溫攪拌21小時。全部以乙酸乙酯(100毫升)稀釋 。混合物分別以水(35毫升)、飽和磺酸氫鈉水溶液(35毫 升X3)及食鹽液(35毫升)洗滌,然後,乙酸乙酯溶液經硫 酸鎂使之乾燥。溶液經減E濃縮,蒱得之殘物進行管柱層 析。以乙酸乙酯-己烷溶離,收集溶離液後予以濃縮。内 容物自己院中固體化。此固體産物經過濾收集,使之乾燥 ,獲得標題化合物(161毫克)。 IRCKBricm-1: 3400, 1714, 1538, 1455, 1399, 1278, 1222. 1H-NMR (CDC la) 5 : 1.07 ( 3 Η , d,J = 7 . 1 Ηζ) t 3.44(3H,s), 3.60(lH,m), 4 . 72 (1 Η , d , J = 2 . 6 Ηζ), 經濟部中央標準局員工消費合、作社印製 (請先閲讀背面之注意事項再填寫本頁) 5.17(lH,d,J=12.0Hz), 5.26(lH,d,J=12.0Hz), 6.31(lH,d,J = 2.4Hz), 7.06-7.52 (12H,m), 7 . 86 (1 Η , bs ) , 7 . 95(1Η , dd , J = 7 . 4Hz). ^ W Μ 2 7 (5S)-5-[(lR)-l-(吲睬-3-基)乙基]-2-U -甲基-N -三氟乙 醛胺基>-2 -D|唑啉-4-酮 »3丨睬徽素(401毫克)溶於四氫呋喃(38毫升)。於此溶 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX297公釐) 95 3 9 22 1 464649 A7 B7 五、發明説明(9 6 ) 液中,加三乙胺(1·5毫升 >及二氟乙酸酐(1.0毫升 >。全部 於室溫攪拌1小時。混合物以乙酸乙酯(100毫升)稀釋。 全部以水、食豔液洗滌,經硫酸鎂使之乾燥。溶液予以濃 縮,獲得之殘物進行矽膠層析,以己烷-丙酮(1:1>溶離, 獲得標題化合物(37 5毫克)。 IR (KBr)cb-1 : 1733 , 1652 , 1634 , 1615 . ^-HMRiCDCls)^ : 1.33(0.45H,d,J = 7.0Hz), 1.34(2.55H,d,J=7.0Hz), 2.97-3.13 (3H,m), 3.77(lH,dq,J=2.2fi[7.0Hz), 4.85(0.15H,d,J=2.2Hz) ,4. 97 ( 0 . 85 H , d , J = 2 . 2Hz) , 7 . 3 - 7 . 7(5H , m ), 8.4-8.51 (lH.bs).Example 1 Q Printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs According to the same procedure as described in Example 6, the following compounds were prepared. (5S) -5-[(lR) -l- (n3 | fluoren-3-yl) ethyl] -2- [K-lauryl-N-methylamino] -2-BMazoline-4- _, IR (KBr) cm-1: 32 98, 2925, 2854, 1 7 29, 1 558, 1538, 1455, 1394, 1195. 1H-NMR (CDC13) δ: 0.83 (3Η, t, J = 6.6Ηζ ), 1.23-1.35 (16Η, ιη), 1.46 (3Hfd, J = 7.2Hz), 1,51-1.64 (2Η, ι), 2.85 (2Η, π), 3.25 (3H, s) f Applicable to this paper size China National Standard (CNS) A4 specification (2 丨 0X297 mm) 91 3 92 21 464649 A7 __B7_ V. Description of the invention (9 2) 3.93 (1H, b), 5.06 (lH, d, J = 3.0Hz >, 7.09 -7.25 (3H.a), 7.37 (lH, d, J = 7.8Hz), 7.64 (1Η, d, J: 7.8Hz), 8.14 (1Η, bs). (5S) -2- [N- Chloroethenyl-N-methylamino] -5-[(lR)-: l- (indio-3-yl) ethyl] -2 -oxazolin-4-one, IR (RBr) cm- 1: 338 3, 2972, 1 73 3, 1 5 58, 1 45 5, 1 436, 1 3 9 8, 1 340, 1 3 1 7, 1 203. ^ -NMR (CDCla) δ: 1.5 2 (3 Η, d, J = 7. 3 Η ζ), 3.28 (3H, s), 3.95 (lH, m), 4. 48 (1 Η, dtJ = 16. 5 Ηζ), 4.72 (lH, d , J = 16.5Hz), 5.08 (lHfd, J = 3.3Hz), 7.08-7.26 (3H, a) f 7.38 (lH, d, J = 7.4Hz), 7.62 (1H, d, J = 7.6Hz ), 8.25 (lH, bs). (5S) -2- [N- [2- (5-amino -Diazol-3-yl) -2 (Z)-Ethyleneimine-acetaldehyde] -N-methylamino] -5- (1R > -1- (b5 丨 Chen-3-yl) ethyl] -2-Miconazole commanded 4-one, IRUBrOcm · 1: 3400, 2 976, 17 47, 1 7 1 4, 1 6 1 6, 1538, 1455, 1403, 1245, 1224. Consumption by employees of the Central Standards Bureau of the Ministry of Economic Affairs Cooperative cooperative policy (please read the notes on the back before filling in this page) 1 H-NMR (CDC 1 3) 5: 1. 14 (3Η, t, J = 7.1 Hz), 1, 2 3 (3 Η, in ), 3 '5 6 (3 Η, s), 3. 7 9 (1 Η m), 5.0 8 (1 Η, m), 6.85-7.25 (5Η, π), 7.33 (lH, d, J = ^. 2Hz), 7.56 (lH, d, J = 7.0Hz), 8.60 (lH, bs). (5S) -2- (N-allyloxalyl-N-methylamino) -5- [ (lR) -l- (Indole-3 -yl) ethyl] -2 -oxazoline-4-one, IR (KBr) cm'1: 1746, 1704, 1634, 1 6 1 5. Size of this paper Applicable to China National Standard (CMS) A4 specification (210X297 mm) 92 39 2 2 1 4 6 4649 A7 B7 V. Description of the invention (93) iH-HMMCDClaM: 1.2 5-1. 4 5 (3 Η, η) , 3.00- 3.U (3H, m), 3.76ilH, dq, J = 3.46.7.2Hz), 4.90-5.01 (3H, b), 5.40 (lH, d, J = 11.2Hz), 5.5 1 (1 H, dd, J = 1.2 & 1 7.0 H z), 5.9 5-6. 1 5 ( 1 H, m). 7.1- 7.7 (5H.n), 8.46 (1H, bs). Guan Yanli 20 According to the same procedure as described in Example 13, the following compounds were prepared. (5S) -2- [N- (3-Alaninyl) -N-methylamino] -5-[(lR) -1- (indyl-3-yl) ethyl] -2 Command-4- 阙, IRUBrOcm · 1: 3266, 2969, 2928, 1705, 1622, 1 584, 1 495, 1 456 t 1 399, 1 34 1, 1 308, 1236. 1 H-NHR (CDC 1 3) 5: 1.27 (3H, d, J = 7.0 Hz), 2.78 (2H, t, J = 7.0 Hz), 3.30 (3H, s), 3.56 (2H, t, J = 7.0Hz) , 3.65 (2H, bs), 3.77 (lH, m), 4.48 (1H, ra), 7.06-7.21 (3 Η, m), 7.35 (lH, d, J = 7.6Hz), 7.71 (lH, d, J = 7.0Hz), 8.08 (1H, bs). Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) (5S) -5-[(lR) -l -〇3 丨 睬 -3-yl) ethyl] -2- [N-[(S) -4 -methylaspartamidinyl] -N -methylamyl] -2 -B -Ketone, IRiKBrJcm-1: 3352, 2966, 1735,4643, 1577, 1488, 1 457, 1 438, 1 40 3, 1 32 2, 1 25 5, 1 0 99. ^ -HMRiCDCls) ^: 1.27 (3H , d, J = 7.1Hz), 2.73 (1H, dd, J = 17.6 & 9. 0Hz), 3.07 (lH, dd, J = 17.6 & 3.4Hz), 3.15 (3H, s), This paper size applies to Chinese National Standard (CNS) A4 specification (21 OX 297 mm) 93 392 2 1 4 64649 A7 B7 V. Description of the invention 9 4) 3 · 5 7 (1 H, bs), 3 · 7 6 (3 Η, s), 3. 8 2 (1 Η, in), 4.46 (lH, ddtJ = 9.0 & 3.4Hz), 4.54 (1Η, ι), (Please read the notes on the back before filling in this page) 7.03-7.27 (3 Η, m), 7.36 (lH, d, J = 7.0Hz), 7.73 (1Η, d, J = 7.4Hz), 8.07 (lH, bs), 9.12 (lH, bs). (5S) -2- [N-[(S) -aspartylamino] -N-methylamino] -5 -[(lR) -1- (Indide-3-yl) ethyl] -2-noxazolidine-4-one, IR (KBr) ci ~ 1: 3400, 1720, 1629, 1560, 1425, 1 39 9, 1 3 42. 1 H-NMR (DMSO-de) 5: 1.1 7 (3 Η, d, J = 7. 0 Ηζ), 2. 3 0-2.7 0 (2 Η, m), 2.99 (3H, s), 3.64 (1 Η, m), 4.24-4.38 (2H, m), 6.93-7.36 (4H, m), 7.60 (1Η, d, J = 8.〇Ηζ), 10.78 ( lHfbs) (5S) -5-[(1R) -1- (b3 丨 睬 -3 -yl) ethyl] -2- [Η -methyl-N- (3-methylaminepropylamino) amino] Azole command-4-_, IRUBrOcm- 1: 3 244, 1 73 3, 16 0 7 ′ -NMR (CDCls) δ: 1. 49 (2. OH, d, J = 7. 4Ηζ), 1.54 (1 .OH, d, J = 7.4Hz), 1.9-2.5 (2Η, ι), printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economy 2.59 (1.0H, d, J = 2.4Hz), 2.71 (2.0H, d, J = 2.4Hz), 2.97 (2.OH, s), 3.00 (1.0Hts), 3.4 ~ 3.6 ( lH, a), 3.6-3.8 (1H, m), 3.86 (lH, dq, J = 3.0 '& 7.4Hz), 4.80 (0.33H, bs), 4.98 (lH, d, J = 3.0Hz), 6.08 (0.67 H, bs), 7.0-7.7 (5 Η, m), 8.6 4 (0.67 Η, bs), 8.7 0 (0.33 H, bs). Wmm 2i Paper size applies Chinese national standard (CNS > A4 size (210X297 mm) 94 3 922 1 4 6 4 6 49 a? B7 V. Description of the invention (95) (5S) -2- [N- (2-Benzyl Phthalofluorenyl)-} (-methylamino] -5-[(lR) -1- (indyl-3-yl) ethyl] -2-oxazoline-4-one phthalic acid monobenzyl ( 1.60 g) of a solution of toluene (20 ml) was added with sulfuric acid gas (1 ml). At 80t: After stirring for 1 hour, the mixture was concentrated under reduced pressure to obtain a residue. Add tetrahydrofuran (20 ml) to the residue, and then add indigoxin (400 mg) at -15¾. After adding triethylamine (1.74 ml), the mixture was stirred at room temperature for 21 hours. All were diluted with ethyl acetate (100 ml). The mixture was washed with water (35 ml), a saturated aqueous solution of sodium hydrogensulfonate (35 ml x 3), and a common salt solution (35 ml), and then the ethyl acetate solution was dried over magnesium sulfate. The solution was concentrated by subtracting E, and the obtained residue was subjected to column chromatography. It was dissolved in ethyl acetate-hexane, and the eluate was collected and concentrated. The contents are solidified in their own hospital. This solid product was collected by filtration and dried to obtain the title compound (161 mg). IRCKBricm-1: 3400, 1714, 1538, 1455, 1399, 1278, 1222. 1H-NMR (CDC la) 5: 1.07 (3 Η, d, J = 7. 1 Ηζ) t 3.44 (3H, s), 3.60 (lH, m), 4.72 (1 Η, d, J = 2. 6 Ηζ), printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs and printed by the company (please read the precautions on the back before filling out this page) 5.17 (lH, d, J = 12.0Hz), 5.26 (lH, d, J = 12.0Hz), 6.31 (lH, d, J = 2.4Hz), 7.06-7.52 (12H, m), 7.86 (1 Η , bs), 7.95 (1Η, dd, J = 7.4Hz). ^ W Μ 2 7 (5S) -5-[(lR) -1- (indio-3-yl) ethyl] -2 -U -Methyl-N-trifluoroacetaldehyde amino group> -2 -D | oxazolin-4-one »3 睬 素 Anhui hormone (401 mg) was dissolved in tetrahydrofuran (38 ml). The size of the paper used here is in accordance with Chinese National Standard (CNS) A4 (2 丨 OX297 mm) 95 3 9 22 1 464649 A7 B7 V. Description of the invention (9 6) Add triethylamine (1.5 ml > and difluoroacetic anhydride (1.0 ml). The whole was stirred at room temperature for 1 hour. The mixture was diluted with ethyl acetate (100 ml). All were washed with water and food liquid and dried over magnesium sulfate. The solution was It was concentrated, and the obtained residue was subjected to silica gel chromatography, and the title compound (375 mg) was obtained by dissociation with hexane-acetone (1: 1). IR (KBr) cb-1: 1733, 1652, 1634, 1615. ^- HMRiCDCls) ^: 1.33 (0.45H, d, J = 7.0Hz), 1.34 (2.55H, d, J = 7.0Hz), 2.97-3.13 (3H, m), 3.77 (lH, dq, J = 2.2fi [ 7.0Hz), 4.85 (0.15H, d, J = 2.2Hz), 4.97 (0.85 H, d, J = 2.2Hz), 7.3-7.7 (5H, m), 8.4- 8.51 (lH.bs).
曹掄例M 2-甲胺基-5-[(5-氦吲味-3-基)甲基]-2-垮唑啉-4-® 經濟部中央標準局員工消費合作社印裂 (請先閱讀背面之注意事項再填寫本頁) .5-氣基-3-甲醯基吲睬(5.00克)於四氫呋喃(135毫升) 之溶液中,加氩化納(60%油懸浮液,3.53克)。混合物於 室溫攛拌20分鐘。加苯甲氣羰基氣(6.64毫升)至混合物。 於室溫攪拌1小時後,全部倒入冰水中。混合物以乙酸乙 酯萃取。所得萃取物經食鹽液洗滌,以硫酸鎂使之乾燥。 溶液予以濃縮,獲得之殘物進行矽膠層析。以己烷-乙酸 乙酯(5 : 1)溶離,獲桿1 -苯甲氣羰基-5 -氣基-3 -甲醯基吲 睜(5*74克),為結晶。 ^-NMR (CDCla) 5 : 5.51(2H,s), 7 . 3 6 - 7 . 5 2 (6 Η , m), 8.10(lH,d(J=9.2Hz), 8.27(lH,s), 8 . 30 (1H , d,J = 2 . 2Hz) , 10.06(lH,s). 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX297公釐) 96 3 9 2 2 1 A7 B7 464649 五、發明説明(9? (請先閲讀背面之注意事項再填寫本頁) 1-苯甲氣羰基-5-氨基-3-甲醯基吲睬(2. 00克)於甲醇 (13毫升)之溶液中,於0T加硼氫化鈉(241毫克)。混合物 於同溫攪拌15分鐘後,加冰水至混合物。加磺酸鉀使混合 物飽和。全部以乙醚萃取,所得萃取物經硫酸鎂使之乾燥 。混合物予以濃縮,加己烷至所得之殘物,獲得1-苯甲氣 羰基-5 -氣基-3 -羥甲基吲睐(1.80克),為結晶。 1 H-HMR (CDC 1 3) a : 1 . 63 (1H , t , J = 5 . 0Hz), 4. 79 (2H , d , J = 5.0Hz) , 5.44(2H,s), 7.2 6 - 7.45 (6H f m) , 7 . 63 (2H , s), 8 . 09(1H,d,J = 8.8flz). 1-苯甲氣羰基-5-氣基-3-羥甲基S3丨睬(1.45克)於二氣 甲烷(23毫升)之溶液中,於-78¾加硫醛氣(0.797徹升)。 混合物於室溫攢拌1.5小時後,反應混合物經減壓濃縮, 獲榑殘物。加己烷至殘物,獲得1-苯甲氣羰基-5-氣基- 3-氣甲基吲睬(1.43克),為結晶。 ^-HMR (CDCls) 5 : 4.70(2H,s), 5.44(2H,s), 7.32(lH,dd,J=8.8&1.8Hz)t 7.39-7.46(5H,m), 經濟部中央標準局—工消費合作杜印製 ί 正 胺加 丙下 異却 二 冷 冰 於 V 8 7 至 却 冷 物 合 溫 室 於 物 合 混 , 混 中 ο 液η 容升 Μ 毫 之 4 2 升5. /|\ (2溶 喃6Μ 呋1. 氫之 四烷 於己 丨於 ?"· 鋰 基 升 毫 本 8 啪 7 脞- ¥至 Τ 却 2 ^ - 冷 基又 胺 , 甲鐘 二 分 1 ο 2 3 加拌,攪 酮曹 抡 例 M 2-Methylamino-5-[(5-helium indole-3-yl) methyl] -2-acetazolin-4-® printed by employee consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please first Read the notes on the back and fill in this page again.) .5-Amino-3-formyl indene (5.00 g) in a solution of tetrahydrofuran (135 ml), add sodium argon (60% oil suspension, 3.53 g) ). The mixture was stirred at room temperature for 20 minutes. Add benzyl carbonyl (6.64 ml) to the mixture. After stirring at room temperature for 1 hour, all was poured into ice water. The mixture was extracted with ethyl acetate. The obtained extract was washed with a common salt solution and dried over magnesium sulfate. The solution was concentrated, and the obtained residue was subjected to silica gel chromatography. Dissolve with hexane-ethyl acetate (5: 1) to obtain 1-benzylcarbonyl-5 -amino-3 -formamidineindole (5 * 74 g) as crystals. ^ -NMR (CDCla) 5: 5.51 (2H, s), 7. 3 6-7. 5 2 (6 Η, m), 8.10 (lH, d (J = 9.2Hz), 8.27 (lH, s), 8.30 (1H, d, J = 2.2Hz), 10.06 (lH, s). This paper size is applicable to China National Standard (CNS) A4 (2 丨 OX297 mm) 96 3 9 2 2 1 A7 B7 464649 V. Description of the invention (9? (Please read the precautions on the back before filling out this page) 1-Benzyl gas carbonyl-5-amino-3-methylamidoindene (2. 00 g) in methanol (13 ml) In the solution, sodium borohydride (241 mg) was added at 0 T. After the mixture was stirred at the same temperature for 15 minutes, ice water was added to the mixture. Potassium sulfonate was added to saturate the mixture. The whole was extracted with ether, and the resulting extract was made with magnesium sulfate. It was dried. The mixture was concentrated, and hexane was added to the obtained residue to obtain 1-benzylcarbonyl-6-amino-3-hydroxymethylindole (1.80 g) as a crystal. 1 H-HMR (CDC 1 3) a: 1.63 (1H, t, J = 5.0 Hz), 4.79 (2H, d, J = 5.0Hz), 5.44 (2H, s), 7.2 6-7.45 (6H fm), 7.63 (2H, s), 8.09 (1H, d, J = 8.8flz). 1-benzylcarbonyl-5-amino-3-hydroxymethyl S3 丨 睬 (1.45 g) in two gases Methane (23 ml) In the solution, sulfur aldehyde gas (0.797 liters) was added at -78¾. After the mixture was stirred at room temperature for 1.5 hours, the reaction mixture was concentrated under reduced pressure to obtain a hydrazone residue. Hexane was added to the residue to obtain 1-benzene. Methanecarbonyl-5-aeroyl-3-aeromethylindole (1.43 g), which is crystalline. ^ -HMR (CDCls) 5: 4.70 (2H, s), 5.44 (2H, s), 7.32 (lH, dd, J = 8.8 & 1.8Hz) t 7.39-7.46 (5H, m), Central Standards Bureau of the Ministry of Economic Affairs-Industrial and Consumer Cooperation Du printed ί n-amine plus propane-isobutadiene is cold at V 8 7 to cold The material greenhouse is mixed with the material, mixed ο liquid η volume liter 4 milliliter 4 2 liters 5. / | \ (2 dissolved 6M furan 1. hydrogen tetrahydroxane in hexanox) in "? Lithium liter milliliter Ben 8 Pa 7 脞-¥ to Τ But 2 ^-cold base and amine, 1 minute 2 ο 2 3 stir, stir ketone
V 加 克甲 07苯 睬 基 甲 氣 - 3 - 基 氯 - 5 墨 基 羰 氧 於 別 分 部 全 ο 克 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 97 3 922 1 464649 A7 B7 五、發明説明(98 ) t:至-40 t:搜拌30分鐘,於〇〇搜拌2小時,及於室溫攪拌 40分鐘。於此反應混合物中加水,金部以乙酸乙酯萃取。 所得萃取物經硫酸鎂使之乾燥,予以濃縮,獲得之殘物進 行矽膠靥析。以己烷-乙酸乙酯(1 : 1)溶離,獲得5-[ (5-氛 时[睬-3-基)甲基-2 -二甲胺基-2-fl咢唑啉-4 -酮(232毫克), 為結晶。 1 H-NMR (CDC I 3) δ : 2.96(3H,s), 2.98(3H,s), 3.22 (1H, dd, J = 15.8&4. 0Hz), 3,45(lH,dd,J = 15.86<4.0Hz;), 4‘98(lH,t,J = 4.0Hz)· 7.07(lH,s) , 7 . 09 (1H , d , J = 8 . 8Hz), 7 . 29 (1 H , d,J = 8 . 8Hz) , 7.59(lH,s), 8.64(lH,bs). 於[(5-氯吲睬-3-基)甲基]-2-二甲胺基- 21¾唑咐-4-_ (200毫克)中加甲胺(20毫升)。混合物於-6¾回流1小 時。移除甲胺,加乙醚至所得之殘物中,獲得標題化合物 (120毫克),為結晶。 IR (KBr) cm" 1 : 29 86 , 1 6 4 1,1413, 1 39 0, 1 3 0 4 , 1242, 1103. 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 1H-NHR (DMSO-de) 5 : 2.73(3H,s), 3.01(1Η,ι), 3.19(lH,m), 4.95(lH,i), 7.03 (1 H , d , J = 8 . 8Hz ), 7.20(lH,s), 7.34(lH,dd,J=8.8&l.«Hz), 7 . 58 (1H , d , J = 1 . 8Hz ) , 8.31(lH,bs). 實旃例24 依實施例23所述之相同程序,製備下述化合物。 2 -甲胺基-5-[(2-甲基吲睬-3-基)甲基]-2-!1等唑啉- 4- 本紙張尺度適用中國國家標準(CNS ) A4规格(2丨0X297公釐) 98 3 9 22 1 464649 A7 B7 五、發明説明(9 9 ) 酮, IR (KBr)cm-15 2912 , 1 655, 1508, 1408 , 1305 , 1251, 1238, 746. iH-NHRiDHSO-de)^ : 2.50(3H,s), 2.70(3H,s), 2.93-3.20(2H,b), 4.86(1H,b), 6.86-7.00(2H,m), 7.20(lH,d,J=7.2Hz), 7.40(lH,d,J=6.9Hz), 8.48(lH,bs), 10.76 (lH,bs). 5-[(5-苯甲氧基吲睬-3-基)甲基]-2-甲胺基-2-鸣挫 稱-4 -酿, IR (KBr) cm"1: 1667 , 1640, 1485 , 1 41 2 , 1304 . 1 H-NHR (DMSO-de) δ : 2 . 68 (1 . 5 Η , s) , 2.99(1Η,η), 3.21(lH,m), 4.95(lH,dd,J=7.0&3.4Hz), 6 . 79 (1 Η , d,J = 8.8Hz) , 7 . 0 8 -7 . 5 2 (8 H , m), 10 . 78 (1H , bs). 2 -甲胺基-5-[(5, 6-亞甲二氣基吲睐-3-基)甲基]-2-喟唑啉-4-酮, ^-HMR (DMSO-de) δ : 2.7 3 ( 3 Η , d , J = 5 . 0 Η ζ ). 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2 ‘ 9 6 - 3 . 1 5 ( 2 Η , βι ) , 4 . 8 9 - 4 . 9 1 (1 H , m ) , 5 . 9 2 ( 2 Η,s ), 6.85(lH,s), 6.96(lH,s), 6.99(lH,s), 8.58(lH,bs). ( 窗施例25 2-甲胺基- 5-(1Η-吡咯并[2,3-b]吡啶-3-基)甲基-2-鸣唑 咐-4-酮 二異丙胺(0.75毫升)於四氫呋喃(35毫升)之溶液中, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) gg 392 2 1 6 4649 A7 B7 . Λ ' ' J _ ._τ . ’ 丁 -1 广.…下r|._^ T,「.U1 五、發明説明(100) 於冰冷却下,加正丁基埋於己烷之1.6M溶液(3.35毫升)。 全部冷却至-7 8 *C加2 -二甲胺基-2 - Hi唑咐-4 -酮(6 8 6毫克) ,然後,全部於室溫攪拌30分鐘。混合物又冷却至-78¾ , 加3 -氣甲基-1H -帐咯并[2,3-b]吡啶(230毫克)。全部於室 溫攪拌4小時。於反應混合物中加水,全部以乙酸乙酯萃 取。所得萃取物經硫酸鎂使之乾燥,予以濃縮,獲得之殘 物進行矽膠層析。以乙酸乙酯-乙醇(10:1)溶離,獲得2-二甲胺基- 5- (1Η -吡咯并[2,3-b]吡啶-3-基)甲基-2-b¥唑 咐-4-酮(51毫克)。 1 Η - H H R ( C D C 1 3 ) δ : 2.9 5 (3 IK s ) , 3 . 0 3 ( 3 H , s ), 3 . 26 (1Η , dd , J = 15 . 9&5 . 5Hz), 3.48 (1Η , dd,J = 15 . 9&4 . 3Ηζ), 4,9 7 (1 Η,d d , J = 5 . 5 & 4 ‘ 3 Η ζ ), 7.09(lH,dd,J = 7.9&4.8Hz) , 7.24(lH,s), 7.98 (1Η,dd , J = 7.9&1 . 5Ηζ), ι 8.29(lH,J=4.8&1.5Hz), 9.64(lH,bs). 經濟部中央標準局負工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2-二甲胺基-5-UH-Blt咯并[2,3-b]吡啶-3-基)甲基-2 -D等唑咐-4-酮(50毫克)加至甲胺(1毫升)。混合物回流1 小時後,移除甲胺,獲得之殘物進行矽膠層析。以乙酸乙 酯-乙醇溶離,予以濃縮,獲得之殘物用錁仿使之固體化 。此固體以乙醚洗滌,使之減壓乾燥,獲得標題化合物( 32毫克)。 IR (KBr)cm-1 i 32 1 5, 1 645, 1 5 1 6. U-NMlUDMSO-dsiS : 2‘71,2.73(金部 3H,各為 s), 本紙張尺度適用中國國家標準(CNS ) A4規格(2Ι0Χ297公釐) 100 3 9 22 1 4 64649 A7 B7 五、發明説明(101) 2.99-3.32(2H,m), 4.97(lH,dd,J=6.7&3.9Hz), 7.03(lH,dd,J=7.8&4.7Hz), 7.24(lH,d,J=2.1Hz), 7.96(lH,d,J = 7.8Hz), 8.18(lH,d,J = 4.7Hz), 8.58(lH,bs), 11.43 (lH,bs).V Jiagjia 07 Benzoyl methyl chloride-3-Chlorochloride-5 Molyl carbonyl oxygen in all branches ο The paper size is applicable to the Chinese National Standard (CNS) Α4 size (210X297 mm) 97 3 922 1 464649 A7 B7 V. Description of the invention (98) t: to -40 t: search and mix for 30 minutes, search and mix for 2 hours, and stir at room temperature for 40 minutes. Water was added to the reaction mixture, and the gold portion was extracted with ethyl acetate. The obtained extract was dried over magnesium sulfate, concentrated, and the obtained residue was subjected to silica gel decantation. Dissolve in hexane-ethyl acetate (1: 1) to obtain 5- [(5-ammonium [fluoren-3-yl) methyl-2 -dimethylamino-2-floxazoline-4 -one (232 mg) as crystals. 1 H-NMR (CDC I 3) δ: 2.96 (3H, s), 2.98 (3H, s), 3.22 (1H, dd, J = 15.8 & 4.0 Hz), 3,45 (lH, dd, J = 15.86 <4.0Hz;), 4'98 (lH, t, J = 4.0Hz) 7.07 (lH, s), 7.09 (1H, d, J = 8.8Hz), 7.29 (1 H, d, J = 8.8 Hz), 7.59 (lH, s), 8.64 (lH, bs). In [(5-chloroindio-3-yl) methyl] -2-dimethylamino- 21¾ Zolamine-4-_ (200 mg) was added with methylamine (20 ml). The mixture was refluxed at -6¾ for 1 hour. The methylamine was removed and ether was added to the obtained residue to obtain the title compound (120 mg) as crystals. IR (KBr) cm " 1: 29 86, 1 6 4 1, 1413, 1 39 0, 1 3 0 4, 1242, 1103. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before (Fill in this page) 1H-NHR (DMSO-de) 5: 2.73 (3H, s), 3.01 (1Η, ι), 3.19 (lH, m), 4.95 (lH, i), 7.03 (1 H, d, J = 8.8Hz), 7.20 (lH, s), 7.34 (lH, dd, J = 8.8 & l. «Hz), 7.58 (1H, d, J = 1.8Hz), 8.31 (lH, bs ). Example 24 According to the same procedure as described in Example 23, the following compound was prepared. 2-Methylamino-5-[(2-methylindio-3-yl) methyl] -2-! 1 and other oxazolines. 4- This paper is sized to Chinese National Standard (CNS) A4 specifications (2 丨0X297 mm) 98 3 9 22 1 464649 A7 B7 V. Description of the invention (9 9) ketone, IR (KBr) cm-15 2912, 1 655, 1508, 1408, 1305, 1251, 1238, 746. iH-NHRiDHSO- de) ^: 2.50 (3H, s), 2.70 (3H, s), 2.93-3.20 (2H, b), 4.86 (1H, b), 6.86-7.00 (2H, m), 7.20 (lH, d, J = 7.2Hz), 7.40 (lH, d, J = 6.9Hz), 8.48 (lH, bs), 10.76 (lH, bs). 5-[(5-Benzyloxyindan-3-yl) methyl ] -2-Methylamino-2-Mesobutanthine -4-Brown, IR (KBr) cm " 1: 1667, 1640, 1485, 1 41 2, 1304. 1 H-NHR (DMSO-de) δ: 2 68 (1 .5 Η, s), 2.99 (1Η, η), 3.21 (lH, m), 4.95 (lH, dd, J = 7.0 & 3.4Hz), 6. 79 (1 Η, d, J = 8.8Hz), 7.08-7.5.2 (8 H, m), 10.78 (1H, bs). 2-methylamino-5-[(5, 6-methylenediazine ind Favor 3-yl) methyl] -2-oxazolin-4-one, ^ -HMR (DMSO-de) δ: 2.7 3 (3 Η, d, J = 5.0 Η ζ). Central Ministry of Economic Affairs Printed by the Consumer Bureau of Standards Bureau (Please read the notes on the back before filling out this page) 2 '9 6 -3. 1 5 (2 Η, βι), 4.8 9-4. 9 1 (1 H, m), 5.9 2 (2 Η, s), 6.85 (lH, s), 6.96 (lH, s), 6.99 (lH, s), 8.58 (lH, bs). (Window Example 25 2-Methylamino-5- (1Η-pyrrolo [2,3-b] pyridin-3-yl) methyl -2-Miconazole is instructed to be 4-ketodiisopropylamine (0.75 ml) in a solution of tetrahydrofuran (35 ml). The paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) gg 392 2 1 6 4649 A7 B7. Λ '' J _ ._τ. 'Ding-1 wide .... under r | ._ ^ T, ".U1 V. Description of the invention (100) Under ice cooling, add n-butyl to 1.6 in hexane. M solution (3.35 ml). All were cooled to -7 ** C plus 2-dimethylamino-2-Hizolam-4-4-one (666 mg), and then all were stirred at room temperature for 30 minutes. The mixture was cooled to -78¾ again, and 3 -gasmethyl-1H-leptro [2,3-b] pyridine (230 mg) was added. All were stirred at room temperature for 4 hours. Water was added to the reaction mixture, and the whole was extracted with ethyl acetate. The obtained extract was dried over magnesium sulfate and concentrated, and the obtained residue was subjected to silica gel chromatography. Dissolve in ethyl acetate-ethanol (10: 1) to obtain 2-dimethylamino-5- (1Η-pyrrolo [2,3-b] pyridin-3-yl) methyl-2-bazolyl 4-one (51 mg). 1 Η-HHR (CDC 1 3) δ: 2.9 5 (3 IK s), 3.0 3 (3 H, s), 3. 26 (1Η, dd, J = 15. 9 & 5.5 Hz), 3.48 (1Η, dd, J = 15. 9 & 4. 3Ηζ), 4, 9 7 (1 Η, dd, J = 5. 5 & 4 '3 Η ζ), 7.09 (lH, dd, J = 7.9 & 4.8Hz), 7.24 (lH, s), 7.98 (1Η, dd, J = 7.9 & 1.5Ηζ), ι 8.29 (lH, J = 4.8 & 1.5Hz), 9.64 (lH, bs). Economy Printed by the Ministry of Standards and Labor ’s Consumer Cooperatives (please read the precautions on the back before filling out this page) Methyl-2 -D and other oxazolones (50 mg) were added to methylamine (1 ml). After the mixture was refluxed for 1 hour, methylamine was removed, and the obtained residue was subjected to silica gel chromatography. Ethyl acetate-ethanol was used to dissociate and concentrate, and the obtained residue was solidified by imitation. This solid was washed with diethyl ether and dried under reduced pressure to obtain the title compound (32 mg). IR (KBr) cm-1 i 32 1 5, 1645 1 5 1 6. U-NMlUDMSO-dsiS: 2'71, 2.73 (Gold Department 3H, each s), this paper size applies Chinese National Standard (CNS ) A4 specification (2IO × 297 mm) 100 3 9 22 1 4 64649 A7 B7 V. Description of the invention (101) 2.99-3.32 (2H, m), 4.97 (lH, dd, J = 6.7 & 3.9Hz), 7.03 ( lH, dd, J = 7.8 & 4.7Hz), 7.24 (lH, d, J = 2.1Hz), 7.96 (lH, d, J = 7.8Hz), 8.18 (lH, d, J = 4.7Hz), 8.58 (lH, bs), 11.43 (lH, bs).
音掄例PR 依實施例25所述之相同程序,製備下述化合物。 5-(苯并[b]l«盼-3-基)甲基-2 -甲胺基-2-B等唑啉- 4- 酮, IRiKBrJcm-1: 3210, 1768, 1678. UMiUDMSO-ddS : 2.68,2.79(全部 3H,各為 s), 3. 18(lH,dd,J = 15.78,8.4Hz), 3.42(lH,m), 5.06(lH,m), 7.35-7.45{2H,ia), 7.51(lH,,s), 7.82 -7.99 ( 2 H , m) , 8.69 (1H , bs). 5-[(l-苯甲基吲睐-3-基)甲基]-2 -甲胺基-2-呜唑咐-4-酮, IRUBrOcm,1: 1 6 6 3,1 50 8, 1 41 0,1402, 1 298, 7 2 9 . 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 1 Η~ΗΗ1ί (DMSO-de) 5 : 2.68(lH,s), 2.72(2H,s), 3.07 (1H,m),3.30 (1H·m), 4.98(lH,dd,J = 6.2&2.4Hz) , 5.37(2fl,s), 6.96-7.38(9H,m), 7.56(lH,d,J=7.0Hz), 8 . 55(1H,bs). 奮施例27 依實施例17所述之相同程序,製備下述化合物。 本紙張尺度適用中國國家標準(CNS ) A4规格(210 X 297公釐) 101 3 92 2 1 4 6 4649 A7 B7 五、發明説明(102) 5-[(1-(4-甲基吲睬-3-基)乙基]-2 -甲胺基-2-枵唑啉 -4 -酮, (請先閲讀背面之注意事項再填寫本頁} IR(KBr)ci-1: 3183, 1733, 1623. lH-NHR (CDCla) 5 : 1 . 25-1 . 50 (3Η, a), 2.69-3.0 (3Η,m) , 4.05-4.25 (1 Η,m), 4.86(0.5H,d,J=3.6Hz), 4.96(0.5H,d,J-2.6Hz), 6.84(lH,m), 6.9 8 - 7 . 25 (3 Η,1) , 8 . 29 (0 . 5 Η , bs), 8 . 38 (0 . 5Η , bs) , 9 . 30 (1Η , bs). 5-[(1- (4-苯甲氧基吲睬-3-基)乙基]-2-甲胺基-2-Β辱 唑啪-4-酮, IR (KBr) cm- 1 : 3 1 9 9 , 1 733 , 16 52 , 1 6 1 5 . ^-NMRiCDCis)^ : 1.22-1.37(3H,m), 2.82-3 . 0 (3Η , n) , 4 . 1 - 4.4 (1 Η,m), 5.0 8 (0 . 5 Η , d,J = 4 . 8 Η ζ ),5 . 1 9 (1 . 5 Η , β ) , 5 · 2 6 (1 Η,s ) ,6 , 5 6 (1 Η ,麄),6 · 9 - 7 . 1 (3 Η,m ),7.2 9 - 7 . 6 ( 5 Η,m ), 8.23(0.5H,bs), 8.37(0.5H,bs), 9.25(lH,bs). 經濟部中央標準局員工消費合作社印製 2 -甲胺基- 5- [1-(7-甲基吲睬-3-基)乙基]-2-_等唑啉-4-圃, IRiKBricn*1! 3357 , 3214 , 1733 , 1 652 , 1615 . UMMDMSO-deM : 1.18(0.96H,d',J = 7.4Hz), 1.25(0.45H,d,J=7.0Hz), 1.42(0.96H,d,J=7.2Hz), 1.50(0.63H,d,J=7.6Hz), 2.41(1.5H,s), 2.44 (1.5H,s) , 2 . 65-2.8 (3H , m) , 3.5 - 3 . 7 (1 Η ,m), 4.8-4.95 (1H,m) , 6.8 - 6,9(2 Η ,b) , 7.0 - 7.15 (1 Η , ), 本紙張尺度適用中國國家標率(CNS ) A4規格(210 X 297公釐) 102 3 92 2 1 464649 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(103) 7.3 5 -7.45 (lH,m) , 8.55 (lH.bs). 5-[l-U-甲氣羰基吲睬-3-基)乙基]-2-甲胺基-2-鸣 唑啉-4-酮, IR (KBr) cm-1 : 3278, 3203 , 1713 , 1 635 . ^-NHR (DMSO-de) δ : 1 . 0 6 ( 1 . 3 3 Η , d , J = 7 . 0 Η z ), 1.14(0,67Htd,J=7.0Hz), 1.32(0.67H,d,J=7.0Hz), 1.41(0.33H,dfJ = 7.6Hz) , 2.7-2.85(3H,i), 3.86(1.08H,s),3.91(1.92H,s), 3.95-4.2(lHtm)( 4. 65 -4 . 85 ( 1 H , m) , 7 . 0 - 7 . 2 (1 Η , i) , 7 . 3 - 7 . 5 ( 2 H , nt), 7.55 - 7 . 6 5 ( 1 H , ra) , 11.40 (lH.bs). 5-[1-(4-異丙基吲睬-3-基)乙基]-2-甲胺基-2-1等唑 啉-4-ϋ I R U B r ) c ] - 1 : 3 2 6 6,3 2 1 6 , 1 7 2 5,1 6 3 4 . ^-HMR (DHSO-de) δ : 1 . 1 - 1 . 5 (9 H , id ), 2.75-2 . 9 (3H , m) , 3.6 - 3.9 (1 H,m) , 4 . 8 - 4.95 (1 Htm), 6 . 8 - 7 · 1 (2 H,b ),7 . 1 - 7 . 2 5 (2 H,腿),8 . 6 7 (1 H , b s ). 奮掄俐 5-[l-(4 -羥基吲睬-3-基)乙基]-2 -甲胺基-2-B琴唑啉-4-酮 5-[1-(4-苯甲氣基吲睬-3-基)乙基]-2-甲胺基-2-鸣唑 咐-4-_ (149毫克)溶於乙醇及四氳呋喃(ϊ:1.6毫升)之混 合液。加10%耙-磺(45毫克),全部於室溫常壓下進行氫 化24小時。自混合物中過濾移除催化劑,又加10¾钯-硪 (45毫克)。金部又於室溫常壓下進行氫化2 4小時。反應混 合物經過濾移除催化劑。所得濾液予以濃缩,獲得之殘物 f 厂、 (請先閲讀背面之注意事項再填寫本頁) 、ν#Sound Example PR According to the same procedure as described in Example 25, the following compounds were prepared. 5- (Benzo [b] l «pan-3-yl) methyl-2-methylamino-2-B and other oxazoline-4-ones, IRiKBrJcm-1: 3210, 1768, 1678. UMiUDMSO-ddS: 2.68, 2.79 (all 3H, each s), 3. 18 (lH, dd, J = 15.78, 8.4Hz), 3.42 (lH, m), 5.06 (lH, m), 7.35-7.45 {2H, ia) , 7.51 (lH ,, s), 7.82 -7.99 (2 H, m), 8.69 (1H, bs). 5-[(l-benzylindolin-3-yl) methyl] -2-methylamine 2--2-oxazolium-4-one, IRUBrOcm, 1: 1 6 6 3, 1 50 8, 1 41 0, 1402, 1 298, 7 2 9. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please Read the precautions on the back before filling this page) 1 Η ~ ΗΗ1ί (DMSO-de) 5: 2.68 (lH, s), 2.72 (2H, s), 3.07 (1H, m), 3.30 (1H · m), 4.98 (lH, dd, J = 6.2 & 2.4Hz), 5.37 (2fl, s), 6.96-7.38 (9H, m), 7.56 (lH, d, J = 7.0Hz), 8.55 (1H, bs ). Example 27 According to the same procedure as described in Example 17, the following compound was prepared. This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 101 3 92 2 1 4 6 4649 A7 B7 V. Description of the invention (102) 5-[(1- (4-methylindionium- 3-yl) ethyl] -2 -methylamino-2-oxazoline-4 -one, (Please read the notes on the back before filling this page} IR (KBr) ci-1: 3183, 1733, 1623 lH-NHR (CDCla) 5: 1.25-1.50 (3Η, a), 2.69-3.0 (3Η, m), 4.05-4.25 (1 Η, m), 4.86 (0.5H, d, J = 3.6Hz), 4.96 (0.5H, d, J-2.6Hz), 6.84 (lH, m), 6.9 8-7.25 (3 Η, 1), 8.29 (0.5 Η, bs), 8 38 (0. 5Η, bs), 9. 30 (1Η, bs). 5-[(1- (4-benzyloxyindio-3-yl) ethyl] -2-methylamino-2 -B-oxazol-4-one, IR (KBr) cm- 1: 3 1 9 9, 1 733, 16 52, 1 6 1 5. ^ -NMRiCDCis) ^: 1.22-1.37 (3H, m), 2.82 -3. 0 (3Η, n), 4.1-4.4 (1 Η, m), 5.0 8 (0.5 Η, d, J = 4. 8 Η ζ), 5. 1 9 (1. 5 Η , β), 5 · 2 6 (1 Η, s), 6, 5 6 (1 Η, 麄), 6 · 9-7.1 (3 Η, m), 7.2 9-7.6 (5 Η, m), 8.23 (0.5H, bs), 8.37 (0.5H, bs), 9.25 (lH, bs). Staff Consumer Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs Preparation of 2-methylamino-5- [1- (7-methylindio-3-yl) ethyl] -2-_ isoxazoline-4-b, IRiKBricn * 1! 3357, 3214, 1733, 1 652, 1615. UMMDMSO-deM: 1.18 (0.96H, d ', J = 7.4Hz), 1.25 (0.45H, d, J = 7.0Hz), 1.42 (0.96H, d, J = 7.2Hz), 1.50 ( 0.63H, d, J = 7.6Hz), 2.41 (1.5H, s), 2.44 (1.5H, s), 2.65-2.8 (3H, m), 3.5-3.7 (1 Η, m), 4.8-4.95 (1H, m), 6.8-6,9 (2 Η, b), 7.0-7.15 (1 Η,), this paper size applies China National Standard (CNS) A4 specification (210 X 297 mm) 102 3 92 2 1 464649 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (103) 7.3 5 -7.45 (lH, m), 8.55 (lH.bs). 5- [lU-methylcarbonyl Indino-3-yl) ethyl] -2-methylamino-2-oxazoline-4-one, IR (KBr) cm-1: 3278, 3203, 1713, 1 635. ^ -NHR (DMSO- de) δ: 1.06 (1.33 3, d, J = 7.00 .z), 1.14 (0, 67Htd, J = 7.0Hz), 1.32 (0.67H, d, J = 7.0Hz) , 1.41 (0.33H, dfJ = 7.6Hz), 2.7-2.85 (3H, i), 3.86 (1.08H, s), 3.91 (1.92H, s), 3.95-4.2 (lHtm) (4.65 -4. 85 (1 H, m), 7.0-7.2 (1 Η, i), 7.3-7.5 (2 H, nt), 7.5 5-7. 6 5 (1 H, ra), 11.40 (lH.bs). 5- [1- (4-isopropylindio-3-yl) ethyl] -2-methylamino-2- 1 isoxazoline-4-ϋ IRUB r) c]-1: 3 2 6 6, 3 2 1 6, 1 7 2 5, 1 6 3 4. ^ -HMR (DHSO-de) δ: 1. 1- 1.5 (9 H, id), 2.75-2. 9 (3H, m), 3.6-3.9 (1 H, m), 4.8-4.95 (1 Htm), 6.8-7 · 1 (2 H, b), 7. 1-7. 2 5 (2 H, legs), 8. 6 7 (1 H, bs). Fen Li Li 5- [l- (4-hydroxyindio-3-yl) Ethyl] -2-methylamino-2-B quinazoline-4-one 5- [1- (4-benzylaminoindan-3-yl) ethyl] -2-methylamino-2 -Miconazole is instructed to be dissolved in a mixture of ethanol and tetrahydrofuran (氲: 1.6 ml). Add 10% rake-sulfur (45 mg), and perform all hydrogenation at room temperature and normal pressure for 24 hours. The catalyst was removed from the mixture by filtration, and 10¾ palladium-rhenium (45 mg) was added. The gold part was hydrogenated again at room temperature and normal pressure for 24 hours. The reaction mixture was filtered to remove the catalyst. The obtained filtrate is concentrated, and the obtained residue is f factory, (please read the precautions on the back before filling this page), ν #
本紙張尺度適用中國國家標準(CMS ) A4規格(21〇X297公釐) 103 39 22 1 Λ 6 4649 Α7 Β7 五、發明説明(10 4) 進行矽膠層析。以己烷-丙_(1 : 1)溶離,獲得標題化合物 (72毫克)。 {請先閲讀背面之注意事頃再填寫本頁) IR (KBr)cm-1 : 3 1 89, 1 733, 1 6 9 8, 1 6 1 5. 1H-NHR(DMS0-d6)S *· 1.0-1.15(1.92H,m), 1 . 3 0 - 1 . 3 5 ( 1 . 0 8 Η , m ) , 2 · 7 - 2 . 8 5 ( 3 Η , in), 3.7-4.0(lH,m), 4.92(0.12Htd,J=6.0Hz), 5.02(0.31H,d,J=6.0Hz), 5.08(0.20H,d,J=2.2Hz), 5.13(0.37H,d,J=2.2Hz), 6.32(lH,d,J=5.2Hz)t 6 . 7-7 . 0 (3H,m) , 8.58(lHtbs)t 9.40(lHtbs). 管旃例29 5-[l-(4 -甲氣基》3丨睬-3-基)乙基]-2 -甲胺基-2-B等唑咐-4-酮 經濟部中央榡準局負工消費合作社印製 5-[l-U-苯甲氣基吲睬-3-基)乙基]-2-二甲胺基-2-B等唑啉-4- _ (268毫克)溶於乙醇及四氫呋喃(7:3.10毫升) 之混合液加10%耙-硕(80毫克),全部於室溫常壓下進行 氫化5小時。自混合物中移除催化劑,又加0%耙-磺(80 毫克)。全部又於室溫常壓下進行氫化24小時。反應混合 物經過濾移除催化劑。濾液予以濃縮,獲得2-二甲胺基-5 -[1-U-羥基吲睬-3-基)乙基]-2-噚唑咐-4-酬(125毫克)。 1 H-NHR (DMSO-de) δ : 1.02-1.15 (3Hs m), 3.00-3.10(6H,m), 3‘98(lH,m), 4.97-5.16(lH,m), 6.30 - 6.34 ( 1 H,m) , 6.77 - 6.83 ( 2 H , m) , 6.95 (1 Ηtm), 9.40 (1H t bs) , 10.69 (1H , bs). 2-二甲胺基-5-[l-(4-羥基吲睬-3-基)乙基]-2-B尋唑 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 104 3 922 1 464649 A7 B7 五、發明説明(105) 咐-4-酮(120毫克)溶於二甲基甲醯胺(3毫升)。加碩酸鉀 (115毫升)及吲睬甲烷(ί56徹升)。混合物於室溫攪拌3小 時,又加吲睬甲烷(78徹升)。混合物於室溫攪拌36小時。 於反應混合物中加水,全部以乙酸乙酯萃取。所得萃取物 以食鹽液洗滌,經硫酸鎂使之乾燥。乙酸乙酯溶液予以濃 縮,獲得之殘物進行矽膠層析。以己烷-丙酮(1:1)溶離, 獲得2-二甲胺基-5-[1-(4-甲氣基吲睬-3-基)乙基]-2-Β等 唑咐-4-酮(54毫克)。 1 H-NMR (CDC 1 3) δ : 1.26 (2.6Η,d,J = 7 . 0Hz), 1.45(0.4H,d,J=7.2Hz), 2,96(0.4H,s), 3 . 00 (2 . 6H , s) , 3 . 17 (2.6H , s) , 3 . 1 9 ( 0.4H,s), 3.90 (0 . 4H , s) , 3 . 93 (2 . 6H , s) , 4.25(lH,m), 4.98(0.13H,d,J = 3.4Hz) . 5.24(0.87H,d,J = 2.2Hz), 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 6.51(d,J=7,8Hz), 6.95-7.14(3H,m), 8.16(lH,bs). 2-二甲胺基-5-[l-(4-甲氣基吲睬-3-基)乙基]-2-鸣 唑啉-4-_ (50毫克)加至甲胺(5毫升)。混合物經回流5小 時,又加甲胺(5毫升)。全部又回流2. 5小時。甲胺經蒸餾 移除,獲得之殘物進行矽膠層析,以己烷-丙酮(1:1)溶離 ,獲得標題化合物(32毫克)。 IR (KBr)cm* 1 : 328 6, 3 1 99 , 1 7 33, 1 6 2 3. ^-NMRiDHSO-de)^ : 1.0-1.15(3H,m)f 2 . 7 - 2 . 8 5 ( 3 Η , m ) , 3 · 8 4 ( 3 Η , s ) , 3 · 7 - 3 . 9 (1 Η , m ), 4.98(0.33H,d,J = 2.2Hz), 5.01(0.67H,d,J = 2.2Hz), 6.46(lH,m), 6 . 9 - 7 . 1 ( 3H , m) , 8.60(lH,bs), 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X297公釐) 105 3 9 2 2 1 464649 A7 B7 五、發明説明(106) 1 0 . 8 δ (1 Η,b s ). 奮掄例30 (請先閲讀背面之注意事項再填寫本頁) 5-[l-(4-氣吲睬-3-基)乙基]-2-甲胺基-2-B弯唑咐-4-酮 3 -氣基吲睐(500毫克)及反式-2,3 -璟氣丁酸乙酯 (472毫克)溶於二氣甲烷(5毫升)。於此混合物中,費 3 0分鐘於-9 0 加四氣化鈦。全部於-9 10攪拌1小時。加 反式-2,3-環氣丁酸乙酯(405毫克)及四氣化鈦( 40 5徹升) 。全部於-9t又攪拌1小時。反應混合物予以濃縮,加乙 酸乙酯至所得殘物中。混合物以食鹽液洗滌,經硫酸鎂使 之乾燥溶液予以濃縮,獲得之殘物進行矽膠層析。以己 烷-乙酸乙酯(1:3)溶離,獲得2S*,3Ι^)-3-(4 -氣基吲睬-3-基)-2-羥基丁酸乙酯(2 0 0毫克)。 »H-NMR (CDC Is) 5 : 1 . 27 ( 3H , d , J = 7.2 Ηz), 1.33(3H,t,J=7.0Hz), 2.81(lH,d,J=5.2Hz), 4 · 2 5 - 4 , 4 0 (4 H , m ) , 4 . 6 4 (1 H , d d , J = 5 . 2 & 2 . 6 H z ), 7.06-7.10(2H,id), 7.24-7.29(2Hti), 8.22(lH,bs). 鈉(100毫克)溶於乙醇(5毫升)。加(2S*, 3R*)-3- 經濟部中央標隼局員工消費合作社印製 (4-氣基吲睬-3-基)-2-羥基丁酸乙酷(200毫克)及Ν,Ν'-二 甲基胍溴酸鹽(143毫克)。全部經回流16小時。加水至反應 混合物,以乙酸乙酯萃取。所得萃取物以食鹽液洗滌,經 硫酸鎂使之乾燥。溶液予以濃縮,獲得之殘物進行矽膠層 析。以己烷-丙酮(1:1)溶離,獲得標題化合物(25毫克)。 1 H-HMR (CDC Is) 5 : 1 . 27 - 1 . 44 (3 Η , m), 2.84-3.00(3Η,ιιι) , 4.36-4.58(lH,m), 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 106 39 2 2 1 464649 A7 B7 五、發明説明(1 Ο?) .4.99-5.11(lH,m), 5.88(lH,m), 7.0,0-7.30(4Η,π>), 8 . 6 0 -8 . 80 ( 1 Η , m). 審施例3 1 5-[1-(吲睐-3-基)-2,2,2-三氟乙基]-2-甲胺基-2-1!_唑啉 -4 -酬 乙醇鈉(580毫克)加至4,4,4 -三氟基-2-羥基- 3- (吲睬 -3-基)丁酸甲酯(980毫克)及N,fT-二甲基胍溴酸鹽(630毫 克)於乙醇(2.5毫升)之溶液中。混合物經回流1.5小時, 然後冷却之。加冰水(20毫升)至經冷却之反應混合物。此 混合物之pH值以乙酸諏至7後,全部以乙酸乙酯萃取。所 得萃取物經飽和磺酸氫鈉水溶液洗滌,然後以硫酸鎂使之 乾燥,溶液經減壓濃縮,獲得之殘物進行矽膠靥析,以乙 酸乙酯-己烷溶離,經收集及濃縮,獲得標題化合物(218 毫克)。 IR(KBr)cm]: 3283, 1769, 1717, 1659, 1541, 1 H-NMR (DMSO-de) δ : 2.38 - 2.5 4 ( 3 Η ,m), 3‘65-4.61(2H,m), 6.24-6.33(1Η,ια), 經濟部中央標準局員工消費合作社印製 (請先聞讀背面之注意事項再填寫本頁) 6 . 9 4 - 7 . 9 8 (5 Η,m ),11 · 1 0 - 1 1 . 1 8 (1 Η,m ), 甯掄剜:¾¾ 2-二乙醯胺基- 5- [1-(吲睬-3-基)乙基]-2-枵唑咐-4-酮 2 -胺基- 5- [l-(n3丨睬-3-基)乙基]-2-d§唑啉-4-酮 (300毫克)溶於四氫呋喃(2毫升)。於冰冷却下加三乙胺 ( 344徹升)及乙醯氣(123微升)。混合物於0¾攪拌2小時 。又加三乙胺(3 44微升)及乙醯氣(123徹升)。全部又攪拌 本紙張尺度適用中國國家標準(CNS > A4規格(210 X 297公釐) 107 3 922 1 464649 A7 B7 五、發明説明(108) 2小時。加水至反應混合物,全部以乙酸乙酯萃取。所得 萃取物以食鹽液洗滌,經硫酸鎂使之乾燥。溶液予以濃縮 ,獲得之殘物進行矽謬層析,以己烷-丙_ (1 :1)溶離,經 收集及濃縮,獲得標題化合物(40毫克)。 1 Η - Η Μ ϋ (C D C 1 3 Μ : 1 · 4 5 ( 1 . 9 2 Η,d,J = 7 . 2 Η z ), 1 . 57 (1 · 08Η , d,J = 7 . 2Ηζ),2 . 17 (6Η,s), 3.7-3.9(1Η,β), 4.99(0.36H,d,J=2.4Hz), 5.07(0.64H,d,J = 2.8Hz),7.0-7.4(4H,m), 7 . 6-7 . 7 (1Η , a) , 8.32 (1H , bs). 窖掄俐 經濟部中央標準局—工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A1 2 3規格(2 410X596公釐) 108 39 22 1 1 ^-NHRfCDCls)^ : 1.42(1.95H,d,J'=7.2Hz), 2 1.62(1.05H, d, J = 7.2Hz),2.1-2.3 (3H,m), 3.88(lH,dq,J=2.2&7.2Hz), 5.00(0.35H,d,J=2.2Hz) 3 ,5.04 ( 0 . 6 5H,d,J = 2.2Hz) , 7.0 - 7.4 ( 5H,m), 4 IR (KBr)cm" 7 : 1 742 , 1 69 8. 5 -胺基-5-[l-(n引睐-3-基)乙基]唑咐-4-_ (100毫克)溶於吡啶(0.5毫升)。加乙酸酐(117徹升)。潺 合物於80Ό攪拌2小時。加水至反應混合物。此混合物以 4Ν鹽酸諏成酸性。全部以乙酸乙酯萃取。所得萃取物以食 鹽液洗滌,經硫酸鎂使之乾燥。溶液予以濃縮,獲得之殘 物進行矽膠層析。以己烷-丙酮(1:1)谘離,經收集及濃縮 ,獲得標題化合物(16毫克)。 6 . 67 (1H , d , J = 8.4Hz) , 8.19(lH,bs). 7 2-乙醯胺基-5-[1-(硕睐-3-基)乙基]-2-〇l唑咐-4-酮 A7 464649 B7 五、發明説明(10 9) 試驗例1 活體外抗徹生物試驗: (請先閱讀背面之注意事項再填寫本頁) 對幽門蜾揑舖好苴他榭生物:> 活鵲外抗榭牛物活袢^測宙 用5種幽門螺桿a菌株、19種其他細崮及2種酵母菌 作受試株,依下述方法(瑷脂稀釋法)測定各種化合物之抗 徹生物活性。受試化合物溶於二甲亞碾;此溶液以無菌蒸 餾水慢慢地稀釋2倍成受試樣品。2毫升之各受試樣品與 作培養基之補充7%馬血之18毫升布魯斯拉琪脂(Brucella agar)混合製備成測定用培養皿。幽門螺捍菌於含Campy PakTW(BBLR Beckton Dickinson微生物条統)之充氣 S[中, 用補充2.5%胎牛血清之布魯斯拉液培養基,於30¾搖盪 培育20小時,成接種用菌(seed in oclan)。其他受試徹 生物,用布魯斯拉液培養基,各於37t:培育20小時,成各 別之接種用菌。 經濟部中央標準局員工消費合作社印製 5徹升之各接種菌,預先以補充2.5%胎牛血清之布 魯斯拉液培養基調至的l〇6CFU/毫升,接種至各測定用盤 養皿,於含Campy PakTM及浸水棉吸收物之充氣缸中,於 37¾培育4天。經培育後,以肉眼檢査菌株生長;逹無菌 株生長時,受試化合物之最少濃度(最低抑制濃度)作HIC 值。 ' 結果示於表2及3 。 本紙張尺度適用中國國家標準(CNS ) A4規格(2I〇X297公釐) 109 3 92 2 1 464649 A7 B7 經濟部中央標準局負工消費合作社印製 五、發明説明(110) 表2 133丨睬徽素對各種撤生物之抗徹生物活性[(MIC(徹克/ 毫升)] 1 大 腸 埃 希 氏 菌 K12 >100 2 大 腸 埃 希 氏 菌 Η IH J JC-2 >100 3 奇 異 變 形 菌 ATCC 21100 >100 4 普 通 變 形 菌 IF0 3045 >100 5 莫 格 尼 氏 變 形 菌 IF0 3168 >100 6 肺 炎 桿 菌 IF0 3317 >100 7 拈 質 沙 雷 氏 菌 IF0 3046 >100 8 鼠 傷 寒 沙 門 氏 菌 IF0 1 252 9 >100 9 腸 炎 沙 門 氏 菌 IF0 3313 >100 10 弗 氏 檸 稼 酸 桿 菌 IF0 1 268 1 >100 11 緣 膿 桿 菌 IF0 3080 >100 12 糞 産 鹼 捍 菌 IF0 13111 >100 13 祜 草 桿 菌 PCI 219 >100 14 蠛 狀 芽 孢 桿 菌 IFO 3514 >100 15 短 小 芽 孢 桿 菌 IFO 3813 >100 16 巨 芽 孢 桿 菌 IFO 12108 >100 17 金 黃 色 葡 萄 球 薗 FDA 209 P >100 18 藤 黃 徹 球 菌 IFO 1 27 0 8 12.5 19 黃 色 撒 球 菌 IFO 32 42 >100 20 幽 門 螺 桿 菌 NCTC 11637 0.006 21 白 色 念 珠 菌 IFO 05 8 3 >100 22 釀 酒 ntMf 酵 母 菌 IFO 02 09 >100 ΤΠΓ (請先閲讀背面之.注意事項再填寫本頁) _ -e ΓThis paper size is in accordance with Chinese National Standard (CMS) A4 specification (21 × 297 mm) 103 39 22 1 Λ 6 4649 Α7 Β7 5. Description of the invention (10 4) The silica gel chromatography is performed. Dissolve in hexane-propane (1: 1) to obtain the title compound (72 mg). {Please read the notes on the back before filling this page) IR (KBr) cm-1: 3 1 89, 1 733, 1 6 9 8, 1 6 1 5. 1H-NHR (DMS0-d6) S * · 1.0-1.15 (1.92H, m), 1.3 .0-1.3 .5 (1.0 8 Η, m), 2 · 7-2. 8 5 (3 Η, in), 3.7-4.0 (lH, m), 4.92 (0.12Htd, J = 6.0Hz), 5.02 (0.31H, d, J = 6.0Hz), 5.08 (0.20H, d, J = 2.2Hz), 5.13 (0.37H, d, J = 2.2 Hz), 6.32 (lH, d, J = 5.2Hz) t 6. 7-7. 0 (3H, m), 8.58 (lHtbs) t 9.40 (lHtbs). Example 29 5- [l- (4- Methenyl group "3 丨 基 -3-yl) ethyl] -2-methylamino-2-B and other oxazol-4-ones Printed by 5- [lU-benzene" Methazinyl-3-yl) ethyl] -2-dimethylamino-2-B and other oxazoline-4- (268 mg) were dissolved in a mixture of ethanol and tetrahydrofuran (7: 3.10 ml). 10% rake-shuo (80 mg), all hydrogenated at room temperature and atmospheric pressure for 5 hours. The catalyst was removed from the mixture, and 0% rake-sulfur (80 mg) was added. All were hydrogenated again at room temperature and normal pressure for 24 hours. The reaction mixture was filtered to remove the catalyst. The filtrate was concentrated to obtain 2-dimethylamino-5-[[1-U-hydroxyindio-3-yl) ethyl] -2-oxazol-4-yl (125 mg). 1 H-NHR (DMSO-de) δ: 1.02-1.15 (3Hs m), 3.00-3.10 (6H, m), 3'98 (lH, m), 4.97-5.16 (lH, m), 6.30-6.34 ( 1 H, m), 6.77-6.83 (2 H, m), 6.95 (1 Ηtm), 9.40 (1H t bs), 10.69 (1H, bs). 2-dimethylamino-5- [l- (4 -Hydroxyindox-3-yl) ethyl] -2-B oxazole This paper is sized to the Chinese National Standard (CNS) A4 (210 X 297 mm) 104 3 922 1 464649 A7 B7 V. Description of the invention (105 ) The 4--4-one (120 mg) was dissolved in dimethylformamide (3 ml). Add potassium sulphate (115 ml) and indylmethane (ί 56 liters). The mixture was stirred at room temperature for 3 hours, and then indanemethane (78 liters) was added. The mixture was stirred at room temperature for 36 hours. Water was added to the reaction mixture, and the whole was extracted with ethyl acetate. The obtained extract was washed with a common salt solution and dried over magnesium sulfate. The ethyl acetate solution was concentrated, and the obtained residue was subjected to silica gel chromatography. Dissolve with hexane-acetone (1: 1) to obtain 2-dimethylamino-5- [1- (4-methylaminoinden-3-yl) ethyl] -2-B, etc. -Ketones (54 mg). 1 H-NMR (CDC 1 3) δ: 1.26 (2.6Η, d, J = 7.0 Hz), 1.45 (0.4H, d, J = 7.2Hz), 2,96 (0.4H, s), 3. 00 (2.6H, s), 3.17 (2.6H, s), 3.19 (0.4H, s), 3.90 (0.4H, s), 3.93 (2.6H, s), 4.25 (lH, m), 4.98 (0.13H, d, J = 3.4Hz). 5.24 (0.87H, d, J = 2.2Hz), printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the note on the back first) Please fill in this page again for matters) 6.51 (d, J = 7,8Hz), 6.95-7.14 (3H, m), 8.16 (lH, bs). 2-dimethylamino-5- [l- (4-methyl gas Indox-3-yl) ethyl] -2-oxazoline-4-_ (50 mg) was added to methylamine (5 ml). The mixture was refluxed for 5 hours and methylamine (5 ml) was added. All again refluxed for 2.5 hours. Methylamine was removed by distillation, and the obtained residue was subjected to silica gel chromatography and eluted with hexane-acetone (1: 1) to obtain the title compound (32 mg). IR (KBr) cm * 1: 328 6, 3 1 99, 1 7 33, 1 6 2 3. ^ -NMRiDHSO-de) ^: 1.0-1.15 (3H, m) f 2. 7-2. 8 5 ( 3 Η, m), 3 · 8 4 (3 Η, s), 3 · 7-3.9 (1 Η, m), 4.98 (0.33H, d, J = 2.2Hz), 5.01 (0.67H, d , J = 2.2Hz), 6.46 (lH, m), 6.9-7.1 (3H, m), 8.60 (lH, bs), this paper size applies Chinese National Standard (CNS) A4 specification (2! 0X297 (Mm) 105 3 9 2 2 1 464649 A7 B7 V. Description of the invention (106) 1 0. 8 δ (1 Η, bs). Example 30 (Please read the notes on the back before filling this page) 5- [l- (4-Gaindino-3-yl) ethyl] -2-methylamino-2-Bcurazol-4-one 3-ketoindene (500 mg) and trans-2, Ethyl 3-tritium butyrate (472 mg) was dissolved in digas methane (5 ml). In this mixture, it took 30 minutes at -90 to add tetragas titanium. Stir all at -9 10 for 1 hour. Add trans-2,3-cyclobutyric acid ethyl ester (405 mg) and titanium tetragas (40 5 liters). All was stirred for an additional hour at -9t. The reaction mixture was concentrated, and ethyl acetate was added to the obtained residue. The mixture was washed with a common salt solution, and the dried solution was concentrated with magnesium sulfate, and the obtained residue was subjected to silica gel chromatography. Dissolve in hexane-ethyl acetate (1: 3) to obtain 2S *, 3l ^)-3- (4-aminoindan-3-yl) -2-hydroxybutyric acid ethyl ester (200 mg) . »H-NMR (CDC Is) 5: 1.27 (3H, d, J = 7.2 Ηz), 1.33 (3H, t, J = 7.0Hz), 2.81 (lH, d, J = 5.2Hz), 4 · 2 5-4, 4 0 (4 H, m), 4. 6 4 (1 H, dd, J = 5. 2 & 2. 6 H z), 7.06-7.10 (2H, id), 7.24-7.29 (2Hti), 8.22 (lH, bs). Sodium (100 mg) was dissolved in ethanol (5 ml). Plus (2S *, 3R *)-3- Printed by (4-Amino-Inden-3-yl) -2-Hydroxybutyric Acid (200 mg) and Ν, Ν printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs '-Dimethylguanidine bromate (143 mg). All were refluxed for 16 hours. Water was added to the reaction mixture, and extraction was performed with ethyl acetate. The obtained extract was washed with a common salt solution and dried over magnesium sulfate. The solution was concentrated, and the obtained residue was subjected to silica gel layer analysis. Dissolve in hexane-acetone (1: 1) to obtain the title compound (25 mg). 1 H-HMR (CDC Is) 5: 1.27-1.44 (3 Η, m), 2.84-3.00 (3Η, ιιι), 4.36-4.58 (lH, m), this paper size applies Chinese national standard ( CNS) A4 specification (210 × 297 mm) 106 39 2 2 1 464649 A7 B7 V. Description of the invention (10?). 4.99-5.11 (lH, m), 5.88 (lH, m), 7.0,0-7.30 (4Η , π >), 8. 6 0 -8. 80 (1 Η, m). Examination Example 3 1 5- [1- (Indyl-3-yl) -2,2,2-trifluoroethyl] 2-Methylamino-2-1! _Oxazoline-4-sodium ethoxide (580 mg) was added to 4,4,4-trifluoro-2-hydroxy-3- (indol-3-yl) A solution of methyl butyrate (980 mg) and N, fT-dimethylguanidine bromate (630 mg) in ethanol (2.5 ml). The mixture was refluxed for 1.5 hours and then cooled. Add ice water (20 ml) to the cooled reaction mixture. After the pH of the mixture was adjusted to 7 with acetic acid, the whole was extracted with ethyl acetate. The obtained extract was washed with a saturated aqueous solution of sodium hydrogen sulfonate, and then dried over magnesium sulfate. The solution was concentrated under reduced pressure, and the obtained residue was subjected to silica gel decantation, and the residue was separated with ethyl acetate-hexane, and collected and concentrated to obtain Title compound (218 mg). IR (KBr) cm]: 3283, 1769, 1717, 1659, 1541, 1 H-NMR (DMSO-de) δ: 2.38-2.5 4 (3 Η, m), 3'65-4.61 (2H, m), 6.24-6.33 (1Η, ια), printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling out this page) 6. 9 4-7. 9 8 (5 Η, m), 11 · 1 0-1 1. 1 8 (1 Η, m), butanidine: ¾¾ 2-diethylamidoamino-5-[1- (indio-3-yl) ethyl] -2-oxazole The 4-keto-2-amino- 5- [l- (n3 睬 睬 -3-yl) ethyl] -2-doxazolin-4-one (300 mg) was dissolved in tetrahydrofuran (2 ml). Add triethylamine (344 liters) and aceton gas (123 μl) under ice cooling. The mixture was stirred at 0¾ for 2 hours. Add triethylamine (3 44 microliters) and aceton gas (123 Chel). All are stirred again. The paper size is in accordance with Chinese national standard (CNS > A4 size (210 X 297 mm) 107 3 922 1 464649 A7 B7. 5. Description of the invention (108) 2 hours. Add water to the reaction mixture, all with ethyl acetate. Extraction. The obtained extract was washed with a common salt solution and dried over magnesium sulfate. The solution was concentrated, and the obtained residue was subjected to silica gel chromatography, which was separated with hexane-propane (1: 1), collected and concentrated to obtain Title compound (40 mg). 1 Η-Η Μ ϋ (CDC 1 3 Μ: 1. 4 5 (1.92 Η, d, J = 7.2 Η z), 1. 57 (1 · 08 Η, d , J = 7. 2Ηζ), 2. 17 (6Η, s), 3.7-3.9 (1Η, β), 4.99 (0.36H, d, J = 2.4Hz), 5.07 (0.64H, d, J = 2.8Hz ), 7.0-7.4 (4H, m), 7. 6-7. 7 (1Η, a), 8.32 (1H, bs). Printed by the Central Standards Bureau of the Ministry of Economic Affairs, Industrial and Consumer Cooperatives (please read the back first) Please pay attention to this page before filling in this page) This paper size is applicable to Chinese National Standard (CNS) A1 2 3 specifications (2 410X596 mm) 108 39 22 1 1 ^ -NHRfCDCls) ^: 1.42 (1.95H, d, J '= 7.2 Hz), 2 1.62 (1.05H, d, J = 7.2Hz), 2.1-2.3 (3H, m), 3.88 (lH dq, J = 2.2 & 7.2Hz), 5.00 (0.35H, d, J = 2.2Hz) 3, 5.04 (0.6 5H, d, J = 2.2Hz), 7.0-7.4 (5H, m), 4 IR (KBr) cm " 7: 1 742, 1 69 8. 5 -Amino-5- [l- (n-preferred-3-yl) ethyl] zolam-4-_ (100 mg) is soluble in pyridine (0.5 ml). Add acetic anhydride (117 liters). Stir the mixture at 80 ° C for 2 hours. Add water to the reaction mixture. This mixture is acidified with 4N hydrochloric acid. The whole is extracted with ethyl acetate. The resulting extract is a common salt solution It was washed and dried over magnesium sulfate. The solution was concentrated, and the obtained residue was subjected to silica gel chromatography. It was isolated with hexane-acetone (1: 1), collected and concentrated to obtain the title compound (16 mg). 6. 67 (1H, d, J = 8.4Hz), 8.19 (lH, bs). 7 2-Ethylamino-5- [1- (great-3-yl) ethyl] -2-〇l -4-keto A7 464649 B7 V. Description of the invention (10 9) Test example 1 In vitro anti-percutaneous biological test: (Please read the precautions on the back before filling out this page) Pave the pylorus 蜾 蜾 榭 榭 榭 生物 biological: > Live 牛 external resistance to cattle 袢 测 测 Test using 5 kinds of Helicobacter pylori a strain, 19 other fine worms and 2 kinds of yeast Strains, anti thorough measurement of the biological activity of various compounds in accordance with the following methods (Ai aliphatic dilution). The test compound was dissolved in dimethyl isocyanate; this solution was slowly diluted twice with sterile distilled water to form a test sample. 2 ml of each test sample was mixed with 18 ml of Brucella agar supplemented with 7% horse blood as a culture medium to prepare a petri dish for measurement. Helicobacter pylori was aerated in S [] containing Campy PakTW (BBLR Beckton Dickinson Microbial System), and cultured with Brucella broth supplemented with 2.5% fetal bovine serum at 30¾ for 20 hours with shaking to form seed in oclan ). The other tested organisms were cultured in Brusella medium at 37t each: 20 hours of incubation to form inoculation bacteria. The Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs printed 5 liters of each inoculum, adjusted in advance to 106 CFU / ml with 2.5% fetal bovine serum supplemented with Brucella broth, and inoculated it into each measuring dish Inflated cylinders containing Campy PakTM and absorbent cotton absorbent were incubated at 37¾ for 4 days. After incubation, check the growth of the strain with the naked eye; when the sterile strain grows, the minimum concentration (minimum inhibitory concentration) of the test compound is used as the HIC value. 'The results are shown in Tables 2 and 3. This paper size applies to China National Standard (CNS) A4 (2I0X297mm) 109 3 92 2 1 464649 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (110) Table 2 133 丨 睬Anti-biological activity of Huimin on various withdrawn organisms [(MIC (Chek / ml)] 1 Escherichia coli K12 > 100 2 Escherichia coli IH J JC-2 > 100 3 Proteus mirabilis ATCC 21100 > 100 4 Common Proteus IF0 3045 > 100 5 Mogni Proteus IF0 3168 > 100 6 Pneumoniae IF0 3317 > 100 7 Serratia marcescens IF0 3046 > 100 8 Salmonella typhimurium IF0 1 252 9 > 100 9 Salmonella enteritidis IF0 3313 > 100 10 C. freundii IF0 1 268 1 > 100 11 Pseudomonas aeruginosa IF0 3080 > 100 12 Alkali-producing bacteria IF0 13111 > 100 13 Bacillus thuringiensis PCI 219 > 100 14 Bacillus saccharus IFO 3514 > 100 15 Bacillus pumilus IFO 3813 > 100 16 Bacillus macrobiosis IFO 12108 > 100 17 Golden yellow Staphylococcus FDA 209 P > 100 18 S. luteus IFO 1 27 0 8 12.5 19 S. flavus IFO 32 42 > 100 20 H. pylori NCTC 11637 0.006 21 Candida albicans IFO 05 8 3 > 100 22 Winemaking ntMf Yeast IFO 02 09 > 100 ΤΠΓ (Please read the back. Note before filling out this page) _ -e Γ
3 9 2 2T 本紙乐尺度適用中國國家操準(CNS ) A4规格(210X:297公釐) 4#^ 4#^ A7 B7 補充 464649 五、發明説明(111 表3對各種幽門螺桿菌之抗微生物活性(活_ mic 化辨I幽菌幽^^菌幽門螺桿菌幽門蝴#菌幽門 11637 11916 CPY433 TN2 TN58 吲哚徽素 0.006 0.013 0.013 0.006 0.025 N-去甲基 吲哚徽素+ 0.05 - 0.2 0.1 0,2 實施例2之 化細 0.025 - 0.05 0.025 0.05 實施例17 之化合物 0.78 - 1.56 0.78 3.13 實施例27之 第一個化合物 0.1 - 0.2 0.1 0.39 實施例28 之化合物 6.25 - 6.25 3,13 6.25 實施例29 之化合物 3.13 - 6.25 1.56 6.25 實施例30 之化合物 0.39 - 0.39 0.2 0.78 '請意事項再填寫本軍I}. 去甲基吲睬徽素之化學式:3 9 2 2T This paper scale is applicable to China National Standards (CNS) A4 specifications (210X: 297 mm) 4 # ^ 4 # ^ A7 B7 Supplement 464649 V. Description of the invention (111 Table 3 Anti-microbial of various Helicobacter pylori Activity (live mic identification of H. pylori H. pylori H. pylori H. pylori butterfly # H. pylori 11637 11916 CPY433 TN2 TN58 indolin 0.006 0.013 0.013 0.006 0.025 N-desmethylindolin + 0.05-0.2 0.1 0,2 Refinement of Example 2 0.025-0.05 0.025 0.05 Compound of Example 17 0.78-1.56 0.78 3.13 Compound of Example 27 0.1-0.2 0.1 0.39 Compound of Example 28 6.25-6.25 3,13 6.25 Implementation The compound of Example 29 3.13-6.25 1.56 6.25 The compound of Example 30 0.39-0.39 0.2 0.78 'Please fill in the matter of the army I}. Chemical formula of desmethylindoxin:
MeMe
Η Ν 瓊脂稀釋法,用補充7妬馬血之布魯斯拉瓊脂·®1 經濟部智慧財產局員工消費合作社印製 定M 1C值。 由表2及3知,化合物(I)對Μ幽們嫘桿菌為代表之 螺桿菌屬细菌,顯示極具選擇性之抗微生物活性。 試酴锎2 (活體内之抗微生物活性試驗) 蒙古沙鼠(raongoHan gerbils,MGS/Sea,雄性,6 週龄)禁食24小時後,幽門螺捍菌TK2dF4M每隻榮古沙鼠 用1〇7·08接種至其窗。感染11天後,受試化合物於5% 392 2 1 本紙張尺度適用中國國家標準(CNS ) A4規格(2i〇X297公釐)1 1 1 (修正頁) 4 6 4 6 49 a7 B7 五、發明説明】2) n& -* *--------- I.·. (請先閱讀背面之注意事項再填寫本頁) 甲基纖維素水溶液成3、10、30或100毫克/公斤之懸浮液, 經口投予,每夭2次(早晩),計3天。最後一日投藥之後, 各隻經感染之蒙古沙鼠之肩予Μ切除及破裂;胃均質物之 連續10倍稀釋液各接種至補充活性碳之經改良的斯克洛氏 .(S k i r r ο ν ’ s )培養基,於3 7 t微量需氧條件下培育4天, 然後,基於细菌之有無生長評定清除效果。結果示於表4 。經與對照組之鄧氏試驗(Dunnett's test)後,细菌细胞 .計數K平均值土標準偏差表示。於表4中,^指p < 0 . 0 1。 表4 受試化合物 劑量 (毫克/公斤) 清除率 (96) 细菌偵測值 (log/CFU/胃壁) 對照組(0.5%甲基纖維素溶液) - 0/4( 0) 6.36士0.19 吲睬徽素 3 0/5(0) 4.61士1.84 10 0/5(0) 2.76±l,04ss 30 1/4(25) 1.96士0,783^ 100 4/5(80) 1,48士O.OO** 由表4知,吲睬徽素 於10毫克 /公斤以 上會使蒙古沙 經濟部智慧財產局員工消費合作社印製 鼠冑部細菌细胞計數隨劑量依賴性降低,而所得之清除率 於3 0毫克/公斤為2 5 % ,而於1 0 0毫克公斤為8 0 %。 由此等發現證明,本發明製劑對由幽門螺桿菌感染引 靼之周潰瘍、罵炎及胃癌均有效。 試驗例:¾ (活體内之抗微生物活性試驗) 本紙張尺度適用中國國家標準(CNS ) A4规格(2!0X297公釐) 112(修正頁)3922 1 I ------------—---464649 A7 B7 五、發明説明 1 1 1 (請先閲讀背面之注意事項再填寫本頁)Η Ν Agar dilution method. M 1C value was printed with Bruce La Agar supplemented with 7 jealous horse blood · 1 Employee Cooperative of Intellectual Property Bureau of Ministry of Economic Affairs. It is known from Tables 2 and 3 that the compound (I) shows extremely selective antimicrobial activity against Helicobacter bacteria represented by M. pylori. Test 2 (in vivo antimicrobial activity test) Mongolian gerbils (raongoHan gerbils, MGS / Sea, male, 6 weeks old) After fasting for 24 hours, Helicobacter pylori TK2dF4M was used per Ronggu gerbil. 7.08 inoculation to its window. After 11 days of infection, the test compound was at 5%. 392 2 1 This paper size applies the Chinese National Standard (CNS) A4 specification (2 × 297 mm) 1 1 1 (correction page) 4 6 4 6 49 a7 B7 V. Invention Explanation] 2) n &-* * --------- I. ·. (Please read the precautions on the back before filling in this page) Methyl cellulose aqueous solution becomes 3, 10, 30 or 100 mg / A kilogram of suspension is administered orally, twice a day (early morning), for 3 days. After the last day of administration, the shoulders of each infected Mongolian gerbil were resected and ruptured; a 10-fold serial dilution of the gastric homogenate was inoculated into modified Scroox supplemented with activated carbon. (Skirr ο ν The culture medium was cultured for 4 days under 37 a trace aerobic conditions, and then the removal effect was evaluated based on the presence or absence of bacteria growth. The results are shown in Table 4. After Dunnett's test with the control group, the mean K value of the bacterial cells was expressed as the standard deviation. In Table 4, ^ means p < 0.01. Table 4 Test compound dosage (mg / kg) Clearance (96) Bacterial detection value (log / CFU / gastric wall) Control group (0.5% methyl cellulose solution)-0/4 (0) 6.36 ± 0.19 indole Huisu 3 0/5 (0) 4.61 ± 1.84 10 0/5 (0) 2.76 ± l, 04ss 30 1/4 (25) 1.96 ± 0,783 ^ 100 4/5 (80) 1,48 ± O.OO * * From Table 4, it is known that indoxin above 10 mg / kg will cause the bacterial cell count of the rat crotch printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs of Mongolia to decrease in a dose-dependent manner, and the resulting clearance rate is 30. Mg / kg is 25%, while 100 mg / kg is 80%. These findings prove that the preparation of the present invention is effective against peripheral ulcers, inflammation, and gastric cancer caused by Helicobacter pylori infection. Test example: ¾ (in vivo antimicrobial activity test) The paper size is applicable to the Chinese National Standard (CNS) A4 specification (2! 0X297 mm) 112 (correction page) 3922 1 I ---------- ------ 464649 A7 B7 V. Description of the invention 1 1 1 (Please read the precautions on the back before filling this page)
Isf 古沙鼠(mongolian gerbils, MON/Jms/Gb.s,雄性, 5週齡)禁食24小時後,幽門螺桿菌TN2GF4M每隻蒙占沙鼠 用1〇7·56接種至其胃。感染11天後,受試化吾物於0.5% 甲基纖維素水溶液成50毫克/公斤之懋浮液,經口投予, 每天2次(早晩),計2天。最後一日於投藥之後,各隻經 感染之緊古沙鼠之琦予以切除及破裂;胄均質物之連績1〇 倍稀釋液各接種至補充活性碳之經改良的斯克洛氏 (Skirrow’s)培養基,於37υ微量需氧條件下培育5天, 然後,基於细菌之有無生長評定清除效果。結果示於表5 經與對照組之鄙氏試驗([)unnett’s test)後,细菌细胞 計數Μ平均值士搮準偏差表示。於表5中,ss指p<〇 〇1。 表5 受試化合物 劑量 (毫克/公斤) 清除率 (96) 细菌偵測值 (log/CFU/胃壁) 對照組(0.5%甲基纖維素溶液) N-去甲基吲睬徽索 50 0/4( 0) 0/4( 0) 6.21±0.06 2.13±0.22 料 _I本 經濟部智慧財產局員工消費合作社印製 由表5知,N-去甲基吲睐徽素於50毫克/公斤Μ上會 使蒙古沙鼠胃部细菌细胞計數顯著降低。 由此等發現證明,本發明製劑對由幽門螺稈菌感染引 起之搏潰瘍、琦炎及胃癌均有效。 (活體内之抗微生物活性試驗) 小鼠(Cr i : ICR ,雄性,5週龄)禁食20小時後.幽門螺 紙張尺度適用中國國家標準(CNS > A4規格(2ΙΟΧ29ϋ )~1 1 2 - 1 ( ^ iE Η ) 39221 4 6 4 649Isf ancient gerbils (mongolian gerbils, MON / Jms / Gb.s, male, 5 weeks old) were fasted for 24 hours, and each Mongolian gerbil of Helicobacter pylori TN2GF4M was inoculated to its stomach with 10.56. After 11 days of infection, the test compound was dissolved in a 0.5% methylcellulose aqueous solution into a 50 mg / kg tincture floating solution and administered orally, twice a day (early mucus) for 2 days. After the last day of administration, each infected tight gerbil rat was removed and ruptured; a 10-fold dilution of the homogenate homogenate was inoculated into modified Skrowrow's supplemented with activated carbon. The culture medium was cultured for 5 days under 37 a microaerobic conditions, and then the removal effect was evaluated based on the presence or absence of bacteria growth. The results are shown in Table 5. The mean value of the bacterial cell count and the standard deviation were shown after the unnett's test with the control group. In Table 5, ss refers to p < 0.01. Table 5 Test compound dose (mg / kg) Clearance (96) Bacterial detection value (log / CFU / gastric wall) Control group (0.5% methylcellulose solution) N-desmethylindoxin 50 50 / 4 (0) 0/4 (0) 6.21 ± 0.06 2.13 ± 0.22 Material _I Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, as shown in Table 5, N-desmethylindene favors emblematin at 50 mg / kg M The above results in a significant reduction in Mongolian gerbil's stomach bacterial cell count. These findings prove that the preparation of the present invention is effective against stroke ulcer, qi inflammation and gastric cancer caused by Helicobacter pylori infection. (In vivo antimicrobial activity test) Mice (Cr i: ICR, male, 5 weeks old) fasted for 20 hours. Pylori paper size applies Chinese national standard (CNS > A4 size (2ΙΟχ29ϋ) ~ 1 1 2 -1 (^ iE Η) 39221 4 6 4 649
稈菌TN2GP4M每隻小鼠用108‘〇5接種至其冑。感染11 (請先聞讀背面之注意事項再填寫本頁) 天後,受試化合物於0.5%甲基纖維素水溶液成50毫克/公 斤之懸浮液,經口投予,每天2次(早晚),計2天。最後 一日於投藥之後,各隻經感染之小鼠之胃予以切除及破裂 胃均質物之連缄10倍稀釋液各接種至補充活性碳之經改 .良的斯克洛氏(Skirrov’s)培養基t於〗1/^微量需氧條件 下培育4天,然後,基於细菌之有無生長評定清除效果。 結果示於表6。經與對照組之鄧氏.試驗(Dunnett’s test) 後,细菌細胞計數以平均值士標準偏差表示。於表6中, s:s:指 ρ<0·01 0 表6 受試化合物 劑量 (毫克/公斤) 淸除率 已淸除/總計 (%) 細菌偵測値 (log/CFU/胃壁) 對照組 (0.25%甲基纖維素溶液) - 0/4 (0) 4.73± 0.18 實施例3之第1種化雜 50 0/4⑼ 2.94± 1.21** 實施例3之第5種化合物 50 1/4 (25) 2.43± 0.78** 實施例3之第6種化合物 50 0/4 (0) 1.96± 0.16** _組 (0.25%甲基纖維素溶液) - 0/4 (0) 4.55+ 0.46 實施例3之第2種化飾 50 0/4⑼ 2.55+ 0.75** 實施例3之第3種化合物 50 0/4⑼ 2.79+ 0.55** 實施例3之第4種化合物 50 0/4 (0) 2.74± 0.64** 經濟部智慧財產局員工消費合作社印製 製劑例 為用作幽門螺桿菌感染之治療劑,含化學式(I)之化 合物或其鹽的本發明製劑,可依下述配方製得之。 1 .膠囊劑__ 112-2(修正頁) 39 22 1 本紙張尺度適用中國國家標準(CNS) Α4規格(210Χ297公釐) A7 B7 五、發明説明(113) (1) B§|睬徽素 (2) 乳糖 (3) 微晶纖維素 (4) 硬脂酸鎂 總量 100毫克 90毫克 70毫克 10毫克 每顆膠嚢劑270毫克 成分(1)、 (2)及(3)及半份成分(4)予以混合後造粒。 於此等顆粒中,加剩餘部分之成分(4),全部混合物裝入 明膠膠囊而成。 2.錠劑 (1)吲睬徽素 (2) 乳糖 (3) 玉米澱粉 (4 )撤晶缫雄素 (5 )硬脂酸鎂 總量 100毫克 35毫克 150毫克 30毫克 5毫克 每顆錠劑3 2 0毫克 成分(1)、 (2)及(3)、2/3份成分(4)及半份成分(5)予 以混合後造粒。於此等顆粒中,加剩餘部分之成分(4)及( (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 劑 錠 成 製 以 予 法 錠 裂 縮 壓 經 物 I 合 W 混件物 部用合 全刹化 :業·5¾. 屬 菌 捍 螺 之 表 代 為 菌 桿 螺 門 幽 以 對 鹽 其 或 物 合 化 之 明 發 本 〇 性 活 菌 細 抗 之 效 有 別 特 極 示 顯 菌 細 遠 量 劑 之 用 所 I 效 想 理 之 劑 菌 稈 螺 門 幽 抗 達 鹽 其 或 劑 菌 細 抗 知 習 之 \»/ 菌 桿 螺 門 是 另 特 /IV 菌 細 靥 Ο 菌低 桿量 螺劑 於效 用有 比之 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X297公釐) 113 3 92 2 1 經濟部中央標準局負工消費合作社印裝 :6 4 9 A7 B7 五、發明説明14) 化合物(I)或其鹽用於預防或治療各種由螺桿菌羼細 菌引起之疾病如十二指腸潰瘍、胃潰瘍、慢性胃炎及胄癌 等均有效,而且,由於幽門螺捍菌為潰瘍愎發症之主因, 因此,化合物(I)或其鹽用於預防潰瘍復發症亦有效。 此外,化合物(I)或其鹽對格黼氏陽性細菌如蕕萄球 菌屬(Staphy lococcus)及穿孢桿菌颶(Bacillus)細菌, 及格蘭氏陰性細菌如埃希氏菌鼷(Escherichia)、假單孢 菌屬(Pseudomonas)、變形菌颶(Proteus)、克雷白桿菌屬 (Klebsiella)、沙雷氏菌屬(Serratia)、沙門氏菌屬 (Salmonella)、檸稼酸桿菌靥(Citrobacter)及産驗桿菌 靥(Alcaligenes)細菌,均無抗細菌作用。因此,化合物 (I)或其鹽用於預防或治療由螺桿菌羼細菌引起之疾病具 選擇性效果,對其他細菌及真菌幾無影響,可用作無不良 作用之安全發藥。 化合物(I)或其鹽具穩定性且毒性低徹。於是,本發 明乃提供一種無不良作用之優異抗幽門螺桿菌劑。 (請先閲讀背面之注意事項再填寫本頁)The stalk fungus TN2GP4M was inoculated to each mouse with 108'05. Infection 11 (Please read the precautions on the reverse side before filling out this page) Days later, the test compound is administered as a 50 mg / kg suspension in 0.5% methylcellulose aqueous solution and administered orally, twice a day (morning and evening) For 2 days. After the last day of administration, the stomachs of each infected mouse were excised and a 10-fold dilution of the flail homogenate was inoculated into the modified supplemented activated carbon. Good Skirrov's medium t Incubate for 4 days under 1 / ^ trace aerobic conditions, and then evaluate the removal effect based on the presence or absence of bacteria growth. The results are shown in Table 6. After Dunnett's test with the control group, the bacterial cell count was expressed as the mean ± standard deviation. In Table 6, s: s: refers to ρ < 0 · 01 0 Table 6 Test compound dose (mg / kg) Elimination rate has been eliminated / total (%) Bacterial detection (log / CFU / stomach wall) Control Group (0.25% methylcellulose solution)-0/4 (0) 4.73 ± 0.18 The first compound of Example 3 50 0 / 4⑼ 2.94 ± 1.21 ** The fifth compound of Example 3 50 1/4 (25) 2.43 ± 0.78 ** The sixth compound of Example 3 50 0/4 (0) 1.96 ± 0.16 ** _group (0.25% methyl cellulose solution)-0/4 (0) 4.55+ 0.46 implementation The second chemical decoration of Example 3 50 0 / 4⑼ 2.55+ 0.75 ** The third compound of Example 3 50 0 / 4⑼ 2.79+ 0.55 ** The fourth compound of Example 3 50 0/4 (0) 2.74 ± 0.64 ** Examples of preparations printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs are used as a therapeutic agent for Helicobacter pylori infection. The preparation of the present invention containing a compound of formula (I) or a salt thereof can be prepared according to the following formula . 1. Capsules __ 112-2 (correction page) 39 22 1 This paper size applies to Chinese National Standards (CNS) A4 specifications (210 × 297 mm) A7 B7 V. Description of the invention (113) (1) B§ | 睬 emblem (2) Lactose (3) Microcrystalline cellulose (4) Total magnesium stearate 100 mg 90 mg 70 mg 10 mg Per capsule tincture 270 mg Ingredients (1), (2) and (3) and half The ingredients (4) are mixed and granulated. To these granules, the remaining component (4) is added, and the whole mixture is filled into gelatin capsules. 2. Lozenges (1) indigoxin (2) lactose (3) corn starch (4) scopolamine androgen (5) total magnesium stearate 100 mg 35 mg 150 mg 30 mg 5 mg per tablet Agent 3 20 mg of ingredients (1), (2) and (3), 2/3 parts of ingredient (4) and half of ingredient (5) are mixed and granulated. In these granules, add the rest of the ingredients (4) and ((Please read the precautions on the back before filling this page) Order the printed tablets of the Consumer Cooperatives of the Central Standard Bureau of the Ministry of Economic Affairs to produce tablets for the French tablets Jingwu I and W mixed parts are used in the entire brake department: industry · 5¾. The genus Bacteria is replaced by the sclerotium snail, which is resistant to salt or the combination of bright hair and natural viable bacteria. It is effective to show the bacteria's fine and long-distance dosage. I It is a rational agent. The stalk spirulina anti-drug salt or the bacterial bacterial resistance is known. Bacterium sclerotiorum bacillus snail agent is effective in proportion to the size of the paper. Applicable to China National Standard (CNS) A4 (2! 0X297 mm) 113 3 92 2 1 Printed by the Consumers ’Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs : 6 4 9 A7 B7 V. Description of the invention 14) Compound (I) or a salt thereof is effective for preventing or treating various diseases caused by Helicobacter pupae bacteria such as duodenal ulcer, gastric ulcer, chronic gastritis, and pimple cancer, and, Due to pylorus Bacteria main cause of the ulcer complications Buc, therefore, compound (I) or a salt thereof for preventing the recurrence of ulcer disease is also effective. In addition, the compound (I) or a salt thereof is effective against Gram-positive bacteria such as Staphy lococcus and Bacillus bacteria, and Gram-negative bacteria such as Escherichia, False Pseudomonas, Proteus, Klebsiella, Serratia, Salmonella, Citrobacter, and production test Alcaligenes bacteria have no antibacterial effect. Therefore, the compound (I) or a salt thereof has a selective effect for preventing or treating a disease caused by Helicobacter pupae bacteria, has little effect on other bacteria and fungi, and can be used as a safe medicine without adverse effects. Compound (I) or a salt thereof is stable and has low toxicity. Therefore, the present invention provides an excellent anti-Helicobacter pylori agent without adverse effects. (Please read the notes on the back before filling this page)
本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐) 114 392 2 1This paper size applies to Chinese national standards (CNS > A4 size (210X297 mm) 114 392 2 1
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2516297 | 1997-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW464649B true TW464649B (en) | 2001-11-21 |
Family
ID=12158329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW86114531A TW464649B (en) | 1997-02-07 | 1997-10-04 | Oxazolone derivatives and their use |
Country Status (2)
Country | Link |
---|---|
ID (1) | ID20518A (en) |
TW (1) | TW464649B (en) |
-
1997
- 1997-10-04 TW TW86114531A patent/TW464649B/en not_active IP Right Cessation
- 1997-12-24 ID IDP973976A patent/ID20518A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ID20518A (en) | 1999-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0866793B1 (en) | Nitroimidazole antibacterial compounds and methods of use thereof | |
US10858360B2 (en) | Tricyclic gyrase inhibitors | |
US5441955A (en) | Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof | |
EP0839040B1 (en) | Use of cgmp-phosphodiesterase inhibitors to treat impotence | |
TWI491591B (en) | Indole compounds and pharmaceutical use thereof | |
TW420663B (en) | Indole compounds for cyclic nucleotide-PDEs inhibitors | |
US6169102B1 (en) | Oxazolone derivatives and their use as anti-Helicobacter pylori agent | |
CN101528711A (en) | Hydantoin derivatives useful as antibacterial agents | |
KR20170132316A (en) | Heterocyclic compounds and their use in the prevention or treatment of bacterial infections | |
US6087358A (en) | Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof | |
EP0923577A2 (en) | Oxazolone derivatives and their use as anti-helicobacter pylori agent | |
MX2007015347A (en) | Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors. | |
TW464649B (en) | Oxazolone derivatives and their use | |
US6476062B2 (en) | Chemokine receptor antagonists | |
PL180278B1 (en) | Imidazopyridine azolydinones | |
WO2000077003A1 (en) | Optically active pyrrolopyridazine compounds | |
US5298523A (en) | Method for treating transplant patients using mycalamide compounds | |
US5367078A (en) | 3-oxadiazolyl-1,6-naphthyridine derivatives | |
JP2911956B2 (en) | 5,11-Dihydro-6H-pyrido [2,3-b] [1,4] benzodiazepin-6-one and -thione and methods of using such compounds in the prevention or treatment of AIDS | |
US20090270379A1 (en) | Quinolone derivatives useful as antibacterial agents | |
US4761414A (en) | Substituted 1H-pyrimido[1,2-a-]-pyrido[3,4-e]pyrazine 6 oxides | |
JPH09183764A (en) | N-benzoylproline ester derivative | |
US4666922A (en) | Method for modulating the immune response | |
JPH0848629A (en) | Pyridonecarboxylic acid derivative and anti-pylori agent with the same as active ingredient | |
JP3305985B2 (en) | Anti-Helicobacter pylori agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |